data_6qfp_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6qfp _Structure_validation_residue.Date_analyzed 2019-04-05 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 . . . . . 0 CA--C 1.495 -1.159 0 CA-C-O 118.391 -0.814 . . . . 0.0 112.725 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.23 136.57 58.0 Favored 'General case' 0 C--O 1.252 1.233 0 O-C-N 125.983 2.052 . . . . 0.0 111.307 164.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.77 142.14 23.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 CA-C-N 113.209 -1.814 . . . . 0.0 112.967 -168.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.8 p -138.98 178.29 7.27 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 -175.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -63.79 -44.91 91.93 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 122.382 1.087 . . . . 0.0 110.413 174.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.15 78.96 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 120.351 -1.468 . . . . 0.0 113.633 172.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -66.94 -43.0 84.31 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-O 117.752 -1.118 . . . . 0.0 112.018 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.7 tp -61.59 -35.98 79.37 Favored 'General case' 0 CA--C 1.582 2.192 0 CA-C-N 120.613 1.551 . . . . 0.0 113.83 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.3 . . 79.02 32.49 0.27 Allowed 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.715 -1.241 . . . . 0.0 112.074 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -156.12 157.96 36.9 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -175.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.9 mt -50.32 127.41 17.22 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 174.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -64.52 124.04 84.78 Favored Pre-proline 0 CA--C 1.567 1.607 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.433 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -99.1 0.76 1.01 Allowed 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.953 2.435 . . . . 0.0 113.5 -159.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 mt -130.91 167.84 18.31 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.2 p -89.6 1.85 55.45 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.7 160.49 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.24 -1.537 . . . . 0.0 111.626 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -77.27 174.36 10.85 Favored 'General case' 0 CA--C 1.561 1.387 0 O-C-N 120.278 -1.514 . . . . 0.0 112.424 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -53.98 140.19 31.95 Favored 'General case' 0 CA--C 1.6 2.887 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.92 -150.29 5.33 Favored Glycine 0 C--N 1.368 2.309 0 C-N-CA 127.877 2.656 . . . . 0.0 115.001 -166.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.3 m -127.58 146.7 50.44 Favored 'General case' 0 C--N 1.364 1.217 0 O-C-N 125.492 1.348 . . . . 0.0 107.821 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.3 pt -115.79 145.69 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 C-N-CA 127.307 2.243 . . . . 0.0 109.699 167.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -147.46 141.21 25.68 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-O 122.473 1.13 . . . . 0.0 111.803 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 62.0 m -88.99 138.23 31.6 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.3 mt -120.32 155.26 56.32 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.257 33.5 Cg_exo -40.67 134.88 2.21 Favored 'Trans proline' 0 N--CA 1.523 3.207 0 N-CA-C 121.804 3.732 . . . . 0.0 121.804 174.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.385 52.9 m 79.59 50.19 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.08 1.352 . . . . 0.0 110.497 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 46.32 44.16 12.29 Favored 'General case' 0 C--N 1.366 1.324 0 CA-C-N 112.456 -2.156 . . . . 0.0 112.365 173.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -96.24 145.38 25.61 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-N 118.964 0.802 . . . . 0.0 110.667 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.71 130.03 51.63 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.0 m -119.47 157.18 21.64 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.798 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -130.39 137.89 50.1 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 102.641 -3.096 . . . . 0.0 102.641 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.0 t -126.57 119.31 53.34 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.76 164.25 2.3 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 171.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.58 -12.21 30.97 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 CA-C-O 114.703 -2.29 . . . . 0.0 114.456 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -90.57 -1.57 57.88 Favored 'General case' 0 C--N 1.367 1.34 0 CA-C-N 120.723 1.601 . . . . 0.0 113.478 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.62 -1.07 42.42 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-O 116.159 -2.467 . . . . 0.0 112.73 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.2 m -79.57 120.18 23.57 Favored 'General case' 0 C--N 1.366 1.314 0 CA-C-N 121.706 2.753 . . . . 0.0 112.899 -171.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.7 m -83.8 130.32 34.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.769 175.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -124.43 162.61 23.53 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.95 1.7 . . . . 0.0 111.743 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.54 129.99 34.98 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 169.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.4 tp -95.46 -45.71 6.98 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 116.89 -1.528 . . . . 0.0 109.43 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -105.95 164.31 12.06 Favored 'General case' 0 C--N 1.368 1.404 0 CA-C-O 122.796 1.284 . . . . 0.0 108.925 174.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -56.62 -36.88 69.95 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 125.637 1.575 . . . . 0.0 112.658 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -60.57 -44.93 95.63 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.572 1.149 . . . . 0.0 111.332 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.95 -37.4 84.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.573 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -71.05 -42.41 69.48 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 118.792 -0.623 . . . . 0.0 110.283 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -55.87 -35.63 66.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 167.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.38 -34.05 77.1 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 116.982 -1.485 . . . . 0.0 114.306 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.48 5.91 6.95 Favored Glycine 0 N--CA 1.504 3.232 0 CA-C-N 120.873 1.67 . . . . 0.0 112.144 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -80.15 130.89 64.42 Favored Pre-proline 0 CA--C 1.565 1.549 0 CA-C-O 118.172 -0.918 . . . . 0.0 108.891 170.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -64.4 148.92 90.85 Favored 'Trans proline' 0 N--CA 1.526 3.419 0 N-CA-C 119.805 2.964 . . . . 0.0 119.805 -168.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -46.49 145.45 6.13 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 N-CA-C 115.031 1.127 . . . . 0.0 115.031 172.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.1 tt -97.06 11.21 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 118.029 -1.468 . . . . 0.0 109.378 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 17.4 p -63.92 -36.45 20.91 Favored Pre-proline 0 N--CA 1.415 -2.206 1 CA-C-O 110.566 -4.54 . . . . 0.0 117.017 -174.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.99 -19.59 22.96 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 125.421 2.972 . . . . 0.0 111.264 -167.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.4 pt -104.97 21.61 3.3 Favored 'Isoleucine or valine' 0 C--N 1.36 1.049 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -175.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.92 139.11 58.09 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 125.555 1.785 . . . . 0.0 113.15 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -96.97 129.73 44.39 Favored 'General case' 0 C--N 1.365 1.262 0 C-N-CA 126.385 1.874 . . . . 0.0 115.145 170.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -81.16 150.91 28.48 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 114.864 -1.062 . . . . 0.0 113.417 166.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.23 176.06 54.33 Favored Glycine 0 CA--C 1.544 1.856 0 O-C-N 125.897 1.998 . . . . 0.0 113.609 163.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.9 m -63.45 146.43 53.62 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 121.037 2.419 . . . . 0.0 116.728 163.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 56.83 24.9 51.04 Favored Glycine 1 C--N 1.4 4.1 0 C-N-CA 126.562 2.029 . . . . 0.0 111.613 -164.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.57 -163.17 51.32 Favored Glycine 0 CA--C 1.551 2.301 0 C-N-CA 127.488 2.47 . . . . 0.0 117.688 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.5 133.08 3.86 Favored Glycine 0 C--N 1.37 2.421 0 CA-C-N 118.967 1.383 . . . . 0.0 111.326 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -79.12 149.95 31.9 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 122.186 0.993 . . . . 0.0 109.89 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 20.5 mm -89.46 147.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 114.649 -1.159 . . . . 0.0 111.576 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.0 t -75.0 147.31 40.88 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.3 mt -96.36 21.0 9.63 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 113.154 -1.839 . . . . 0.0 111.947 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.59 -47.12 5.24 Favored Glycine 0 CA--C 1.499 -0.958 0 CA-C-O 118.291 -1.283 . . . . 0.0 115.804 -168.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.43 93.24 Favored 'General case' 0 N--CA 1.44 -0.926 0 O-C-N 126.954 2.208 . . . . 0.0 109.106 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.4 tp -67.15 -44.36 79.97 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 124.156 0.982 . . . . 0.0 110.985 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.2 tp -61.92 -54.78 37.19 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.846 0.858 . . . . 0.0 110.197 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.0 p -56.52 -44.7 81.03 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.65 0.594 . . . . 0.0 110.588 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.7 m -63.02 -39.74 95.66 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.463 1.105 . . . . 0.0 110.797 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.6 m -62.96 -37.23 86.29 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 115.426 -2.226 . . . . 0.0 114.27 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 35.6 mt -88.39 -19.26 26.84 Favored 'General case' 0 C--N 1.383 2.043 0 CA-C-N 121.019 1.736 . . . . 0.0 114.272 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -61.6 -41.12 96.98 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.125 -0.984 . . . . 0.0 110.782 161.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.7 mt -61.04 -43.27 99.14 Favored 'General case' 0 C--N 1.374 1.669 0 O-C-N 124.92 1.387 . . . . 0.0 110.587 -173.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 25.5 p -101.62 27.76 6.12 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.674 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.199 -2.061 0 C-N-CA 126.352 1.929 . . . . 0.0 115.137 175.803 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -90.91 126.62 36.11 Favored 'General case' 0 C--N 1.379 1.879 0 CA-C-O 123.28 1.514 . . . . 0.0 110.023 162.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 tp -115.74 138.02 47.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 127.792 2.437 . . . . 0.0 111.334 -169.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.2 p -131.51 164.55 25.55 Favored 'General case' 0 C--N 1.38 1.894 0 O-C-N 125.725 1.891 . . . . 0.0 111.069 -168.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.78 -43.02 72.45 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 117.102 -3.499 . . . . 0.0 113.104 170.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.08 85.54 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 125.659 1.85 . . . . 0.0 110.869 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -81.38 -18.38 45.73 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.7 tp -74.05 -27.83 61.11 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 119.762 -1.836 . . . . 0.0 107.497 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 66.22 39.37 4.21 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 130.514 3.526 . . . . 0.0 112.433 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -167.67 -161.95 0.42 Allowed 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.5 mt -64.33 126.79 28.91 Favored 'General case' 0 C--O 1.208 -1.112 0 C-N-CA 128.246 2.619 . . . . 0.0 111.452 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -80.94 113.95 44.67 Favored Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.87 9.96 2.79 Favored 'Trans proline' 0 C--N 1.291 -2.482 0 C-N-CA 124.106 3.204 . . . . 0.0 113.894 -171.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.0 mt -131.29 151.45 51.49 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 124.884 1.365 . . . . 0.0 112.636 -171.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.6 p -75.13 -35.85 61.65 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.71 -1.244 . . . . 0.0 110.992 172.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.4 m -75.13 156.13 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.774 0 C-N-CA 118.29 -1.364 . . . . 0.0 114.308 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -87.87 164.71 15.74 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 126.579 3.085 . . . . 0.0 107.837 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -24.3 118.76 0.05 OUTLIER 'General case' 0 N--CA 1.524 3.233 0 C-N-CA 130.25 3.42 . . . . 0.0 115.967 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -135.98 177.52 19.46 Favored Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 104.84 -3.304 . . . . 0.0 104.84 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 m -71.57 145.06 49.3 Favored 'General case' 0 C--N 1.363 1.155 0 O-C-N 127.025 2.25 . . . . 0.0 115.58 170.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 pt -116.86 135.3 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 118.689 -2.507 . . . . 0.0 105.981 168.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -155.98 146.75 22.04 Favored 'General case' 0 C--O 1.191 -1.999 0 C-N-CA 125.083 1.353 . . . . 0.0 109.924 -168.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 96.4 m -107.25 151.0 26.04 Favored 'General case' 0 C--N 1.381 1.956 0 C-N-CA 125.819 1.648 . . . . 0.0 107.886 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.0 mt -127.02 156.84 73.66 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-N 114.233 -1.348 . . . . 0.0 107.689 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -45.06 144.85 3.56 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 N-CA-C 118.971 2.643 . . . . 0.0 118.971 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t 73.94 41.43 0.41 Allowed 'General case' 0 C--N 1.366 1.3 0 C-N-CA 128.105 2.562 . . . . 0.0 111.37 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 67.64 26.77 7.89 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 119.272 3.064 . . . . 0.0 119.272 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -90.05 135.29 33.74 Favored 'General case' 0 N--CA 1.508 2.464 0 C-N-CA 127.752 2.421 . . . . 0.0 111.466 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.07 140.42 52.29 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 113.174 -1.83 . . . . 0.0 111.825 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.49 153.94 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 -168.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -116.63 118.58 33.0 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 127.234 2.214 . . . . 0.0 106.564 170.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.1 t -101.0 107.74 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.825 0 O-C-N 118.104 -2.873 . . . . 0.0 108.141 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.68 158.55 59.32 Favored Pre-proline 0 N--CA 1.432 -1.354 0 CA-C-N 113.117 -1.856 . . . . 0.0 114.348 -176.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -42.99 -28.22 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 125.21 3.94 . . . . 0.0 115.701 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 59.3 p30 -100.65 8.28 43.46 Favored 'General case' 0 C--O 1.26 1.639 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.46 7.09 82.85 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 116.416 -2.324 . . . . 0.0 117.872 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.2 m -81.07 119.71 23.89 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 123.434 3.617 . . . . 0.0 109.658 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.2 m -92.09 91.86 7.99 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -171.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -70.34 141.51 52.26 Favored 'General case' 0 C--O 1.202 -1.399 0 O-C-N 119.72 -1.863 . . . . 0.0 114.796 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.48 108.52 3.81 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.757 -1.116 . . . . 0.0 110.827 170.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.5 tp -92.84 -8.76 42.58 Favored 'General case' 0 C--O 1.251 1.159 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -135.42 171.31 14.63 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 123.94 1.829 . . . . 0.0 108.75 166.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -67.29 -39.05 85.95 Favored 'General case' 0 CA--C 1.571 1.783 0 O-C-N 118.048 -2.907 . . . . 0.0 109.467 -170.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -58.47 -42.64 87.94 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.057 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . 0.348 . . -51.86 -44.95 63.89 Favored 'General case' 0 C--N 1.37 1.493 0 CA-C-O 125.441 2.543 . . . . 0.0 114.387 170.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -69.42 -42.36 75.11 Favored 'General case' 0 CA--C 1.579 2.091 0 O-C-N 117.281 -3.387 . . . . 0.0 110.974 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -62.08 -35.66 79.33 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 128.165 2.586 . . . . 0.0 113.524 170.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.26 -16.93 58.78 Favored 'General case' 0 CA--C 1.568 1.67 0 O-C-N 121.084 -1.01 . . . . 0.0 110.163 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.0 33.82 4.2 Favored Glycine 0 CA--C 1.487 -1.68 0 N-CA-C 117.939 1.935 . . . . 0.0 117.939 173.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -80.08 154.17 74.92 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-N 118.881 1.34 . . . . 0.0 110.308 165.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -43.58 129.71 6.94 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 124.511 3.474 . . . . 0.0 118.716 164.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.42 142.41 58.48 Favored 'Trans proline' 0 N--CA 1.428 -2.378 0 C-N-CA 123.711 2.94 . . . . 0.0 110.989 169.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.9 tt -90.84 -0.78 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 C-N-CA 125.605 1.562 . . . . 0.0 109.42 -173.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 52.5 m -41.89 -65.72 0.48 Allowed Pre-proline 0 C--N 1.38 1.906 1 CA-C-O 111.203 -4.237 . . . . 0.0 120.153 170.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -70.62 -6.61 19.43 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 125.589 3.032 . . . . 0.0 118.551 -170.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 5.2 pt -107.21 8.05 9.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 122.324 2.329 . . . . 0.0 113.208 165.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -64.73 126.29 27.47 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 123.066 2.666 . . . . 0.0 113.096 169.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.73 144.09 57.48 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.575 1.172 . . . . 0.0 110.179 171.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -80.98 154.68 26.81 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.185 -1.572 . . . . 0.0 113.497 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -84.06 -174.39 50.33 Favored Glycine 0 CA--C 1.501 -0.824 0 CA-C-O 124.331 2.073 . . . . 0.0 113.701 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.5 t -102.06 139.96 36.98 Favored 'General case' 0 CA--C 1.59 2.494 0 O-C-N 118.126 -2.985 . . . . 0.0 105.604 166.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.43 35.87 21.9 Favored Glycine 0 CA--C 1.502 -0.736 0 O-C-N 118.809 -2.432 . . . . 0.0 111.97 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.27 -170.12 12.61 Favored Glycine 1 CA--C 1.58 4.11 0 CA-C-N 117.885 0.843 . . . . 0.0 114.738 -165.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.61 -179.3 49.24 Favored Glycine 0 C--N 1.361 1.929 0 N-CA-C 120.407 2.923 . . . . 0.0 120.407 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -122.07 154.12 37.75 Favored 'General case' 0 N--CA 1.509 2.491 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.4 mm -79.89 117.08 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 C-N-CA 125.081 1.352 . . . . 0.0 110.292 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.8 t -58.23 135.75 57.17 Favored 'General case' 0 CA--C 1.585 2.294 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.6 mt -92.25 10.52 29.24 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 124.763 1.225 . . . . 0.0 113.726 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.14 -53.72 29.57 Favored Glycine 0 N--CA 1.488 2.118 0 CA-C-O 123.832 1.795 . . . . 0.0 114.004 170.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.73 85.7 Favored 'General case' 0 CA--C 1.546 0.816 1 O-C-N 115.255 -4.674 . . . . 0.0 113.959 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.4 tp -64.29 -42.37 96.43 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 173.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.7 tp -59.3 -45.93 89.95 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 118.964 -2.335 . . . . 0.0 111.986 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . 0.323 19.4 p -61.94 -48.49 80.17 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 126.847 2.059 . . . . 0.0 110.426 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 45.4 m -52.98 -44.5 67.22 Favored 'General case' 0 CA--C 1.579 2.069 0 C-N-CA 126.75 2.02 . . . . 0.0 112.448 169.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 37.5 m -60.19 -46.39 89.89 Favored 'General case' 0 C--O 1.194 -1.839 0 O-C-N 117.966 -2.959 . . . . 0.0 109.119 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.0 mt -68.18 -37.22 80.71 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 123.999 1.857 . . . . 0.0 111.42 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -60.61 -42.49 96.91 Favored 'General case' 0 C--O 1.267 2.005 0 O-C-N 118.613 -2.555 . . . . 0.0 116.757 169.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.0 mt -82.77 -21.05 34.76 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . 0.373 2.0 p -98.11 3.79 49.16 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 118.834 2.901 . . . . 0.0 118.834 162.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.074 0 C-N-CA 127.301 2.382 . . . . 0.0 115.541 173.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 . . . . . 0 CA--C 1.466 -2.255 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -57.34 139.12 53.85 Favored 'General case' 0 C--O 1.261 1.675 0 CA-C-O 124.842 2.258 . . . . 0.0 110.419 166.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.8 tp -149.13 142.23 18.14 Favored 'Isoleucine or valine' 0 C--N 1.365 1.269 0 CA-C-O 124.37 2.033 . . . . 0.0 113.747 -167.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.1 p -140.76 177.16 8.22 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -63.39 -45.95 88.7 Favored 'General case' 0 CA--C 1.579 2.09 0 C-N-CA 126.572 1.949 . . . . 0.0 109.068 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.44 75.96 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 119.319 -2.113 . . . . 0.0 116.2 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -67.65 -42.99 81.33 Favored 'General case' 0 C--O 1.178 -2.689 0 CA-C-O 117.056 -1.449 . . . . 0.0 111.875 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.7 tp -62.11 -37.19 84.14 Favored 'General case' 0 CA--C 1.582 2.194 0 CA-C-N 121.678 2.035 . . . . 0.0 114.243 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.351 . . 82.62 30.63 0.1 Allowed 'General case' 0 C--N 1.371 1.532 0 O-C-N 119.719 -1.863 . . . . 0.0 110.589 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -155.02 159.57 40.42 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.81 125.12 14.19 Favored 'General case' 0 N--CA 1.423 -1.806 0 C-N-CA 128.563 2.745 . . . . 0.0 115.225 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -64.41 128.02 92.85 Favored Pre-proline 0 CA--C 1.586 2.331 0 O-C-N 117.029 -3.544 . . . . 0.0 110.818 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -105.76 0.46 0.2 Allowed 'Trans proline' 0 CA--C 1.481 -2.131 0 C-N-CA 123.598 2.865 . . . . 0.0 108.891 -154.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.7 mt -132.82 171.34 14.04 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 p -92.2 -0.27 57.43 Favored 'General case' 0 C--O 1.19 -2.049 0 CA-C-O 124.161 1.934 . . . . 0.0 111.245 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.0 m -93.49 161.26 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 117.045 -3.534 . . . . 0.0 110.474 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -78.9 174.3 11.65 Favored 'General case' 0 C--O 1.205 -1.267 0 O-C-N 120.33 -1.481 . . . . 0.0 113.655 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -53.01 138.84 29.53 Favored 'General case' 0 CA--C 1.61 3.267 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.74 -150.74 5.37 Favored Glycine 0 C--N 1.379 2.956 0 C-N-CA 130.392 3.853 . . . . 0.0 114.386 -166.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.7 m -128.4 145.5 51.07 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 111.762 -2.219 . . . . 0.0 106.177 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.5 pt -113.48 144.45 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.034 0 C-N-CA 129.663 3.185 . . . . 0.0 110.207 165.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -145.84 142.76 29.14 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-O 122.609 1.195 . . . . 0.0 112.093 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 69.7 m -91.45 138.36 31.63 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 170.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.0 mt -120.78 155.91 56.79 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 118.836 -2.415 . . . . 0.0 105.312 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.288 36.9 Cg_exo -39.64 135.3 1.35 Allowed 'Trans proline' 0 N--CA 1.505 2.15 1 C-N-CA 125.696 4.264 . . . . 0.0 122.21 173.046 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.452 68.3 m 78.52 48.12 0.04 OUTLIER 'General case' 0 C--N 1.378 1.842 0 O-C-N 119.553 -1.967 . . . . 0.0 112.348 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 46.5 43.29 12.02 Favored 'General case' 0 C--N 1.391 2.37 0 CA-C-N 112.983 -1.917 . . . . 0.0 113.46 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -95.45 143.8 26.49 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 126.216 1.806 . . . . 0.0 111.465 170.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.36 129.34 49.73 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-O 124.648 2.166 . . . . 0.0 106.142 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.2 m -118.22 157.73 19.5 Favored 'Isoleucine or valine' 0 C--N 1.381 1.957 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.993 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -131.26 137.29 48.8 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -125.72 118.76 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 O-C-N 120.623 -1.298 . . . . 0.0 108.033 173.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.57 162.87 1.16 Allowed Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 170.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -68.81 -13.22 36.44 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 CA-C-O 113.786 -2.673 . . . . 0.0 114.589 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -91.75 -1.93 57.18 Favored 'General case' 0 C--N 1.37 1.458 0 CA-C-N 121.084 1.765 . . . . 0.0 112.902 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.61 0.17 36.98 Favored Glycine 0 CA--C 1.49 -1.523 0 CA-C-O 114.397 -3.446 . . . . 0.0 109.843 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.8 m -81.6 119.04 23.29 Favored 'General case' 0 C--N 1.361 1.08 1 CA-C-N 124.212 4.006 . . . . 0.0 112.93 -170.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.7 m -82.06 130.59 35.12 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.015 175.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -125.36 160.81 28.44 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 126.891 2.076 . . . . 0.0 111.675 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.99 127.42 32.94 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 167.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.9 tp -94.77 -47.5 6.45 Favored 'General case' 0 C--O 1.206 -1.227 0 O-C-N 119.671 -1.893 . . . . 0.0 109.844 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -101.77 163.56 12.19 Favored 'General case' 0 C--N 1.391 2.392 0 CA-C-O 123.739 1.733 . . . . 0.0 108.834 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . 0.274 12.9 p-10 -55.29 -36.8 66.53 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 126.432 1.893 . . . . 0.0 113.758 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -61.89 -44.37 96.95 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.808 1.243 . . . . 0.0 112.064 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.95 -40.83 94.79 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.666 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -68.38 -42.02 79.72 Favored 'General case' 0 CA--C 1.557 1.218 0 O-C-N 121.774 -0.579 . . . . 0.0 111.52 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -54.9 -39.63 68.96 Favored 'General case' 0 C--N 1.369 1.422 0 O-C-N 120.224 -1.547 . . . . 0.0 112.542 167.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.01 -36.65 84.27 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 127.0 6.46 5.39 Favored Glycine 0 N--CA 1.507 3.369 0 CA-C-O 124.125 1.959 . . . . 0.0 110.464 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -80.33 133.67 56.45 Favored Pre-proline 0 CA--C 1.588 2.433 0 CA-C-O 116.67 -1.633 . . . . 0.0 110.161 170.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -70.64 150.7 63.29 Favored 'Trans proline' 0 CA--C 1.484 -2.018 0 CA-C-N 126.892 3.497 . . . . 0.0 119.182 -164.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . 0.269 74.7 Cg_exo -44.7 146.92 2.0 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 N-CA-C 117.769 2.18 . . . . 0.0 117.769 171.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.7 tt -98.99 10.15 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 C-N-CA 116.979 -1.888 . . . . 0.0 107.336 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.4 p -62.17 -35.83 23.95 Favored Pre-proline 0 C--N 1.374 1.639 1 CA-C-O 109.169 -5.205 . . . . 0.0 116.972 -174.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.16 -17.59 16.97 Favored 'Trans proline' 0 C--N 1.36 1.137 0 CA-C-N 127.141 3.586 . . . . 0.0 109.018 -165.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.6 pt -106.53 20.65 4.43 Favored 'Isoleucine or valine' 0 C--N 1.368 1.389 0 C-N-CA 125.699 1.6 . . . . 0.0 113.458 -172.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -63.59 138.36 58.47 Favored 'General case' 0 C--N 1.363 1.188 0 C-N-CA 126.645 1.978 . . . . 0.0 111.86 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -95.83 128.13 42.45 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 127.647 2.379 . . . . 0.0 116.999 168.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -78.03 149.47 34.0 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 120.257 -1.527 . . . . 0.0 114.576 166.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.95 174.6 54.34 Favored Glycine 0 C--O 1.202 -1.885 0 C-N-CA 126.438 1.97 . . . . 0.0 113.655 162.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.0 m -60.43 146.97 42.61 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 122.215 3.007 . . . . 0.0 118.584 161.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 52.53 27.87 27.45 Favored Glycine 1 C--N 1.415 4.942 0 C-N-CA 128.471 2.938 . . . . 0.0 111.665 -162.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.23 -161.61 53.84 Favored Glycine 0 CA--C 1.544 1.863 0 C-N-CA 129.892 3.615 . . . . 0.0 119.291 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.26 133.6 4.42 Favored Glycine 0 CA--C 1.549 2.195 0 CA-C-N 120.459 2.129 . . . . 0.0 109.873 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -79.18 151.69 31.12 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 124.842 2.258 . . . . 0.0 107.916 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 22.4 mm -91.17 144.27 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 126.717 2.007 . . . . 0.0 111.529 173.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.4 t -71.71 147.31 47.52 Favored 'General case' 0 C--O 1.195 -1.796 0 N-CA-C 119.868 3.285 . . . . 0.0 119.868 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.5 mt -97.78 20.92 11.21 Favored 'General case' 0 C--O 1.204 -1.338 0 C-N-CA 126.231 1.812 . . . . 0.0 112.317 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -88.71 -41.3 6.05 Favored Glycine 0 CA--C 1.496 -1.121 0 N-CA-C 118.207 2.043 . . . . 0.0 118.207 -169.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.47 98.55 Favored 'General case' 0 N--CA 1.431 -1.375 0 O-C-N 127.045 2.262 . . . . 0.0 110.199 170.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.8 tp -66.69 -44.12 82.58 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-O 122.563 1.173 . . . . 0.0 111.702 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.3 tp -62.68 -53.16 58.73 Favored 'General case' 0 C--N 1.364 1.23 0 O-C-N 120.329 -1.482 . . . . 0.0 110.465 175.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.2 p -57.66 -44.76 85.94 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.66 0.743 . . . . 0.0 111.088 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 83.0 m -62.31 -42.35 99.3 Favored 'General case' 0 C--O 1.264 1.822 0 C-N-CA 125.611 1.564 . . . . 0.0 110.982 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 26.2 m -60.22 -36.88 78.69 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 173.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.7 mt -89.59 -16.78 29.82 Favored 'General case' 0 C--N 1.376 1.722 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 176.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -63.41 -38.57 91.65 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 117.12 -1.419 . . . . 0.0 111.375 158.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.4 mt -63.47 -43.0 98.59 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-O 125.227 2.441 . . . . 0.0 110.507 -171.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 21.6 p -100.61 25.66 7.57 Favored 'General case' 0 C--N 1.376 1.74 0 CA-C-N 112.779 -2.009 . . . . 0.0 112.414 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.158 0 C-N-CA 128.368 2.889 . . . . 0.0 114.863 175.626 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 CA--C 1.497 -1.069 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -59.23 137.34 58.01 Favored 'General case' 0 C--O 1.252 1.226 0 O-C-N 126.416 2.323 . . . . 0.0 111.334 164.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.5 tp -145.8 142.33 21.83 Favored 'Isoleucine or valine' 0 C--O 1.264 1.86 0 CA-C-N 112.791 -2.004 . . . . 0.0 113.036 -167.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.9 p -139.36 177.91 7.58 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -63.78 -44.56 93.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 124.704 1.252 . . . . 0.0 110.579 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.92 79.71 Favored 'General case' 0 C--O 1.247 0.946 0 O-C-N 120.228 -1.545 . . . . 0.0 112.972 173.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -67.19 -42.97 83.31 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-O 117.415 -1.278 . . . . 0.0 111.901 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.1 tp -61.94 -36.19 80.64 Favored 'General case' 0 CA--C 1.587 2.392 0 CA-C-N 121.002 1.728 . . . . 0.0 113.293 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.287 . . 79.38 32.66 0.24 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.038 1.335 . . . . 0.0 111.99 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -155.85 158.2 37.66 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.4 mt -50.92 127.39 18.55 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 124.116 1.912 . . . . 0.0 115.461 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -63.82 124.42 84.89 Favored Pre-proline 0 CA--C 1.573 1.86 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.262 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -100.11 1.98 0.82 Allowed 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 122.02 1.813 . . . . 0.0 113.285 -160.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.5 mt -131.15 168.01 18.18 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.2 p -90.01 1.62 56.09 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 122.381 1.086 . . . . 0.0 113.781 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.5 m -92.53 160.54 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 119.976 -1.703 . . . . 0.0 111.654 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -77.39 174.37 10.9 Favored 'General case' 0 CA--C 1.567 1.63 0 O-C-N 119.221 -2.174 . . . . 0.0 111.827 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -53.91 140.35 31.03 Favored 'General case' 0 CA--C 1.601 2.941 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 -177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.2 -150.09 5.28 Favored Glycine 0 C--N 1.369 2.409 0 C-N-CA 127.53 2.491 . . . . 0.0 114.909 -166.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.1 m -127.88 146.5 50.6 Favored 'General case' 0 C--N 1.371 1.506 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.2 pt -115.49 145.89 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 126.925 2.09 . . . . 0.0 110.081 166.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -147.22 141.63 26.39 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 122.94 1.353 . . . . 0.0 111.426 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 61.8 m -89.27 138.15 31.69 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 169.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.0 mt -120.13 155.41 55.74 Favored Pre-proline 0 N--CA 1.482 1.17 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 172.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.268 31.9 Cg_exo -40.55 134.93 2.11 Favored 'Trans proline' 0 N--CA 1.529 3.583 0 N-CA-C 122.133 3.859 . . . . 0.0 122.133 173.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.383 50.4 m 79.53 50.22 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.075 1.35 . . . . 0.0 110.311 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 45.94 44.64 11.48 Favored 'General case' 0 C--O 1.203 -1.383 0 O-C-N 126.803 2.564 . . . . 0.0 111.954 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.89 145.71 25.63 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 118.644 0.656 . . . . 0.0 110.438 170.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.65 129.9 51.42 Favored 'General case' 0 C--O 1.273 2.312 0 CA-C-O 123.22 1.486 . . . . 0.0 107.481 174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.19 157.24 21.13 Favored 'Isoleucine or valine' 0 C--N 1.362 1.114 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.157 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -130.36 137.78 50.07 Favored 'General case' 0 C--O 1.254 1.321 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 t -126.35 119.32 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.1 164.53 2.36 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 171.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.79 -11.78 29.99 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 CA-C-O 114.481 -2.383 . . . . 0.0 114.466 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -91.03 -1.43 57.81 Favored 'General case' 0 C--N 1.371 1.529 0 CA-C-N 121.132 1.787 . . . . 0.0 113.544 173.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.81 -0.85 41.83 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-O 116.748 -2.14 . . . . 0.0 113.207 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.5 m -80.01 120.24 23.92 Favored 'General case' 0 C--N 1.38 1.899 0 CA-C-N 120.979 2.39 . . . . 0.0 113.374 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.7 m -83.52 130.54 35.01 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.05 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -124.56 162.18 24.6 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.678 1.591 . . . . 0.0 111.209 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.53 130.2 35.17 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.42 -46.79 6.55 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 116.45 -1.738 . . . . 0.0 108.83 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -105.28 164.33 11.92 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-O 123.398 1.57 . . . . 0.0 108.898 174.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -56.29 -37.41 69.82 Favored 'General case' 0 N--CA 1.511 2.588 0 CA-C-N 113.448 -1.705 . . . . 0.0 112.469 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.6 mtp85 -60.53 -44.59 95.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 124.784 1.303 . . . . 0.0 111.327 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.36 -37.18 84.68 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.78 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -71.2 -42.07 69.46 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 117.767 -1.111 . . . . 0.0 110.084 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -56.57 -35.5 68.24 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 168.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.71 76.23 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 116.223 -1.846 . . . . 0.0 114.124 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.54 6.27 6.76 Favored Glycine 1 N--CA 1.518 4.165 0 CA-C-N 121.162 1.801 . . . . 0.0 111.839 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -80.27 131.45 62.26 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-O 118.054 -0.974 . . . . 0.0 108.642 170.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -65.37 149.28 88.36 Favored 'Trans proline' 1 N--CA 1.546 4.565 0 N-CA-C 119.478 2.838 . . . . 0.0 119.478 -168.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.41 145.74 5.68 Favored 'Trans proline' 0 N--CA 1.519 2.979 0 C-N-CA 117.243 -1.371 . . . . 0.0 114.905 172.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.4 tt -97.46 11.25 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 117.811 -1.555 . . . . 0.0 109.499 175.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 17.2 p -63.96 -35.63 16.64 Favored Pre-proline 0 N--CA 1.399 -2.993 1 CA-C-O 110.185 -4.721 . . . . 0.0 117.667 -174.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.9 -19.68 23.18 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 CA-C-N 124.744 2.73 . . . . 0.0 111.294 -168.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.2 pt -105.56 22.52 3.07 Favored 'Isoleucine or valine' 0 C--N 1.372 1.583 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -61.67 139.3 58.31 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 125.895 1.997 . . . . 0.0 112.978 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . 0.251 . . -97.46 130.13 44.59 Favored 'General case' 0 C--N 1.376 1.731 0 C-N-CA 125.976 1.71 . . . . 0.0 115.138 170.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -82.02 151.37 27.14 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.936 167.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.36 176.08 54.41 Favored Glycine 0 CA--C 1.544 1.887 0 O-C-N 126.99 2.681 . . . . 0.0 113.683 164.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.9 m -63.62 146.66 53.33 Favored 'General case' 0 CA--C 1.597 2.762 0 CA-C-N 120.966 2.383 . . . . 0.0 116.395 164.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 57.2 24.43 51.24 Favored Glycine 1 C--N 1.402 4.212 0 O-C-N 125.735 1.897 . . . . 0.0 111.814 -164.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.81 -163.2 50.97 Favored Glycine 0 CA--C 1.553 2.441 0 C-N-CA 126.951 2.215 . . . . 0.0 117.288 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.52 132.79 3.78 Favored Glycine 0 C--N 1.377 2.86 0 CA-C-N 118.313 1.056 . . . . 0.0 111.358 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -79.42 150.67 31.24 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 122.533 1.159 . . . . 0.0 109.631 -174.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 20.3 mm -90.3 147.52 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.974 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.5 t -74.93 147.74 40.67 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 174.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.0 mt -97.01 21.51 9.66 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 112.807 -1.997 . . . . 0.0 111.741 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.9 -46.66 5.31 Favored Glycine 0 C--O 1.219 -0.784 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 -168.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.48 -43.24 93.32 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 127.514 2.538 . . . . 0.0 109.056 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.2 tp -67.33 -43.92 80.42 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.713 0.805 . . . . 0.0 111.08 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.3 tp -62.03 -54.35 42.81 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.154 0.582 . . . . 0.0 110.589 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.1 p -56.78 -44.28 81.7 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 124.066 0.854 . . . . 0.0 110.823 -175.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.9 m -62.98 -40.26 97.19 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.252 1.021 . . . . 0.0 110.547 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.4 m -62.94 -36.52 83.72 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 115.355 -2.259 . . . . 0.0 114.642 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 37.1 mt -89.01 -18.65 26.92 Favored 'General case' 0 C--N 1.387 2.208 0 CA-C-N 121.401 1.91 . . . . 0.0 114.31 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -61.69 -40.79 96.23 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 121.411 -0.806 . . . . 0.0 111.215 160.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.0 mt -61.79 -42.98 99.69 Favored 'General case' 0 C--N 1.381 1.938 0 O-C-N 125.458 1.723 . . . . 0.0 110.074 -173.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.0 p -101.95 27.84 6.22 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.807 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.199 -2.051 0 C-N-CA 125.9 1.715 . . . . 0.0 115.343 175.676 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 . . . . . 0 CA--C 1.552 1.046 0 CA-C-O 121.512 0.673 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -87.37 145.47 26.3 Favored 'General case' 0 C--O 1.264 1.831 0 O-C-N 128.698 3.749 . . . . 0.0 111.519 171.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 tp -115.56 144.43 23.17 Favored 'Isoleucine or valine' 0 C--N 1.364 1.219 0 CA-C-N 112.335 -2.211 . . . . 0.0 108.701 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.51 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 38.5 p -132.08 163.05 29.32 Favored 'General case' 0 C--O 1.198 -1.623 0 C-N-CA 126.206 1.803 . . . . 0.0 114.082 -174.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 29.5 mt-10 -62.05 -45.97 91.2 Favored 'General case' 0 C--O 1.202 -1.416 0 C-N-CA 127.536 2.334 . . . . 0.0 108.951 168.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.81 -24.62 61.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 119.346 -2.096 . . . . 0.0 116.161 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -62.55 -46.38 88.63 Favored 'General case' 0 CA--C 1.593 2.623 0 CA-C-O 122.132 0.968 . . . . 0.0 111.418 172.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 mt -71.04 -38.0 72.54 Favored 'General case' 0 C--O 1.211 -0.925 0 C-N-CA 129.275 3.03 . . . . 0.0 114.066 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.36 . . 67.14 -22.29 0.11 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 119.351 3.093 . . . . 0.0 119.351 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . 0.303 84.9 t80 -77.12 167.2 22.19 Favored 'General case' 0 C--O 1.254 1.304 0 CA-C-O 122.615 1.198 . . . . 0.0 112.791 161.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.8 tp -48.09 118.61 2.46 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.097 1.759 . . . . 0.0 115.509 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -61.48 122.04 67.94 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 119.299 -2.125 . . . . 0.0 111.011 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -95.5 26.39 0.29 Allowed 'Trans proline' 0 CA--C 1.552 1.393 0 C-N-CA 122.869 2.379 . . . . 0.0 114.301 -169.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.2 mt -136.9 153.41 50.74 Favored 'General case' 0 C--N 1.39 2.347 0 CA-C-N 120.057 1.299 . . . . 0.0 109.463 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.4 p -73.11 -22.62 60.52 Favored 'General case' 0 C--N 1.364 1.203 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.5 m -83.92 160.55 3.42 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 1 O-C-N 129.435 4.209 . . . . 0.0 108.236 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -91.5 114.62 27.19 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 115.481 -2.199 . . . . 0.0 109.993 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.51 ' CD2' ' HA ' ' A' ' 63' ' ' SER . 61.3 m170 52.85 -167.88 0.05 Allowed 'General case' 0 C--N 1.36 1.025 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.59 -167.45 40.33 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.757 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.1 m -121.45 149.04 43.62 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 103.166 -2.902 . . . . 0.0 103.166 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 pt -121.36 151.65 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.311 0 C-N-CA 124.747 1.219 . . . . 0.0 110.474 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -145.12 139.81 27.57 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 3.8 m -99.25 123.97 43.96 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.0 mt -96.49 151.35 37.96 Favored Pre-proline 0 N--CA 1.508 2.45 0 CA-C-O 114.265 -2.778 . . . . 0.0 112.58 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -57.59 150.0 63.72 Favored 'Trans proline' 0 N--CA 1.508 2.348 0 CA-C-N 124.654 2.698 . . . . 0.0 117.952 -173.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.9 m 59.46 54.27 4.73 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -168.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 57.11 48.65 15.04 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 170.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -117.03 159.41 22.57 Favored 'General case' 0 C--N 1.369 1.422 0 CA-C-O 117.995 -1.003 . . . . 0.0 111.761 169.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.95 148.04 43.01 Favored 'General case' 0 C--N 1.384 2.089 0 O-C-N 125.53 1.769 . . . . 0.0 112.451 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.8 m -138.31 170.92 16.12 Favored 'Isoleucine or valine' 0 C--N 1.396 2.61 0 O-C-N 127.068 2.73 . . . . 0.0 113.64 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -140.67 124.5 17.18 Favored 'General case' 0 C--O 1.265 1.87 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -172.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.1 t -102.69 107.76 22.67 Favored 'Isoleucine or valine' 0 C--N 1.359 0.995 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . 0.332 . . -60.18 150.61 70.61 Favored Pre-proline 0 N--CA 1.515 2.818 0 N-CA-C 119.979 3.325 . . . . 0.0 119.979 174.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -46.3 -23.75 2.19 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 N-CA-C 119.952 3.02 . . . . 0.0 119.952 177.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -86.55 -15.26 40.49 Favored 'General case' 0 C--N 1.375 1.716 0 CA-C-O 124.166 1.936 . . . . 0.0 115.589 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 114.15 -3.66 23.88 Favored Glycine 0 N--CA 1.483 1.829 0 C-N-CA 130.304 3.811 . . . . 0.0 116.387 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.323 8.3 m -68.94 114.27 7.09 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 46.6 m -90.16 108.7 19.9 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 124.736 1.272 . . . . 0.0 112.873 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -100.87 142.84 31.77 Favored 'General case' 0 N--CA 1.434 -1.259 0 O-C-N 126.166 2.166 . . . . 0.0 111.259 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.28 128.34 36.05 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-N 113.46 -1.7 . . . . 0.0 112.861 169.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.1 tp -108.57 1.34 21.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.355 -1.466 . . . . 0.0 108.672 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . 0.34 52.9 p-10 -148.86 159.53 44.08 Favored 'General case' 0 C--N 1.368 1.391 0 O-C-N 120.762 -1.211 . . . . 0.0 111.681 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -58.63 -43.45 89.71 Favored 'General case' 0 C--N 1.363 1.191 0 CA-C-N 112.814 -1.994 . . . . 0.0 113.528 -169.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -66.71 -34.65 78.32 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 121.16 -0.962 . . . . 0.0 111.648 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . 0.371 . . -61.43 -40.52 94.73 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 174.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -62.02 -41.83 98.51 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 115.363 -2.256 . . . . 0.0 108.702 169.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.303 42.5 mmtm -63.24 -42.88 99.27 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.84 2.533 . . . . 0.0 117.84 175.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.95 -34.29 65.54 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 115.497 -2.192 . . . . 0.0 111.396 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 130.57 -1.72 5.64 Favored Glycine 0 C--N 1.366 2.234 0 CA-C-N 121.362 1.892 . . . . 0.0 115.474 173.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -71.25 148.1 93.58 Favored Pre-proline 0 C--N 1.369 1.443 0 CA-C-O 116.818 -1.563 . . . . 0.0 111.706 171.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.09 139.01 23.55 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-O 114.381 -2.425 . . . . 0.0 111.702 -171.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -54.01 142.37 65.28 Favored 'Trans proline' 0 CA--C 1.482 -2.109 0 N-CA-C 119.88 2.992 . . . . 0.0 119.88 168.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.3 tt -89.89 15.56 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.948 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.8 p -64.3 -43.37 72.53 Favored Pre-proline 0 C--N 1.378 1.82 0 CA-C-O 113.127 -3.321 . . . . 0.0 117.077 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -74.35 -1.65 11.28 Favored 'Trans proline' 0 N--CA 1.5 1.863 1 CA-C-N 129.798 4.535 . . . . 0.0 117.408 174.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 27.4 mm -91.2 -0.79 9.65 Favored 'Isoleucine or valine' 0 C--N 1.367 1.349 0 C-N-CA 127.567 2.347 . . . . 0.0 113.595 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -61.92 140.36 58.31 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 119.191 -2.193 . . . . 0.0 116.902 166.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -81.22 128.95 34.34 Favored 'General case' 0 C--O 1.199 -1.599 0 CA-C-O 123.108 1.432 . . . . 0.0 113.62 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -55.92 145.32 25.35 Favored 'General case' 0 N--CA 1.535 3.79 1 N-CA-C 122.609 4.3 . . . . 0.0 122.609 175.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.15 173.8 42.01 Favored Glycine 0 C--N 1.356 1.668 0 CA-C-N 113.287 -1.779 . . . . 0.0 112.381 156.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.6 t -93.73 127.6 39.53 Favored 'General case' 0 C--N 1.386 2.186 0 O-C-N 126.568 1.981 . . . . 0.0 109.916 167.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 67.59 39.37 90.77 Favored Glycine 0 N--CA 1.51 3.612 0 C-N-CA 118.404 -1.855 . . . . 0.0 115.983 -169.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 105.85 -168.9 15.43 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 164.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.33 -170.09 50.76 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-O 123.882 1.823 . . . . 0.0 112.208 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -149.74 149.67 30.91 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.9 mt -66.36 137.16 25.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 O-C-N 119.197 -2.189 . . . . 0.0 109.57 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.3 t -50.56 129.49 22.44 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 58.7 mt -98.93 6.86 46.53 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.501 -1.375 . . . . 0.0 111.594 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.12 -60.15 9.41 Favored Glycine 0 C--N 1.377 2.833 0 C-N-CA 128.563 2.983 . . . . 0.0 114.9 -170.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . 0.354 . . -65.29 -32.21 73.74 Favored 'General case' 0 CA--C 1.6 2.891 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 10.3 tp -55.66 -48.38 75.11 Favored 'General case' 0 C--N 1.383 2.051 0 CA-C-N 120.6 1.545 . . . . 0.0 112.14 163.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 20.2 tp -65.28 -42.53 93.06 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . 0.29 17.7 p -69.07 -40.37 78.52 Favored 'General case' 0 C--N 1.371 1.513 0 CA-C-O 115.79 -2.052 . . . . 0.0 112.758 170.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 90.2 m -64.08 -31.07 72.12 Favored 'General case' 0 C--N 1.36 1.033 0 CA-C-N 122.928 2.604 . . . . 0.0 110.138 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.5 m -64.89 -48.92 72.51 Favored 'General case' 0 C--N 1.389 2.312 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.1 mt -69.29 -43.11 74.49 Favored 'General case' 0 CA--C 1.495 -1.161 0 O-C-N 126.843 2.589 . . . . 0.0 112.883 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.08 -33.94 69.61 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 127.016 2.697 . . . . 0.0 114.885 173.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . 0.291 40.0 tp -69.19 -28.96 66.85 Favored 'General case' 0 N--CA 1.421 -1.892 0 O-C-N 126.338 2.274 . . . . 0.0 110.879 -176.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.6 p -108.01 12.96 26.51 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 174.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.584 0 C-N-CA 128.114 2.769 . . . . 0.0 118.581 -176.312 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 . . . . . 0 C--O 1.193 -1.884 0 CA-C-O 122.018 0.913 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -64.86 140.56 58.88 Favored 'General case' 0 C--N 1.368 1.371 0 C-N-CA 128.09 2.556 . . . . 0.0 111.688 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.5 tp -142.13 142.59 27.52 Favored 'Isoleucine or valine' 0 C--O 1.263 1.781 0 O-C-N 117.78 -3.075 . . . . 0.0 110.702 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.3 p -145.78 172.23 13.62 Favored 'General case' 0 C--N 1.39 2.34 0 CA-C-N 112.308 -2.224 . . . . 0.0 112.711 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.68 -46.33 82.9 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 117.516 -1.231 . . . . 0.0 109.006 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.73 -34.96 67.43 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 120.714 1.597 . . . . 0.0 107.67 -174.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -66.12 -40.05 90.38 Favored 'General case' 0 C--N 1.369 1.456 0 O-C-N 120.241 -1.537 . . . . 0.0 113.511 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.2 tp -67.97 -44.91 75.6 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 124.112 0.965 . . . . 0.0 113.556 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 88.61 21.09 0.04 OUTLIER 'General case' 0 C--N 1.356 0.89 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 171.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -151.26 173.6 14.27 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 101.124 -3.658 . . . . 0.0 101.124 -166.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.1 mt -73.69 144.67 45.71 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 118.069 -2.894 . . . . 0.0 114.089 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -92.18 127.97 47.06 Favored Pre-proline 0 C--O 1.208 -1.109 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.705 -170.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -93.7 6.36 2.76 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 CA-C-O 115.206 -2.081 . . . . 0.0 110.919 -157.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.5 mt -124.7 158.17 33.87 Favored 'General case' 0 C--N 1.361 1.077 0 CA-C-N 122.638 2.472 . . . . 0.0 108.654 -169.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.2 p -62.38 -48.27 80.48 Favored 'General case' 0 N--CA 1.507 2.401 0 C-N-CA 124.118 0.967 . . . . 0.0 113.156 163.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.1 m -65.6 149.17 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 125.14 2.4 . . . . 0.0 113.022 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.37 176.59 4.51 Favored 'General case' 0 CA--C 1.561 1.369 0 O-C-N 120.275 -1.515 . . . . 0.0 109.084 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -25.16 137.32 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 153.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.33 -118.77 0.95 Allowed Glycine 0 C--N 1.373 2.608 0 CA-C-O 123.962 1.868 . . . . 0.0 112.636 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 m -156.54 154.11 29.77 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 pt -133.35 129.22 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-O 124.447 2.07 . . . . 0.0 107.579 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -130.38 154.43 47.7 Favored 'General case' 0 C--N 1.359 0.984 0 CA-C-N 112.157 -2.292 . . . . 0.0 111.848 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 96.9 m -122.15 134.3 54.74 Favored 'General case' 0 C--O 1.189 -2.116 0 O-C-N 119.959 -1.713 . . . . 0.0 108.275 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.79 153.67 81.68 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-N 122.977 2.626 . . . . 0.0 107.431 -171.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -43.28 150.13 0.44 Allowed 'Trans proline' 0 CA--C 1.509 -0.726 0 C-N-CA 122.09 1.86 . . . . 0.0 114.799 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.338 37.8 m 82.1 33.28 0.09 Allowed 'General case' 0 C--N 1.361 1.106 0 O-C-N 127.529 3.018 . . . . 0.0 116.216 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 49.05 40.95 18.42 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 130.735 3.614 . . . . 0.0 115.037 -167.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -94.75 133.92 37.92 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 123.3 1.524 . . . . 0.0 109.27 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.31 141.25 52.18 Favored 'General case' 0 C--O 1.192 -1.935 0 O-C-N 119.647 -1.908 . . . . 0.0 109.528 171.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.25 153.31 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.382 0 C-N-CA 126.654 1.982 . . . . 0.0 112.232 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -111.74 121.75 45.93 Favored 'General case' 0 CA--C 1.562 1.432 1 C-N-CA 132.282 4.233 . . . . 0.0 106.802 170.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.32 108.49 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 118.697 -2.502 . . . . 0.0 108.321 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.44 154.05 93.75 Favored Pre-proline 0 N--CA 1.434 -1.273 0 C-N-CA 127.245 2.218 . . . . 0.0 115.937 169.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -74.91 12.46 1.19 Allowed 'Trans proline' 0 N--CA 1.515 2.785 0 N-CA-C 116.051 1.52 . . . . 0.0 116.051 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -100.99 1.13 39.34 Favored 'General case' 0 C--N 1.361 1.107 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.528 158.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.33 11.62 60.83 Favored Glycine 0 CA--C 1.465 -3.072 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 m -76.04 117.47 17.79 Favored 'General case' 0 N--CA 1.435 -1.225 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.641 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . 0.263 53.9 m -93.34 80.68 4.41 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 -171.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -70.59 153.64 42.67 Favored 'General case' 0 C--O 1.254 1.318 0 O-C-N 121.1 -1.0 . . . . 0.0 112.882 -173.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.27 114.7 7.77 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 167.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.2 tp -92.33 -25.59 18.48 Favored 'General case' 0 CA--C 1.558 1.267 0 CA-C-O 121.698 0.761 . . . . 0.0 112.997 173.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -120.99 173.84 7.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 119.164 -2.21 . . . . 0.0 110.093 163.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -60.43 -30.99 69.99 Favored 'General case' 0 CA--C 1.576 1.946 0 C-N-CA 130.436 3.494 . . . . 0.0 116.581 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -67.65 -54.08 22.51 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.444 172.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.83 -35.12 74.08 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -61.88 -45.51 93.44 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 122.385 1.088 . . . . 0.0 112.153 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -68.29 -28.12 66.91 Favored 'General case' 0 C--O 1.259 1.554 0 CA-C-O 124.368 2.032 . . . . 0.0 115.859 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.62 -21.13 61.88 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 116.662 2.097 . . . . 0.0 116.662 168.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.69 15.07 11.46 Favored Glycine 0 CA--C 1.463 -3.202 0 CA-C-O 114.915 -3.159 . . . . 0.0 114.396 -174.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -87.31 150.39 49.14 Favored Pre-proline 0 N--CA 1.429 -1.498 0 C-N-CA 114.079 -3.049 . . . . 0.0 110.461 164.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -57.23 142.16 94.6 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 CA-C-O 116.668 -1.472 . . . . 0.0 115.668 -172.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -68.06 139.35 46.49 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 CA-C-O 125.316 2.132 . . . . 0.0 116.532 169.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.4 tt -90.05 10.64 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 O-C-N 118.584 -2.573 . . . . 0.0 107.116 -171.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.27 -52.23 70.8 Favored Pre-proline 0 C--N 1.369 1.45 0 O-C-N 119.791 -1.818 . . . . 0.0 114.093 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.94 -7.34 20.89 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 CA-C-N 121.539 1.585 . . . . 0.0 113.204 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.6 pt -103.79 9.03 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.198 0.908 . . . . 0.0 111.174 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -69.82 137.03 51.46 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.996 0.903 . . . . 0.0 112.794 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -94.31 129.37 41.0 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 122.979 1.371 . . . . 0.0 112.171 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -89.59 140.78 29.21 Favored 'General case' 0 C--O 1.253 1.241 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.49 -168.89 7.75 Favored Glycine 0 C--N 1.383 3.171 0 N-CA-C 118.475 2.15 . . . . 0.0 118.475 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 m -96.97 123.35 40.67 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 124.626 0.839 . . . . 0.0 112.817 164.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 62.68 50.29 65.5 Favored Glycine 0 CA--C 1.496 -1.153 0 C-N-CA 126.362 1.934 . . . . 0.0 113.876 -168.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.89 -175.91 51.91 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 125.865 1.698 . . . . 0.0 113.093 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.7 174.16 44.11 Favored Glycine 0 CA--C 1.539 1.538 0 O-C-N 127.33 2.429 . . . . 0.0 111.977 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -126.75 143.42 51.25 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 -172.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 37.3 mm -74.17 140.55 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 O-C-N 120.077 -1.639 . . . . 0.0 111.657 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 30.9 t -62.01 127.62 32.27 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 -169.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.6 mt -72.62 -17.52 61.67 Favored 'General case' 0 C--N 1.378 1.828 0 O-C-N 118.052 -2.905 . . . . 0.0 111.806 169.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -41.52 -53.85 4.18 Favored Glycine 0 C--N 1.343 0.964 0 C-N-CA 127.548 2.499 . . . . 0.0 117.688 -166.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.37 89.82 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 120.263 -1.728 . . . . 0.0 115.007 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 48.9 tp -64.7 -48.25 75.38 Favored 'General case' 0 C--O 1.206 -1.204 0 O-C-N 118.471 -2.643 . . . . 0.0 112.48 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.0 tp -64.51 -52.15 59.31 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 121.437 -0.789 . . . . 0.0 109.032 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.4 p -60.13 -41.99 93.85 Favored 'General case' 0 N--CA 1.509 2.516 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.7 m -55.75 -42.66 75.73 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 126.419 1.888 . . . . 0.0 110.036 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 78.4 m -60.12 -43.53 95.58 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 127.961 3.288 . . . . 0.0 108.655 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 12.1 mt -66.19 -36.7 83.76 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -57.91 -42.32 84.48 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 119.347 -2.096 . . . . 0.0 112.495 172.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.2 mt -62.96 -42.61 99.87 Favored 'General case' 0 C--O 1.193 -1.914 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.738 -172.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 28.4 p -113.94 27.37 9.57 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 115.332 -2.271 . . . . 0.0 110.625 -165.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.37 2.444 0 CA-C-N 123.714 2.961 . . . . 0.0 115.019 -178.762 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 . . . . . 0 C--O 1.214 -0.803 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -74.4 155.37 38.16 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 111.58 -2.554 . . . . 0.0 109.784 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 tp -147.54 138.67 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.199 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 -175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.7 t -145.01 154.3 42.39 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.67 -1.269 . . . . 0.0 109.113 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -54.9 -30.16 57.58 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 126.065 1.746 . . . . 0.0 112.246 168.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.96 -37.44 82.4 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 171.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -70.77 -44.7 66.15 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.297 1.839 . . . . 0.0 113.108 168.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.4 mt -58.76 -43.19 90.26 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 82.18 -3.96 1.47 Allowed 'General case' 0 N--CA 1.411 -2.388 0 CA-C-O 122.427 1.108 . . . . 0.0 108.969 -177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -138.53 151.07 47.02 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 118.678 -2.513 . . . . 0.0 106.147 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 tp -51.09 142.24 12.72 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 126.133 1.773 . . . . 0.0 114.039 -167.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -55.9 134.83 73.19 Favored Pre-proline 0 CA--C 1.583 2.234 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -97.76 2.31 1.47 Allowed 'Trans proline' 0 C--O 1.206 -1.097 0 CA-C-O 113.898 -2.626 . . . . 0.0 112.273 -174.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.3 mt -112.34 165.95 11.73 Favored 'General case' 0 C--N 1.364 1.221 0 CA-C-N 121.558 1.981 . . . . 0.0 110.986 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.2 p -91.99 -25.26 18.93 Favored 'General case' 0 C--N 1.361 1.097 0 O-C-N 120.564 -1.335 . . . . 0.0 111.381 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 m -71.3 135.12 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -79.31 115.11 18.77 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 124.076 0.86 . . . . 0.0 109.207 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.345 38.5 m80 57.74 -164.74 0.17 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 117.115 -1.422 . . . . 0.0 112.042 -178.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.19 -162.48 34.81 Favored Glycine 0 C--N 1.371 2.502 0 N-CA-C 103.37 -3.892 . . . . 0.0 103.37 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.38 151.29 43.38 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 103.49 -2.781 . . . . 0.0 103.49 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.97 161.04 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-O 124.303 2.001 . . . . 0.0 106.821 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -139.36 156.91 46.69 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 118.799 -2.438 . . . . 0.0 106.523 170.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.4 m -134.68 128.48 33.1 Favored 'General case' 0 C--N 1.37 1.461 0 O-C-N 120.041 -1.662 . . . . 0.0 110.808 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.1 mt -113.92 148.0 38.96 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 115.783 -2.056 . . . . 0.0 106.812 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.262 31.3 Cg_exo -50.26 147.75 15.52 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 125.21 3.94 . . . . 0.0 116.485 -166.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.257 12.3 m 72.22 39.97 0.73 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.974 1.71 . . . . 0.0 113.815 -175.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 58.53 46.72 14.46 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 128.688 2.795 . . . . 0.0 112.357 172.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.69 113.27 24.9 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 171.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.27 130.76 50.61 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.883 -1.136 . . . . 0.0 110.979 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.9 t -114.12 140.78 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-O 125.484 2.564 . . . . 0.0 106.968 -175.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -111.44 150.24 30.13 Favored 'General case' 0 C--N 1.354 0.799 0 CA-C-N 113.263 -1.79 . . . . 0.0 107.096 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.9 t -132.97 123.27 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 N-CA-C 102.174 -3.269 . . . . 0.0 102.174 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.94 163.05 17.77 Favored Pre-proline 0 CA--C 1.588 2.415 0 CA-C-O 122.625 1.203 . . . . 0.0 112.316 172.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.47 -38.96 28.43 Favored 'Trans proline' 0 N--CA 1.517 2.891 0 C-N-CA 124.861 3.707 . . . . 0.0 114.598 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.2 p-10 -84.24 -10.43 57.69 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 121.253 1.842 . . . . 0.0 113.291 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.9 4.85 36.08 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 125.645 1.593 . . . . 0.0 115.221 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.4 m -58.88 139.4 56.57 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 122.684 1.231 . . . . 0.0 114.015 167.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.1 m -111.74 125.62 54.18 Favored 'General case' 0 C--O 1.206 -1.219 0 O-C-N 121.088 -1.008 . . . . 0.0 110.942 -165.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -133.95 166.23 23.19 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 123.454 1.597 . . . . 0.0 110.641 -165.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -117.38 124.19 48.3 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 119.824 -1.798 . . . . 0.0 112.394 -171.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.1 tp -90.02 -26.76 20.15 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -173.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -135.81 178.17 7.25 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.734 -1.229 . . . . 0.0 108.727 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -53.34 -43.88 68.04 Favored 'General case' 0 C--N 1.399 2.72 0 C-N-CA 125.611 1.564 . . . . 0.0 114.504 -171.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -70.65 -31.71 68.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.64 -37.53 65.31 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 122.578 1.18 . . . . 0.0 109.241 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -62.52 -50.52 71.04 Favored 'General case' 0 C--N 1.364 1.205 0 O-C-N 119.926 -1.734 . . . . 0.0 109.824 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -53.81 -31.77 50.28 Favored 'General case' 0 CA--C 1.586 2.333 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.92 -22.8 66.52 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 115.953 -1.975 . . . . 0.0 112.422 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 128.81 8.47 3.81 Favored Glycine 0 C--N 1.378 2.885 0 CA-C-N 122.696 2.498 . . . . 0.0 116.12 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -118.79 145.65 38.23 Favored Pre-proline 0 C--N 1.376 1.741 0 CA-C-N 121.862 2.831 . . . . 0.0 108.496 -174.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -51.68 148.62 20.95 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.945 3.097 . . . . 0.0 111.042 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -78.98 146.98 20.83 Favored 'Trans proline' 0 CA--C 1.511 -0.641 1 C-N-CA 125.418 4.079 . . . . 0.0 108.048 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.7 tp -89.25 -0.32 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 125.295 2.474 . . . . 0.0 111.229 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.6 p -56.1 -42.21 94.99 Favored Pre-proline 0 C--O 1.213 -0.827 0 CA-C-O 113.663 -3.065 . . . . 0.0 112.9 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -59.94 -31.8 94.19 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 CA-C-N 126.509 3.36 . . . . 0.0 115.693 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.3 tt -98.75 13.55 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -55.19 149.06 13.09 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.011 -1.449 . . . . 0.0 110.3 162.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -92.79 136.09 33.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 112.767 -2.015 . . . . 0.0 110.623 172.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -67.66 145.69 54.56 Favored 'General case' 0 C--O 1.201 -1.489 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.759 164.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.91 175.63 23.3 Favored Glycine 0 N--CA 1.484 1.851 0 CA-C-O 122.947 1.304 . . . . 0.0 110.883 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.3 t -71.72 125.46 27.19 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 112.745 -1.727 . . . . 0.0 110.668 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.1 7.61 57.21 Favored Glycine 0 C--N 1.353 1.525 0 O-C-N 125.385 1.678 . . . . 0.0 116.887 -165.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.98 156.9 22.25 Favored Glycine 0 CA--C 1.54 1.598 0 O-C-N 121.516 -0.991 . . . . 0.0 114.409 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.82 161.0 11.54 Favored Glycine 0 C--N 1.368 2.346 0 C-N-CA 130.347 3.832 . . . . 0.0 114.107 167.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -71.1 138.97 50.15 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 125.941 1.696 . . . . 0.0 108.442 -167.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.1 mt -73.77 140.24 18.04 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-N 110.087 -3.233 . . . . 0.0 112.62 168.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.4 t -65.03 152.15 44.18 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 118.296 2.702 . . . . 0.0 118.296 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 59.5 mt -102.22 11.74 37.76 Favored 'General case' 0 C--O 1.206 -1.214 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -177.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.85 -51.81 56.27 Favored Glycine 0 CA--C 1.555 2.584 0 O-C-N 119.177 -2.202 . . . . 0.0 116.981 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.452 ' HA ' ' HG ' ' A' ' 132' ' ' SER . . . -67.66 -37.38 82.29 Favored 'General case' 0 N--CA 1.42 -1.928 0 O-C-N 119.164 -2.374 . . . . 0.0 114.184 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.8 tp -60.98 -45.43 94.82 Favored 'General case' 0 C--O 1.252 1.227 0 C-N-CA 124.399 1.079 . . . . 0.0 111.111 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.8 tp -69.95 -42.21 73.52 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.452 ' HG ' ' HA ' ' A' ' 129' ' ' ALA . 22.6 p -63.41 -45.31 91.59 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.16 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 94.4 m -64.23 -42.72 96.44 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 126.118 2.136 . . . . 0.0 109.398 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 92.4 m -46.92 -55.76 7.52 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 115.104 -2.379 . . . . 0.0 116.379 167.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 25.1 mt -71.56 -25.21 62.11 Favored 'General case' 0 CA--C 1.568 1.654 0 O-C-N 128.173 3.42 . . . . 0.0 113.781 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -60.38 -45.88 91.96 Favored 'General case' 0 CA--C 1.58 2.112 0 C-N-CA 126.853 2.061 . . . . 0.0 110.327 164.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.4 mt -65.2 -42.96 93.04 Favored 'General case' 0 C--N 1.416 3.497 0 O-C-N 119.58 -1.95 . . . . 0.0 114.281 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 16.6 p -101.81 15.76 27.97 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 127.256 2.222 . . . . 0.0 110.702 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.942 0 CA-C-O 115.901 -2.611 . . . . 0.0 114.092 174.892 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 . . . . . 0 CA--C 1.557 1.222 0 CA-C-O 123.29 1.519 . . . . 0.0 108.106 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -87.18 155.82 19.94 Favored 'General case' 0 CA--C 1.557 1.248 0 O-C-N 117.502 -3.249 . . . . 0.0 111.62 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.7 tp -113.48 117.85 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 123.292 1.52 . . . . 0.0 113.443 165.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.475 ' HB2' ' CD2' ' A' ' 77' ' ' HIS . 92.0 p -128.87 179.25 5.83 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 123.645 1.688 . . . . 0.0 109.285 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -61.65 -29.68 70.22 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 119.581 -1.95 . . . . 0.0 114.284 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.99 -42.57 84.8 Favored 'General case' 0 C--O 1.266 1.936 0 C-N-CA 125.448 1.499 . . . . 0.0 112.932 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.44 -46.2 84.18 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 164.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.27 83.3 mt -73.73 -17.38 61.12 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 122.78 2.536 . . . . 0.0 113.872 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.3 . . 65.18 11.76 7.46 Favored 'General case' 0 C--O 1.192 -1.961 0 O-C-N 127.915 3.259 . . . . 0.0 115.953 -177.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -165.12 166.4 19.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 127.307 2.243 . . . . 0.0 107.004 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.7 mt -18.93 133.07 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.443 3.097 . . . . 0.0 119.209 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -73.72 127.01 89.19 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 116.622 -3.799 . . . . 0.0 114.975 164.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -89.15 15.49 2.01 Favored 'Trans proline' 0 CA--C 1.57 2.294 0 CA-C-N 123.292 2.211 . . . . 0.0 112.229 -168.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 mt -136.0 165.1 26.46 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-O 123.753 1.739 . . . . 0.0 110.727 -172.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.8 p -100.97 -1.56 34.1 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.561 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.2 m -90.27 171.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.381 1.962 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 169.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -81.26 174.7 11.27 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 122.27 1.033 . . . . 0.0 111.816 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.475 ' CD2' ' HB2' ' A' ' 63' ' ' SER . 8.7 m-70 -73.37 144.18 46.55 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 128.838 2.855 . . . . 0.0 106.012 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.03 179.54 36.42 Favored Glycine 0 C--N 1.367 2.304 0 CA-C-N 112.058 -2.337 . . . . 0.0 110.501 -164.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.3 m -84.65 120.21 26.12 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-O 123.716 1.722 . . . . 0.0 113.593 -173.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -86.69 143.68 10.91 Favored 'Isoleucine or valine' 0 C--O 1.257 1.489 0 CA-C-O 124.243 1.973 . . . . 0.0 111.574 165.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -145.67 151.68 38.42 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 112.577 -2.101 . . . . 0.0 107.125 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 89.6 m -121.51 115.02 22.07 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-O 125.086 2.374 . . . . 0.0 107.132 172.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mt -92.86 150.81 40.09 Favored Pre-proline 0 CA--C 1.507 -0.701 0 CA-C-O 116.093 -1.908 . . . . 0.0 106.564 -174.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -47.07 138.75 15.93 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 123.848 3.032 . . . . 0.0 116.545 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.6 m 80.14 49.26 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 120.757 1.617 . . . . 0.0 115.229 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 46.98 49.19 14.99 Favored 'General case' 0 C--N 1.392 2.448 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -106.32 116.51 32.06 Favored 'General case' 0 C--N 1.385 2.119 0 C-N-CA 117.868 -1.533 . . . . 0.0 111.942 170.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.77 106.94 15.85 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-O 123.291 1.52 . . . . 0.0 107.575 -173.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.7 m -122.67 144.79 30.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 C-N-CA 127.589 2.356 . . . . 0.0 109.089 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -113.33 128.47 56.47 Favored 'General case' 0 N--CA 1.425 -1.687 0 O-C-N 119.006 -2.309 . . . . 0.0 106.165 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.9 t -106.49 111.64 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.98 156.3 92.02 Favored Pre-proline 0 C--O 1.27 2.153 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.598 171.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.61 2.36 2.98 Favored 'Trans proline' 0 CA--C 1.498 -1.31 0 C-N-CA 124.409 3.406 . . . . 0.0 113.241 -166.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -102.66 -25.13 13.67 Favored 'General case' 0 C--O 1.245 0.834 0 O-C-N 127.139 2.774 . . . . 0.0 110.188 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.11 24.85 3.16 Favored Glycine 0 C--N 1.348 1.242 0 C-N-CA 126.282 1.896 . . . . 0.0 110.815 172.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.46 147.32 24.35 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.0 m -129.47 125.68 36.97 Favored 'General case' 0 C--O 1.263 1.814 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -167.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -128.94 126.81 40.45 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 125.852 1.97 . . . . 0.0 108.581 -165.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.04 124.26 19.99 Favored 'General case' 0 C--O 1.211 -0.932 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 69.7 mt -93.77 -30.49 14.83 Favored 'General case' 0 C--N 1.369 1.441 0 O-C-N 119.638 -1.914 . . . . 0.0 112.571 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -122.12 178.11 5.05 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 124.132 1.92 . . . . 0.0 106.51 174.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -79.04 -19.51 51.26 Favored 'General case' 0 CA--C 1.583 2.223 0 O-C-N 118.402 -2.687 . . . . 0.0 117.751 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -59.18 -37.78 78.19 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 126.018 2.074 . . . . 0.0 110.168 172.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.23 -30.75 69.89 Favored 'General case' 0 CA--C 1.472 -2.029 0 CA-C-O 114.998 -2.429 . . . . 0.0 113.271 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -62.7 -41.31 99.06 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 126.788 2.035 . . . . 0.0 114.014 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -66.34 -37.01 84.36 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 168.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.32 -4.68 40.61 Favored 'General case' 0 C--O 1.257 1.475 0 O-C-N 118.801 -2.437 . . . . 0.0 112.348 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.94 28.63 9.83 Favored Glycine 0 C--N 1.353 1.526 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.75 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -86.43 134.92 37.13 Favored Pre-proline 0 CA--C 1.58 2.1 0 CA-C-O 115.468 -2.206 . . . . 0.0 107.862 170.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -56.8 128.26 29.23 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 O-C-N 125.667 2.404 . . . . 0.0 114.313 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -32.27 145.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.362 2.041 . . . . 0.0 115.824 161.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.9 tt -99.96 19.46 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 C-N-CA 126.188 1.795 . . . . 0.0 110.453 173.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.05 -30.47 1.13 Allowed Pre-proline 0 CA--C 1.558 1.251 0 CA-C-O 112.165 -3.778 . . . . 0.0 116.439 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -71.59 -42.33 1.85 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 125.342 2.944 . . . . 0.0 111.716 -169.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 21.5 pt -88.28 6.19 3.75 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 C-N-CA 128.243 2.617 . . . . 0.0 111.774 -165.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -53.11 155.9 2.39 Favored 'General case' 0 C--O 1.221 -0.419 1 O-C-N 116.021 -4.174 . . . . 0.0 118.355 168.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -98.68 147.33 24.96 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 117.31 -1.756 . . . . 0.0 110.04 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . 0.353 13.7 mmmm -64.94 143.99 57.58 Favored 'General case' 0 C--N 1.37 1.476 0 CA-C-O 124.072 1.891 . . . . 0.0 110.568 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -82.06 -146.19 5.6 Favored Glycine 0 CA--C 1.57 3.489 0 CA-C-O 126.374 3.208 . . . . 0.0 117.503 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.4 t -111.42 111.74 22.99 Favored 'General case' 0 CA--C 1.512 -0.507 1 O-C-N 116.113 -4.169 . . . . 0.0 102.86 170.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.48 48.27 5.37 Favored Glycine 1 C--N 1.399 4.053 0 CA-C-N 120.319 1.418 . . . . 0.0 110.096 177.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.82 -164.52 54.78 Favored Glycine 0 C--N 1.381 3.075 0 N-CA-C 117.12 1.608 . . . . 0.0 117.12 -171.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.39 -166.4 1.14 Allowed Glycine 0 C--N 1.338 0.684 1 N-CA-C 123.491 4.157 . . . . 0.0 123.491 -173.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . 0.317 74.3 m-85 -133.54 149.06 51.68 Favored 'General case' 0 C--O 1.253 1.269 0 O-C-N 117.414 -3.403 . . . . 0.0 110.296 -173.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 79.6 mt -63.92 151.67 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.163 0 CA-C-N 124.082 3.128 . . . . 0.0 108.784 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.0 t -62.55 145.24 54.84 Favored 'General case' 0 C--O 1.198 -1.64 0 O-C-N 118.273 -2.767 . . . . 0.0 113.17 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.7 mt -97.52 4.92 50.26 Favored 'General case' 0 CA--C 1.58 2.116 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 -172.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -76.59 -41.72 23.83 Favored Glycine 0 C--N 1.394 3.789 0 C-N-CA 119.683 -1.246 . . . . 0.0 115.38 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.26 -34.52 72.91 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 117.389 -3.418 . . . . 0.0 115.767 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 27.9 tp -54.26 -58.71 6.36 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 126.083 1.753 . . . . 0.0 112.133 165.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 38.3 tp -63.09 -40.3 97.25 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.3 p -71.82 -33.45 68.52 Favored 'General case' 0 C--O 1.251 1.175 0 O-C-N 119.296 -2.128 . . . . 0.0 115.108 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 32.4 m -61.71 -42.69 99.28 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.92 1.288 . . . . 0.0 108.656 169.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.1 m -57.56 -46.85 83.43 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.8 mt -72.12 -30.13 64.75 Favored 'General case' 0 CA--C 1.562 1.406 0 O-C-N 124.865 1.353 . . . . 0.0 112.232 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -58.25 -46.62 85.65 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 116.845 -1.55 . . . . 0.0 113.14 168.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 71.9 mt -72.63 -45.25 59.96 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 119.236 0.926 . . . . 0.0 111.29 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . 0.342 1.2 p -74.44 -17.76 60.74 Favored 'General case' 0 C--O 1.202 -1.429 0 CA-C-O 115.75 -2.072 . . . . 0.0 113.328 -170.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.381 3.065 0 N-CA-C 120.035 2.774 . . . . 0.0 120.035 169.757 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 . . . . . 0 CA--C 1.466 -2.26 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.75 139.06 55.32 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.1 tt -116.24 142.6 29.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 121.458 -0.776 . . . . 0.0 109.408 162.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.508 ' HB2' ' CE1' ' A' ' 77' ' ' HIS . 90.3 p -152.76 158.88 42.93 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-O 116.143 -1.885 . . . . 0.0 107.207 -169.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -64.28 -18.16 64.32 Favored 'General case' 0 C--N 1.367 1.365 0 CA-C-N 123.608 2.913 . . . . 0.0 110.598 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.96 -25.9 53.37 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 120.476 -1.39 . . . . 0.0 111.817 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -73.29 -28.66 62.23 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 125.949 1.7 . . . . 0.0 111.275 173.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mt -88.98 3.77 50.45 Favored 'General case' 0 C--O 1.203 -1.35 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 36.8 63.01 0.72 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 120.747 3.61 . . . . 0.0 120.747 -168.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . 0.297 51.0 t80 83.58 149.12 0.08 Allowed 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 129.214 3.006 . . . . 0.0 109.714 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.324 2.1 tp 89.57 81.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 128.989 2.916 . . . . 0.0 109.601 173.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -85.7 124.79 70.64 Favored Pre-proline 0 N--CA 1.479 0.989 0 O-C-N 120.37 -1.456 . . . . 0.0 112.474 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.72 3.2 8.0 Favored 'Trans proline' 0 C--N 1.362 1.253 0 CA-C-N 122.037 1.763 . . . . 0.0 114.637 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.9 mt -120.63 158.27 27.77 Favored 'General case' 0 C--N 1.375 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.95 -165.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.0 p -78.83 -30.08 45.07 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 170.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.5 m -71.91 147.71 10.4 Favored 'Isoleucine or valine' 0 C--N 1.367 1.36 0 C-N-CA 124.506 1.122 . . . . 0.0 111.491 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . 0.256 62.7 t0 -90.15 82.35 6.07 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 118.49 -2.631 . . . . 0.0 111.426 -172.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.508 ' CE1' ' HB2' ' A' ' 63' ' ' SER 0.33 27.5 m170 77.84 178.12 0.15 Allowed 'General case' 0 CA--C 1.474 -1.956 0 O-C-N 120.567 -1.333 . . . . 0.0 114.013 179.016 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.21 -176.57 39.86 Favored Glycine 0 N--CA 1.433 -1.535 0 O-C-N 117.977 -2.952 . . . . 0.0 114.711 -172.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.495 ' HG1' ' HB ' ' A' ' 91' ' ' VAL 0.259 17.0 p -124.24 146.29 48.84 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 118.591 -2.711 . . . . 0.0 105.757 171.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 pp -119.84 150.09 22.45 Favored 'Isoleucine or valine' 0 C--N 1.366 1.29 0 CA-C-O 126.644 3.116 . . . . 0.0 112.379 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -141.66 137.9 32.1 Favored 'General case' 0 CA--C 1.57 1.745 0 O-C-N 116.536 -3.852 . . . . 0.0 108.524 168.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.9 m -108.29 140.78 41.06 Favored 'General case' 0 C--N 1.368 1.385 0 O-C-N 117.342 -3.349 . . . . 0.0 104.906 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.7 mt -111.38 146.99 35.73 Favored Pre-proline 0 N--CA 1.432 -1.359 0 C-N-CA 129.501 3.12 . . . . 0.0 102.909 -173.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -40.35 134.58 2.01 Favored 'Trans proline' 0 N--CA 1.507 2.274 1 C-N-CA 126.45 4.767 . . . . 0.0 113.059 -173.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.272 1.0 OUTLIER 85.2 31.59 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 122.489 1.137 . . . . 0.0 108.909 170.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . 0.281 21.8 m-20 65.84 44.54 2.79 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 116.872 -3.642 . . . . 0.0 115.448 176.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -101.74 114.07 27.81 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.21 120.82 36.09 Favored 'General case' 0 N--CA 1.409 -2.508 0 O-C-N 125.013 1.446 . . . . 0.0 111.284 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.1 t -99.87 145.35 10.84 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 CA-C-O 127.737 3.637 . . . . 0.0 109.883 166.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -111.3 128.56 55.98 Favored 'General case' 0 N--CA 1.44 -0.94 1 O-C-N 115.038 -4.789 . . . . 0.0 106.714 168.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.495 ' HB ' ' HG1' ' A' ' 79' ' ' THR . 40.8 t -110.44 124.57 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.723 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.36 167.15 19.69 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-O 117.222 -1.37 . . . . 0.0 114.367 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -41.13 -34.31 1.54 Allowed 'Trans proline' 0 N--CA 1.52 3.079 0 N-CA-C 120.518 3.238 . . . . 0.0 120.518 165.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.0 p30 -96.99 3.89 51.77 Favored 'General case' 0 CA--C 1.477 -1.846 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.77 -13.25 29.71 Favored Glycine 0 CA--C 1.526 0.725 0 O-C-N 120.262 -1.524 . . . . 0.0 111.91 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.282 47.0 m -66.47 113.02 4.38 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -173.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.68 119.58 10.16 Favored 'General case' 0 C--N 1.375 1.691 0 C-N-CA 128.014 2.526 . . . . 0.0 115.6 171.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -120.04 141.52 49.67 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 166.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.04 149.3 37.37 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 153.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . 0.255 23.1 tp -118.76 -3.26 10.81 Favored 'General case' 0 C--N 1.379 1.883 0 C-N-CA 129.87 3.268 . . . . 0.0 111.848 177.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.2 p30 -158.07 175.1 14.23 Favored 'General case' 0 C--N 1.38 1.897 0 CA-C-N 120.412 1.46 . . . . 0.0 109.916 169.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . 0.315 69.4 m-20 -60.34 -36.91 79.07 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -173.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.4 mtt85 -59.19 -41.34 88.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 127.811 3.194 . . . . 0.0 111.639 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.12 -23.5 28.42 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-O 124.932 2.301 . . . . 0.0 114.659 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -63.7 -47.28 81.78 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.63 -1.623 . . . . 0.0 112.391 163.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -61.32 -38.12 85.71 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-O 125.157 2.408 . . . . 0.0 115.427 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.39 -34.23 68.66 Favored 'General case' 0 CA--C 1.572 1.819 0 O-C-N 119.308 -2.12 . . . . 0.0 113.388 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 127.92 -3.83 6.92 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 120.807 3.083 . . . . 0.0 120.807 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -70.66 143.49 89.88 Favored Pre-proline 0 N--CA 1.487 1.421 0 CA-C-N 121.654 2.727 . . . . 0.0 112.161 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -48.44 146.8 9.84 Favored 'Trans proline' 0 C--N 1.296 -2.229 1 C-N-CA 126.323 4.682 . . . . 0.0 119.431 175.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -82.25 151.76 15.85 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 118.266 -1.492 . . . . 0.0 109.503 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.9 tt -86.08 4.19 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.554 1.942 . . . . 0.0 109.784 -171.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.65 -40.28 74.1 Favored Pre-proline 0 CA--C 1.578 2.029 1 N-CA-C 122.04 4.089 . . . . 0.0 122.04 -168.339 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.84 -6.66 14.31 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 113.974 -3.751 . . . . 0.0 114.308 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 31.4 mm -86.19 -16.61 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 C-N-CA 125.904 1.682 . . . . 0.0 106.952 176.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -56.93 145.39 30.2 Favored 'General case' 0 C--O 1.194 -1.834 0 CA-C-O 126.04 2.829 . . . . 0.0 117.49 164.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -93.7 132.59 37.91 Favored 'General case' 0 C--O 1.209 -1.07 0 CA-C-N 112.459 -2.155 . . . . 0.0 111.774 174.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . 0.467 41.3 mtpt -57.65 144.58 37.13 Favored 'General case' 0 C--O 1.178 -2.676 0 O-C-N 119.322 -2.111 . . . . 0.0 112.989 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -110.79 -168.88 19.21 Favored Glycine 0 N--CA 1.494 2.524 0 CA-C-N 119.943 1.247 . . . . 0.0 112.215 -159.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 64.4 m -76.05 119.89 20.61 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 116.145 -1.883 . . . . 0.0 113.487 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.55 49.33 5.83 Favored Glycine 0 C--N 1.365 2.147 0 CA-C-N 121.669 2.031 . . . . 0.0 114.194 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 59.62 -155.85 28.36 Favored Glycine 1 CA--C 1.593 4.918 0 O-C-N 118.245 -2.914 . . . . 0.0 116.375 -158.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 49.81 -152.69 3.58 Favored Glycine 0 C--O 1.213 -1.163 0 CA-C-O 124.395 2.108 . . . . 0.0 114.904 -167.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -134.58 148.44 50.46 Favored 'General case' 0 N--CA 1.418 -2.041 0 C-N-CA 126.594 1.958 . . . . 0.0 111.721 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.9 mt -60.9 140.17 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.363 0 O-C-N 120.324 -1.485 . . . . 0.0 112.391 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.5 t -52.61 137.65 30.13 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 128.844 2.857 . . . . 0.0 112.999 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.4 mt -98.46 4.48 48.37 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.481 -1.387 . . . . 0.0 111.47 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -44.25 -63.88 2.21 Favored Glycine 0 CA--C 1.486 -1.726 0 C-N-CA 127.775 2.607 . . . . 0.0 113.823 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.9 -45.08 93.68 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 173.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.0 tp -63.18 -43.44 98.22 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 124.502 1.126 . . . . 0.0 113.561 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.8 tp -64.72 -45.97 84.27 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 121.736 0.779 . . . . 0.0 112.405 168.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 78.4 p -74.8 -36.46 62.48 Favored 'General case' 0 CA--C 1.497 -1.095 0 O-C-N 117.919 -2.988 . . . . 0.0 113.347 -169.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 52.0 m -59.89 -43.09 94.99 Favored 'General case' 0 C--O 1.266 1.97 0 C-N-CA 128.695 2.798 . . . . 0.0 105.588 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 47.0 m -63.05 -41.65 99.54 Favored 'General case' 0 C--N 1.377 1.787 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.527 -174.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 17.8 mt -69.64 -36.95 76.57 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 117.719 2.489 . . . . 0.0 117.719 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -61.39 -37.89 85.09 Favored 'General case' 0 CA--C 1.57 1.715 0 O-C-N 116.801 -3.687 . . . . 0.0 109.839 165.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.0 tp -69.92 -31.25 68.92 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 118.155 -2.841 . . . . 0.0 115.622 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 28.6 p -92.21 14.86 14.96 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.088 -1.008 . . . . 0.0 110.957 176.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.984 0 C-N-CA 125.779 1.656 . . . . 0.0 109.993 -179.902 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -73.76 135.02 43.54 Favored 'General case' 0 N--CA 1.411 -2.402 0 O-C-N 128.338 3.524 . . . . 0.0 111.464 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.9 tp -136.54 128.88 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 125.571 2.605 . . . . 0.0 112.945 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.9 p -162.76 171.78 16.24 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 127.271 2.228 . . . . 0.0 107.832 -159.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -45.1 -52.17 9.42 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 128.253 2.621 . . . . 0.0 114.756 173.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.76 93.55 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 174.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -82.45 -19.87 38.08 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 120.293 -1.504 . . . . 0.0 111.522 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.6 tp -75.06 -42.57 56.67 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 117.971 2.582 . . . . 0.0 117.971 166.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 65.56 15.71 10.16 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 130.006 3.322 . . . . 0.0 114.289 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -134.27 166.81 21.94 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 162.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.6 mt -39.31 128.67 1.8 Allowed 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -174.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.436 ' CD2' ' HD2' ' A' ' 72' ' ' PRO . 53.9 t-105 -66.27 139.62 96.44 Favored Pre-proline 0 CA--C 1.567 1.621 0 CA-C-O 113.296 -3.24 . . . . 0.0 114.806 176.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HD2' ' CD2' ' A' ' 71' ' ' TRP . 2.1 Cg_endo -116.97 -3.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 2.015 0 CA-C-O 111.187 -3.755 . . . . 0.0 110.302 -167.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 mt -113.13 152.95 29.01 Favored 'General case' 0 C--N 1.401 2.818 0 O-C-N 127.484 2.99 . . . . 0.0 112.929 -177.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.2 p -79.28 -17.12 55.31 Favored 'General case' 0 N--CA 1.416 -2.132 0 O-C-N 118.281 -2.762 . . . . 0.0 113.64 -171.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.8 m -72.16 147.94 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 129.986 3.314 . . . . 0.0 115.003 166.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -56.59 171.24 0.32 Allowed 'General case' 0 C--O 1.2 -1.527 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 154.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -36.32 127.13 0.79 Allowed 'General case' 0 C--N 1.373 1.62 0 C-N-CA 130.322 3.449 . . . . 0.0 109.778 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.58 -168.24 22.68 Favored Glycine 0 N--CA 1.434 -1.459 0 CA-C-O 123.322 1.512 . . . . 0.0 111.659 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.9 m -120.97 115.57 23.43 Favored 'General case' 0 C--N 1.378 1.825 0 CA-C-N 111.228 -2.486 . . . . 0.0 109.031 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . 0.328 1.9 pp -88.81 138.38 19.31 Favored 'Isoleucine or valine' 0 C--N 1.396 2.605 0 CA-C-N 121.074 1.761 . . . . 0.0 110.534 172.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -133.39 132.5 41.28 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.4 m -100.16 130.32 46.28 Favored 'General case' 0 C--N 1.382 1.994 0 CA-C-O 124.053 1.883 . . . . 0.0 110.322 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.3 mt -105.52 157.53 34.31 Favored Pre-proline 0 CA--C 1.569 1.706 0 O-C-N 119.32 -2.113 . . . . 0.0 113.589 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -40.35 145.73 0.32 Allowed 'Trans proline' 0 CA--C 1.475 -2.475 1 C-N-CA 127.084 5.19 . . . . 0.0 113.425 169.1 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.1 m 70.55 41.41 0.95 Allowed 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 118.971 2.952 . . . . 0.0 118.971 173.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 64.98 30.35 11.88 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 129.343 3.057 . . . . 0.0 112.751 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.254 65.5 m-20 -101.06 137.31 39.59 Favored 'General case' 0 C--N 1.373 1.615 0 CA-C-N 120.009 1.277 . . . . 0.0 109.497 -169.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.12 124.2 36.35 Favored 'General case' 0 C--O 1.2 -1.535 0 CA-C-N 122.431 2.378 . . . . 0.0 111.002 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.254 32.7 m -120.11 144.29 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-O 124.361 2.029 . . . . 0.0 113.252 -174.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -121.06 131.37 54.24 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 120.236 -1.54 . . . . 0.0 107.594 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.35 118.32 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.323 0 C-N-CA 126.309 1.843 . . . . 0.0 110.867 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.17 156.51 76.51 Favored Pre-proline 0 CA--C 1.577 1.99 0 O-C-N 126.435 2.334 . . . . 0.0 115.401 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -43.69 -35.1 6.18 Favored 'Trans proline' 0 C--O 1.255 1.372 0 N-CA-C 120.395 3.19 . . . . 0.0 120.395 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -69.98 -33.54 72.19 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 116.779 -1.581 . . . . 0.0 113.719 172.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 127.86 -3.31 6.94 Favored Glycine 0 C--N 1.364 2.086 1 C-N-CA 130.915 4.102 . . . . 0.0 113.745 176.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.8 m -57.07 132.47 53.01 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 125.257 1.423 . . . . 0.0 113.834 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.4 m -106.19 109.0 20.8 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 123.163 2.711 . . . . 0.0 107.072 -174.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -113.26 148.4 35.64 Favored 'General case' 0 C--O 1.255 1.351 0 O-C-N 120.631 -1.293 . . . . 0.0 108.837 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.3 127.65 33.44 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 114.636 -2.602 . . . . 0.0 111.438 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.38 -9.43 30.0 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 120.339 1.427 . . . . 0.0 112.393 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -141.75 171.02 14.63 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.414 1.102 . . . . 0.0 110.484 172.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -65.27 -32.54 74.26 Favored 'General case' 0 N--CA 1.416 -2.172 0 C-N-CA 130.396 3.478 . . . . 0.0 110.909 -171.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -59.09 -42.48 90.55 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 125.482 1.739 . . . . 0.0 113.352 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.6 -17.31 39.12 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -172.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -66.23 -44.14 84.6 Favored 'General case' 0 C--N 1.381 1.952 0 CA-C-O 116.262 -1.828 . . . . 0.0 110.289 158.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -65.31 -42.78 92.66 Favored 'General case' 0 C--N 1.362 1.117 0 O-C-N 126.445 2.341 . . . . 0.0 116.878 173.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.6 -34.74 73.12 Favored 'General case' 0 C--N 1.374 1.67 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 166.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 140.27 -17.88 2.9 Favored Glycine 0 C--N 1.376 2.753 0 N-CA-C 119.408 2.523 . . . . 0.0 119.408 166.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -71.47 140.96 85.01 Favored Pre-proline 0 C--O 1.272 2.243 0 CA-C-N 119.904 1.852 . . . . 0.0 111.4 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.66 136.5 0.66 Allowed 'Trans proline' 0 C--N 1.378 2.113 1 C-N-CA 125.358 4.039 . . . . 0.0 117.412 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -55.61 155.64 20.9 Favored 'Trans proline' 0 CA--C 1.565 2.031 0 C-N-CA 122.862 2.375 . . . . 0.0 112.106 173.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 tp -79.92 -14.7 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 122.455 1.121 . . . . 0.0 113.821 -172.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . 0.303 2.3 m -15.71 -61.61 0.04 OUTLIER Pre-proline 0 C--O 1.248 1.001 1 N-CA-C 122.254 4.168 . . . . 0.0 122.254 169.254 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -48.82 -45.36 28.61 Favored 'Trans proline' 0 C--N 1.29 -2.532 0 C-N-CA 124.207 3.271 . . . . 0.0 115.887 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . 0.255 8.4 pt -106.98 12.82 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 117.531 -3.23 . . . . 0.0 111.415 -162.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -62.96 140.19 58.83 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 166.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.92 137.84 39.67 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 120.62 -1.3 . . . . 0.0 108.082 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -58.49 156.23 10.82 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 116.709 2.115 . . . . 0.0 116.709 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -108.53 -165.25 20.95 Favored Glycine 0 CA--C 1.563 3.057 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.8 t -110.19 116.99 32.5 Favored 'General case' 0 C--N 1.388 2.254 0 CA-C-O 116.383 -1.77 . . . . 0.0 108.747 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.16 55.61 2.73 Favored Glycine 0 C--N 1.388 3.439 0 C-N-CA 127.122 2.296 . . . . 0.0 115.988 -162.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.65 -161.84 11.84 Favored Glycine 0 CA--C 1.455 -3.666 0 N-CA-C 119.08 2.392 . . . . 0.0 119.08 -164.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.44 -175.27 25.92 Favored Glycine 0 C--N 1.365 2.157 0 N-CA-C 119.223 2.449 . . . . 0.0 119.223 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -127.59 163.81 23.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 175.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.0 mm -61.99 120.5 8.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.92 0 O-C-N 126.559 2.412 . . . . 0.0 108.881 166.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.7 t -62.12 154.83 25.95 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.1 mt -102.43 10.3 39.09 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 124.602 2.144 . . . . 0.0 115.223 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.51 -40.2 86.54 Favored Glycine 0 N--CA 1.486 2.011 0 O-C-N 117.393 -3.317 . . . . 0.0 118.548 -165.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.36 -42.57 96.14 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-O 125.174 2.416 . . . . 0.0 106.614 168.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.45 -38.99 88.59 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 118.437 -2.664 . . . . 0.0 110.267 -174.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.314 8.4 tt -63.26 -53.08 58.54 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.261 1.424 . . . . 0.0 113.96 175.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 89.2 p -69.77 -30.26 67.79 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 122.145 0.974 . . . . 0.0 110.935 -171.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.4 m -67.82 -40.0 83.87 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 171.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 96.0 m -50.01 -48.68 52.43 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.587 1.955 . . . . 0.0 113.32 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 39.2 mt -67.13 -37.11 83.29 Favored 'General case' 0 N--CA 1.389 -3.521 0 O-C-N 127.635 3.085 . . . . 0.0 114.96 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -61.68 -48.44 80.79 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 121.9 2.136 . . . . 0.0 113.875 157.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.13 -42.38 94.69 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 117.24 -1.362 . . . . 0.0 114.198 -176.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . 0.272 15.6 p -92.67 9.11 36.28 Favored 'General case' 0 C--N 1.38 1.927 0 N-CA-C 118.18 2.659 . . . . 0.0 118.18 173.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.529 0 CA-C-O 114.53 -3.372 . . . . 0.0 116.963 -175.908 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.2 p . . . . . 0 C--O 1.239 0.533 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -47.55 157.62 0.83 Allowed 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 123.16 2.573 . . . . 0.0 114.722 169.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.0 136.0 96.47 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.67 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.77 36.13 0.27 Allowed 'Trans proline' 0 N--CA 1.513 2.637 0 C-N-CA 121.555 1.503 . . . . 0.0 113.523 -174.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.2 mt -119.13 152.91 52.79 Favored Pre-proline 0 CA--C 1.566 1.594 0 O-C-N 119.906 -1.746 . . . . 0.0 108.147 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.36 154.76 3.75 Favored 'Trans proline' 0 N--CA 1.513 2.656 0 C-N-CA 124.022 3.148 . . . . 0.0 114.141 153.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 m 39.95 59.68 6.87 Favored Pre-proline 0 C--N 1.359 0.995 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 174.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.54 19.85 0.62 Allowed 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 121.572 1.515 . . . . 0.0 112.223 -156.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.7 m 59.53 32.97 22.0 Favored 'General case' 0 N--CA 1.508 2.473 0 C-N-CA 125.395 1.478 . . . . 0.0 111.277 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.1 m 68.2 25.91 7.15 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 127.302 2.241 . . . . 0.0 113.388 -174.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 82.92 -4.89 1.29 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.589 1.556 . . . . 0.0 111.724 173.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -70.47 142.26 51.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.657 166.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -131.97 110.51 10.81 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 118.391 -0.814 . . . . 0.0 112.725 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.23 136.57 58.0 Favored 'General case' 0 C--O 1.252 1.233 0 O-C-N 125.983 2.052 . . . . 0.0 111.307 164.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.77 142.14 23.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 CA-C-N 113.209 -1.814 . . . . 0.0 112.967 -168.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.8 p -138.98 178.29 7.27 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 -175.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -63.79 -44.91 91.93 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 122.382 1.087 . . . . 0.0 110.413 174.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.15 78.96 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 120.351 -1.468 . . . . 0.0 113.633 172.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -66.94 -43.0 84.31 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-O 117.752 -1.118 . . . . 0.0 112.018 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.7 tp -61.59 -35.98 79.37 Favored 'General case' 0 CA--C 1.582 2.192 0 CA-C-N 120.613 1.551 . . . . 0.0 113.83 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.3 . . 79.02 32.49 0.27 Allowed 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.715 -1.241 . . . . 0.0 112.074 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -156.12 157.96 36.9 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -175.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.9 mt -50.32 127.41 17.22 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 174.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -64.52 124.04 84.78 Favored Pre-proline 0 CA--C 1.567 1.607 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.433 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -99.1 0.76 1.01 Allowed 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.953 2.435 . . . . 0.0 113.5 -159.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 mt -130.91 167.84 18.31 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.2 p -89.6 1.85 55.45 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.7 160.49 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.24 -1.537 . . . . 0.0 111.626 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -77.27 174.36 10.85 Favored 'General case' 0 CA--C 1.561 1.387 0 O-C-N 120.278 -1.514 . . . . 0.0 112.424 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -53.98 140.19 31.95 Favored 'General case' 0 CA--C 1.6 2.887 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.92 -150.29 5.33 Favored Glycine 0 C--N 1.368 2.309 0 C-N-CA 127.877 2.656 . . . . 0.0 115.001 -166.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.3 m -127.58 146.7 50.44 Favored 'General case' 0 C--N 1.364 1.217 0 O-C-N 125.492 1.348 . . . . 0.0 107.821 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.3 pt -115.79 145.69 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 C-N-CA 127.307 2.243 . . . . 0.0 109.699 167.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -147.46 141.21 25.68 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-O 122.473 1.13 . . . . 0.0 111.803 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 62.0 m -88.99 138.23 31.6 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.3 mt -120.32 155.26 56.32 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.257 33.5 Cg_exo -40.67 134.88 2.21 Favored 'Trans proline' 0 N--CA 1.523 3.207 0 N-CA-C 121.804 3.732 . . . . 0.0 121.804 174.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.385 52.9 m 79.59 50.19 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.08 1.352 . . . . 0.0 110.497 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 46.32 44.16 12.29 Favored 'General case' 0 C--N 1.366 1.324 0 CA-C-N 112.456 -2.156 . . . . 0.0 112.365 173.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -96.24 145.38 25.61 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-N 118.964 0.802 . . . . 0.0 110.667 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.71 130.03 51.63 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.0 m -119.47 157.18 21.64 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.798 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -130.39 137.89 50.1 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 102.641 -3.096 . . . . 0.0 102.641 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.0 t -126.57 119.31 53.34 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.76 164.25 2.3 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 171.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.58 -12.21 30.97 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 CA-C-O 114.703 -2.29 . . . . 0.0 114.456 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -90.57 -1.57 57.88 Favored 'General case' 0 C--N 1.367 1.34 0 CA-C-N 120.723 1.601 . . . . 0.0 113.478 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.62 -1.07 42.42 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-O 116.159 -2.467 . . . . 0.0 112.73 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.2 m -79.57 120.18 23.57 Favored 'General case' 0 C--N 1.366 1.314 0 CA-C-N 121.706 2.753 . . . . 0.0 112.899 -171.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.7 m -83.8 130.32 34.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.769 175.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -124.43 162.61 23.53 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.95 1.7 . . . . 0.0 111.743 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.54 129.99 34.98 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 169.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.4 tp -95.46 -45.71 6.98 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 116.89 -1.528 . . . . 0.0 109.43 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -105.95 164.31 12.06 Favored 'General case' 0 C--N 1.368 1.404 0 CA-C-O 122.796 1.284 . . . . 0.0 108.925 174.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -56.62 -36.88 69.95 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 125.637 1.575 . . . . 0.0 112.658 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -60.57 -44.93 95.63 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.572 1.149 . . . . 0.0 111.332 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.95 -37.4 84.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.573 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -71.05 -42.41 69.48 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 118.792 -0.623 . . . . 0.0 110.283 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -55.87 -35.63 66.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 167.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.38 -34.05 77.1 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 116.982 -1.485 . . . . 0.0 114.306 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.48 5.91 6.95 Favored Glycine 0 N--CA 1.504 3.232 0 CA-C-N 120.873 1.67 . . . . 0.0 112.144 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -80.15 130.89 64.42 Favored Pre-proline 0 CA--C 1.565 1.549 0 CA-C-O 118.172 -0.918 . . . . 0.0 108.891 170.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -64.4 148.92 90.85 Favored 'Trans proline' 0 N--CA 1.526 3.419 0 N-CA-C 119.805 2.964 . . . . 0.0 119.805 -168.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -46.49 145.45 6.13 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 N-CA-C 115.031 1.127 . . . . 0.0 115.031 172.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.1 tt -97.06 11.21 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 118.029 -1.468 . . . . 0.0 109.378 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 17.4 p -63.92 -36.45 20.91 Favored Pre-proline 0 N--CA 1.415 -2.206 1 CA-C-O 110.566 -4.54 . . . . 0.0 117.017 -174.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.99 -19.59 22.96 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 125.421 2.972 . . . . 0.0 111.264 -167.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.4 pt -104.97 21.61 3.3 Favored 'Isoleucine or valine' 0 C--N 1.36 1.049 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -175.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.92 139.11 58.09 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 125.555 1.785 . . . . 0.0 113.15 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -96.97 129.73 44.39 Favored 'General case' 0 C--N 1.365 1.262 0 C-N-CA 126.385 1.874 . . . . 0.0 115.145 170.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -81.16 150.91 28.48 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 114.864 -1.062 . . . . 0.0 113.417 166.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.23 176.06 54.33 Favored Glycine 0 CA--C 1.544 1.856 0 O-C-N 125.897 1.998 . . . . 0.0 113.609 163.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.9 m -63.45 146.43 53.62 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 121.037 2.419 . . . . 0.0 116.728 163.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 56.83 24.9 51.04 Favored Glycine 1 C--N 1.4 4.1 0 C-N-CA 126.562 2.029 . . . . 0.0 111.613 -164.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.57 -163.17 51.32 Favored Glycine 0 CA--C 1.551 2.301 0 C-N-CA 127.488 2.47 . . . . 0.0 117.688 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.5 133.08 3.86 Favored Glycine 0 C--N 1.37 2.421 0 CA-C-N 118.967 1.383 . . . . 0.0 111.326 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -79.12 149.95 31.9 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 122.186 0.993 . . . . 0.0 109.89 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 20.5 mm -89.46 147.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 114.649 -1.159 . . . . 0.0 111.576 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.0 t -75.0 147.31 40.88 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.3 mt -96.36 21.0 9.63 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 113.154 -1.839 . . . . 0.0 111.947 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.59 -47.12 5.24 Favored Glycine 0 CA--C 1.499 -0.958 0 CA-C-O 118.291 -1.283 . . . . 0.0 115.804 -168.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.43 93.24 Favored 'General case' 0 N--CA 1.44 -0.926 0 O-C-N 126.954 2.208 . . . . 0.0 109.106 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.4 tp -67.15 -44.36 79.97 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 124.156 0.982 . . . . 0.0 110.985 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.2 tp -61.92 -54.78 37.19 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.846 0.858 . . . . 0.0 110.197 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.0 p -56.52 -44.7 81.03 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.65 0.594 . . . . 0.0 110.588 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.7 m -63.02 -39.74 95.66 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.463 1.105 . . . . 0.0 110.797 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.6 m -62.96 -37.23 86.29 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 115.426 -2.226 . . . . 0.0 114.27 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 35.6 mt -88.39 -19.26 26.84 Favored 'General case' 0 C--N 1.383 2.043 0 CA-C-N 121.019 1.736 . . . . 0.0 114.272 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -61.6 -41.12 96.98 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.125 -0.984 . . . . 0.0 110.782 161.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.7 mt -61.04 -43.27 99.14 Favored 'General case' 0 C--N 1.374 1.669 0 O-C-N 124.92 1.387 . . . . 0.0 110.587 -173.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 25.5 p -101.62 27.76 6.12 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.674 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.199 -2.061 0 C-N-CA 126.352 1.929 . . . . 0.0 115.137 175.803 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.2 p . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 114.459 -2.686 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -45.7 143.11 6.68 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 CA-C-O 113.221 -2.908 . . . . 0.0 116.734 167.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.8 t -84.54 120.15 73.82 Favored Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 128.554 3.659 . . . . 0.0 109.086 160.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -81.31 30.78 0.51 Allowed 'Trans proline' 0 C--O 1.262 1.722 0 C-N-CA 124.345 3.363 . . . . 0.0 114.886 -171.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.3 mt -116.12 143.97 31.99 Favored Pre-proline 0 C--N 1.385 2.124 1 C-N-CA 131.83 4.052 . . . . 0.0 109.436 -173.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -37.14 130.8 0.54 Allowed 'Trans proline' 0 C--O 1.2 -1.379 0 C-N-CA 123.151 2.567 . . . . 0.0 116.116 166.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . 0.278 1.2 m 56.84 51.98 5.89 Favored Pre-proline 0 C--O 1.256 1.414 0 C-N-CA 127.039 2.135 . . . . 0.0 112.128 167.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -64.96 -19.22 63.83 Favored 'Trans proline' 0 C--N 1.388 2.608 0 O-C-N 126.047 2.604 . . . . 0.0 115.867 -164.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.296 1.2 m 43.28 49.37 5.85 Favored 'General case' 0 C--N 1.372 1.561 0 N-CA-C 121.103 3.742 . . . . 0.0 121.103 168.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.4 13.2 m 98.64 25.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 128.716 2.806 . . . . 0.0 113.923 174.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.298 23.6 m-20 62.74 49.15 3.87 Favored 'General case' 0 C--N 1.395 2.552 0 O-C-N 118.903 -2.373 . . . . 0.0 112.895 176.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.46 157.74 46.08 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 129.436 3.094 . . . . 0.0 108.852 174.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -137.07 155.03 50.15 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.119 -1.433 . . . . 0.0 109.931 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -90.91 126.62 36.11 Favored 'General case' 0 C--N 1.379 1.879 0 CA-C-O 123.28 1.514 . . . . 0.0 110.023 162.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 tp -115.74 138.02 47.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 127.792 2.437 . . . . 0.0 111.334 -169.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.2 p -131.51 164.55 25.55 Favored 'General case' 0 C--N 1.38 1.894 0 O-C-N 125.725 1.891 . . . . 0.0 111.069 -168.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.78 -43.02 72.45 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 117.102 -3.499 . . . . 0.0 113.104 170.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.08 85.54 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 125.659 1.85 . . . . 0.0 110.869 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -81.38 -18.38 45.73 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.7 tp -74.05 -27.83 61.11 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 119.762 -1.836 . . . . 0.0 107.497 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 66.22 39.37 4.21 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 130.514 3.526 . . . . 0.0 112.433 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -167.67 -161.95 0.42 Allowed 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.5 mt -64.33 126.79 28.91 Favored 'General case' 0 C--O 1.208 -1.112 0 C-N-CA 128.246 2.619 . . . . 0.0 111.452 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -80.94 113.95 44.67 Favored Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.87 9.96 2.79 Favored 'Trans proline' 0 C--N 1.291 -2.482 0 C-N-CA 124.106 3.204 . . . . 0.0 113.894 -171.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.0 mt -131.29 151.45 51.49 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 124.884 1.365 . . . . 0.0 112.636 -171.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.6 p -75.13 -35.85 61.65 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.71 -1.244 . . . . 0.0 110.992 172.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.4 m -75.13 156.13 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.774 0 C-N-CA 118.29 -1.364 . . . . 0.0 114.308 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -87.87 164.71 15.74 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 126.579 3.085 . . . . 0.0 107.837 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -24.3 118.76 0.05 OUTLIER 'General case' 0 N--CA 1.524 3.233 0 C-N-CA 130.25 3.42 . . . . 0.0 115.967 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -135.98 177.52 19.46 Favored Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 104.84 -3.304 . . . . 0.0 104.84 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 m -71.57 145.06 49.3 Favored 'General case' 0 C--N 1.363 1.155 0 O-C-N 127.025 2.25 . . . . 0.0 115.58 170.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 pt -116.86 135.3 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 118.689 -2.507 . . . . 0.0 105.981 168.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -155.98 146.75 22.04 Favored 'General case' 0 C--O 1.191 -1.999 0 C-N-CA 125.083 1.353 . . . . 0.0 109.924 -168.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 96.4 m -107.25 151.0 26.04 Favored 'General case' 0 C--N 1.381 1.956 0 C-N-CA 125.819 1.648 . . . . 0.0 107.886 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.0 mt -127.02 156.84 73.66 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-N 114.233 -1.348 . . . . 0.0 107.689 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -45.06 144.85 3.56 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 N-CA-C 118.971 2.643 . . . . 0.0 118.971 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t 73.94 41.43 0.41 Allowed 'General case' 0 C--N 1.366 1.3 0 C-N-CA 128.105 2.562 . . . . 0.0 111.37 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 67.64 26.77 7.89 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 119.272 3.064 . . . . 0.0 119.272 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -90.05 135.29 33.74 Favored 'General case' 0 N--CA 1.508 2.464 0 C-N-CA 127.752 2.421 . . . . 0.0 111.466 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.07 140.42 52.29 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 113.174 -1.83 . . . . 0.0 111.825 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.49 153.94 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 -168.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -116.63 118.58 33.0 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 127.234 2.214 . . . . 0.0 106.564 170.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.1 t -101.0 107.74 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.825 0 O-C-N 118.104 -2.873 . . . . 0.0 108.141 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.68 158.55 59.32 Favored Pre-proline 0 N--CA 1.432 -1.354 0 CA-C-N 113.117 -1.856 . . . . 0.0 114.348 -176.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -42.99 -28.22 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 125.21 3.94 . . . . 0.0 115.701 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 59.3 p30 -100.65 8.28 43.46 Favored 'General case' 0 C--O 1.26 1.639 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.46 7.09 82.85 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 116.416 -2.324 . . . . 0.0 117.872 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.2 m -81.07 119.71 23.89 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 123.434 3.617 . . . . 0.0 109.658 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.2 m -92.09 91.86 7.99 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -171.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -70.34 141.51 52.26 Favored 'General case' 0 C--O 1.202 -1.399 0 O-C-N 119.72 -1.863 . . . . 0.0 114.796 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.48 108.52 3.81 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.757 -1.116 . . . . 0.0 110.827 170.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.5 tp -92.84 -8.76 42.58 Favored 'General case' 0 C--O 1.251 1.159 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -135.42 171.31 14.63 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 123.94 1.829 . . . . 0.0 108.75 166.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -67.29 -39.05 85.95 Favored 'General case' 0 CA--C 1.571 1.783 0 O-C-N 118.048 -2.907 . . . . 0.0 109.467 -170.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -58.47 -42.64 87.94 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.057 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . 0.348 . . -51.86 -44.95 63.89 Favored 'General case' 0 C--N 1.37 1.493 0 CA-C-O 125.441 2.543 . . . . 0.0 114.387 170.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -69.42 -42.36 75.11 Favored 'General case' 0 CA--C 1.579 2.091 0 O-C-N 117.281 -3.387 . . . . 0.0 110.974 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -62.08 -35.66 79.33 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 128.165 2.586 . . . . 0.0 113.524 170.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.26 -16.93 58.78 Favored 'General case' 0 CA--C 1.568 1.67 0 O-C-N 121.084 -1.01 . . . . 0.0 110.163 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.0 33.82 4.2 Favored Glycine 0 CA--C 1.487 -1.68 0 N-CA-C 117.939 1.935 . . . . 0.0 117.939 173.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -80.08 154.17 74.92 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-N 118.881 1.34 . . . . 0.0 110.308 165.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -43.58 129.71 6.94 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 124.511 3.474 . . . . 0.0 118.716 164.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.42 142.41 58.48 Favored 'Trans proline' 0 N--CA 1.428 -2.378 0 C-N-CA 123.711 2.94 . . . . 0.0 110.989 169.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.9 tt -90.84 -0.78 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 C-N-CA 125.605 1.562 . . . . 0.0 109.42 -173.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 52.5 m -41.89 -65.72 0.48 Allowed Pre-proline 0 C--N 1.38 1.906 1 CA-C-O 111.203 -4.237 . . . . 0.0 120.153 170.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -70.62 -6.61 19.43 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 125.589 3.032 . . . . 0.0 118.551 -170.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 5.2 pt -107.21 8.05 9.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 122.324 2.329 . . . . 0.0 113.208 165.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -64.73 126.29 27.47 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 123.066 2.666 . . . . 0.0 113.096 169.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.73 144.09 57.48 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.575 1.172 . . . . 0.0 110.179 171.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -80.98 154.68 26.81 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.185 -1.572 . . . . 0.0 113.497 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -84.06 -174.39 50.33 Favored Glycine 0 CA--C 1.501 -0.824 0 CA-C-O 124.331 2.073 . . . . 0.0 113.701 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.5 t -102.06 139.96 36.98 Favored 'General case' 0 CA--C 1.59 2.494 0 O-C-N 118.126 -2.985 . . . . 0.0 105.604 166.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.43 35.87 21.9 Favored Glycine 0 CA--C 1.502 -0.736 0 O-C-N 118.809 -2.432 . . . . 0.0 111.97 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.27 -170.12 12.61 Favored Glycine 1 CA--C 1.58 4.11 0 CA-C-N 117.885 0.843 . . . . 0.0 114.738 -165.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.61 -179.3 49.24 Favored Glycine 0 C--N 1.361 1.929 0 N-CA-C 120.407 2.923 . . . . 0.0 120.407 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -122.07 154.12 37.75 Favored 'General case' 0 N--CA 1.509 2.491 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.4 mm -79.89 117.08 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 C-N-CA 125.081 1.352 . . . . 0.0 110.292 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.8 t -58.23 135.75 57.17 Favored 'General case' 0 CA--C 1.585 2.294 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.6 mt -92.25 10.52 29.24 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 124.763 1.225 . . . . 0.0 113.726 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.14 -53.72 29.57 Favored Glycine 0 N--CA 1.488 2.118 0 CA-C-O 123.832 1.795 . . . . 0.0 114.004 170.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.73 85.7 Favored 'General case' 0 CA--C 1.546 0.816 1 O-C-N 115.255 -4.674 . . . . 0.0 113.959 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.4 tp -64.29 -42.37 96.43 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 173.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.7 tp -59.3 -45.93 89.95 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 118.964 -2.335 . . . . 0.0 111.986 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . 0.323 19.4 p -61.94 -48.49 80.17 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 126.847 2.059 . . . . 0.0 110.426 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 45.4 m -52.98 -44.5 67.22 Favored 'General case' 0 CA--C 1.579 2.069 0 C-N-CA 126.75 2.02 . . . . 0.0 112.448 169.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 37.5 m -60.19 -46.39 89.89 Favored 'General case' 0 C--O 1.194 -1.839 0 O-C-N 117.966 -2.959 . . . . 0.0 109.119 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.0 mt -68.18 -37.22 80.71 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 123.999 1.857 . . . . 0.0 111.42 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -60.61 -42.49 96.91 Favored 'General case' 0 C--O 1.267 2.005 0 O-C-N 118.613 -2.555 . . . . 0.0 116.757 169.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.0 mt -82.77 -21.05 34.76 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . 0.373 2.0 p -98.11 3.79 49.16 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 118.834 2.901 . . . . 0.0 118.834 162.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.074 0 C-N-CA 127.301 2.382 . . . . 0.0 115.541 173.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.107 -1.425 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -49.51 156.81 2.59 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 123.524 2.816 . . . . 0.0 115.539 168.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.4 t -61.42 136.21 94.19 Favored Pre-proline 0 N--CA 1.493 1.71 0 CA-C-O 115.816 -2.04 . . . . 0.0 109.257 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -72.06 33.1 0.27 Allowed 'Trans proline' 0 C--N 1.293 -2.343 0 C-N-CA 122.073 1.849 . . . . 0.0 112.26 -172.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -115.41 154.0 47.62 Favored Pre-proline 0 CA--C 1.584 2.278 0 O-C-N 118.326 -2.734 . . . . 0.0 111.882 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -45.53 151.52 1.09 Allowed 'Trans proline' 0 C--O 1.216 -0.587 1 C-N-CA 125.515 4.143 . . . . 0.0 115.475 152.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . 0.281 4.8 m 42.6 56.06 10.64 Favored Pre-proline 0 C--N 1.364 1.214 0 O-C-N 118.778 -2.451 . . . . 0.0 116.411 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.41 18.05 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 123.865 3.043 . . . . 0.0 110.711 -152.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 m 61.53 32.55 18.71 Favored 'General case' 0 N--CA 1.508 2.436 0 C-N-CA 126.324 1.85 . . . . 0.0 110.478 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.5 m 66.82 24.9 9.71 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 129.347 3.059 . . . . 0.0 112.851 -173.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 87.15 -7.24 0.65 Allowed 'General case' 0 C--O 1.247 0.971 0 C-N-CA 126.789 2.035 . . . . 0.0 109.973 170.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -64.67 140.2 58.84 Favored 'General case' 0 C--N 1.374 1.638 0 CA-C-O 116.632 -1.652 . . . . 0.0 114.601 162.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -132.28 108.64 9.35 Favored 'General case' 0 CA--C 1.466 -2.255 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -57.34 139.12 53.85 Favored 'General case' 0 C--O 1.261 1.675 0 CA-C-O 124.842 2.258 . . . . 0.0 110.419 166.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.8 tp -149.13 142.23 18.14 Favored 'Isoleucine or valine' 0 C--N 1.365 1.269 0 CA-C-O 124.37 2.033 . . . . 0.0 113.747 -167.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.1 p -140.76 177.16 8.22 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -63.39 -45.95 88.7 Favored 'General case' 0 CA--C 1.579 2.09 0 C-N-CA 126.572 1.949 . . . . 0.0 109.068 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.44 75.96 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 119.319 -2.113 . . . . 0.0 116.2 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -67.65 -42.99 81.33 Favored 'General case' 0 C--O 1.178 -2.689 0 CA-C-O 117.056 -1.449 . . . . 0.0 111.875 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.7 tp -62.11 -37.19 84.14 Favored 'General case' 0 CA--C 1.582 2.194 0 CA-C-N 121.678 2.035 . . . . 0.0 114.243 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.351 . . 82.62 30.63 0.1 Allowed 'General case' 0 C--N 1.371 1.532 0 O-C-N 119.719 -1.863 . . . . 0.0 110.589 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -155.02 159.57 40.42 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.81 125.12 14.19 Favored 'General case' 0 N--CA 1.423 -1.806 0 C-N-CA 128.563 2.745 . . . . 0.0 115.225 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -64.41 128.02 92.85 Favored Pre-proline 0 CA--C 1.586 2.331 0 O-C-N 117.029 -3.544 . . . . 0.0 110.818 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -105.76 0.46 0.2 Allowed 'Trans proline' 0 CA--C 1.481 -2.131 0 C-N-CA 123.598 2.865 . . . . 0.0 108.891 -154.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.7 mt -132.82 171.34 14.04 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 p -92.2 -0.27 57.43 Favored 'General case' 0 C--O 1.19 -2.049 0 CA-C-O 124.161 1.934 . . . . 0.0 111.245 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.0 m -93.49 161.26 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 117.045 -3.534 . . . . 0.0 110.474 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -78.9 174.3 11.65 Favored 'General case' 0 C--O 1.205 -1.267 0 O-C-N 120.33 -1.481 . . . . 0.0 113.655 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -53.01 138.84 29.53 Favored 'General case' 0 CA--C 1.61 3.267 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.74 -150.74 5.37 Favored Glycine 0 C--N 1.379 2.956 0 C-N-CA 130.392 3.853 . . . . 0.0 114.386 -166.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.7 m -128.4 145.5 51.07 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 111.762 -2.219 . . . . 0.0 106.177 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.5 pt -113.48 144.45 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.034 0 C-N-CA 129.663 3.185 . . . . 0.0 110.207 165.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -145.84 142.76 29.14 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-O 122.609 1.195 . . . . 0.0 112.093 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 69.7 m -91.45 138.36 31.63 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 170.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.0 mt -120.78 155.91 56.79 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 118.836 -2.415 . . . . 0.0 105.312 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.288 36.9 Cg_exo -39.64 135.3 1.35 Allowed 'Trans proline' 0 N--CA 1.505 2.15 1 C-N-CA 125.696 4.264 . . . . 0.0 122.21 173.046 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.452 68.3 m 78.52 48.12 0.04 OUTLIER 'General case' 0 C--N 1.378 1.842 0 O-C-N 119.553 -1.967 . . . . 0.0 112.348 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 46.5 43.29 12.02 Favored 'General case' 0 C--N 1.391 2.37 0 CA-C-N 112.983 -1.917 . . . . 0.0 113.46 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -95.45 143.8 26.49 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 126.216 1.806 . . . . 0.0 111.465 170.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.36 129.34 49.73 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-O 124.648 2.166 . . . . 0.0 106.142 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.2 m -118.22 157.73 19.5 Favored 'Isoleucine or valine' 0 C--N 1.381 1.957 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.993 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -131.26 137.29 48.8 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -125.72 118.76 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 O-C-N 120.623 -1.298 . . . . 0.0 108.033 173.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.57 162.87 1.16 Allowed Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 170.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -68.81 -13.22 36.44 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 CA-C-O 113.786 -2.673 . . . . 0.0 114.589 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -91.75 -1.93 57.18 Favored 'General case' 0 C--N 1.37 1.458 0 CA-C-N 121.084 1.765 . . . . 0.0 112.902 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.61 0.17 36.98 Favored Glycine 0 CA--C 1.49 -1.523 0 CA-C-O 114.397 -3.446 . . . . 0.0 109.843 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.8 m -81.6 119.04 23.29 Favored 'General case' 0 C--N 1.361 1.08 1 CA-C-N 124.212 4.006 . . . . 0.0 112.93 -170.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.7 m -82.06 130.59 35.12 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.015 175.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -125.36 160.81 28.44 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 126.891 2.076 . . . . 0.0 111.675 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.99 127.42 32.94 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 167.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.9 tp -94.77 -47.5 6.45 Favored 'General case' 0 C--O 1.206 -1.227 0 O-C-N 119.671 -1.893 . . . . 0.0 109.844 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -101.77 163.56 12.19 Favored 'General case' 0 C--N 1.391 2.392 0 CA-C-O 123.739 1.733 . . . . 0.0 108.834 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . 0.274 12.9 p-10 -55.29 -36.8 66.53 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 126.432 1.893 . . . . 0.0 113.758 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -61.89 -44.37 96.95 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.808 1.243 . . . . 0.0 112.064 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.95 -40.83 94.79 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.666 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -68.38 -42.02 79.72 Favored 'General case' 0 CA--C 1.557 1.218 0 O-C-N 121.774 -0.579 . . . . 0.0 111.52 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -54.9 -39.63 68.96 Favored 'General case' 0 C--N 1.369 1.422 0 O-C-N 120.224 -1.547 . . . . 0.0 112.542 167.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.01 -36.65 84.27 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 127.0 6.46 5.39 Favored Glycine 0 N--CA 1.507 3.369 0 CA-C-O 124.125 1.959 . . . . 0.0 110.464 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -80.33 133.67 56.45 Favored Pre-proline 0 CA--C 1.588 2.433 0 CA-C-O 116.67 -1.633 . . . . 0.0 110.161 170.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -70.64 150.7 63.29 Favored 'Trans proline' 0 CA--C 1.484 -2.018 0 CA-C-N 126.892 3.497 . . . . 0.0 119.182 -164.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . 0.269 74.7 Cg_exo -44.7 146.92 2.0 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 N-CA-C 117.769 2.18 . . . . 0.0 117.769 171.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.7 tt -98.99 10.15 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 C-N-CA 116.979 -1.888 . . . . 0.0 107.336 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.4 p -62.17 -35.83 23.95 Favored Pre-proline 0 C--N 1.374 1.639 1 CA-C-O 109.169 -5.205 . . . . 0.0 116.972 -174.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.16 -17.59 16.97 Favored 'Trans proline' 0 C--N 1.36 1.137 0 CA-C-N 127.141 3.586 . . . . 0.0 109.018 -165.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.6 pt -106.53 20.65 4.43 Favored 'Isoleucine or valine' 0 C--N 1.368 1.389 0 C-N-CA 125.699 1.6 . . . . 0.0 113.458 -172.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -63.59 138.36 58.47 Favored 'General case' 0 C--N 1.363 1.188 0 C-N-CA 126.645 1.978 . . . . 0.0 111.86 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -95.83 128.13 42.45 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 127.647 2.379 . . . . 0.0 116.999 168.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -78.03 149.47 34.0 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 120.257 -1.527 . . . . 0.0 114.576 166.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.95 174.6 54.34 Favored Glycine 0 C--O 1.202 -1.885 0 C-N-CA 126.438 1.97 . . . . 0.0 113.655 162.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.0 m -60.43 146.97 42.61 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 122.215 3.007 . . . . 0.0 118.584 161.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 52.53 27.87 27.45 Favored Glycine 1 C--N 1.415 4.942 0 C-N-CA 128.471 2.938 . . . . 0.0 111.665 -162.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.23 -161.61 53.84 Favored Glycine 0 CA--C 1.544 1.863 0 C-N-CA 129.892 3.615 . . . . 0.0 119.291 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.26 133.6 4.42 Favored Glycine 0 CA--C 1.549 2.195 0 CA-C-N 120.459 2.129 . . . . 0.0 109.873 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -79.18 151.69 31.12 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 124.842 2.258 . . . . 0.0 107.916 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 22.4 mm -91.17 144.27 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 126.717 2.007 . . . . 0.0 111.529 173.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.4 t -71.71 147.31 47.52 Favored 'General case' 0 C--O 1.195 -1.796 0 N-CA-C 119.868 3.285 . . . . 0.0 119.868 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.5 mt -97.78 20.92 11.21 Favored 'General case' 0 C--O 1.204 -1.338 0 C-N-CA 126.231 1.812 . . . . 0.0 112.317 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -88.71 -41.3 6.05 Favored Glycine 0 CA--C 1.496 -1.121 0 N-CA-C 118.207 2.043 . . . . 0.0 118.207 -169.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.47 98.55 Favored 'General case' 0 N--CA 1.431 -1.375 0 O-C-N 127.045 2.262 . . . . 0.0 110.199 170.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.8 tp -66.69 -44.12 82.58 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-O 122.563 1.173 . . . . 0.0 111.702 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.3 tp -62.68 -53.16 58.73 Favored 'General case' 0 C--N 1.364 1.23 0 O-C-N 120.329 -1.482 . . . . 0.0 110.465 175.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.2 p -57.66 -44.76 85.94 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.66 0.743 . . . . 0.0 111.088 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 83.0 m -62.31 -42.35 99.3 Favored 'General case' 0 C--O 1.264 1.822 0 C-N-CA 125.611 1.564 . . . . 0.0 110.982 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 26.2 m -60.22 -36.88 78.69 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 173.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.7 mt -89.59 -16.78 29.82 Favored 'General case' 0 C--N 1.376 1.722 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 176.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -63.41 -38.57 91.65 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 117.12 -1.419 . . . . 0.0 111.375 158.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.4 mt -63.47 -43.0 98.59 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-O 125.227 2.441 . . . . 0.0 110.507 -171.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 21.6 p -100.61 25.66 7.57 Favored 'General case' 0 C--N 1.376 1.74 0 CA-C-N 112.779 -2.009 . . . . 0.0 112.414 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.158 0 C-N-CA 128.368 2.889 . . . . 0.0 114.863 175.626 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 p . . . . . 0 N--CA 1.439 -0.979 0 CA-C-O 117.504 -1.236 . . . . 0.0 108.305 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -47.9 157.4 1.07 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 123.452 2.768 . . . . 0.0 114.425 169.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.06 136.03 96.49 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.731 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -70.94 35.96 0.27 Allowed 'Trans proline' 0 N--CA 1.517 2.879 0 C-N-CA 121.302 1.334 . . . . 0.0 113.34 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.9 mt -118.54 153.21 51.96 Favored Pre-proline 0 CA--C 1.572 1.814 0 O-C-N 119.619 -1.925 . . . . 0.0 107.968 172.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.67 154.68 4.41 Favored 'Trans proline' 0 N--CA 1.519 3.015 0 C-N-CA 123.23 2.62 . . . . 0.0 114.295 153.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . 0.256 7.1 m 40.97 58.87 8.45 Favored Pre-proline 0 C--N 1.362 1.145 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 174.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.62 20.13 0.62 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.446 1.431 . . . . 0.0 112.271 -156.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 m 60.08 32.73 21.11 Favored 'General case' 0 N--CA 1.516 2.856 0 C-N-CA 125.294 1.438 . . . . 0.0 110.717 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 m 68.0 25.68 7.54 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 127.051 2.14 . . . . 0.0 113.386 -174.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 83.41 -5.15 1.2 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.241 1.417 . . . . 0.0 111.605 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -70.62 142.67 51.64 Favored 'General case' 0 C--N 1.36 1.056 0 O-C-N 124.372 1.045 . . . . 0.0 110.747 166.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -132.05 110.15 10.51 Favored 'General case' 0 C--N 1.366 1.323 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.365 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -59.23 137.34 58.01 Favored 'General case' 0 C--O 1.252 1.226 0 O-C-N 126.416 2.323 . . . . 0.0 111.334 164.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.5 tp -145.8 142.33 21.83 Favored 'Isoleucine or valine' 0 C--O 1.264 1.86 0 CA-C-N 112.791 -2.004 . . . . 0.0 113.036 -167.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.9 p -139.36 177.91 7.58 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -63.78 -44.56 93.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 124.704 1.252 . . . . 0.0 110.579 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.92 79.71 Favored 'General case' 0 C--O 1.247 0.946 0 O-C-N 120.228 -1.545 . . . . 0.0 112.972 173.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -67.19 -42.97 83.31 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-O 117.415 -1.278 . . . . 0.0 111.901 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.1 tp -61.94 -36.19 80.64 Favored 'General case' 0 CA--C 1.587 2.392 0 CA-C-N 121.002 1.728 . . . . 0.0 113.293 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.287 . . 79.38 32.66 0.24 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.038 1.335 . . . . 0.0 111.99 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -155.85 158.2 37.66 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.4 mt -50.92 127.39 18.55 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 124.116 1.912 . . . . 0.0 115.461 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -63.82 124.42 84.89 Favored Pre-proline 0 CA--C 1.573 1.86 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.262 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -100.11 1.98 0.82 Allowed 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 122.02 1.813 . . . . 0.0 113.285 -160.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.5 mt -131.15 168.01 18.18 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.2 p -90.01 1.62 56.09 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 122.381 1.086 . . . . 0.0 113.781 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.5 m -92.53 160.54 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 119.976 -1.703 . . . . 0.0 111.654 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -77.39 174.37 10.9 Favored 'General case' 0 CA--C 1.567 1.63 0 O-C-N 119.221 -2.174 . . . . 0.0 111.827 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -53.91 140.35 31.03 Favored 'General case' 0 CA--C 1.601 2.941 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 -177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.2 -150.09 5.28 Favored Glycine 0 C--N 1.369 2.409 0 C-N-CA 127.53 2.491 . . . . 0.0 114.909 -166.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.1 m -127.88 146.5 50.6 Favored 'General case' 0 C--N 1.371 1.506 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.2 pt -115.49 145.89 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 126.925 2.09 . . . . 0.0 110.081 166.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -147.22 141.63 26.39 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 122.94 1.353 . . . . 0.0 111.426 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 61.8 m -89.27 138.15 31.69 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 169.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.0 mt -120.13 155.41 55.74 Favored Pre-proline 0 N--CA 1.482 1.17 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 172.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.268 31.9 Cg_exo -40.55 134.93 2.11 Favored 'Trans proline' 0 N--CA 1.529 3.583 0 N-CA-C 122.133 3.859 . . . . 0.0 122.133 173.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.383 50.4 m 79.53 50.22 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.075 1.35 . . . . 0.0 110.311 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 45.94 44.64 11.48 Favored 'General case' 0 C--O 1.203 -1.383 0 O-C-N 126.803 2.564 . . . . 0.0 111.954 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.89 145.71 25.63 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 118.644 0.656 . . . . 0.0 110.438 170.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.65 129.9 51.42 Favored 'General case' 0 C--O 1.273 2.312 0 CA-C-O 123.22 1.486 . . . . 0.0 107.481 174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.19 157.24 21.13 Favored 'Isoleucine or valine' 0 C--N 1.362 1.114 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.157 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -130.36 137.78 50.07 Favored 'General case' 0 C--O 1.254 1.321 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 t -126.35 119.32 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.1 164.53 2.36 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 171.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.79 -11.78 29.99 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 CA-C-O 114.481 -2.383 . . . . 0.0 114.466 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -91.03 -1.43 57.81 Favored 'General case' 0 C--N 1.371 1.529 0 CA-C-N 121.132 1.787 . . . . 0.0 113.544 173.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.81 -0.85 41.83 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-O 116.748 -2.14 . . . . 0.0 113.207 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.5 m -80.01 120.24 23.92 Favored 'General case' 0 C--N 1.38 1.899 0 CA-C-N 120.979 2.39 . . . . 0.0 113.374 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.7 m -83.52 130.54 35.01 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.05 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -124.56 162.18 24.6 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.678 1.591 . . . . 0.0 111.209 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.53 130.2 35.17 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.42 -46.79 6.55 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 116.45 -1.738 . . . . 0.0 108.83 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -105.28 164.33 11.92 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-O 123.398 1.57 . . . . 0.0 108.898 174.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -56.29 -37.41 69.82 Favored 'General case' 0 N--CA 1.511 2.588 0 CA-C-N 113.448 -1.705 . . . . 0.0 112.469 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.6 mtp85 -60.53 -44.59 95.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 124.784 1.303 . . . . 0.0 111.327 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.36 -37.18 84.68 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.78 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -71.2 -42.07 69.46 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 117.767 -1.111 . . . . 0.0 110.084 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -56.57 -35.5 68.24 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 168.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.71 76.23 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 116.223 -1.846 . . . . 0.0 114.124 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.54 6.27 6.76 Favored Glycine 1 N--CA 1.518 4.165 0 CA-C-N 121.162 1.801 . . . . 0.0 111.839 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -80.27 131.45 62.26 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-O 118.054 -0.974 . . . . 0.0 108.642 170.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -65.37 149.28 88.36 Favored 'Trans proline' 1 N--CA 1.546 4.565 0 N-CA-C 119.478 2.838 . . . . 0.0 119.478 -168.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.41 145.74 5.68 Favored 'Trans proline' 0 N--CA 1.519 2.979 0 C-N-CA 117.243 -1.371 . . . . 0.0 114.905 172.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.4 tt -97.46 11.25 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 117.811 -1.555 . . . . 0.0 109.499 175.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 17.2 p -63.96 -35.63 16.64 Favored Pre-proline 0 N--CA 1.399 -2.993 1 CA-C-O 110.185 -4.721 . . . . 0.0 117.667 -174.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.9 -19.68 23.18 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 CA-C-N 124.744 2.73 . . . . 0.0 111.294 -168.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.2 pt -105.56 22.52 3.07 Favored 'Isoleucine or valine' 0 C--N 1.372 1.583 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -61.67 139.3 58.31 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 125.895 1.997 . . . . 0.0 112.978 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . 0.251 . . -97.46 130.13 44.59 Favored 'General case' 0 C--N 1.376 1.731 0 C-N-CA 125.976 1.71 . . . . 0.0 115.138 170.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -82.02 151.37 27.14 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.936 167.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.36 176.08 54.41 Favored Glycine 0 CA--C 1.544 1.887 0 O-C-N 126.99 2.681 . . . . 0.0 113.683 164.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.9 m -63.62 146.66 53.33 Favored 'General case' 0 CA--C 1.597 2.762 0 CA-C-N 120.966 2.383 . . . . 0.0 116.395 164.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 57.2 24.43 51.24 Favored Glycine 1 C--N 1.402 4.212 0 O-C-N 125.735 1.897 . . . . 0.0 111.814 -164.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.81 -163.2 50.97 Favored Glycine 0 CA--C 1.553 2.441 0 C-N-CA 126.951 2.215 . . . . 0.0 117.288 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.52 132.79 3.78 Favored Glycine 0 C--N 1.377 2.86 0 CA-C-N 118.313 1.056 . . . . 0.0 111.358 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -79.42 150.67 31.24 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 122.533 1.159 . . . . 0.0 109.631 -174.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 20.3 mm -90.3 147.52 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.974 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.5 t -74.93 147.74 40.67 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 174.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.0 mt -97.01 21.51 9.66 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 112.807 -1.997 . . . . 0.0 111.741 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.9 -46.66 5.31 Favored Glycine 0 C--O 1.219 -0.784 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 -168.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.48 -43.24 93.32 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 127.514 2.538 . . . . 0.0 109.056 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.2 tp -67.33 -43.92 80.42 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.713 0.805 . . . . 0.0 111.08 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.3 tp -62.03 -54.35 42.81 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.154 0.582 . . . . 0.0 110.589 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.1 p -56.78 -44.28 81.7 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 124.066 0.854 . . . . 0.0 110.823 -175.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.9 m -62.98 -40.26 97.19 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.252 1.021 . . . . 0.0 110.547 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.4 m -62.94 -36.52 83.72 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 115.355 -2.259 . . . . 0.0 114.642 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 37.1 mt -89.01 -18.65 26.92 Favored 'General case' 0 C--N 1.387 2.208 0 CA-C-N 121.401 1.91 . . . . 0.0 114.31 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -61.69 -40.79 96.23 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 121.411 -0.806 . . . . 0.0 111.215 160.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.0 mt -61.79 -42.98 99.69 Favored 'General case' 0 C--N 1.381 1.938 0 O-C-N 125.458 1.723 . . . . 0.0 110.074 -173.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.0 p -101.95 27.84 6.22 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.807 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.199 -2.051 0 C-N-CA 125.9 1.715 . . . . 0.0 115.343 175.676 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.564 1.486 0 CA-C-O 114.84 -2.505 . . . . 0.0 114.839 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -40.87 137.58 1.78 Allowed 'Trans proline' 0 N--CA 1.511 2.522 0 C-N-CA 125.167 3.911 . . . . 0.0 116.456 165.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.6 t -118.93 110.26 38.49 Favored Pre-proline 0 CA--C 1.599 2.853 0 O-C-N 125.236 1.585 . . . . 0.0 110.437 -169.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -49.86 134.76 35.41 Favored 'Trans proline' 0 N--CA 1.526 3.405 1 C-N-CA 126.968 5.112 . . . . 0.0 117.197 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.5 mt -51.8 146.11 14.87 Favored Pre-proline 0 C--N 1.363 1.189 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -82.86 66.32 7.97 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 O-C-N 118.879 -1.169 . . . . 0.0 111.425 167.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.6 t -154.66 140.76 12.81 Favored Pre-proline 0 N--CA 1.498 1.93 0 CA-C-O 113.939 -2.934 . . . . 0.0 105.05 170.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -40.25 124.21 1.58 Allowed 'Trans proline' 0 N--CA 1.495 1.569 1 C-N-CA 126.46 4.774 . . . . 0.0 118.71 -170.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 m 50.66 45.23 27.17 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 123.457 1.599 . . . . 0.0 107.981 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.263 46.6 m 61.79 54.08 3.0 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 127.466 3.508 . . . . 0.0 116.522 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.383 39.6 t30 68.25 33.37 4.34 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-N 110.667 -2.97 . . . . 0.0 111.478 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . 0.368 0.0 OUTLIER 69.75 112.62 0.05 OUTLIER 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 116.799 2.148 . . . . 0.0 116.799 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -77.64 155.04 31.65 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.756 0.822 . . . . 0.0 111.0 173.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -87.37 145.47 26.3 Favored 'General case' 0 C--O 1.264 1.831 0 O-C-N 128.698 3.749 . . . . 0.0 111.519 171.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 tp -115.56 144.43 23.17 Favored 'Isoleucine or valine' 0 C--N 1.364 1.219 0 CA-C-N 112.335 -2.211 . . . . 0.0 108.701 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.51 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 38.5 p -132.08 163.05 29.32 Favored 'General case' 0 C--O 1.198 -1.623 0 C-N-CA 126.206 1.803 . . . . 0.0 114.082 -174.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 29.5 mt-10 -62.05 -45.97 91.2 Favored 'General case' 0 C--O 1.202 -1.416 0 C-N-CA 127.536 2.334 . . . . 0.0 108.951 168.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.81 -24.62 61.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 119.346 -2.096 . . . . 0.0 116.161 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -62.55 -46.38 88.63 Favored 'General case' 0 CA--C 1.593 2.623 0 CA-C-O 122.132 0.968 . . . . 0.0 111.418 172.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 mt -71.04 -38.0 72.54 Favored 'General case' 0 C--O 1.211 -0.925 0 C-N-CA 129.275 3.03 . . . . 0.0 114.066 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.36 . . 67.14 -22.29 0.11 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 119.351 3.093 . . . . 0.0 119.351 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . 0.303 84.9 t80 -77.12 167.2 22.19 Favored 'General case' 0 C--O 1.254 1.304 0 CA-C-O 122.615 1.198 . . . . 0.0 112.791 161.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.8 tp -48.09 118.61 2.46 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.097 1.759 . . . . 0.0 115.509 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -61.48 122.04 67.94 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 119.299 -2.125 . . . . 0.0 111.011 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -95.5 26.39 0.29 Allowed 'Trans proline' 0 CA--C 1.552 1.393 0 C-N-CA 122.869 2.379 . . . . 0.0 114.301 -169.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.2 mt -136.9 153.41 50.74 Favored 'General case' 0 C--N 1.39 2.347 0 CA-C-N 120.057 1.299 . . . . 0.0 109.463 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.4 p -73.11 -22.62 60.52 Favored 'General case' 0 C--N 1.364 1.203 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.5 m -83.92 160.55 3.42 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 1 O-C-N 129.435 4.209 . . . . 0.0 108.236 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -91.5 114.62 27.19 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 115.481 -2.199 . . . . 0.0 109.993 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.51 ' CD2' ' HA ' ' A' ' 63' ' ' SER . 61.3 m170 52.85 -167.88 0.05 Allowed 'General case' 0 C--N 1.36 1.025 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.59 -167.45 40.33 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.757 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.1 m -121.45 149.04 43.62 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 103.166 -2.902 . . . . 0.0 103.166 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 pt -121.36 151.65 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.311 0 C-N-CA 124.747 1.219 . . . . 0.0 110.474 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -145.12 139.81 27.57 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 3.8 m -99.25 123.97 43.96 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.0 mt -96.49 151.35 37.96 Favored Pre-proline 0 N--CA 1.508 2.45 0 CA-C-O 114.265 -2.778 . . . . 0.0 112.58 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -57.59 150.0 63.72 Favored 'Trans proline' 0 N--CA 1.508 2.348 0 CA-C-N 124.654 2.698 . . . . 0.0 117.952 -173.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.9 m 59.46 54.27 4.73 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -168.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 57.11 48.65 15.04 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 170.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -117.03 159.41 22.57 Favored 'General case' 0 C--N 1.369 1.422 0 CA-C-O 117.995 -1.003 . . . . 0.0 111.761 169.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.95 148.04 43.01 Favored 'General case' 0 C--N 1.384 2.089 0 O-C-N 125.53 1.769 . . . . 0.0 112.451 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.8 m -138.31 170.92 16.12 Favored 'Isoleucine or valine' 0 C--N 1.396 2.61 0 O-C-N 127.068 2.73 . . . . 0.0 113.64 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -140.67 124.5 17.18 Favored 'General case' 0 C--O 1.265 1.87 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -172.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.1 t -102.69 107.76 22.67 Favored 'Isoleucine or valine' 0 C--N 1.359 0.995 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . 0.332 . . -60.18 150.61 70.61 Favored Pre-proline 0 N--CA 1.515 2.818 0 N-CA-C 119.979 3.325 . . . . 0.0 119.979 174.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -46.3 -23.75 2.19 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 N-CA-C 119.952 3.02 . . . . 0.0 119.952 177.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -86.55 -15.26 40.49 Favored 'General case' 0 C--N 1.375 1.716 0 CA-C-O 124.166 1.936 . . . . 0.0 115.589 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 114.15 -3.66 23.88 Favored Glycine 0 N--CA 1.483 1.829 0 C-N-CA 130.304 3.811 . . . . 0.0 116.387 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.323 8.3 m -68.94 114.27 7.09 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 46.6 m -90.16 108.7 19.9 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 124.736 1.272 . . . . 0.0 112.873 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -100.87 142.84 31.77 Favored 'General case' 0 N--CA 1.434 -1.259 0 O-C-N 126.166 2.166 . . . . 0.0 111.259 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.28 128.34 36.05 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-N 113.46 -1.7 . . . . 0.0 112.861 169.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.1 tp -108.57 1.34 21.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.355 -1.466 . . . . 0.0 108.672 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . 0.34 52.9 p-10 -148.86 159.53 44.08 Favored 'General case' 0 C--N 1.368 1.391 0 O-C-N 120.762 -1.211 . . . . 0.0 111.681 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -58.63 -43.45 89.71 Favored 'General case' 0 C--N 1.363 1.191 0 CA-C-N 112.814 -1.994 . . . . 0.0 113.528 -169.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -66.71 -34.65 78.32 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 121.16 -0.962 . . . . 0.0 111.648 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . 0.371 . . -61.43 -40.52 94.73 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 174.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -62.02 -41.83 98.51 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 115.363 -2.256 . . . . 0.0 108.702 169.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.303 42.5 mmtm -63.24 -42.88 99.27 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.84 2.533 . . . . 0.0 117.84 175.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.95 -34.29 65.54 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 115.497 -2.192 . . . . 0.0 111.396 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 130.57 -1.72 5.64 Favored Glycine 0 C--N 1.366 2.234 0 CA-C-N 121.362 1.892 . . . . 0.0 115.474 173.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -71.25 148.1 93.58 Favored Pre-proline 0 C--N 1.369 1.443 0 CA-C-O 116.818 -1.563 . . . . 0.0 111.706 171.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.09 139.01 23.55 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-O 114.381 -2.425 . . . . 0.0 111.702 -171.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -54.01 142.37 65.28 Favored 'Trans proline' 0 CA--C 1.482 -2.109 0 N-CA-C 119.88 2.992 . . . . 0.0 119.88 168.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.3 tt -89.89 15.56 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.948 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.8 p -64.3 -43.37 72.53 Favored Pre-proline 0 C--N 1.378 1.82 0 CA-C-O 113.127 -3.321 . . . . 0.0 117.077 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -74.35 -1.65 11.28 Favored 'Trans proline' 0 N--CA 1.5 1.863 1 CA-C-N 129.798 4.535 . . . . 0.0 117.408 174.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 27.4 mm -91.2 -0.79 9.65 Favored 'Isoleucine or valine' 0 C--N 1.367 1.349 0 C-N-CA 127.567 2.347 . . . . 0.0 113.595 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -61.92 140.36 58.31 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 119.191 -2.193 . . . . 0.0 116.902 166.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -81.22 128.95 34.34 Favored 'General case' 0 C--O 1.199 -1.599 0 CA-C-O 123.108 1.432 . . . . 0.0 113.62 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -55.92 145.32 25.35 Favored 'General case' 0 N--CA 1.535 3.79 1 N-CA-C 122.609 4.3 . . . . 0.0 122.609 175.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.15 173.8 42.01 Favored Glycine 0 C--N 1.356 1.668 0 CA-C-N 113.287 -1.779 . . . . 0.0 112.381 156.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.6 t -93.73 127.6 39.53 Favored 'General case' 0 C--N 1.386 2.186 0 O-C-N 126.568 1.981 . . . . 0.0 109.916 167.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 67.59 39.37 90.77 Favored Glycine 0 N--CA 1.51 3.612 0 C-N-CA 118.404 -1.855 . . . . 0.0 115.983 -169.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 105.85 -168.9 15.43 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 164.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.33 -170.09 50.76 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-O 123.882 1.823 . . . . 0.0 112.208 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -149.74 149.67 30.91 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.9 mt -66.36 137.16 25.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 O-C-N 119.197 -2.189 . . . . 0.0 109.57 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.3 t -50.56 129.49 22.44 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 58.7 mt -98.93 6.86 46.53 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.501 -1.375 . . . . 0.0 111.594 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.12 -60.15 9.41 Favored Glycine 0 C--N 1.377 2.833 0 C-N-CA 128.563 2.983 . . . . 0.0 114.9 -170.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . 0.354 . . -65.29 -32.21 73.74 Favored 'General case' 0 CA--C 1.6 2.891 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 10.3 tp -55.66 -48.38 75.11 Favored 'General case' 0 C--N 1.383 2.051 0 CA-C-N 120.6 1.545 . . . . 0.0 112.14 163.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 20.2 tp -65.28 -42.53 93.06 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . 0.29 17.7 p -69.07 -40.37 78.52 Favored 'General case' 0 C--N 1.371 1.513 0 CA-C-O 115.79 -2.052 . . . . 0.0 112.758 170.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 90.2 m -64.08 -31.07 72.12 Favored 'General case' 0 C--N 1.36 1.033 0 CA-C-N 122.928 2.604 . . . . 0.0 110.138 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.5 m -64.89 -48.92 72.51 Favored 'General case' 0 C--N 1.389 2.312 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.1 mt -69.29 -43.11 74.49 Favored 'General case' 0 CA--C 1.495 -1.161 0 O-C-N 126.843 2.589 . . . . 0.0 112.883 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.08 -33.94 69.61 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 127.016 2.697 . . . . 0.0 114.885 173.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . 0.291 40.0 tp -69.19 -28.96 66.85 Favored 'General case' 0 N--CA 1.421 -1.892 0 O-C-N 126.338 2.274 . . . . 0.0 110.879 -176.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.6 p -108.01 12.96 26.51 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 174.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.584 0 C-N-CA 128.114 2.769 . . . . 0.0 118.581 -176.312 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.197 -1.709 0 CA-C-O 113.828 -2.987 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -47.31 152.57 2.21 Favored 'Trans proline' 0 N--CA 1.495 1.564 1 C-N-CA 126.889 5.059 . . . . 0.0 114.275 -167.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 t -59.28 116.78 17.4 Favored Pre-proline 0 C--O 1.213 -0.832 0 O-C-N 126.593 2.433 . . . . 0.0 113.005 173.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -98.44 54.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 123.175 2.583 . . . . 0.0 107.734 -168.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.274 24.3 mt -144.79 147.81 36.92 Favored Pre-proline 0 N--CA 1.477 0.907 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 -165.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -59.94 156.54 38.24 Favored 'Trans proline' 0 N--CA 1.508 2.362 0 CA-C-N 122.83 2.046 . . . . 0.0 110.778 169.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.2 m 54.51 67.03 3.63 Favored Pre-proline 0 N--CA 1.517 2.924 0 CA-C-O 114.847 -2.501 . . . . 0.0 116.718 -173.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -85.96 -25.88 1.34 Allowed 'Trans proline' 0 CA--C 1.483 -2.04 0 CA-C-N 127.467 3.703 . . . . 0.0 116.681 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.379 0.7 OUTLIER 63.78 41.5 6.85 Favored 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 125.845 1.658 . . . . 0.0 114.094 169.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.9 m 64.5 33.56 10.88 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 112.322 -2.217 . . . . 0.0 109.956 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.312 92.2 m-20 83.01 46.08 0.02 OUTLIER 'General case' 0 C--N 1.352 0.683 0 C-N-CA 127.669 2.387 . . . . 0.0 112.684 174.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -128.24 120.23 26.77 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 118.305 -2.747 . . . . 0.0 107.216 -174.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -123.38 112.55 17.7 Favored 'General case' 0 C--O 1.193 -1.884 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.436 -159.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -64.86 140.56 58.88 Favored 'General case' 0 C--N 1.368 1.371 0 C-N-CA 128.09 2.556 . . . . 0.0 111.688 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.5 tp -142.13 142.59 27.52 Favored 'Isoleucine or valine' 0 C--O 1.263 1.781 0 O-C-N 117.78 -3.075 . . . . 0.0 110.702 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.3 p -145.78 172.23 13.62 Favored 'General case' 0 C--N 1.39 2.34 0 CA-C-N 112.308 -2.224 . . . . 0.0 112.711 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.68 -46.33 82.9 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 117.516 -1.231 . . . . 0.0 109.006 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.73 -34.96 67.43 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 120.714 1.597 . . . . 0.0 107.67 -174.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -66.12 -40.05 90.38 Favored 'General case' 0 C--N 1.369 1.456 0 O-C-N 120.241 -1.537 . . . . 0.0 113.511 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.2 tp -67.97 -44.91 75.6 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 124.112 0.965 . . . . 0.0 113.556 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 88.61 21.09 0.04 OUTLIER 'General case' 0 C--N 1.356 0.89 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 171.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -151.26 173.6 14.27 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 101.124 -3.658 . . . . 0.0 101.124 -166.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.1 mt -73.69 144.67 45.71 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 118.069 -2.894 . . . . 0.0 114.089 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -92.18 127.97 47.06 Favored Pre-proline 0 C--O 1.208 -1.109 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.705 -170.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -93.7 6.36 2.76 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 CA-C-O 115.206 -2.081 . . . . 0.0 110.919 -157.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.5 mt -124.7 158.17 33.87 Favored 'General case' 0 C--N 1.361 1.077 0 CA-C-N 122.638 2.472 . . . . 0.0 108.654 -169.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.2 p -62.38 -48.27 80.48 Favored 'General case' 0 N--CA 1.507 2.401 0 C-N-CA 124.118 0.967 . . . . 0.0 113.156 163.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.1 m -65.6 149.17 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 125.14 2.4 . . . . 0.0 113.022 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.37 176.59 4.51 Favored 'General case' 0 CA--C 1.561 1.369 0 O-C-N 120.275 -1.515 . . . . 0.0 109.084 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -25.16 137.32 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 153.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.33 -118.77 0.95 Allowed Glycine 0 C--N 1.373 2.608 0 CA-C-O 123.962 1.868 . . . . 0.0 112.636 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 m -156.54 154.11 29.77 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 pt -133.35 129.22 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-O 124.447 2.07 . . . . 0.0 107.579 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -130.38 154.43 47.7 Favored 'General case' 0 C--N 1.359 0.984 0 CA-C-N 112.157 -2.292 . . . . 0.0 111.848 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 96.9 m -122.15 134.3 54.74 Favored 'General case' 0 C--O 1.189 -2.116 0 O-C-N 119.959 -1.713 . . . . 0.0 108.275 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.79 153.67 81.68 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-N 122.977 2.626 . . . . 0.0 107.431 -171.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -43.28 150.13 0.44 Allowed 'Trans proline' 0 CA--C 1.509 -0.726 0 C-N-CA 122.09 1.86 . . . . 0.0 114.799 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.338 37.8 m 82.1 33.28 0.09 Allowed 'General case' 0 C--N 1.361 1.106 0 O-C-N 127.529 3.018 . . . . 0.0 116.216 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 49.05 40.95 18.42 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 130.735 3.614 . . . . 0.0 115.037 -167.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -94.75 133.92 37.92 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 123.3 1.524 . . . . 0.0 109.27 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.31 141.25 52.18 Favored 'General case' 0 C--O 1.192 -1.935 0 O-C-N 119.647 -1.908 . . . . 0.0 109.528 171.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.25 153.31 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.382 0 C-N-CA 126.654 1.982 . . . . 0.0 112.232 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -111.74 121.75 45.93 Favored 'General case' 0 CA--C 1.562 1.432 1 C-N-CA 132.282 4.233 . . . . 0.0 106.802 170.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.32 108.49 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 118.697 -2.502 . . . . 0.0 108.321 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.44 154.05 93.75 Favored Pre-proline 0 N--CA 1.434 -1.273 0 C-N-CA 127.245 2.218 . . . . 0.0 115.937 169.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -74.91 12.46 1.19 Allowed 'Trans proline' 0 N--CA 1.515 2.785 0 N-CA-C 116.051 1.52 . . . . 0.0 116.051 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -100.99 1.13 39.34 Favored 'General case' 0 C--N 1.361 1.107 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.528 158.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.33 11.62 60.83 Favored Glycine 0 CA--C 1.465 -3.072 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 m -76.04 117.47 17.79 Favored 'General case' 0 N--CA 1.435 -1.225 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.641 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . 0.263 53.9 m -93.34 80.68 4.41 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 -171.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -70.59 153.64 42.67 Favored 'General case' 0 C--O 1.254 1.318 0 O-C-N 121.1 -1.0 . . . . 0.0 112.882 -173.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.27 114.7 7.77 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 167.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.2 tp -92.33 -25.59 18.48 Favored 'General case' 0 CA--C 1.558 1.267 0 CA-C-O 121.698 0.761 . . . . 0.0 112.997 173.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -120.99 173.84 7.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 119.164 -2.21 . . . . 0.0 110.093 163.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -60.43 -30.99 69.99 Favored 'General case' 0 CA--C 1.576 1.946 0 C-N-CA 130.436 3.494 . . . . 0.0 116.581 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -67.65 -54.08 22.51 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.444 172.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.83 -35.12 74.08 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -61.88 -45.51 93.44 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 122.385 1.088 . . . . 0.0 112.153 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -68.29 -28.12 66.91 Favored 'General case' 0 C--O 1.259 1.554 0 CA-C-O 124.368 2.032 . . . . 0.0 115.859 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.62 -21.13 61.88 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 116.662 2.097 . . . . 0.0 116.662 168.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.69 15.07 11.46 Favored Glycine 0 CA--C 1.463 -3.202 0 CA-C-O 114.915 -3.159 . . . . 0.0 114.396 -174.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -87.31 150.39 49.14 Favored Pre-proline 0 N--CA 1.429 -1.498 0 C-N-CA 114.079 -3.049 . . . . 0.0 110.461 164.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -57.23 142.16 94.6 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 CA-C-O 116.668 -1.472 . . . . 0.0 115.668 -172.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -68.06 139.35 46.49 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 CA-C-O 125.316 2.132 . . . . 0.0 116.532 169.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.4 tt -90.05 10.64 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 O-C-N 118.584 -2.573 . . . . 0.0 107.116 -171.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.27 -52.23 70.8 Favored Pre-proline 0 C--N 1.369 1.45 0 O-C-N 119.791 -1.818 . . . . 0.0 114.093 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.94 -7.34 20.89 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 CA-C-N 121.539 1.585 . . . . 0.0 113.204 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.6 pt -103.79 9.03 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.198 0.908 . . . . 0.0 111.174 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -69.82 137.03 51.46 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.996 0.903 . . . . 0.0 112.794 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -94.31 129.37 41.0 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 122.979 1.371 . . . . 0.0 112.171 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -89.59 140.78 29.21 Favored 'General case' 0 C--O 1.253 1.241 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.49 -168.89 7.75 Favored Glycine 0 C--N 1.383 3.171 0 N-CA-C 118.475 2.15 . . . . 0.0 118.475 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 m -96.97 123.35 40.67 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 124.626 0.839 . . . . 0.0 112.817 164.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 62.68 50.29 65.5 Favored Glycine 0 CA--C 1.496 -1.153 0 C-N-CA 126.362 1.934 . . . . 0.0 113.876 -168.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.89 -175.91 51.91 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 125.865 1.698 . . . . 0.0 113.093 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.7 174.16 44.11 Favored Glycine 0 CA--C 1.539 1.538 0 O-C-N 127.33 2.429 . . . . 0.0 111.977 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -126.75 143.42 51.25 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 -172.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 37.3 mm -74.17 140.55 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 O-C-N 120.077 -1.639 . . . . 0.0 111.657 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 30.9 t -62.01 127.62 32.27 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 -169.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.6 mt -72.62 -17.52 61.67 Favored 'General case' 0 C--N 1.378 1.828 0 O-C-N 118.052 -2.905 . . . . 0.0 111.806 169.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -41.52 -53.85 4.18 Favored Glycine 0 C--N 1.343 0.964 0 C-N-CA 127.548 2.499 . . . . 0.0 117.688 -166.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.37 89.82 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 120.263 -1.728 . . . . 0.0 115.007 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 48.9 tp -64.7 -48.25 75.38 Favored 'General case' 0 C--O 1.206 -1.204 0 O-C-N 118.471 -2.643 . . . . 0.0 112.48 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.0 tp -64.51 -52.15 59.31 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 121.437 -0.789 . . . . 0.0 109.032 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.4 p -60.13 -41.99 93.85 Favored 'General case' 0 N--CA 1.509 2.516 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.7 m -55.75 -42.66 75.73 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 126.419 1.888 . . . . 0.0 110.036 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 78.4 m -60.12 -43.53 95.58 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 127.961 3.288 . . . . 0.0 108.655 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 12.1 mt -66.19 -36.7 83.76 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -57.91 -42.32 84.48 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 119.347 -2.096 . . . . 0.0 112.495 172.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.2 mt -62.96 -42.61 99.87 Favored 'General case' 0 C--O 1.193 -1.914 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.738 -172.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 28.4 p -113.94 27.37 9.57 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 115.332 -2.271 . . . . 0.0 110.625 -165.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.37 2.444 0 CA-C-N 123.714 2.961 . . . . 0.0 115.019 -178.762 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 CA--C 1.604 3.048 0 CA-C-O 115.679 -2.105 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.61 160.73 34.83 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 CA-C-N 125.381 2.957 . . . . 0.0 109.241 162.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.44 136.62 96.79 Favored Pre-proline 0 C--N 1.374 1.643 0 CA-C-O 117.148 -1.406 . . . . 0.0 108.277 174.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -70.68 -32.87 14.0 Favored 'Trans proline' 0 N--CA 1.507 2.27 0 CA-C-O 124.467 1.778 . . . . 0.0 115.358 -162.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.6 mt -117.95 135.03 23.26 Favored Pre-proline 0 C--O 1.264 1.818 0 O-C-N 118.53 -2.607 . . . . 0.0 107.944 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -86.3 77.64 2.31 Favored 'Trans proline' 0 C--N 1.297 -2.163 0 N-CA-C 105.278 -2.624 . . . . 0.0 105.278 172.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.1 t -56.93 131.35 79.5 Favored Pre-proline 0 CA--C 1.584 2.273 0 C-N-CA 126.464 1.906 . . . . 0.0 112.155 -169.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -42.68 120.95 1.96 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 125.064 3.843 . . . . 0.0 115.799 -170.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.279 13.0 m 82.22 89.9 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 171.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.327 2.1 t 52.7 47.06 25.49 Favored 'General case' 0 C--N 1.391 2.385 0 O-C-N 124.864 1.352 . . . . 0.0 114.21 -174.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.452 64.5 t30 28.15 60.66 0.12 Allowed 'General case' 0 C--N 1.376 1.74 0 N-CA-C 121.158 3.762 . . . . 0.0 121.158 171.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -90.26 106.45 18.5 Favored 'General case' 0 C--N 1.38 1.924 0 CA-C-O 123.052 1.406 . . . . 0.0 111.88 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -72.82 119.85 17.63 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 110.92 -2.855 . . . . 0.0 115.024 -167.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -74.4 155.37 38.16 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 111.58 -2.554 . . . . 0.0 109.784 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 tp -147.54 138.67 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.199 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 -175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.7 t -145.01 154.3 42.39 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.67 -1.269 . . . . 0.0 109.113 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -54.9 -30.16 57.58 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 126.065 1.746 . . . . 0.0 112.246 168.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.96 -37.44 82.4 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 171.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -70.77 -44.7 66.15 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.297 1.839 . . . . 0.0 113.108 168.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.4 mt -58.76 -43.19 90.26 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 82.18 -3.96 1.47 Allowed 'General case' 0 N--CA 1.411 -2.388 0 CA-C-O 122.427 1.108 . . . . 0.0 108.969 -177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -138.53 151.07 47.02 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 118.678 -2.513 . . . . 0.0 106.147 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 tp -51.09 142.24 12.72 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 126.133 1.773 . . . . 0.0 114.039 -167.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -55.9 134.83 73.19 Favored Pre-proline 0 CA--C 1.583 2.234 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -97.76 2.31 1.47 Allowed 'Trans proline' 0 C--O 1.206 -1.097 0 CA-C-O 113.898 -2.626 . . . . 0.0 112.273 -174.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.3 mt -112.34 165.95 11.73 Favored 'General case' 0 C--N 1.364 1.221 0 CA-C-N 121.558 1.981 . . . . 0.0 110.986 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.2 p -91.99 -25.26 18.93 Favored 'General case' 0 C--N 1.361 1.097 0 O-C-N 120.564 -1.335 . . . . 0.0 111.381 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 m -71.3 135.12 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -79.31 115.11 18.77 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 124.076 0.86 . . . . 0.0 109.207 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.345 38.5 m80 57.74 -164.74 0.17 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 117.115 -1.422 . . . . 0.0 112.042 -178.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.19 -162.48 34.81 Favored Glycine 0 C--N 1.371 2.502 0 N-CA-C 103.37 -3.892 . . . . 0.0 103.37 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.38 151.29 43.38 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 103.49 -2.781 . . . . 0.0 103.49 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.97 161.04 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-O 124.303 2.001 . . . . 0.0 106.821 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -139.36 156.91 46.69 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 118.799 -2.438 . . . . 0.0 106.523 170.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.4 m -134.68 128.48 33.1 Favored 'General case' 0 C--N 1.37 1.461 0 O-C-N 120.041 -1.662 . . . . 0.0 110.808 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.1 mt -113.92 148.0 38.96 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 115.783 -2.056 . . . . 0.0 106.812 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.262 31.3 Cg_exo -50.26 147.75 15.52 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 125.21 3.94 . . . . 0.0 116.485 -166.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.257 12.3 m 72.22 39.97 0.73 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.974 1.71 . . . . 0.0 113.815 -175.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 58.53 46.72 14.46 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 128.688 2.795 . . . . 0.0 112.357 172.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.69 113.27 24.9 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 171.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.27 130.76 50.61 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.883 -1.136 . . . . 0.0 110.979 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.9 t -114.12 140.78 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-O 125.484 2.564 . . . . 0.0 106.968 -175.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -111.44 150.24 30.13 Favored 'General case' 0 C--N 1.354 0.799 0 CA-C-N 113.263 -1.79 . . . . 0.0 107.096 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.9 t -132.97 123.27 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 N-CA-C 102.174 -3.269 . . . . 0.0 102.174 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.94 163.05 17.77 Favored Pre-proline 0 CA--C 1.588 2.415 0 CA-C-O 122.625 1.203 . . . . 0.0 112.316 172.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.47 -38.96 28.43 Favored 'Trans proline' 0 N--CA 1.517 2.891 0 C-N-CA 124.861 3.707 . . . . 0.0 114.598 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.2 p-10 -84.24 -10.43 57.69 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 121.253 1.842 . . . . 0.0 113.291 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.9 4.85 36.08 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 125.645 1.593 . . . . 0.0 115.221 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.4 m -58.88 139.4 56.57 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 122.684 1.231 . . . . 0.0 114.015 167.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.1 m -111.74 125.62 54.18 Favored 'General case' 0 C--O 1.206 -1.219 0 O-C-N 121.088 -1.008 . . . . 0.0 110.942 -165.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -133.95 166.23 23.19 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 123.454 1.597 . . . . 0.0 110.641 -165.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -117.38 124.19 48.3 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 119.824 -1.798 . . . . 0.0 112.394 -171.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.1 tp -90.02 -26.76 20.15 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -173.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -135.81 178.17 7.25 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.734 -1.229 . . . . 0.0 108.727 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -53.34 -43.88 68.04 Favored 'General case' 0 C--N 1.399 2.72 0 C-N-CA 125.611 1.564 . . . . 0.0 114.504 -171.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -70.65 -31.71 68.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.64 -37.53 65.31 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 122.578 1.18 . . . . 0.0 109.241 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -62.52 -50.52 71.04 Favored 'General case' 0 C--N 1.364 1.205 0 O-C-N 119.926 -1.734 . . . . 0.0 109.824 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -53.81 -31.77 50.28 Favored 'General case' 0 CA--C 1.586 2.333 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.92 -22.8 66.52 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 115.953 -1.975 . . . . 0.0 112.422 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 128.81 8.47 3.81 Favored Glycine 0 C--N 1.378 2.885 0 CA-C-N 122.696 2.498 . . . . 0.0 116.12 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -118.79 145.65 38.23 Favored Pre-proline 0 C--N 1.376 1.741 0 CA-C-N 121.862 2.831 . . . . 0.0 108.496 -174.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -51.68 148.62 20.95 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.945 3.097 . . . . 0.0 111.042 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -78.98 146.98 20.83 Favored 'Trans proline' 0 CA--C 1.511 -0.641 1 C-N-CA 125.418 4.079 . . . . 0.0 108.048 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.7 tp -89.25 -0.32 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 125.295 2.474 . . . . 0.0 111.229 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.6 p -56.1 -42.21 94.99 Favored Pre-proline 0 C--O 1.213 -0.827 0 CA-C-O 113.663 -3.065 . . . . 0.0 112.9 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -59.94 -31.8 94.19 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 CA-C-N 126.509 3.36 . . . . 0.0 115.693 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.3 tt -98.75 13.55 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -55.19 149.06 13.09 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.011 -1.449 . . . . 0.0 110.3 162.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -92.79 136.09 33.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 112.767 -2.015 . . . . 0.0 110.623 172.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -67.66 145.69 54.56 Favored 'General case' 0 C--O 1.201 -1.489 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.759 164.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.91 175.63 23.3 Favored Glycine 0 N--CA 1.484 1.851 0 CA-C-O 122.947 1.304 . . . . 0.0 110.883 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.3 t -71.72 125.46 27.19 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 112.745 -1.727 . . . . 0.0 110.668 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.1 7.61 57.21 Favored Glycine 0 C--N 1.353 1.525 0 O-C-N 125.385 1.678 . . . . 0.0 116.887 -165.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.98 156.9 22.25 Favored Glycine 0 CA--C 1.54 1.598 0 O-C-N 121.516 -0.991 . . . . 0.0 114.409 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.82 161.0 11.54 Favored Glycine 0 C--N 1.368 2.346 0 C-N-CA 130.347 3.832 . . . . 0.0 114.107 167.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -71.1 138.97 50.15 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 125.941 1.696 . . . . 0.0 108.442 -167.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.1 mt -73.77 140.24 18.04 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-N 110.087 -3.233 . . . . 0.0 112.62 168.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.4 t -65.03 152.15 44.18 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 118.296 2.702 . . . . 0.0 118.296 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 59.5 mt -102.22 11.74 37.76 Favored 'General case' 0 C--O 1.206 -1.214 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -177.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.85 -51.81 56.27 Favored Glycine 0 CA--C 1.555 2.584 0 O-C-N 119.177 -2.202 . . . . 0.0 116.981 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.452 ' HA ' ' HG ' ' A' ' 132' ' ' SER . . . -67.66 -37.38 82.29 Favored 'General case' 0 N--CA 1.42 -1.928 0 O-C-N 119.164 -2.374 . . . . 0.0 114.184 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.8 tp -60.98 -45.43 94.82 Favored 'General case' 0 C--O 1.252 1.227 0 C-N-CA 124.399 1.079 . . . . 0.0 111.111 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.8 tp -69.95 -42.21 73.52 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.452 ' HG ' ' HA ' ' A' ' 129' ' ' ALA . 22.6 p -63.41 -45.31 91.59 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.16 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 94.4 m -64.23 -42.72 96.44 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 126.118 2.136 . . . . 0.0 109.398 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 92.4 m -46.92 -55.76 7.52 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 115.104 -2.379 . . . . 0.0 116.379 167.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 25.1 mt -71.56 -25.21 62.11 Favored 'General case' 0 CA--C 1.568 1.654 0 O-C-N 128.173 3.42 . . . . 0.0 113.781 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -60.38 -45.88 91.96 Favored 'General case' 0 CA--C 1.58 2.112 0 C-N-CA 126.853 2.061 . . . . 0.0 110.327 164.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.4 mt -65.2 -42.96 93.04 Favored 'General case' 0 C--N 1.416 3.497 0 O-C-N 119.58 -1.95 . . . . 0.0 114.281 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 16.6 p -101.81 15.76 27.97 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 127.256 2.222 . . . . 0.0 110.702 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.942 0 CA-C-O 115.901 -2.611 . . . . 0.0 114.092 174.892 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 137' ' ' LEU . 5.0 t . . . . . 0 N--CA 1.503 2.182 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -93.88 133.74 0.86 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 122.336 1.87 . . . . 0.0 108.239 -167.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.7 p -95.17 131.26 30.37 Favored Pre-proline 0 N--CA 1.431 -1.402 0 C-N-CA 117.446 -1.702 . . . . 0.0 106.778 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -46.46 123.61 7.0 Favored 'Trans proline' 0 N--CA 1.511 2.556 0 N-CA-C 116.853 1.828 . . . . 0.0 116.853 170.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.3 mt -138.47 165.74 30.72 Favored Pre-proline 0 C--N 1.378 1.812 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -64.54 134.77 42.69 Favored 'Trans proline' 0 C--O 1.253 1.272 0 CA-C-O 124.836 1.932 . . . . 0.0 112.189 158.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . 0.279 31.7 t 52.62 68.7 2.85 Favored Pre-proline 0 CA--C 1.577 1.982 0 N-CA-C 120.136 3.384 . . . . 0.0 120.136 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.79 -24.9 20.85 Favored 'Trans proline' 0 N--CA 1.506 2.216 0 CA-C-N 125.67 3.061 . . . . 0.0 117.48 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.28 14.1 p 52.37 47.6 24.38 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 120.508 1.504 . . . . 0.0 114.86 172.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t 84.64 35.14 0.04 OUTLIER 'General case' 0 C--O 1.204 -1.327 0 C-N-CA 128.777 2.831 . . . . 0.0 111.228 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 64.02 48.2 3.13 Favored 'General case' 0 N--CA 1.486 1.332 1 C-N-CA 132.499 4.32 . . . . 0.0 115.709 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -79.21 117.36 20.16 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 115.999 -2.28 . . . . 0.0 115.432 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -97.93 126.02 43.12 Favored 'General case' 0 CA--C 1.557 1.222 0 O-C-N 117.704 -3.122 . . . . 0.0 108.106 -177.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -87.18 155.82 19.94 Favored 'General case' 0 CA--C 1.557 1.248 0 O-C-N 117.502 -3.249 . . . . 0.0 111.62 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.7 tp -113.48 117.85 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 123.292 1.52 . . . . 0.0 113.443 165.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.475 ' HB2' ' CD2' ' A' ' 77' ' ' HIS . 92.0 p -128.87 179.25 5.83 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 123.645 1.688 . . . . 0.0 109.285 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -61.65 -29.68 70.22 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 119.581 -1.95 . . . . 0.0 114.284 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.99 -42.57 84.8 Favored 'General case' 0 C--O 1.266 1.936 0 C-N-CA 125.448 1.499 . . . . 0.0 112.932 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.44 -46.2 84.18 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 164.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.27 83.3 mt -73.73 -17.38 61.12 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 122.78 2.536 . . . . 0.0 113.872 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.3 . . 65.18 11.76 7.46 Favored 'General case' 0 C--O 1.192 -1.961 0 O-C-N 127.915 3.259 . . . . 0.0 115.953 -177.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -165.12 166.4 19.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 127.307 2.243 . . . . 0.0 107.004 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.7 mt -18.93 133.07 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.443 3.097 . . . . 0.0 119.209 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -73.72 127.01 89.19 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 116.622 -3.799 . . . . 0.0 114.975 164.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -89.15 15.49 2.01 Favored 'Trans proline' 0 CA--C 1.57 2.294 0 CA-C-N 123.292 2.211 . . . . 0.0 112.229 -168.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 mt -136.0 165.1 26.46 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-O 123.753 1.739 . . . . 0.0 110.727 -172.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.8 p -100.97 -1.56 34.1 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.561 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.2 m -90.27 171.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.381 1.962 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 169.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -81.26 174.7 11.27 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 122.27 1.033 . . . . 0.0 111.816 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.475 ' CD2' ' HB2' ' A' ' 63' ' ' SER . 8.7 m-70 -73.37 144.18 46.55 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 128.838 2.855 . . . . 0.0 106.012 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.03 179.54 36.42 Favored Glycine 0 C--N 1.367 2.304 0 CA-C-N 112.058 -2.337 . . . . 0.0 110.501 -164.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.3 m -84.65 120.21 26.12 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-O 123.716 1.722 . . . . 0.0 113.593 -173.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -86.69 143.68 10.91 Favored 'Isoleucine or valine' 0 C--O 1.257 1.489 0 CA-C-O 124.243 1.973 . . . . 0.0 111.574 165.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -145.67 151.68 38.42 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 112.577 -2.101 . . . . 0.0 107.125 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 89.6 m -121.51 115.02 22.07 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-O 125.086 2.374 . . . . 0.0 107.132 172.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mt -92.86 150.81 40.09 Favored Pre-proline 0 CA--C 1.507 -0.701 0 CA-C-O 116.093 -1.908 . . . . 0.0 106.564 -174.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -47.07 138.75 15.93 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 123.848 3.032 . . . . 0.0 116.545 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.6 m 80.14 49.26 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 120.757 1.617 . . . . 0.0 115.229 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 46.98 49.19 14.99 Favored 'General case' 0 C--N 1.392 2.448 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -106.32 116.51 32.06 Favored 'General case' 0 C--N 1.385 2.119 0 C-N-CA 117.868 -1.533 . . . . 0.0 111.942 170.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.77 106.94 15.85 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-O 123.291 1.52 . . . . 0.0 107.575 -173.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.7 m -122.67 144.79 30.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 C-N-CA 127.589 2.356 . . . . 0.0 109.089 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -113.33 128.47 56.47 Favored 'General case' 0 N--CA 1.425 -1.687 0 O-C-N 119.006 -2.309 . . . . 0.0 106.165 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.9 t -106.49 111.64 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.98 156.3 92.02 Favored Pre-proline 0 C--O 1.27 2.153 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.598 171.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.61 2.36 2.98 Favored 'Trans proline' 0 CA--C 1.498 -1.31 0 C-N-CA 124.409 3.406 . . . . 0.0 113.241 -166.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -102.66 -25.13 13.67 Favored 'General case' 0 C--O 1.245 0.834 0 O-C-N 127.139 2.774 . . . . 0.0 110.188 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.11 24.85 3.16 Favored Glycine 0 C--N 1.348 1.242 0 C-N-CA 126.282 1.896 . . . . 0.0 110.815 172.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.46 147.32 24.35 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.0 m -129.47 125.68 36.97 Favored 'General case' 0 C--O 1.263 1.814 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -167.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -128.94 126.81 40.45 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 125.852 1.97 . . . . 0.0 108.581 -165.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.04 124.26 19.99 Favored 'General case' 0 C--O 1.211 -0.932 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 69.7 mt -93.77 -30.49 14.83 Favored 'General case' 0 C--N 1.369 1.441 0 O-C-N 119.638 -1.914 . . . . 0.0 112.571 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -122.12 178.11 5.05 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 124.132 1.92 . . . . 0.0 106.51 174.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -79.04 -19.51 51.26 Favored 'General case' 0 CA--C 1.583 2.223 0 O-C-N 118.402 -2.687 . . . . 0.0 117.751 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -59.18 -37.78 78.19 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 126.018 2.074 . . . . 0.0 110.168 172.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.23 -30.75 69.89 Favored 'General case' 0 CA--C 1.472 -2.029 0 CA-C-O 114.998 -2.429 . . . . 0.0 113.271 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -62.7 -41.31 99.06 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 126.788 2.035 . . . . 0.0 114.014 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -66.34 -37.01 84.36 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 168.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.32 -4.68 40.61 Favored 'General case' 0 C--O 1.257 1.475 0 O-C-N 118.801 -2.437 . . . . 0.0 112.348 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.94 28.63 9.83 Favored Glycine 0 C--N 1.353 1.526 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.75 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -86.43 134.92 37.13 Favored Pre-proline 0 CA--C 1.58 2.1 0 CA-C-O 115.468 -2.206 . . . . 0.0 107.862 170.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -56.8 128.26 29.23 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 O-C-N 125.667 2.404 . . . . 0.0 114.313 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -32.27 145.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.362 2.041 . . . . 0.0 115.824 161.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.9 tt -99.96 19.46 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 C-N-CA 126.188 1.795 . . . . 0.0 110.453 173.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.05 -30.47 1.13 Allowed Pre-proline 0 CA--C 1.558 1.251 0 CA-C-O 112.165 -3.778 . . . . 0.0 116.439 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -71.59 -42.33 1.85 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 125.342 2.944 . . . . 0.0 111.716 -169.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 21.5 pt -88.28 6.19 3.75 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 C-N-CA 128.243 2.617 . . . . 0.0 111.774 -165.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -53.11 155.9 2.39 Favored 'General case' 0 C--O 1.221 -0.419 1 O-C-N 116.021 -4.174 . . . . 0.0 118.355 168.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -98.68 147.33 24.96 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 117.31 -1.756 . . . . 0.0 110.04 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . 0.353 13.7 mmmm -64.94 143.99 57.58 Favored 'General case' 0 C--N 1.37 1.476 0 CA-C-O 124.072 1.891 . . . . 0.0 110.568 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -82.06 -146.19 5.6 Favored Glycine 0 CA--C 1.57 3.489 0 CA-C-O 126.374 3.208 . . . . 0.0 117.503 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.4 t -111.42 111.74 22.99 Favored 'General case' 0 CA--C 1.512 -0.507 1 O-C-N 116.113 -4.169 . . . . 0.0 102.86 170.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.48 48.27 5.37 Favored Glycine 1 C--N 1.399 4.053 0 CA-C-N 120.319 1.418 . . . . 0.0 110.096 177.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.82 -164.52 54.78 Favored Glycine 0 C--N 1.381 3.075 0 N-CA-C 117.12 1.608 . . . . 0.0 117.12 -171.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.39 -166.4 1.14 Allowed Glycine 0 C--N 1.338 0.684 1 N-CA-C 123.491 4.157 . . . . 0.0 123.491 -173.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . 0.317 74.3 m-85 -133.54 149.06 51.68 Favored 'General case' 0 C--O 1.253 1.269 0 O-C-N 117.414 -3.403 . . . . 0.0 110.296 -173.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 79.6 mt -63.92 151.67 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.163 0 CA-C-N 124.082 3.128 . . . . 0.0 108.784 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.0 t -62.55 145.24 54.84 Favored 'General case' 0 C--O 1.198 -1.64 0 O-C-N 118.273 -2.767 . . . . 0.0 113.17 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.7 mt -97.52 4.92 50.26 Favored 'General case' 0 CA--C 1.58 2.116 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 -172.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -76.59 -41.72 23.83 Favored Glycine 0 C--N 1.394 3.789 0 C-N-CA 119.683 -1.246 . . . . 0.0 115.38 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.26 -34.52 72.91 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 117.389 -3.418 . . . . 0.0 115.767 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 27.9 tp -54.26 -58.71 6.36 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 126.083 1.753 . . . . 0.0 112.133 165.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 38.3 tp -63.09 -40.3 97.25 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.3 p -71.82 -33.45 68.52 Favored 'General case' 0 C--O 1.251 1.175 0 O-C-N 119.296 -2.128 . . . . 0.0 115.108 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 32.4 m -61.71 -42.69 99.28 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.92 1.288 . . . . 0.0 108.656 169.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.1 m -57.56 -46.85 83.43 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.8 mt -72.12 -30.13 64.75 Favored 'General case' 0 CA--C 1.562 1.406 0 O-C-N 124.865 1.353 . . . . 0.0 112.232 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -58.25 -46.62 85.65 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 116.845 -1.55 . . . . 0.0 113.14 168.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 48' ' ' SER . 71.9 mt -72.63 -45.25 59.96 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 119.236 0.926 . . . . 0.0 111.29 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . 0.342 1.2 p -74.44 -17.76 60.74 Favored 'General case' 0 C--O 1.202 -1.429 0 CA-C-O 115.75 -2.072 . . . . 0.0 113.328 -170.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.381 3.065 0 N-CA-C 120.035 2.774 . . . . 0.0 120.035 169.757 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.508 2.43 0 CA-C-O 115.807 -2.044 . . . . 0.0 116.113 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -50.7 152.15 9.82 Favored 'Trans proline' 0 C--O 1.199 -1.453 0 C-N-CA 124.432 3.421 . . . . 0.0 114.583 164.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.3 m -67.13 140.95 96.02 Favored Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-O 117.128 -1.415 . . . . 0.0 112.422 -165.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -41.1 130.81 3.1 Favored 'Trans proline' 0 C--N 1.286 -2.714 0 N-CA-C 120.83 3.358 . . . . 0.0 120.83 167.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.1 tp -129.76 101.12 18.71 Favored Pre-proline 0 CA--C 1.591 2.521 0 O-C-N 125.633 1.833 . . . . 0.0 111.952 -168.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -86.96 89.75 0.62 Allowed 'Trans proline' 0 CA--C 1.474 -2.483 1 C-N-CA 126.822 5.015 . . . . 0.0 108.072 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.8 t -163.77 116.01 1.02 Allowed Pre-proline 0 C--N 1.288 -2.071 0 C-N-CA 119.288 -0.965 . . . . 0.0 112.122 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -33.94 134.7 0.12 Allowed 'Trans proline' 0 CA--C 1.508 -0.802 1 C-N-CA 126.686 4.924 . . . . 0.0 118.572 -175.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 35.78 42.07 0.13 Allowed 'General case' 0 C--O 1.257 1.454 0 C-N-CA 129.771 3.228 . . . . 0.0 114.63 -167.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.364 7.4 m 59.29 54.49 4.74 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 125.999 1.719 . . . . 0.0 114.938 -173.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.0 t30 66.36 38.39 4.42 Favored 'General case' 0 CA--C 1.597 2.76 0 C-N-CA 130.743 3.617 . . . . 0.0 113.759 -175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.79 145.53 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.417 2.687 . . . . 0.0 114.758 -176.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -114.49 104.35 11.94 Favored 'General case' 0 CA--C 1.466 -2.26 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -170.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.75 139.06 55.32 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.1 tt -116.24 142.6 29.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 121.458 -0.776 . . . . 0.0 109.408 162.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.508 ' HB2' ' CE1' ' A' ' 77' ' ' HIS . 90.3 p -152.76 158.88 42.93 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-O 116.143 -1.885 . . . . 0.0 107.207 -169.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -64.28 -18.16 64.32 Favored 'General case' 0 C--N 1.367 1.365 0 CA-C-N 123.608 2.913 . . . . 0.0 110.598 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.96 -25.9 53.37 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 120.476 -1.39 . . . . 0.0 111.817 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -73.29 -28.66 62.23 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 125.949 1.7 . . . . 0.0 111.275 173.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mt -88.98 3.77 50.45 Favored 'General case' 0 C--O 1.203 -1.35 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 36.8 63.01 0.72 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 120.747 3.61 . . . . 0.0 120.747 -168.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . 0.297 51.0 t80 83.58 149.12 0.08 Allowed 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 129.214 3.006 . . . . 0.0 109.714 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.324 2.1 tp 89.57 81.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 128.989 2.916 . . . . 0.0 109.601 173.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -85.7 124.79 70.64 Favored Pre-proline 0 N--CA 1.479 0.989 0 O-C-N 120.37 -1.456 . . . . 0.0 112.474 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.72 3.2 8.0 Favored 'Trans proline' 0 C--N 1.362 1.253 0 CA-C-N 122.037 1.763 . . . . 0.0 114.637 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.9 mt -120.63 158.27 27.77 Favored 'General case' 0 C--N 1.375 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.95 -165.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.0 p -78.83 -30.08 45.07 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 170.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.5 m -71.91 147.71 10.4 Favored 'Isoleucine or valine' 0 C--N 1.367 1.36 0 C-N-CA 124.506 1.122 . . . . 0.0 111.491 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . 0.256 62.7 t0 -90.15 82.35 6.07 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 118.49 -2.631 . . . . 0.0 111.426 -172.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.508 ' CE1' ' HB2' ' A' ' 63' ' ' SER 0.33 27.5 m170 77.84 178.12 0.15 Allowed 'General case' 0 CA--C 1.474 -1.956 0 O-C-N 120.567 -1.333 . . . . 0.0 114.013 179.016 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.21 -176.57 39.86 Favored Glycine 0 N--CA 1.433 -1.535 0 O-C-N 117.977 -2.952 . . . . 0.0 114.711 -172.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.495 ' HG1' ' HB ' ' A' ' 91' ' ' VAL 0.259 17.0 p -124.24 146.29 48.84 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 118.591 -2.711 . . . . 0.0 105.757 171.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 pp -119.84 150.09 22.45 Favored 'Isoleucine or valine' 0 C--N 1.366 1.29 0 CA-C-O 126.644 3.116 . . . . 0.0 112.379 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -141.66 137.9 32.1 Favored 'General case' 0 CA--C 1.57 1.745 0 O-C-N 116.536 -3.852 . . . . 0.0 108.524 168.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.9 m -108.29 140.78 41.06 Favored 'General case' 0 C--N 1.368 1.385 0 O-C-N 117.342 -3.349 . . . . 0.0 104.906 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.7 mt -111.38 146.99 35.73 Favored Pre-proline 0 N--CA 1.432 -1.359 0 C-N-CA 129.501 3.12 . . . . 0.0 102.909 -173.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -40.35 134.58 2.01 Favored 'Trans proline' 0 N--CA 1.507 2.274 1 C-N-CA 126.45 4.767 . . . . 0.0 113.059 -173.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.272 1.0 OUTLIER 85.2 31.59 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 122.489 1.137 . . . . 0.0 108.909 170.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . 0.281 21.8 m-20 65.84 44.54 2.79 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 116.872 -3.642 . . . . 0.0 115.448 176.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -101.74 114.07 27.81 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.21 120.82 36.09 Favored 'General case' 0 N--CA 1.409 -2.508 0 O-C-N 125.013 1.446 . . . . 0.0 111.284 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.1 t -99.87 145.35 10.84 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 CA-C-O 127.737 3.637 . . . . 0.0 109.883 166.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -111.3 128.56 55.98 Favored 'General case' 0 N--CA 1.44 -0.94 1 O-C-N 115.038 -4.789 . . . . 0.0 106.714 168.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.495 ' HB ' ' HG1' ' A' ' 79' ' ' THR . 40.8 t -110.44 124.57 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.723 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.36 167.15 19.69 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-O 117.222 -1.37 . . . . 0.0 114.367 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -41.13 -34.31 1.54 Allowed 'Trans proline' 0 N--CA 1.52 3.079 0 N-CA-C 120.518 3.238 . . . . 0.0 120.518 165.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.0 p30 -96.99 3.89 51.77 Favored 'General case' 0 CA--C 1.477 -1.846 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.77 -13.25 29.71 Favored Glycine 0 CA--C 1.526 0.725 0 O-C-N 120.262 -1.524 . . . . 0.0 111.91 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.282 47.0 m -66.47 113.02 4.38 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -173.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.68 119.58 10.16 Favored 'General case' 0 C--N 1.375 1.691 0 C-N-CA 128.014 2.526 . . . . 0.0 115.6 171.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -120.04 141.52 49.67 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 166.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.04 149.3 37.37 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 153.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . 0.255 23.1 tp -118.76 -3.26 10.81 Favored 'General case' 0 C--N 1.379 1.883 0 C-N-CA 129.87 3.268 . . . . 0.0 111.848 177.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.2 p30 -158.07 175.1 14.23 Favored 'General case' 0 C--N 1.38 1.897 0 CA-C-N 120.412 1.46 . . . . 0.0 109.916 169.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . 0.315 69.4 m-20 -60.34 -36.91 79.07 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -173.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.4 mtt85 -59.19 -41.34 88.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 127.811 3.194 . . . . 0.0 111.639 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.12 -23.5 28.42 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-O 124.932 2.301 . . . . 0.0 114.659 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -63.7 -47.28 81.78 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.63 -1.623 . . . . 0.0 112.391 163.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -61.32 -38.12 85.71 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-O 125.157 2.408 . . . . 0.0 115.427 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.39 -34.23 68.66 Favored 'General case' 0 CA--C 1.572 1.819 0 O-C-N 119.308 -2.12 . . . . 0.0 113.388 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 127.92 -3.83 6.92 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 120.807 3.083 . . . . 0.0 120.807 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -70.66 143.49 89.88 Favored Pre-proline 0 N--CA 1.487 1.421 0 CA-C-N 121.654 2.727 . . . . 0.0 112.161 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -48.44 146.8 9.84 Favored 'Trans proline' 0 C--N 1.296 -2.229 1 C-N-CA 126.323 4.682 . . . . 0.0 119.431 175.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -82.25 151.76 15.85 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 118.266 -1.492 . . . . 0.0 109.503 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.9 tt -86.08 4.19 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.554 1.942 . . . . 0.0 109.784 -171.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.65 -40.28 74.1 Favored Pre-proline 0 CA--C 1.578 2.029 1 N-CA-C 122.04 4.089 . . . . 0.0 122.04 -168.339 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.84 -6.66 14.31 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 113.974 -3.751 . . . . 0.0 114.308 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 31.4 mm -86.19 -16.61 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 C-N-CA 125.904 1.682 . . . . 0.0 106.952 176.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -56.93 145.39 30.2 Favored 'General case' 0 C--O 1.194 -1.834 0 CA-C-O 126.04 2.829 . . . . 0.0 117.49 164.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -93.7 132.59 37.91 Favored 'General case' 0 C--O 1.209 -1.07 0 CA-C-N 112.459 -2.155 . . . . 0.0 111.774 174.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . 0.467 41.3 mtpt -57.65 144.58 37.13 Favored 'General case' 0 C--O 1.178 -2.676 0 O-C-N 119.322 -2.111 . . . . 0.0 112.989 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -110.79 -168.88 19.21 Favored Glycine 0 N--CA 1.494 2.524 0 CA-C-N 119.943 1.247 . . . . 0.0 112.215 -159.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 64.4 m -76.05 119.89 20.61 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 116.145 -1.883 . . . . 0.0 113.487 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.55 49.33 5.83 Favored Glycine 0 C--N 1.365 2.147 0 CA-C-N 121.669 2.031 . . . . 0.0 114.194 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 59.62 -155.85 28.36 Favored Glycine 1 CA--C 1.593 4.918 0 O-C-N 118.245 -2.914 . . . . 0.0 116.375 -158.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 49.81 -152.69 3.58 Favored Glycine 0 C--O 1.213 -1.163 0 CA-C-O 124.395 2.108 . . . . 0.0 114.904 -167.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -134.58 148.44 50.46 Favored 'General case' 0 N--CA 1.418 -2.041 0 C-N-CA 126.594 1.958 . . . . 0.0 111.721 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.9 mt -60.9 140.17 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.363 0 O-C-N 120.324 -1.485 . . . . 0.0 112.391 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.5 t -52.61 137.65 30.13 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 128.844 2.857 . . . . 0.0 112.999 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.4 mt -98.46 4.48 48.37 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.481 -1.387 . . . . 0.0 111.47 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -44.25 -63.88 2.21 Favored Glycine 0 CA--C 1.486 -1.726 0 C-N-CA 127.775 2.607 . . . . 0.0 113.823 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.9 -45.08 93.68 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 173.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.0 tp -63.18 -43.44 98.22 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 124.502 1.126 . . . . 0.0 113.561 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.8 tp -64.72 -45.97 84.27 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 121.736 0.779 . . . . 0.0 112.405 168.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 78.4 p -74.8 -36.46 62.48 Favored 'General case' 0 CA--C 1.497 -1.095 0 O-C-N 117.919 -2.988 . . . . 0.0 113.347 -169.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 52.0 m -59.89 -43.09 94.99 Favored 'General case' 0 C--O 1.266 1.97 0 C-N-CA 128.695 2.798 . . . . 0.0 105.588 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 47.0 m -63.05 -41.65 99.54 Favored 'General case' 0 C--N 1.377 1.787 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.527 -174.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 17.8 mt -69.64 -36.95 76.57 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 117.719 2.489 . . . . 0.0 117.719 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -61.39 -37.89 85.09 Favored 'General case' 0 CA--C 1.57 1.715 0 O-C-N 116.801 -3.687 . . . . 0.0 109.839 165.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 49.0 tp -69.92 -31.25 68.92 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 118.155 -2.841 . . . . 0.0 115.622 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 28.6 p -92.21 14.86 14.96 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.088 -1.008 . . . . 0.0 110.957 176.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.984 0 C-N-CA 125.779 1.656 . . . . 0.0 109.993 -179.902 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.41 ' HG ' ' C ' ' A' ' 139' ' ' GLY . 4.5 p . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -41.67 116.27 0.51 Allowed 'Trans proline' 0 N--CA 1.506 2.262 0 C-N-CA 124.521 3.481 . . . . 0.0 115.577 -168.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.4 t -80.98 107.4 7.48 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 125.651 1.845 . . . . 0.0 110.674 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -77.67 33.34 0.45 Allowed 'Trans proline' 0 N--CA 1.505 2.168 0 N-CA-C 114.876 1.068 . . . . 0.0 114.876 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.9 mt -115.0 160.17 34.8 Favored Pre-proline 0 C--N 1.378 1.835 0 O-C-N 120.313 -1.492 . . . . 0.0 110.399 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -45.79 147.01 3.43 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 N-CA-C 119.088 2.688 . . . . 0.0 119.088 164.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.7 m 35.04 73.13 0.65 Allowed Pre-proline 0 N--CA 1.512 2.629 0 N-CA-C 120.224 3.416 . . . . 0.0 120.224 -167.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.25 -18.28 44.81 Favored 'Trans proline' 0 C--N 1.366 1.485 0 C-N-CA 122.006 1.804 . . . . 0.0 114.103 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.2 m 43.5 58.85 3.28 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 127.552 2.341 . . . . 0.0 113.131 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.275 74.1 m 52.86 34.68 17.1 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 119.969 3.322 . . . . 0.0 119.969 -171.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 60.32 54.91 3.74 Favored 'General case' 0 C--O 1.248 1.026 0 C-N-CA 127.627 2.371 . . . . 0.0 116.438 -167.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.4 mttm -133.05 152.09 51.99 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -145.85 147.06 31.4 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.104 -1.407 . . . . 0.0 113.85 -162.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -73.76 135.02 43.54 Favored 'General case' 0 N--CA 1.411 -2.402 0 O-C-N 128.338 3.524 . . . . 0.0 111.464 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.9 tp -136.54 128.88 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 125.571 2.605 . . . . 0.0 112.945 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.9 p -162.76 171.78 16.24 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 127.271 2.228 . . . . 0.0 107.832 -159.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -45.1 -52.17 9.42 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 128.253 2.621 . . . . 0.0 114.756 173.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.76 93.55 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 174.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -82.45 -19.87 38.08 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 120.293 -1.504 . . . . 0.0 111.522 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.6 tp -75.06 -42.57 56.67 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 117.971 2.582 . . . . 0.0 117.971 166.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 65.56 15.71 10.16 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 130.006 3.322 . . . . 0.0 114.289 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -134.27 166.81 21.94 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 162.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.6 mt -39.31 128.67 1.8 Allowed 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -174.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.436 ' CD2' ' HD2' ' A' ' 72' ' ' PRO . 53.9 t-105 -66.27 139.62 96.44 Favored Pre-proline 0 CA--C 1.567 1.621 0 CA-C-O 113.296 -3.24 . . . . 0.0 114.806 176.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HD2' ' CD2' ' A' ' 71' ' ' TRP . 2.1 Cg_endo -116.97 -3.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 2.015 0 CA-C-O 111.187 -3.755 . . . . 0.0 110.302 -167.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 mt -113.13 152.95 29.01 Favored 'General case' 0 C--N 1.401 2.818 0 O-C-N 127.484 2.99 . . . . 0.0 112.929 -177.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.2 p -79.28 -17.12 55.31 Favored 'General case' 0 N--CA 1.416 -2.132 0 O-C-N 118.281 -2.762 . . . . 0.0 113.64 -171.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.8 m -72.16 147.94 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 129.986 3.314 . . . . 0.0 115.003 166.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -56.59 171.24 0.32 Allowed 'General case' 0 C--O 1.2 -1.527 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 154.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -36.32 127.13 0.79 Allowed 'General case' 0 C--N 1.373 1.62 0 C-N-CA 130.322 3.449 . . . . 0.0 109.778 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.58 -168.24 22.68 Favored Glycine 0 N--CA 1.434 -1.459 0 CA-C-O 123.322 1.512 . . . . 0.0 111.659 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.9 m -120.97 115.57 23.43 Favored 'General case' 0 C--N 1.378 1.825 0 CA-C-N 111.228 -2.486 . . . . 0.0 109.031 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . 0.328 1.9 pp -88.81 138.38 19.31 Favored 'Isoleucine or valine' 0 C--N 1.396 2.605 0 CA-C-N 121.074 1.761 . . . . 0.0 110.534 172.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -133.39 132.5 41.28 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.4 m -100.16 130.32 46.28 Favored 'General case' 0 C--N 1.382 1.994 0 CA-C-O 124.053 1.883 . . . . 0.0 110.322 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.3 mt -105.52 157.53 34.31 Favored Pre-proline 0 CA--C 1.569 1.706 0 O-C-N 119.32 -2.113 . . . . 0.0 113.589 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -40.35 145.73 0.32 Allowed 'Trans proline' 0 CA--C 1.475 -2.475 1 C-N-CA 127.084 5.19 . . . . 0.0 113.425 169.1 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.1 m 70.55 41.41 0.95 Allowed 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 118.971 2.952 . . . . 0.0 118.971 173.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 64.98 30.35 11.88 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 129.343 3.057 . . . . 0.0 112.751 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.254 65.5 m-20 -101.06 137.31 39.59 Favored 'General case' 0 C--N 1.373 1.615 0 CA-C-N 120.009 1.277 . . . . 0.0 109.497 -169.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.12 124.2 36.35 Favored 'General case' 0 C--O 1.2 -1.535 0 CA-C-N 122.431 2.378 . . . . 0.0 111.002 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.254 32.7 m -120.11 144.29 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-O 124.361 2.029 . . . . 0.0 113.252 -174.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -121.06 131.37 54.24 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 120.236 -1.54 . . . . 0.0 107.594 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.35 118.32 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.323 0 C-N-CA 126.309 1.843 . . . . 0.0 110.867 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.17 156.51 76.51 Favored Pre-proline 0 CA--C 1.577 1.99 0 O-C-N 126.435 2.334 . . . . 0.0 115.401 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -43.69 -35.1 6.18 Favored 'Trans proline' 0 C--O 1.255 1.372 0 N-CA-C 120.395 3.19 . . . . 0.0 120.395 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -69.98 -33.54 72.19 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 116.779 -1.581 . . . . 0.0 113.719 172.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 127.86 -3.31 6.94 Favored Glycine 0 C--N 1.364 2.086 1 C-N-CA 130.915 4.102 . . . . 0.0 113.745 176.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.8 m -57.07 132.47 53.01 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 125.257 1.423 . . . . 0.0 113.834 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.4 m -106.19 109.0 20.8 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 123.163 2.711 . . . . 0.0 107.072 -174.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -113.26 148.4 35.64 Favored 'General case' 0 C--O 1.255 1.351 0 O-C-N 120.631 -1.293 . . . . 0.0 108.837 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.3 127.65 33.44 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 114.636 -2.602 . . . . 0.0 111.438 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.38 -9.43 30.0 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 120.339 1.427 . . . . 0.0 112.393 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -141.75 171.02 14.63 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.414 1.102 . . . . 0.0 110.484 172.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -65.27 -32.54 74.26 Favored 'General case' 0 N--CA 1.416 -2.172 0 C-N-CA 130.396 3.478 . . . . 0.0 110.909 -171.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -59.09 -42.48 90.55 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 125.482 1.739 . . . . 0.0 113.352 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.6 -17.31 39.12 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -172.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -66.23 -44.14 84.6 Favored 'General case' 0 C--N 1.381 1.952 0 CA-C-O 116.262 -1.828 . . . . 0.0 110.289 158.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -65.31 -42.78 92.66 Favored 'General case' 0 C--N 1.362 1.117 0 O-C-N 126.445 2.341 . . . . 0.0 116.878 173.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.6 -34.74 73.12 Favored 'General case' 0 C--N 1.374 1.67 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 166.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 140.27 -17.88 2.9 Favored Glycine 0 C--N 1.376 2.753 0 N-CA-C 119.408 2.523 . . . . 0.0 119.408 166.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -71.47 140.96 85.01 Favored Pre-proline 0 C--O 1.272 2.243 0 CA-C-N 119.904 1.852 . . . . 0.0 111.4 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.66 136.5 0.66 Allowed 'Trans proline' 0 C--N 1.378 2.113 1 C-N-CA 125.358 4.039 . . . . 0.0 117.412 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -55.61 155.64 20.9 Favored 'Trans proline' 0 CA--C 1.565 2.031 0 C-N-CA 122.862 2.375 . . . . 0.0 112.106 173.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 tp -79.92 -14.7 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 122.455 1.121 . . . . 0.0 113.821 -172.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . 0.303 2.3 m -15.71 -61.61 0.04 OUTLIER Pre-proline 0 C--O 1.248 1.001 1 N-CA-C 122.254 4.168 . . . . 0.0 122.254 169.254 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -48.82 -45.36 28.61 Favored 'Trans proline' 0 C--N 1.29 -2.532 0 C-N-CA 124.207 3.271 . . . . 0.0 115.887 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . 0.255 8.4 pt -106.98 12.82 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 117.531 -3.23 . . . . 0.0 111.415 -162.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -62.96 140.19 58.83 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 166.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.92 137.84 39.67 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 120.62 -1.3 . . . . 0.0 108.082 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -58.49 156.23 10.82 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 116.709 2.115 . . . . 0.0 116.709 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -108.53 -165.25 20.95 Favored Glycine 0 CA--C 1.563 3.057 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.8 t -110.19 116.99 32.5 Favored 'General case' 0 C--N 1.388 2.254 0 CA-C-O 116.383 -1.77 . . . . 0.0 108.747 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.16 55.61 2.73 Favored Glycine 0 C--N 1.388 3.439 0 C-N-CA 127.122 2.296 . . . . 0.0 115.988 -162.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.65 -161.84 11.84 Favored Glycine 0 CA--C 1.455 -3.666 0 N-CA-C 119.08 2.392 . . . . 0.0 119.08 -164.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.44 -175.27 25.92 Favored Glycine 0 C--N 1.365 2.157 0 N-CA-C 119.223 2.449 . . . . 0.0 119.223 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -127.59 163.81 23.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 175.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.0 mm -61.99 120.5 8.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.92 0 O-C-N 126.559 2.412 . . . . 0.0 108.881 166.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.7 t -62.12 154.83 25.95 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.1 mt -102.43 10.3 39.09 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 124.602 2.144 . . . . 0.0 115.223 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.51 -40.2 86.54 Favored Glycine 0 N--CA 1.486 2.011 0 O-C-N 117.393 -3.317 . . . . 0.0 118.548 -165.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.36 -42.57 96.14 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-O 125.174 2.416 . . . . 0.0 106.614 168.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.45 -38.99 88.59 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 118.437 -2.664 . . . . 0.0 110.267 -174.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.314 8.4 tt -63.26 -53.08 58.54 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.261 1.424 . . . . 0.0 113.96 175.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 89.2 p -69.77 -30.26 67.79 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 122.145 0.974 . . . . 0.0 110.935 -171.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.4 m -67.82 -40.0 83.87 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 171.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 96.0 m -50.01 -48.68 52.43 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.587 1.955 . . . . 0.0 113.32 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 39.2 mt -67.13 -37.11 83.29 Favored 'General case' 0 N--CA 1.389 -3.521 0 O-C-N 127.635 3.085 . . . . 0.0 114.96 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -61.68 -48.44 80.79 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 121.9 2.136 . . . . 0.0 113.875 157.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.13 -42.38 94.69 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 117.24 -1.362 . . . . 0.0 114.198 -176.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . 0.272 15.6 p -92.67 9.11 36.28 Favored 'General case' 0 C--N 1.38 1.927 0 N-CA-C 118.18 2.659 . . . . 0.0 118.18 173.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.41 ' C ' ' HG ' ' A' ' 48' ' ' SER . . . . . . . . 0 C--O 1.256 1.529 0 CA-C-O 114.53 -3.372 . . . . 0.0 116.963 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 . . . . . 0 CA--C 1.495 -1.159 0 CA-C-O 118.391 -0.814 . . . . 0.0 112.725 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.23 136.57 58.0 Favored 'General case' 0 C--O 1.252 1.233 0 O-C-N 125.983 2.052 . . . . 0.0 111.307 164.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.77 142.14 23.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 CA-C-N 113.209 -1.814 . . . . 0.0 112.967 -168.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.8 p -138.98 178.29 7.27 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 -175.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -63.79 -44.91 91.93 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 122.382 1.087 . . . . 0.0 110.413 174.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.15 78.96 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 120.351 -1.468 . . . . 0.0 113.633 172.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -66.94 -43.0 84.31 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-O 117.752 -1.118 . . . . 0.0 112.018 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.7 tp -61.59 -35.98 79.37 Favored 'General case' 0 CA--C 1.582 2.192 0 CA-C-N 120.613 1.551 . . . . 0.0 113.83 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.3 . . 79.02 32.49 0.27 Allowed 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.715 -1.241 . . . . 0.0 112.074 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -156.12 157.96 36.9 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -175.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.9 mt -50.32 127.41 17.22 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 174.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -64.52 124.04 84.78 Favored Pre-proline 0 CA--C 1.567 1.607 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.433 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -99.1 0.76 1.01 Allowed 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.953 2.435 . . . . 0.0 113.5 -159.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 mt -130.91 167.84 18.31 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.2 p -89.6 1.85 55.45 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.7 160.49 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.24 -1.537 . . . . 0.0 111.626 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -77.27 174.36 10.85 Favored 'General case' 0 CA--C 1.561 1.387 0 O-C-N 120.278 -1.514 . . . . 0.0 112.424 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -53.98 140.19 31.95 Favored 'General case' 0 CA--C 1.6 2.887 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.92 -150.29 5.33 Favored Glycine 0 C--N 1.368 2.309 0 C-N-CA 127.877 2.656 . . . . 0.0 115.001 -166.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.3 m -127.58 146.7 50.44 Favored 'General case' 0 C--N 1.364 1.217 0 O-C-N 125.492 1.348 . . . . 0.0 107.821 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.3 pt -115.79 145.69 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 C-N-CA 127.307 2.243 . . . . 0.0 109.699 167.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -147.46 141.21 25.68 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-O 122.473 1.13 . . . . 0.0 111.803 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 62.0 m -88.99 138.23 31.6 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.3 mt -120.32 155.26 56.32 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.257 33.5 Cg_exo -40.67 134.88 2.21 Favored 'Trans proline' 0 N--CA 1.523 3.207 0 N-CA-C 121.804 3.732 . . . . 0.0 121.804 174.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.385 52.9 m 79.59 50.19 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.08 1.352 . . . . 0.0 110.497 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 46.32 44.16 12.29 Favored 'General case' 0 C--N 1.366 1.324 0 CA-C-N 112.456 -2.156 . . . . 0.0 112.365 173.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -96.24 145.38 25.61 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-N 118.964 0.802 . . . . 0.0 110.667 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.659 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -124.71 130.03 51.63 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.0 m -119.47 157.18 21.64 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.798 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -130.39 137.89 50.1 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 102.641 -3.096 . . . . 0.0 102.641 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.0 t -126.57 119.31 53.34 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.76 164.25 2.3 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 171.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.58 -12.21 30.97 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 CA-C-O 114.703 -2.29 . . . . 0.0 114.456 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -90.57 -1.57 57.88 Favored 'General case' 0 C--N 1.367 1.34 0 CA-C-N 120.723 1.601 . . . . 0.0 113.478 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.62 -1.07 42.42 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-O 116.159 -2.467 . . . . 0.0 112.73 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.2 m -79.57 120.18 23.57 Favored 'General case' 0 C--N 1.366 1.314 0 CA-C-N 121.706 2.753 . . . . 0.0 112.899 -171.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.7 m -83.8 130.32 34.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.769 175.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -124.43 162.61 23.53 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.95 1.7 . . . . 0.0 111.743 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.54 129.99 34.98 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 169.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.4 tp -95.46 -45.71 6.98 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 116.89 -1.528 . . . . 0.0 109.43 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -105.95 164.31 12.06 Favored 'General case' 0 C--N 1.368 1.404 0 CA-C-O 122.796 1.284 . . . . 0.0 108.925 174.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -56.62 -36.88 69.95 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 125.637 1.575 . . . . 0.0 112.658 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -60.57 -44.93 95.63 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.572 1.149 . . . . 0.0 111.332 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.95 -37.4 84.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.573 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -71.05 -42.41 69.48 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 118.792 -0.623 . . . . 0.0 110.283 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -55.87 -35.63 66.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 167.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.38 -34.05 77.1 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 116.982 -1.485 . . . . 0.0 114.306 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.48 5.91 6.95 Favored Glycine 0 N--CA 1.504 3.232 0 CA-C-N 120.873 1.67 . . . . 0.0 112.144 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -80.15 130.89 64.42 Favored Pre-proline 0 CA--C 1.565 1.549 0 CA-C-O 118.172 -0.918 . . . . 0.0 108.891 170.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -64.4 148.92 90.85 Favored 'Trans proline' 0 N--CA 1.526 3.419 0 N-CA-C 119.805 2.964 . . . . 0.0 119.805 -168.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -46.49 145.45 6.13 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 N-CA-C 115.031 1.127 . . . . 0.0 115.031 172.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.1 tt -97.06 11.21 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 118.029 -1.468 . . . . 0.0 109.378 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 17.4 p -63.92 -36.45 20.91 Favored Pre-proline 0 N--CA 1.415 -2.206 1 CA-C-O 110.566 -4.54 . . . . 0.0 117.017 -174.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.99 -19.59 22.96 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 125.421 2.972 . . . . 0.0 111.264 -167.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.4 pt -104.97 21.61 3.3 Favored 'Isoleucine or valine' 0 C--N 1.36 1.049 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -175.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.92 139.11 58.09 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 125.555 1.785 . . . . 0.0 113.15 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -96.97 129.73 44.39 Favored 'General case' 0 C--N 1.365 1.262 0 C-N-CA 126.385 1.874 . . . . 0.0 115.145 170.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -81.16 150.91 28.48 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 114.864 -1.062 . . . . 0.0 113.417 166.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.23 176.06 54.33 Favored Glycine 0 CA--C 1.544 1.856 0 O-C-N 125.897 1.998 . . . . 0.0 113.609 163.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.9 m -63.45 146.43 53.62 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 121.037 2.419 . . . . 0.0 116.728 163.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 56.83 24.9 51.04 Favored Glycine 1 C--N 1.4 4.1 0 C-N-CA 126.562 2.029 . . . . 0.0 111.613 -164.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.57 -163.17 51.32 Favored Glycine 0 CA--C 1.551 2.301 0 C-N-CA 127.488 2.47 . . . . 0.0 117.688 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.5 133.08 3.86 Favored Glycine 0 C--N 1.37 2.421 0 CA-C-N 118.967 1.383 . . . . 0.0 111.326 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -79.12 149.95 31.9 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 122.186 0.993 . . . . 0.0 109.89 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 20.5 mm -89.46 147.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 114.649 -1.159 . . . . 0.0 111.576 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.0 t -75.0 147.31 40.88 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.3 mt -96.36 21.0 9.63 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 113.154 -1.839 . . . . 0.0 111.947 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.59 -47.12 5.24 Favored Glycine 0 CA--C 1.499 -0.958 0 CA-C-O 118.291 -1.283 . . . . 0.0 115.804 -168.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.43 93.24 Favored 'General case' 0 N--CA 1.44 -0.926 0 O-C-N 126.954 2.208 . . . . 0.0 109.106 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.4 tp -67.15 -44.36 79.97 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 124.156 0.982 . . . . 0.0 110.985 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.2 tp -61.92 -54.78 37.19 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.846 0.858 . . . . 0.0 110.197 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.0 p -56.52 -44.7 81.03 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.65 0.594 . . . . 0.0 110.588 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.7 m -63.02 -39.74 95.66 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.463 1.105 . . . . 0.0 110.797 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.6 m -62.96 -37.23 86.29 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 115.426 -2.226 . . . . 0.0 114.27 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 88' ' ' ALA . 35.6 mt -88.39 -19.26 26.84 Favored 'General case' 0 C--N 1.383 2.043 0 CA-C-N 121.019 1.736 . . . . 0.0 114.272 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -61.6 -41.12 96.98 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.125 -0.984 . . . . 0.0 110.782 161.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.7 mt -61.04 -43.27 99.14 Favored 'General case' 0 C--N 1.374 1.669 0 O-C-N 124.92 1.387 . . . . 0.0 110.587 -173.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 25.5 p -101.62 27.76 6.12 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.674 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.199 -2.061 0 C-N-CA 126.352 1.929 . . . . 0.0 115.137 175.803 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 76.8 m-20 -90.91 126.62 36.11 Favored 'General case' 0 C--N 1.379 1.879 0 CA-C-O 123.28 1.514 . . . . 0.0 110.023 162.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 tp -115.74 138.02 47.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 127.792 2.437 . . . . 0.0 111.334 -169.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.2 p -131.51 164.55 25.55 Favored 'General case' 0 C--N 1.38 1.894 0 O-C-N 125.725 1.891 . . . . 0.0 111.069 -168.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.78 -43.02 72.45 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 117.102 -3.499 . . . . 0.0 113.104 170.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.08 85.54 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 125.659 1.85 . . . . 0.0 110.869 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -81.38 -18.38 45.73 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.7 tp -74.05 -27.83 61.11 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 119.762 -1.836 . . . . 0.0 107.497 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 66.22 39.37 4.21 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 130.514 3.526 . . . . 0.0 112.433 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -167.67 -161.95 0.42 Allowed 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.5 mt -64.33 126.79 28.91 Favored 'General case' 0 C--O 1.208 -1.112 0 C-N-CA 128.246 2.619 . . . . 0.0 111.452 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -80.94 113.95 44.67 Favored Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.87 9.96 2.79 Favored 'Trans proline' 0 C--N 1.291 -2.482 0 C-N-CA 124.106 3.204 . . . . 0.0 113.894 -171.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.0 mt -131.29 151.45 51.49 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 124.884 1.365 . . . . 0.0 112.636 -171.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.6 p -75.13 -35.85 61.65 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.71 -1.244 . . . . 0.0 110.992 172.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.4 m -75.13 156.13 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.774 0 C-N-CA 118.29 -1.364 . . . . 0.0 114.308 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -87.87 164.71 15.74 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 126.579 3.085 . . . . 0.0 107.837 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -24.3 118.76 0.05 OUTLIER 'General case' 0 N--CA 1.524 3.233 0 C-N-CA 130.25 3.42 . . . . 0.0 115.967 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -135.98 177.52 19.46 Favored Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 104.84 -3.304 . . . . 0.0 104.84 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 5.5 m -71.57 145.06 49.3 Favored 'General case' 0 C--N 1.363 1.155 0 O-C-N 127.025 2.25 . . . . 0.0 115.58 170.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 pt -116.86 135.3 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 118.689 -2.507 . . . . 0.0 105.981 168.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -155.98 146.75 22.04 Favored 'General case' 0 C--O 1.191 -1.999 0 C-N-CA 125.083 1.353 . . . . 0.0 109.924 -168.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 96.4 m -107.25 151.0 26.04 Favored 'General case' 0 C--N 1.381 1.956 0 C-N-CA 125.819 1.648 . . . . 0.0 107.886 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.0 mt -127.02 156.84 73.66 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-N 114.233 -1.348 . . . . 0.0 107.689 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -45.06 144.85 3.56 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 N-CA-C 118.971 2.643 . . . . 0.0 118.971 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t 73.94 41.43 0.41 Allowed 'General case' 0 C--N 1.366 1.3 0 C-N-CA 128.105 2.562 . . . . 0.0 111.37 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 67.64 26.77 7.89 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 119.272 3.064 . . . . 0.0 119.272 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -90.05 135.29 33.74 Favored 'General case' 0 N--CA 1.508 2.464 0 C-N-CA 127.752 2.421 . . . . 0.0 111.466 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.07 140.42 52.29 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 113.174 -1.83 . . . . 0.0 111.825 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.49 153.94 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 -168.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -116.63 118.58 33.0 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 127.234 2.214 . . . . 0.0 106.564 170.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.1 t -101.0 107.74 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.825 0 O-C-N 118.104 -2.873 . . . . 0.0 108.141 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.68 158.55 59.32 Favored Pre-proline 0 N--CA 1.432 -1.354 0 CA-C-N 113.117 -1.856 . . . . 0.0 114.348 -176.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -42.99 -28.22 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 125.21 3.94 . . . . 0.0 115.701 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 59.3 p30 -100.65 8.28 43.46 Favored 'General case' 0 C--O 1.26 1.639 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.46 7.09 82.85 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 116.416 -2.324 . . . . 0.0 117.872 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.2 m -81.07 119.71 23.89 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 123.434 3.617 . . . . 0.0 109.658 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.2 m -92.09 91.86 7.99 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -171.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -70.34 141.51 52.26 Favored 'General case' 0 C--O 1.202 -1.399 0 O-C-N 119.72 -1.863 . . . . 0.0 114.796 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.48 108.52 3.81 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.757 -1.116 . . . . 0.0 110.827 170.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.5 tp -92.84 -8.76 42.58 Favored 'General case' 0 C--O 1.251 1.159 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -135.42 171.31 14.63 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 123.94 1.829 . . . . 0.0 108.75 166.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -67.29 -39.05 85.95 Favored 'General case' 0 CA--C 1.571 1.783 0 O-C-N 118.048 -2.907 . . . . 0.0 109.467 -170.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -58.47 -42.64 87.94 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.057 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . 0.348 . . -51.86 -44.95 63.89 Favored 'General case' 0 C--N 1.37 1.493 0 CA-C-O 125.441 2.543 . . . . 0.0 114.387 170.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -69.42 -42.36 75.11 Favored 'General case' 0 CA--C 1.579 2.091 0 O-C-N 117.281 -3.387 . . . . 0.0 110.974 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -62.08 -35.66 79.33 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 128.165 2.586 . . . . 0.0 113.524 170.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.26 -16.93 58.78 Favored 'General case' 0 CA--C 1.568 1.67 0 O-C-N 121.084 -1.01 . . . . 0.0 110.163 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.0 33.82 4.2 Favored Glycine 0 CA--C 1.487 -1.68 0 N-CA-C 117.939 1.935 . . . . 0.0 117.939 173.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -80.08 154.17 74.92 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-N 118.881 1.34 . . . . 0.0 110.308 165.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -43.58 129.71 6.94 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 124.511 3.474 . . . . 0.0 118.716 164.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.42 142.41 58.48 Favored 'Trans proline' 0 N--CA 1.428 -2.378 0 C-N-CA 123.711 2.94 . . . . 0.0 110.989 169.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.9 tt -90.84 -0.78 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 C-N-CA 125.605 1.562 . . . . 0.0 109.42 -173.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 52.5 m -41.89 -65.72 0.48 Allowed Pre-proline 0 C--N 1.38 1.906 1 CA-C-O 111.203 -4.237 . . . . 0.0 120.153 170.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -70.62 -6.61 19.43 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 125.589 3.032 . . . . 0.0 118.551 -170.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 5.2 pt -107.21 8.05 9.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 122.324 2.329 . . . . 0.0 113.208 165.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -64.73 126.29 27.47 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 123.066 2.666 . . . . 0.0 113.096 169.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.73 144.09 57.48 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.575 1.172 . . . . 0.0 110.179 171.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -80.98 154.68 26.81 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.185 -1.572 . . . . 0.0 113.497 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.485 ' HA2' HD11 ' A' ' 125' ' ' ILE . . . -84.06 -174.39 50.33 Favored Glycine 0 CA--C 1.501 -0.824 0 CA-C-O 124.331 2.073 . . . . 0.0 113.701 172.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.5 t -102.06 139.96 36.98 Favored 'General case' 0 CA--C 1.59 2.494 0 O-C-N 118.126 -2.985 . . . . 0.0 105.604 166.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.43 35.87 21.9 Favored Glycine 0 CA--C 1.502 -0.736 0 O-C-N 118.809 -2.432 . . . . 0.0 111.97 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.27 -170.12 12.61 Favored Glycine 1 CA--C 1.58 4.11 0 CA-C-N 117.885 0.843 . . . . 0.0 114.738 -165.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.61 -179.3 49.24 Favored Glycine 0 C--N 1.361 1.929 0 N-CA-C 120.407 2.923 . . . . 0.0 120.407 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -122.07 154.12 37.75 Favored 'General case' 0 N--CA 1.509 2.491 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.485 HD11 ' HA2' ' A' ' 119' ' ' GLY . 6.4 mm -79.89 117.08 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 C-N-CA 125.081 1.352 . . . . 0.0 110.292 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.8 t -58.23 135.75 57.17 Favored 'General case' 0 CA--C 1.585 2.294 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.6 mt -92.25 10.52 29.24 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 124.763 1.225 . . . . 0.0 113.726 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.14 -53.72 29.57 Favored Glycine 0 N--CA 1.488 2.118 0 CA-C-O 123.832 1.795 . . . . 0.0 114.004 170.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.73 85.7 Favored 'General case' 0 CA--C 1.546 0.816 1 O-C-N 115.255 -4.674 . . . . 0.0 113.959 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.4 tp -64.29 -42.37 96.43 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 173.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.7 tp -59.3 -45.93 89.95 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 118.964 -2.335 . . . . 0.0 111.986 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . 0.323 19.4 p -61.94 -48.49 80.17 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 126.847 2.059 . . . . 0.0 110.426 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 45.4 m -52.98 -44.5 67.22 Favored 'General case' 0 CA--C 1.579 2.069 0 C-N-CA 126.75 2.02 . . . . 0.0 112.448 169.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 37.5 m -60.19 -46.39 89.89 Favored 'General case' 0 C--O 1.194 -1.839 0 O-C-N 117.966 -2.959 . . . . 0.0 109.119 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.0 mt -68.18 -37.22 80.71 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 123.999 1.857 . . . . 0.0 111.42 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -60.61 -42.49 96.91 Favored 'General case' 0 C--O 1.267 2.005 0 O-C-N 118.613 -2.555 . . . . 0.0 116.757 169.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.0 mt -82.77 -21.05 34.76 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . 0.373 2.0 p -98.11 3.79 49.16 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 118.834 2.901 . . . . 0.0 118.834 162.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.074 0 C-N-CA 127.301 2.382 . . . . 0.0 115.541 173.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 . . . . . 0 CA--C 1.466 -2.255 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -57.34 139.12 53.85 Favored 'General case' 0 C--O 1.261 1.675 0 CA-C-O 124.842 2.258 . . . . 0.0 110.419 166.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.8 tp -149.13 142.23 18.14 Favored 'Isoleucine or valine' 0 C--N 1.365 1.269 0 CA-C-O 124.37 2.033 . . . . 0.0 113.747 -167.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.1 p -140.76 177.16 8.22 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -63.39 -45.95 88.7 Favored 'General case' 0 CA--C 1.579 2.09 0 C-N-CA 126.572 1.949 . . . . 0.0 109.068 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.44 75.96 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 119.319 -2.113 . . . . 0.0 116.2 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -67.65 -42.99 81.33 Favored 'General case' 0 C--O 1.178 -2.689 0 CA-C-O 117.056 -1.449 . . . . 0.0 111.875 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.7 tp -62.11 -37.19 84.14 Favored 'General case' 0 CA--C 1.582 2.194 0 CA-C-N 121.678 2.035 . . . . 0.0 114.243 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.351 . . 82.62 30.63 0.1 Allowed 'General case' 0 C--N 1.371 1.532 0 O-C-N 119.719 -1.863 . . . . 0.0 110.589 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -155.02 159.57 40.42 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.81 125.12 14.19 Favored 'General case' 0 N--CA 1.423 -1.806 0 C-N-CA 128.563 2.745 . . . . 0.0 115.225 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -64.41 128.02 92.85 Favored Pre-proline 0 CA--C 1.586 2.331 0 O-C-N 117.029 -3.544 . . . . 0.0 110.818 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -105.76 0.46 0.2 Allowed 'Trans proline' 0 CA--C 1.481 -2.131 0 C-N-CA 123.598 2.865 . . . . 0.0 108.891 -154.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.7 mt -132.82 171.34 14.04 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 p -92.2 -0.27 57.43 Favored 'General case' 0 C--O 1.19 -2.049 0 CA-C-O 124.161 1.934 . . . . 0.0 111.245 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.0 m -93.49 161.26 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 117.045 -3.534 . . . . 0.0 110.474 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -78.9 174.3 11.65 Favored 'General case' 0 C--O 1.205 -1.267 0 O-C-N 120.33 -1.481 . . . . 0.0 113.655 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -53.01 138.84 29.53 Favored 'General case' 0 CA--C 1.61 3.267 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.74 -150.74 5.37 Favored Glycine 0 C--N 1.379 2.956 0 C-N-CA 130.392 3.853 . . . . 0.0 114.386 -166.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.7 m -128.4 145.5 51.07 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 111.762 -2.219 . . . . 0.0 106.177 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.5 pt -113.48 144.45 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.034 0 C-N-CA 129.663 3.185 . . . . 0.0 110.207 165.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -145.84 142.76 29.14 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-O 122.609 1.195 . . . . 0.0 112.093 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 69.7 m -91.45 138.36 31.63 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 170.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.0 mt -120.78 155.91 56.79 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 118.836 -2.415 . . . . 0.0 105.312 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.288 36.9 Cg_exo -39.64 135.3 1.35 Allowed 'Trans proline' 0 N--CA 1.505 2.15 1 C-N-CA 125.696 4.264 . . . . 0.0 122.21 173.046 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.452 68.3 m 78.52 48.12 0.04 OUTLIER 'General case' 0 C--N 1.378 1.842 0 O-C-N 119.553 -1.967 . . . . 0.0 112.348 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 46.5 43.29 12.02 Favored 'General case' 0 C--N 1.391 2.37 0 CA-C-N 112.983 -1.917 . . . . 0.0 113.46 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -95.45 143.8 26.49 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 126.216 1.806 . . . . 0.0 111.465 170.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.689 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -125.36 129.34 49.73 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-O 124.648 2.166 . . . . 0.0 106.142 175.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.2 m -118.22 157.73 19.5 Favored 'Isoleucine or valine' 0 C--N 1.381 1.957 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.993 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -131.26 137.29 48.8 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -125.72 118.76 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 O-C-N 120.623 -1.298 . . . . 0.0 108.033 173.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.57 162.87 1.16 Allowed Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 170.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -68.81 -13.22 36.44 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 CA-C-O 113.786 -2.673 . . . . 0.0 114.589 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -91.75 -1.93 57.18 Favored 'General case' 0 C--N 1.37 1.458 0 CA-C-N 121.084 1.765 . . . . 0.0 112.902 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.61 0.17 36.98 Favored Glycine 0 CA--C 1.49 -1.523 0 CA-C-O 114.397 -3.446 . . . . 0.0 109.843 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.8 m -81.6 119.04 23.29 Favored 'General case' 0 C--N 1.361 1.08 1 CA-C-N 124.212 4.006 . . . . 0.0 112.93 -170.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.7 m -82.06 130.59 35.12 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.015 175.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -125.36 160.81 28.44 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 126.891 2.076 . . . . 0.0 111.675 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.99 127.42 32.94 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 167.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.9 tp -94.77 -47.5 6.45 Favored 'General case' 0 C--O 1.206 -1.227 0 O-C-N 119.671 -1.893 . . . . 0.0 109.844 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -101.77 163.56 12.19 Favored 'General case' 0 C--N 1.391 2.392 0 CA-C-O 123.739 1.733 . . . . 0.0 108.834 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . 0.274 12.9 p-10 -55.29 -36.8 66.53 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 126.432 1.893 . . . . 0.0 113.758 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -61.89 -44.37 96.95 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.808 1.243 . . . . 0.0 112.064 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.95 -40.83 94.79 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.666 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -68.38 -42.02 79.72 Favored 'General case' 0 CA--C 1.557 1.218 0 O-C-N 121.774 -0.579 . . . . 0.0 111.52 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -54.9 -39.63 68.96 Favored 'General case' 0 C--N 1.369 1.422 0 O-C-N 120.224 -1.547 . . . . 0.0 112.542 167.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.01 -36.65 84.27 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 127.0 6.46 5.39 Favored Glycine 0 N--CA 1.507 3.369 0 CA-C-O 124.125 1.959 . . . . 0.0 110.464 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -80.33 133.67 56.45 Favored Pre-proline 0 CA--C 1.588 2.433 0 CA-C-O 116.67 -1.633 . . . . 0.0 110.161 170.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -70.64 150.7 63.29 Favored 'Trans proline' 0 CA--C 1.484 -2.018 0 CA-C-N 126.892 3.497 . . . . 0.0 119.182 -164.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . 0.269 74.7 Cg_exo -44.7 146.92 2.0 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 N-CA-C 117.769 2.18 . . . . 0.0 117.769 171.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.7 tt -98.99 10.15 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 C-N-CA 116.979 -1.888 . . . . 0.0 107.336 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.4 p -62.17 -35.83 23.95 Favored Pre-proline 0 C--N 1.374 1.639 1 CA-C-O 109.169 -5.205 . . . . 0.0 116.972 -174.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.16 -17.59 16.97 Favored 'Trans proline' 0 C--N 1.36 1.137 0 CA-C-N 127.141 3.586 . . . . 0.0 109.018 -165.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.6 pt -106.53 20.65 4.43 Favored 'Isoleucine or valine' 0 C--N 1.368 1.389 0 C-N-CA 125.699 1.6 . . . . 0.0 113.458 -172.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -63.59 138.36 58.47 Favored 'General case' 0 C--N 1.363 1.188 0 C-N-CA 126.645 1.978 . . . . 0.0 111.86 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -95.83 128.13 42.45 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 127.647 2.379 . . . . 0.0 116.999 168.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -78.03 149.47 34.0 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 120.257 -1.527 . . . . 0.0 114.576 166.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.95 174.6 54.34 Favored Glycine 0 C--O 1.202 -1.885 0 C-N-CA 126.438 1.97 . . . . 0.0 113.655 162.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.0 m -60.43 146.97 42.61 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 122.215 3.007 . . . . 0.0 118.584 161.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 52.53 27.87 27.45 Favored Glycine 1 C--N 1.415 4.942 0 C-N-CA 128.471 2.938 . . . . 0.0 111.665 -162.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.23 -161.61 53.84 Favored Glycine 0 CA--C 1.544 1.863 0 C-N-CA 129.892 3.615 . . . . 0.0 119.291 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.26 133.6 4.42 Favored Glycine 0 CA--C 1.549 2.195 0 CA-C-N 120.459 2.129 . . . . 0.0 109.873 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -79.18 151.69 31.12 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 124.842 2.258 . . . . 0.0 107.916 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 22.4 mm -91.17 144.27 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 126.717 2.007 . . . . 0.0 111.529 173.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.4 t -71.71 147.31 47.52 Favored 'General case' 0 C--O 1.195 -1.796 0 N-CA-C 119.868 3.285 . . . . 0.0 119.868 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.5 mt -97.78 20.92 11.21 Favored 'General case' 0 C--O 1.204 -1.338 0 C-N-CA 126.231 1.812 . . . . 0.0 112.317 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -88.71 -41.3 6.05 Favored Glycine 0 CA--C 1.496 -1.121 0 N-CA-C 118.207 2.043 . . . . 0.0 118.207 -169.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.47 98.55 Favored 'General case' 0 N--CA 1.431 -1.375 0 O-C-N 127.045 2.262 . . . . 0.0 110.199 170.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.8 tp -66.69 -44.12 82.58 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-O 122.563 1.173 . . . . 0.0 111.702 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.3 tp -62.68 -53.16 58.73 Favored 'General case' 0 C--N 1.364 1.23 0 O-C-N 120.329 -1.482 . . . . 0.0 110.465 175.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.2 p -57.66 -44.76 85.94 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.66 0.743 . . . . 0.0 111.088 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 83.0 m -62.31 -42.35 99.3 Favored 'General case' 0 C--O 1.264 1.822 0 C-N-CA 125.611 1.564 . . . . 0.0 110.982 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 26.2 m -60.22 -36.88 78.69 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 173.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.689 HD21 ' HB2' ' A' ' 88' ' ' ALA . 23.7 mt -89.59 -16.78 29.82 Favored 'General case' 0 C--N 1.376 1.722 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 176.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -63.41 -38.57 91.65 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 117.12 -1.419 . . . . 0.0 111.375 158.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.4 mt -63.47 -43.0 98.59 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-O 125.227 2.441 . . . . 0.0 110.507 -171.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 21.6 p -100.61 25.66 7.57 Favored 'General case' 0 C--N 1.376 1.74 0 CA-C-N 112.779 -2.009 . . . . 0.0 112.414 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.158 0 C-N-CA 128.368 2.889 . . . . 0.0 114.863 175.626 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 CA--C 1.497 -1.069 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -59.23 137.34 58.01 Favored 'General case' 0 C--O 1.252 1.226 0 O-C-N 126.416 2.323 . . . . 0.0 111.334 164.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.5 tp -145.8 142.33 21.83 Favored 'Isoleucine or valine' 0 C--O 1.264 1.86 0 CA-C-N 112.791 -2.004 . . . . 0.0 113.036 -167.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.9 p -139.36 177.91 7.58 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -63.78 -44.56 93.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 124.704 1.252 . . . . 0.0 110.579 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.92 79.71 Favored 'General case' 0 C--O 1.247 0.946 0 O-C-N 120.228 -1.545 . . . . 0.0 112.972 173.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -67.19 -42.97 83.31 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-O 117.415 -1.278 . . . . 0.0 111.901 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.1 tp -61.94 -36.19 80.64 Favored 'General case' 0 CA--C 1.587 2.392 0 CA-C-N 121.002 1.728 . . . . 0.0 113.293 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.287 . . 79.38 32.66 0.24 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.038 1.335 . . . . 0.0 111.99 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -155.85 158.2 37.66 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.4 mt -50.92 127.39 18.55 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 124.116 1.912 . . . . 0.0 115.461 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -63.82 124.42 84.89 Favored Pre-proline 0 CA--C 1.573 1.86 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.262 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -100.11 1.98 0.82 Allowed 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 122.02 1.813 . . . . 0.0 113.285 -160.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.5 mt -131.15 168.01 18.18 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.2 p -90.01 1.62 56.09 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 122.381 1.086 . . . . 0.0 113.781 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.5 m -92.53 160.54 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 119.976 -1.703 . . . . 0.0 111.654 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -77.39 174.37 10.9 Favored 'General case' 0 CA--C 1.567 1.63 0 O-C-N 119.221 -2.174 . . . . 0.0 111.827 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -53.91 140.35 31.03 Favored 'General case' 0 CA--C 1.601 2.941 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 -177.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.2 -150.09 5.28 Favored Glycine 0 C--N 1.369 2.409 0 C-N-CA 127.53 2.491 . . . . 0.0 114.909 -166.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.1 m -127.88 146.5 50.6 Favored 'General case' 0 C--N 1.371 1.506 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.2 pt -115.49 145.89 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 126.925 2.09 . . . . 0.0 110.081 166.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -147.22 141.63 26.39 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 122.94 1.353 . . . . 0.0 111.426 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 61.8 m -89.27 138.15 31.69 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 169.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.0 mt -120.13 155.41 55.74 Favored Pre-proline 0 N--CA 1.482 1.17 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 172.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.268 31.9 Cg_exo -40.55 134.93 2.11 Favored 'Trans proline' 0 N--CA 1.529 3.583 0 N-CA-C 122.133 3.859 . . . . 0.0 122.133 173.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.383 50.4 m 79.53 50.22 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.075 1.35 . . . . 0.0 110.311 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 45.94 44.64 11.48 Favored 'General case' 0 C--O 1.203 -1.383 0 O-C-N 126.803 2.564 . . . . 0.0 111.954 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.89 145.71 25.63 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 118.644 0.656 . . . . 0.0 110.438 170.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.662 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -124.65 129.9 51.42 Favored 'General case' 0 C--O 1.273 2.312 0 CA-C-O 123.22 1.486 . . . . 0.0 107.481 174.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.19 157.24 21.13 Favored 'Isoleucine or valine' 0 C--N 1.362 1.114 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.157 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -130.36 137.78 50.07 Favored 'General case' 0 C--O 1.254 1.321 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 t -126.35 119.32 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.1 164.53 2.36 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 171.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.79 -11.78 29.99 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 CA-C-O 114.481 -2.383 . . . . 0.0 114.466 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -91.03 -1.43 57.81 Favored 'General case' 0 C--N 1.371 1.529 0 CA-C-N 121.132 1.787 . . . . 0.0 113.544 173.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.81 -0.85 41.83 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-O 116.748 -2.14 . . . . 0.0 113.207 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.5 m -80.01 120.24 23.92 Favored 'General case' 0 C--N 1.38 1.899 0 CA-C-N 120.979 2.39 . . . . 0.0 113.374 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.7 m -83.52 130.54 35.01 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.05 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -124.56 162.18 24.6 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.678 1.591 . . . . 0.0 111.209 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.53 130.2 35.17 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.42 -46.79 6.55 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 116.45 -1.738 . . . . 0.0 108.83 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -105.28 164.33 11.92 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-O 123.398 1.57 . . . . 0.0 108.898 174.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -56.29 -37.41 69.82 Favored 'General case' 0 N--CA 1.511 2.588 0 CA-C-N 113.448 -1.705 . . . . 0.0 112.469 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.6 mtp85 -60.53 -44.59 95.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 124.784 1.303 . . . . 0.0 111.327 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.36 -37.18 84.68 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.78 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -71.2 -42.07 69.46 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 117.767 -1.111 . . . . 0.0 110.084 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -56.57 -35.5 68.24 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 168.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.71 76.23 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 116.223 -1.846 . . . . 0.0 114.124 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.54 6.27 6.76 Favored Glycine 1 N--CA 1.518 4.165 0 CA-C-N 121.162 1.801 . . . . 0.0 111.839 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -80.27 131.45 62.26 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-O 118.054 -0.974 . . . . 0.0 108.642 170.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -65.37 149.28 88.36 Favored 'Trans proline' 1 N--CA 1.546 4.565 0 N-CA-C 119.478 2.838 . . . . 0.0 119.478 -168.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.41 145.74 5.68 Favored 'Trans proline' 0 N--CA 1.519 2.979 0 C-N-CA 117.243 -1.371 . . . . 0.0 114.905 172.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.4 tt -97.46 11.25 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 117.811 -1.555 . . . . 0.0 109.499 175.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 17.2 p -63.96 -35.63 16.64 Favored Pre-proline 0 N--CA 1.399 -2.993 1 CA-C-O 110.185 -4.721 . . . . 0.0 117.667 -174.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.9 -19.68 23.18 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 CA-C-N 124.744 2.73 . . . . 0.0 111.294 -168.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.2 pt -105.56 22.52 3.07 Favored 'Isoleucine or valine' 0 C--N 1.372 1.583 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -61.67 139.3 58.31 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 125.895 1.997 . . . . 0.0 112.978 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . 0.251 . . -97.46 130.13 44.59 Favored 'General case' 0 C--N 1.376 1.731 0 C-N-CA 125.976 1.71 . . . . 0.0 115.138 170.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -82.02 151.37 27.14 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.936 167.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.36 176.08 54.41 Favored Glycine 0 CA--C 1.544 1.887 0 O-C-N 126.99 2.681 . . . . 0.0 113.683 164.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.9 m -63.62 146.66 53.33 Favored 'General case' 0 CA--C 1.597 2.762 0 CA-C-N 120.966 2.383 . . . . 0.0 116.395 164.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 57.2 24.43 51.24 Favored Glycine 1 C--N 1.402 4.212 0 O-C-N 125.735 1.897 . . . . 0.0 111.814 -164.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.81 -163.2 50.97 Favored Glycine 0 CA--C 1.553 2.441 0 C-N-CA 126.951 2.215 . . . . 0.0 117.288 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.52 132.79 3.78 Favored Glycine 0 C--N 1.377 2.86 0 CA-C-N 118.313 1.056 . . . . 0.0 111.358 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -79.42 150.67 31.24 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 122.533 1.159 . . . . 0.0 109.631 -174.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 20.3 mm -90.3 147.52 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.974 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.5 t -74.93 147.74 40.67 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 174.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.0 mt -97.01 21.51 9.66 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 112.807 -1.997 . . . . 0.0 111.741 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.9 -46.66 5.31 Favored Glycine 0 C--O 1.219 -0.784 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 -168.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.48 -43.24 93.32 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 127.514 2.538 . . . . 0.0 109.056 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.2 tp -67.33 -43.92 80.42 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.713 0.805 . . . . 0.0 111.08 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.3 tp -62.03 -54.35 42.81 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.154 0.582 . . . . 0.0 110.589 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.1 p -56.78 -44.28 81.7 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 124.066 0.854 . . . . 0.0 110.823 -175.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.9 m -62.98 -40.26 97.19 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.252 1.021 . . . . 0.0 110.547 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.4 m -62.94 -36.52 83.72 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 115.355 -2.259 . . . . 0.0 114.642 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 88' ' ' ALA . 37.1 mt -89.01 -18.65 26.92 Favored 'General case' 0 C--N 1.387 2.208 0 CA-C-N 121.401 1.91 . . . . 0.0 114.31 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -61.69 -40.79 96.23 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 121.411 -0.806 . . . . 0.0 111.215 160.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.0 mt -61.79 -42.98 99.69 Favored 'General case' 0 C--N 1.381 1.938 0 O-C-N 125.458 1.723 . . . . 0.0 110.074 -173.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.0 p -101.95 27.84 6.22 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.807 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.199 -2.051 0 C-N-CA 125.9 1.715 . . . . 0.0 115.343 175.676 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 . . . . . 0 CA--C 1.552 1.046 0 CA-C-O 121.512 0.673 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -87.37 145.47 26.3 Favored 'General case' 0 C--O 1.264 1.831 0 O-C-N 128.698 3.749 . . . . 0.0 111.519 171.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 tp -115.56 144.43 23.17 Favored 'Isoleucine or valine' 0 C--N 1.364 1.219 0 CA-C-N 112.335 -2.211 . . . . 0.0 108.701 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.501 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 38.5 p -132.08 163.05 29.32 Favored 'General case' 0 C--O 1.198 -1.623 0 C-N-CA 126.206 1.803 . . . . 0.0 114.082 -174.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 29.5 mt-10 -62.05 -45.97 91.2 Favored 'General case' 0 C--O 1.202 -1.416 0 C-N-CA 127.536 2.334 . . . . 0.0 108.951 168.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.81 -24.62 61.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 119.346 -2.096 . . . . 0.0 116.161 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -62.55 -46.38 88.63 Favored 'General case' 0 CA--C 1.593 2.623 0 CA-C-O 122.132 0.968 . . . . 0.0 111.418 172.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 mt -71.04 -38.0 72.54 Favored 'General case' 0 C--O 1.211 -0.925 0 C-N-CA 129.275 3.03 . . . . 0.0 114.066 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.36 . . 67.14 -22.29 0.11 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 119.351 3.093 . . . . 0.0 119.351 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . 0.303 84.9 t80 -77.12 167.2 22.19 Favored 'General case' 0 C--O 1.254 1.304 0 CA-C-O 122.615 1.198 . . . . 0.0 112.791 161.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.8 tp -48.09 118.61 2.46 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.097 1.759 . . . . 0.0 115.509 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -61.48 122.04 67.94 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 119.299 -2.125 . . . . 0.0 111.011 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -95.5 26.39 0.29 Allowed 'Trans proline' 0 CA--C 1.552 1.393 0 C-N-CA 122.869 2.379 . . . . 0.0 114.301 -169.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.2 mt -136.9 153.41 50.74 Favored 'General case' 0 C--N 1.39 2.347 0 CA-C-N 120.057 1.299 . . . . 0.0 109.463 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.4 p -73.11 -22.62 60.52 Favored 'General case' 0 C--N 1.364 1.203 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.5 m -83.92 160.55 3.42 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 1 O-C-N 129.435 4.209 . . . . 0.0 108.236 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -91.5 114.62 27.19 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 115.481 -2.199 . . . . 0.0 109.993 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.501 ' CD2' ' HA ' ' A' ' 63' ' ' SER . 61.3 m170 52.85 -167.88 0.05 Allowed 'General case' 0 C--N 1.36 1.025 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.59 -167.45 40.33 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.757 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.1 m -121.45 149.04 43.62 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 103.166 -2.902 . . . . 0.0 103.166 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 pt -121.36 151.65 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.311 0 C-N-CA 124.747 1.219 . . . . 0.0 110.474 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -145.12 139.81 27.57 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 3.8 m -99.25 123.97 43.96 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 83' ' ' LEU . 90.0 mt -96.49 151.35 37.96 Favored Pre-proline 0 N--CA 1.508 2.45 0 CA-C-O 114.265 -2.778 . . . . 0.0 112.58 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -57.59 150.0 63.72 Favored 'Trans proline' 0 N--CA 1.508 2.348 0 CA-C-N 124.654 2.698 . . . . 0.0 117.952 -173.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.9 m 59.46 54.27 4.73 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -168.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 57.11 48.65 15.04 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 170.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -117.03 159.41 22.57 Favored 'General case' 0 C--N 1.369 1.422 0 CA-C-O 117.995 -1.003 . . . . 0.0 111.761 169.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.95 148.04 43.01 Favored 'General case' 0 C--N 1.384 2.089 0 O-C-N 125.53 1.769 . . . . 0.0 112.451 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 99' ' ' ALA . 24.8 m -138.31 170.92 16.12 Favored 'Isoleucine or valine' 0 C--N 1.396 2.61 0 O-C-N 127.068 2.73 . . . . 0.0 113.64 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -140.67 124.5 17.18 Favored 'General case' 0 C--O 1.265 1.87 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -172.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.1 t -102.69 107.76 22.67 Favored 'Isoleucine or valine' 0 C--N 1.359 0.995 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . 0.332 . . -60.18 150.61 70.61 Favored Pre-proline 0 N--CA 1.515 2.818 0 N-CA-C 119.979 3.325 . . . . 0.0 119.979 174.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -46.3 -23.75 2.19 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 N-CA-C 119.952 3.02 . . . . 0.0 119.952 177.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -86.55 -15.26 40.49 Favored 'General case' 0 C--N 1.375 1.716 0 CA-C-O 124.166 1.936 . . . . 0.0 115.589 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 114.15 -3.66 23.88 Favored Glycine 0 N--CA 1.483 1.829 0 C-N-CA 130.304 3.811 . . . . 0.0 116.387 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.323 8.3 m -68.94 114.27 7.09 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 46.6 m -90.16 108.7 19.9 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 124.736 1.272 . . . . 0.0 112.873 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -100.87 142.84 31.77 Favored 'General case' 0 N--CA 1.434 -1.259 0 O-C-N 126.166 2.166 . . . . 0.0 111.259 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.402 ' HA ' HG12 ' A' ' 89' ' ' VAL . . . -67.28 128.34 36.05 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-N 113.46 -1.7 . . . . 0.0 112.861 169.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.1 tp -108.57 1.34 21.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.355 -1.466 . . . . 0.0 108.672 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . 0.34 52.9 p-10 -148.86 159.53 44.08 Favored 'General case' 0 C--N 1.368 1.391 0 O-C-N 120.762 -1.211 . . . . 0.0 111.681 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -58.63 -43.45 89.71 Favored 'General case' 0 C--N 1.363 1.191 0 CA-C-N 112.814 -1.994 . . . . 0.0 113.528 -169.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -66.71 -34.65 78.32 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 121.16 -0.962 . . . . 0.0 111.648 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . 0.371 . . -61.43 -40.52 94.73 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 174.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -62.02 -41.83 98.51 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 115.363 -2.256 . . . . 0.0 108.702 169.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.303 42.5 mmtm -63.24 -42.88 99.27 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.84 2.533 . . . . 0.0 117.84 175.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.95 -34.29 65.54 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 115.497 -2.192 . . . . 0.0 111.396 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 130.57 -1.72 5.64 Favored Glycine 0 C--N 1.366 2.234 0 CA-C-N 121.362 1.892 . . . . 0.0 115.474 173.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -71.25 148.1 93.58 Favored Pre-proline 0 C--N 1.369 1.443 0 CA-C-O 116.818 -1.563 . . . . 0.0 111.706 171.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.09 139.01 23.55 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-O 114.381 -2.425 . . . . 0.0 111.702 -171.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -54.01 142.37 65.28 Favored 'Trans proline' 0 CA--C 1.482 -2.109 0 N-CA-C 119.88 2.992 . . . . 0.0 119.88 168.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.3 tt -89.89 15.56 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.948 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.8 p -64.3 -43.37 72.53 Favored Pre-proline 0 C--N 1.378 1.82 0 CA-C-O 113.127 -3.321 . . . . 0.0 117.077 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -74.35 -1.65 11.28 Favored 'Trans proline' 0 N--CA 1.5 1.863 1 CA-C-N 129.798 4.535 . . . . 0.0 117.408 174.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 27.4 mm -91.2 -0.79 9.65 Favored 'Isoleucine or valine' 0 C--N 1.367 1.349 0 C-N-CA 127.567 2.347 . . . . 0.0 113.595 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -61.92 140.36 58.31 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 119.191 -2.193 . . . . 0.0 116.902 166.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -81.22 128.95 34.34 Favored 'General case' 0 C--O 1.199 -1.599 0 CA-C-O 123.108 1.432 . . . . 0.0 113.62 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -55.92 145.32 25.35 Favored 'General case' 0 N--CA 1.535 3.79 1 N-CA-C 122.609 4.3 . . . . 0.0 122.609 175.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.15 173.8 42.01 Favored Glycine 0 C--N 1.356 1.668 0 CA-C-N 113.287 -1.779 . . . . 0.0 112.381 156.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.6 t -93.73 127.6 39.53 Favored 'General case' 0 C--N 1.386 2.186 0 O-C-N 126.568 1.981 . . . . 0.0 109.916 167.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 67.59 39.37 90.77 Favored Glycine 0 N--CA 1.51 3.612 0 C-N-CA 118.404 -1.855 . . . . 0.0 115.983 -169.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 105.85 -168.9 15.43 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 164.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.33 -170.09 50.76 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-O 123.882 1.823 . . . . 0.0 112.208 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -149.74 149.67 30.91 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.9 mt -66.36 137.16 25.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 O-C-N 119.197 -2.189 . . . . 0.0 109.57 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.3 t -50.56 129.49 22.44 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 58.7 mt -98.93 6.86 46.53 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.501 -1.375 . . . . 0.0 111.594 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.12 -60.15 9.41 Favored Glycine 0 C--N 1.377 2.833 0 C-N-CA 128.563 2.983 . . . . 0.0 114.9 -170.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . 0.354 . . -65.29 -32.21 73.74 Favored 'General case' 0 CA--C 1.6 2.891 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 10.3 tp -55.66 -48.38 75.11 Favored 'General case' 0 C--N 1.383 2.051 0 CA-C-N 120.6 1.545 . . . . 0.0 112.14 163.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 20.2 tp -65.28 -42.53 93.06 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . 0.29 17.7 p -69.07 -40.37 78.52 Favored 'General case' 0 C--N 1.371 1.513 0 CA-C-O 115.79 -2.052 . . . . 0.0 112.758 170.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 90.2 m -64.08 -31.07 72.12 Favored 'General case' 0 C--N 1.36 1.033 0 CA-C-N 122.928 2.604 . . . . 0.0 110.138 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.5 m -64.89 -48.92 72.51 Favored 'General case' 0 C--N 1.389 2.312 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.1 mt -69.29 -43.11 74.49 Favored 'General case' 0 CA--C 1.495 -1.161 0 O-C-N 126.843 2.589 . . . . 0.0 112.883 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.08 -33.94 69.61 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 127.016 2.697 . . . . 0.0 114.885 173.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . 0.291 40.0 tp -69.19 -28.96 66.85 Favored 'General case' 0 N--CA 1.421 -1.892 0 O-C-N 126.338 2.274 . . . . 0.0 110.879 -176.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.6 p -108.01 12.96 26.51 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 174.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.584 0 C-N-CA 128.114 2.769 . . . . 0.0 118.581 -176.312 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 . . . . . 0 C--O 1.193 -1.884 0 CA-C-O 122.018 0.913 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -64.86 140.56 58.88 Favored 'General case' 0 C--N 1.368 1.371 0 C-N-CA 128.09 2.556 . . . . 0.0 111.688 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.5 tp -142.13 142.59 27.52 Favored 'Isoleucine or valine' 0 C--O 1.263 1.781 0 O-C-N 117.78 -3.075 . . . . 0.0 110.702 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.3 p -145.78 172.23 13.62 Favored 'General case' 0 C--N 1.39 2.34 0 CA-C-N 112.308 -2.224 . . . . 0.0 112.711 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.68 -46.33 82.9 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 117.516 -1.231 . . . . 0.0 109.006 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.73 -34.96 67.43 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 120.714 1.597 . . . . 0.0 107.67 -174.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -66.12 -40.05 90.38 Favored 'General case' 0 C--N 1.369 1.456 0 O-C-N 120.241 -1.537 . . . . 0.0 113.511 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.2 tp -67.97 -44.91 75.6 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 124.112 0.965 . . . . 0.0 113.556 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 88.61 21.09 0.04 OUTLIER 'General case' 0 C--N 1.356 0.89 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 171.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -151.26 173.6 14.27 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 101.124 -3.658 . . . . 0.0 101.124 -166.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.1 mt -73.69 144.67 45.71 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 118.069 -2.894 . . . . 0.0 114.089 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.448 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 66.0 t-105 -92.18 127.97 47.06 Favored Pre-proline 0 C--O 1.208 -1.109 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.705 -170.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 71' ' ' TRP . 88.0 Cg_endo -93.7 6.36 2.76 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 CA-C-O 115.206 -2.081 . . . . 0.0 110.919 -157.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.5 mt -124.7 158.17 33.87 Favored 'General case' 0 C--N 1.361 1.077 0 CA-C-N 122.638 2.472 . . . . 0.0 108.654 -169.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.2 p -62.38 -48.27 80.48 Favored 'General case' 0 N--CA 1.507 2.401 0 C-N-CA 124.118 0.967 . . . . 0.0 113.156 163.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.1 m -65.6 149.17 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 125.14 2.4 . . . . 0.0 113.022 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.37 176.59 4.51 Favored 'General case' 0 CA--C 1.561 1.369 0 O-C-N 120.275 -1.515 . . . . 0.0 109.084 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -25.16 137.32 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 153.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.33 -118.77 0.95 Allowed Glycine 0 C--N 1.373 2.608 0 CA-C-O 123.962 1.868 . . . . 0.0 112.636 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 m -156.54 154.11 29.77 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 pt -133.35 129.22 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-O 124.447 2.07 . . . . 0.0 107.579 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -130.38 154.43 47.7 Favored 'General case' 0 C--N 1.359 0.984 0 CA-C-N 112.157 -2.292 . . . . 0.0 111.848 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 96.9 m -122.15 134.3 54.74 Favored 'General case' 0 C--O 1.189 -2.116 0 O-C-N 119.959 -1.713 . . . . 0.0 108.275 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.79 153.67 81.68 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-N 122.977 2.626 . . . . 0.0 107.431 -171.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -43.28 150.13 0.44 Allowed 'Trans proline' 0 CA--C 1.509 -0.726 0 C-N-CA 122.09 1.86 . . . . 0.0 114.799 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.338 37.8 m 82.1 33.28 0.09 Allowed 'General case' 0 C--N 1.361 1.106 0 O-C-N 127.529 3.018 . . . . 0.0 116.216 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 49.05 40.95 18.42 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 130.735 3.614 . . . . 0.0 115.037 -167.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -94.75 133.92 37.92 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 123.3 1.524 . . . . 0.0 109.27 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.31 141.25 52.18 Favored 'General case' 0 C--O 1.192 -1.935 0 O-C-N 119.647 -1.908 . . . . 0.0 109.528 171.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.25 153.31 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.382 0 C-N-CA 126.654 1.982 . . . . 0.0 112.232 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -111.74 121.75 45.93 Favored 'General case' 0 CA--C 1.562 1.432 1 C-N-CA 132.282 4.233 . . . . 0.0 106.802 170.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.32 108.49 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 118.697 -2.502 . . . . 0.0 108.321 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.44 154.05 93.75 Favored Pre-proline 0 N--CA 1.434 -1.273 0 C-N-CA 127.245 2.218 . . . . 0.0 115.937 169.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -74.91 12.46 1.19 Allowed 'Trans proline' 0 N--CA 1.515 2.785 0 N-CA-C 116.051 1.52 . . . . 0.0 116.051 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -100.99 1.13 39.34 Favored 'General case' 0 C--N 1.361 1.107 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.528 158.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.33 11.62 60.83 Favored Glycine 0 CA--C 1.465 -3.072 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 m -76.04 117.47 17.79 Favored 'General case' 0 N--CA 1.435 -1.225 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.641 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . 0.263 53.9 m -93.34 80.68 4.41 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 -171.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -70.59 153.64 42.67 Favored 'General case' 0 C--O 1.254 1.318 0 O-C-N 121.1 -1.0 . . . . 0.0 112.882 -173.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.27 114.7 7.77 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 167.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.2 tp -92.33 -25.59 18.48 Favored 'General case' 0 CA--C 1.558 1.267 0 CA-C-O 121.698 0.761 . . . . 0.0 112.997 173.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -120.99 173.84 7.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 119.164 -2.21 . . . . 0.0 110.093 163.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -60.43 -30.99 69.99 Favored 'General case' 0 CA--C 1.576 1.946 0 C-N-CA 130.436 3.494 . . . . 0.0 116.581 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -67.65 -54.08 22.51 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.444 172.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.83 -35.12 74.08 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -61.88 -45.51 93.44 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 122.385 1.088 . . . . 0.0 112.153 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -68.29 -28.12 66.91 Favored 'General case' 0 C--O 1.259 1.554 0 CA-C-O 124.368 2.032 . . . . 0.0 115.859 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.62 -21.13 61.88 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 116.662 2.097 . . . . 0.0 116.662 168.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.69 15.07 11.46 Favored Glycine 0 CA--C 1.463 -3.202 0 CA-C-O 114.915 -3.159 . . . . 0.0 114.396 -174.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -87.31 150.39 49.14 Favored Pre-proline 0 N--CA 1.429 -1.498 0 C-N-CA 114.079 -3.049 . . . . 0.0 110.461 164.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -57.23 142.16 94.6 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 CA-C-O 116.668 -1.472 . . . . 0.0 115.668 -172.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -68.06 139.35 46.49 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 CA-C-O 125.316 2.132 . . . . 0.0 116.532 169.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.4 tt -90.05 10.64 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 O-C-N 118.584 -2.573 . . . . 0.0 107.116 -171.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.27 -52.23 70.8 Favored Pre-proline 0 C--N 1.369 1.45 0 O-C-N 119.791 -1.818 . . . . 0.0 114.093 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.94 -7.34 20.89 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 CA-C-N 121.539 1.585 . . . . 0.0 113.204 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.6 pt -103.79 9.03 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.198 0.908 . . . . 0.0 111.174 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -69.82 137.03 51.46 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.996 0.903 . . . . 0.0 112.794 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -94.31 129.37 41.0 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 122.979 1.371 . . . . 0.0 112.171 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -89.59 140.78 29.21 Favored 'General case' 0 C--O 1.253 1.241 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.49 -168.89 7.75 Favored Glycine 0 C--N 1.383 3.171 0 N-CA-C 118.475 2.15 . . . . 0.0 118.475 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 m -96.97 123.35 40.67 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 124.626 0.839 . . . . 0.0 112.817 164.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 62.68 50.29 65.5 Favored Glycine 0 CA--C 1.496 -1.153 0 C-N-CA 126.362 1.934 . . . . 0.0 113.876 -168.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.89 -175.91 51.91 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 125.865 1.698 . . . . 0.0 113.093 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.7 174.16 44.11 Favored Glycine 0 CA--C 1.539 1.538 0 O-C-N 127.33 2.429 . . . . 0.0 111.977 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -126.75 143.42 51.25 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 -172.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 37.3 mm -74.17 140.55 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 O-C-N 120.077 -1.639 . . . . 0.0 111.657 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 30.9 t -62.01 127.62 32.27 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 -169.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.6 mt -72.62 -17.52 61.67 Favored 'General case' 0 C--N 1.378 1.828 0 O-C-N 118.052 -2.905 . . . . 0.0 111.806 169.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -41.52 -53.85 4.18 Favored Glycine 0 C--N 1.343 0.964 0 C-N-CA 127.548 2.499 . . . . 0.0 117.688 -166.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.37 89.82 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 120.263 -1.728 . . . . 0.0 115.007 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 48.9 tp -64.7 -48.25 75.38 Favored 'General case' 0 C--O 1.206 -1.204 0 O-C-N 118.471 -2.643 . . . . 0.0 112.48 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.0 tp -64.51 -52.15 59.31 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 121.437 -0.789 . . . . 0.0 109.032 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.4 p -60.13 -41.99 93.85 Favored 'General case' 0 N--CA 1.509 2.516 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.7 m -55.75 -42.66 75.73 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 126.419 1.888 . . . . 0.0 110.036 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 78.4 m -60.12 -43.53 95.58 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 127.961 3.288 . . . . 0.0 108.655 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 12.1 mt -66.19 -36.7 83.76 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -57.91 -42.32 84.48 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 119.347 -2.096 . . . . 0.0 112.495 172.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.2 mt -62.96 -42.61 99.87 Favored 'General case' 0 C--O 1.193 -1.914 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.738 -172.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 28.4 p -113.94 27.37 9.57 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 115.332 -2.271 . . . . 0.0 110.625 -165.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.37 2.444 0 CA-C-N 123.714 2.961 . . . . 0.0 115.019 -178.762 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 . . . . . 0 C--O 1.214 -0.803 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -74.4 155.37 38.16 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 111.58 -2.554 . . . . 0.0 109.784 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 tp -147.54 138.67 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.199 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 -175.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.7 t -145.01 154.3 42.39 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.67 -1.269 . . . . 0.0 109.113 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -54.9 -30.16 57.58 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 126.065 1.746 . . . . 0.0 112.246 168.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.96 -37.44 82.4 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 171.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -70.77 -44.7 66.15 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.297 1.839 . . . . 0.0 113.108 168.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 8.4 mt -58.76 -43.19 90.26 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 82.18 -3.96 1.47 Allowed 'General case' 0 N--CA 1.411 -2.388 0 CA-C-O 122.427 1.108 . . . . 0.0 108.969 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -138.53 151.07 47.02 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 118.678 -2.513 . . . . 0.0 106.147 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 tp -51.09 142.24 12.72 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 126.133 1.773 . . . . 0.0 114.039 -167.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -55.9 134.83 73.19 Favored Pre-proline 0 CA--C 1.583 2.234 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -97.76 2.31 1.47 Allowed 'Trans proline' 0 C--O 1.206 -1.097 0 CA-C-O 113.898 -2.626 . . . . 0.0 112.273 -174.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.3 mt -112.34 165.95 11.73 Favored 'General case' 0 C--N 1.364 1.221 0 CA-C-N 121.558 1.981 . . . . 0.0 110.986 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.2 p -91.99 -25.26 18.93 Favored 'General case' 0 C--N 1.361 1.097 0 O-C-N 120.564 -1.335 . . . . 0.0 111.381 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 m -71.3 135.12 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -79.31 115.11 18.77 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 124.076 0.86 . . . . 0.0 109.207 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.345 38.5 m80 57.74 -164.74 0.17 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 117.115 -1.422 . . . . 0.0 112.042 -178.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.19 -162.48 34.81 Favored Glycine 0 C--N 1.371 2.502 0 N-CA-C 103.37 -3.892 . . . . 0.0 103.37 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.38 151.29 43.38 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 103.49 -2.781 . . . . 0.0 103.49 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.97 161.04 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-O 124.303 2.001 . . . . 0.0 106.821 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -139.36 156.91 46.69 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 118.799 -2.438 . . . . 0.0 106.523 170.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.4 m -134.68 128.48 33.1 Favored 'General case' 0 C--N 1.37 1.461 0 O-C-N 120.041 -1.662 . . . . 0.0 110.808 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.1 mt -113.92 148.0 38.96 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 115.783 -2.056 . . . . 0.0 106.812 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.262 31.3 Cg_exo -50.26 147.75 15.52 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 125.21 3.94 . . . . 0.0 116.485 -166.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.257 12.3 m 72.22 39.97 0.73 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.974 1.71 . . . . 0.0 113.815 -175.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 58.53 46.72 14.46 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 128.688 2.795 . . . . 0.0 112.357 172.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -95.69 113.27 24.9 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 171.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.27 130.76 50.61 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.883 -1.136 . . . . 0.0 110.979 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.9 t -114.12 140.78 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-O 125.484 2.564 . . . . 0.0 106.968 -175.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -111.44 150.24 30.13 Favored 'General case' 0 C--N 1.354 0.799 0 CA-C-N 113.263 -1.79 . . . . 0.0 107.096 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.9 t -132.97 123.27 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 N-CA-C 102.174 -3.269 . . . . 0.0 102.174 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.94 163.05 17.77 Favored Pre-proline 0 CA--C 1.588 2.415 0 CA-C-O 122.625 1.203 . . . . 0.0 112.316 172.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.47 -38.96 28.43 Favored 'Trans proline' 0 N--CA 1.517 2.891 0 C-N-CA 124.861 3.707 . . . . 0.0 114.598 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.2 p-10 -84.24 -10.43 57.69 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 121.253 1.842 . . . . 0.0 113.291 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.9 4.85 36.08 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 125.645 1.593 . . . . 0.0 115.221 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.4 m -58.88 139.4 56.57 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 122.684 1.231 . . . . 0.0 114.015 167.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.1 m -111.74 125.62 54.18 Favored 'General case' 0 C--O 1.206 -1.219 0 O-C-N 121.088 -1.008 . . . . 0.0 110.942 -165.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -133.95 166.23 23.19 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 123.454 1.597 . . . . 0.0 110.641 -165.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -117.38 124.19 48.3 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 119.824 -1.798 . . . . 0.0 112.394 -171.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.1 tp -90.02 -26.76 20.15 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -173.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -135.81 178.17 7.25 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.734 -1.229 . . . . 0.0 108.727 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -53.34 -43.88 68.04 Favored 'General case' 0 C--N 1.399 2.72 0 C-N-CA 125.611 1.564 . . . . 0.0 114.504 -171.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -70.65 -31.71 68.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.64 -37.53 65.31 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 122.578 1.18 . . . . 0.0 109.241 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -62.52 -50.52 71.04 Favored 'General case' 0 C--N 1.364 1.205 0 O-C-N 119.926 -1.734 . . . . 0.0 109.824 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -53.81 -31.77 50.28 Favored 'General case' 0 CA--C 1.586 2.333 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.92 -22.8 66.52 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 115.953 -1.975 . . . . 0.0 112.422 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 128.81 8.47 3.81 Favored Glycine 0 C--N 1.378 2.885 0 CA-C-N 122.696 2.498 . . . . 0.0 116.12 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -118.79 145.65 38.23 Favored Pre-proline 0 C--N 1.376 1.741 0 CA-C-N 121.862 2.831 . . . . 0.0 108.496 -174.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -51.68 148.62 20.95 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.945 3.097 . . . . 0.0 111.042 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -78.98 146.98 20.83 Favored 'Trans proline' 0 CA--C 1.511 -0.641 1 C-N-CA 125.418 4.079 . . . . 0.0 108.048 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.7 tp -89.25 -0.32 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 125.295 2.474 . . . . 0.0 111.229 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.6 p -56.1 -42.21 94.99 Favored Pre-proline 0 C--O 1.213 -0.827 0 CA-C-O 113.663 -3.065 . . . . 0.0 112.9 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -59.94 -31.8 94.19 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 CA-C-N 126.509 3.36 . . . . 0.0 115.693 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.3 tt -98.75 13.55 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -55.19 149.06 13.09 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.011 -1.449 . . . . 0.0 110.3 162.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -92.79 136.09 33.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 112.767 -2.015 . . . . 0.0 110.623 172.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -67.66 145.69 54.56 Favored 'General case' 0 C--O 1.201 -1.489 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.759 164.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.91 175.63 23.3 Favored Glycine 0 N--CA 1.484 1.851 0 CA-C-O 122.947 1.304 . . . . 0.0 110.883 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.3 t -71.72 125.46 27.19 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 112.745 -1.727 . . . . 0.0 110.668 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.1 7.61 57.21 Favored Glycine 0 C--N 1.353 1.525 0 O-C-N 125.385 1.678 . . . . 0.0 116.887 -165.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.98 156.9 22.25 Favored Glycine 0 CA--C 1.54 1.598 0 O-C-N 121.516 -0.991 . . . . 0.0 114.409 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.82 161.0 11.54 Favored Glycine 0 C--N 1.368 2.346 0 C-N-CA 130.347 3.832 . . . . 0.0 114.107 167.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -71.1 138.97 50.15 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 125.941 1.696 . . . . 0.0 108.442 -167.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.1 mt -73.77 140.24 18.04 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-N 110.087 -3.233 . . . . 0.0 112.62 168.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.4 t -65.03 152.15 44.18 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 118.296 2.702 . . . . 0.0 118.296 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 59.5 mt -102.22 11.74 37.76 Favored 'General case' 0 C--O 1.206 -1.214 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -177.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.85 -51.81 56.27 Favored Glycine 0 CA--C 1.555 2.584 0 O-C-N 119.177 -2.202 . . . . 0.0 116.981 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.66 -37.38 82.29 Favored 'General case' 0 N--CA 1.42 -1.928 0 O-C-N 119.164 -2.374 . . . . 0.0 114.184 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.8 tp -60.98 -45.43 94.82 Favored 'General case' 0 C--O 1.252 1.227 0 C-N-CA 124.399 1.079 . . . . 0.0 111.111 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.8 tp -69.95 -42.21 73.52 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 p -63.41 -45.31 91.59 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.16 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 94.4 m -64.23 -42.72 96.44 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 126.118 2.136 . . . . 0.0 109.398 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 92.4 m -46.92 -55.76 7.52 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 115.104 -2.379 . . . . 0.0 116.379 167.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 25.1 mt -71.56 -25.21 62.11 Favored 'General case' 0 CA--C 1.568 1.654 0 O-C-N 128.173 3.42 . . . . 0.0 113.781 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -60.38 -45.88 91.96 Favored 'General case' 0 CA--C 1.58 2.112 0 C-N-CA 126.853 2.061 . . . . 0.0 110.327 164.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.4 mt -65.2 -42.96 93.04 Favored 'General case' 0 C--N 1.416 3.497 0 O-C-N 119.58 -1.95 . . . . 0.0 114.281 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 16.6 p -101.81 15.76 27.97 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 127.256 2.222 . . . . 0.0 110.702 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.942 0 CA-C-O 115.901 -2.611 . . . . 0.0 114.092 174.892 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 . . . . . 0 CA--C 1.557 1.222 0 CA-C-O 123.29 1.519 . . . . 0.0 108.106 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -87.18 155.82 19.94 Favored 'General case' 0 CA--C 1.557 1.248 0 O-C-N 117.502 -3.249 . . . . 0.0 111.62 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.7 tp -113.48 117.85 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 123.292 1.52 . . . . 0.0 113.443 165.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.0 p -128.87 179.25 5.83 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 123.645 1.688 . . . . 0.0 109.285 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -61.65 -29.68 70.22 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 119.581 -1.95 . . . . 0.0 114.284 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.99 -42.57 84.8 Favored 'General case' 0 C--O 1.266 1.936 0 C-N-CA 125.448 1.499 . . . . 0.0 112.932 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.44 -46.2 84.18 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 164.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.27 83.3 mt -73.73 -17.38 61.12 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 122.78 2.536 . . . . 0.0 113.872 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.3 . . 65.18 11.76 7.46 Favored 'General case' 0 C--O 1.192 -1.961 0 O-C-N 127.915 3.259 . . . . 0.0 115.953 -177.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -165.12 166.4 19.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 127.307 2.243 . . . . 0.0 107.004 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.7 mt -18.93 133.07 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.443 3.097 . . . . 0.0 119.209 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -73.72 127.01 89.19 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 116.622 -3.799 . . . . 0.0 114.975 164.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -89.15 15.49 2.01 Favored 'Trans proline' 0 CA--C 1.57 2.294 0 CA-C-N 123.292 2.211 . . . . 0.0 112.229 -168.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 mt -136.0 165.1 26.46 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-O 123.753 1.739 . . . . 0.0 110.727 -172.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.8 p -100.97 -1.56 34.1 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.561 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.415 ' H ' HG22 ' A' ' 75' ' ' VAL . 17.2 m -90.27 171.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.381 1.962 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 169.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -81.26 174.7 11.27 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 122.27 1.033 . . . . 0.0 111.816 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -73.37 144.18 46.55 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 128.838 2.855 . . . . 0.0 106.012 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.03 179.54 36.42 Favored Glycine 0 C--N 1.367 2.304 0 CA-C-N 112.058 -2.337 . . . . 0.0 110.501 -164.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.3 m -84.65 120.21 26.12 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-O 123.716 1.722 . . . . 0.0 113.593 -173.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -86.69 143.68 10.91 Favored 'Isoleucine or valine' 0 C--O 1.257 1.489 0 CA-C-O 124.243 1.973 . . . . 0.0 111.574 165.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -145.67 151.68 38.42 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 112.577 -2.101 . . . . 0.0 107.125 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 89.6 m -121.51 115.02 22.07 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-O 125.086 2.374 . . . . 0.0 107.132 172.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mt -92.86 150.81 40.09 Favored Pre-proline 0 CA--C 1.507 -0.701 0 CA-C-O 116.093 -1.908 . . . . 0.0 106.564 -174.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -47.07 138.75 15.93 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 123.848 3.032 . . . . 0.0 116.545 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.6 m 80.14 49.26 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 120.757 1.617 . . . . 0.0 115.229 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 46.98 49.19 14.99 Favored 'General case' 0 C--N 1.392 2.448 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -106.32 116.51 32.06 Favored 'General case' 0 C--N 1.385 2.119 0 C-N-CA 117.868 -1.533 . . . . 0.0 111.942 170.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.77 106.94 15.85 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-O 123.291 1.52 . . . . 0.0 107.575 -173.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.7 m -122.67 144.79 30.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 C-N-CA 127.589 2.356 . . . . 0.0 109.089 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -113.33 128.47 56.47 Favored 'General case' 0 N--CA 1.425 -1.687 0 O-C-N 119.006 -2.309 . . . . 0.0 106.165 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.9 t -106.49 111.64 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -69.98 156.3 92.02 Favored Pre-proline 0 C--O 1.27 2.153 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.598 171.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.478 ' HD2' ' HB1' ' A' ' 92' ' ' ALA . 41.1 Cg_endo -68.61 2.36 2.98 Favored 'Trans proline' 0 CA--C 1.498 -1.31 0 C-N-CA 124.409 3.406 . . . . 0.0 113.241 -166.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -102.66 -25.13 13.67 Favored 'General case' 0 C--O 1.245 0.834 0 O-C-N 127.139 2.774 . . . . 0.0 110.188 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.11 24.85 3.16 Favored Glycine 0 C--N 1.348 1.242 0 C-N-CA 126.282 1.896 . . . . 0.0 110.815 172.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.46 147.32 24.35 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.0 m -129.47 125.68 36.97 Favored 'General case' 0 C--O 1.263 1.814 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -167.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -128.94 126.81 40.45 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 125.852 1.97 . . . . 0.0 108.581 -165.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.04 124.26 19.99 Favored 'General case' 0 C--O 1.211 -0.932 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 69.7 mt -93.77 -30.49 14.83 Favored 'General case' 0 C--N 1.369 1.441 0 O-C-N 119.638 -1.914 . . . . 0.0 112.571 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -122.12 178.11 5.05 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 124.132 1.92 . . . . 0.0 106.51 174.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -79.04 -19.51 51.26 Favored 'General case' 0 CA--C 1.583 2.223 0 O-C-N 118.402 -2.687 . . . . 0.0 117.751 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -59.18 -37.78 78.19 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 126.018 2.074 . . . . 0.0 110.168 172.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.23 -30.75 69.89 Favored 'General case' 0 CA--C 1.472 -2.029 0 CA-C-O 114.998 -2.429 . . . . 0.0 113.271 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -62.7 -41.31 99.06 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 126.788 2.035 . . . . 0.0 114.014 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -66.34 -37.01 84.36 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 168.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.32 -4.68 40.61 Favored 'General case' 0 C--O 1.257 1.475 0 O-C-N 118.801 -2.437 . . . . 0.0 112.348 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.94 28.63 9.83 Favored Glycine 0 C--N 1.353 1.526 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.75 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -86.43 134.92 37.13 Favored Pre-proline 0 CA--C 1.58 2.1 0 CA-C-O 115.468 -2.206 . . . . 0.0 107.862 170.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -56.8 128.26 29.23 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 O-C-N 125.667 2.404 . . . . 0.0 114.313 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -32.27 145.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.362 2.041 . . . . 0.0 115.824 161.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.9 tt -99.96 19.46 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 C-N-CA 126.188 1.795 . . . . 0.0 110.453 173.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.05 -30.47 1.13 Allowed Pre-proline 0 CA--C 1.558 1.251 0 CA-C-O 112.165 -3.778 . . . . 0.0 116.439 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -71.59 -42.33 1.85 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 125.342 2.944 . . . . 0.0 111.716 -169.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 21.5 pt -88.28 6.19 3.75 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 C-N-CA 128.243 2.617 . . . . 0.0 111.774 -165.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -53.11 155.9 2.39 Favored 'General case' 0 C--O 1.221 -0.419 1 O-C-N 116.021 -4.174 . . . . 0.0 118.355 168.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -98.68 147.33 24.96 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 117.31 -1.756 . . . . 0.0 110.04 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . 0.353 13.7 mmmm -64.94 143.99 57.58 Favored 'General case' 0 C--N 1.37 1.476 0 CA-C-O 124.072 1.891 . . . . 0.0 110.568 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -82.06 -146.19 5.6 Favored Glycine 0 CA--C 1.57 3.489 0 CA-C-O 126.374 3.208 . . . . 0.0 117.503 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.4 t -111.42 111.74 22.99 Favored 'General case' 0 CA--C 1.512 -0.507 1 O-C-N 116.113 -4.169 . . . . 0.0 102.86 170.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.48 48.27 5.37 Favored Glycine 1 C--N 1.399 4.053 0 CA-C-N 120.319 1.418 . . . . 0.0 110.096 177.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.82 -164.52 54.78 Favored Glycine 0 C--N 1.381 3.075 0 N-CA-C 117.12 1.608 . . . . 0.0 117.12 -171.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.39 -166.4 1.14 Allowed Glycine 0 C--N 1.338 0.684 1 N-CA-C 123.491 4.157 . . . . 0.0 123.491 -173.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . 0.317 74.3 m-85 -133.54 149.06 51.68 Favored 'General case' 0 C--O 1.253 1.269 0 O-C-N 117.414 -3.403 . . . . 0.0 110.296 -173.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 79.6 mt -63.92 151.67 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.163 0 CA-C-N 124.082 3.128 . . . . 0.0 108.784 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.0 t -62.55 145.24 54.84 Favored 'General case' 0 C--O 1.198 -1.64 0 O-C-N 118.273 -2.767 . . . . 0.0 113.17 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.7 mt -97.52 4.92 50.26 Favored 'General case' 0 CA--C 1.58 2.116 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 -172.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -76.59 -41.72 23.83 Favored Glycine 0 C--N 1.394 3.789 0 C-N-CA 119.683 -1.246 . . . . 0.0 115.38 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.26 -34.52 72.91 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 117.389 -3.418 . . . . 0.0 115.767 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 27.9 tp -54.26 -58.71 6.36 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 126.083 1.753 . . . . 0.0 112.133 165.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 38.3 tp -63.09 -40.3 97.25 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.3 p -71.82 -33.45 68.52 Favored 'General case' 0 C--O 1.251 1.175 0 O-C-N 119.296 -2.128 . . . . 0.0 115.108 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 32.4 m -61.71 -42.69 99.28 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.92 1.288 . . . . 0.0 108.656 169.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.1 m -57.56 -46.85 83.43 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.8 mt -72.12 -30.13 64.75 Favored 'General case' 0 CA--C 1.562 1.406 0 O-C-N 124.865 1.353 . . . . 0.0 112.232 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -58.25 -46.62 85.65 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 116.845 -1.55 . . . . 0.0 113.14 168.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 71.9 mt -72.63 -45.25 59.96 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 119.236 0.926 . . . . 0.0 111.29 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . 0.342 1.2 p -74.44 -17.76 60.74 Favored 'General case' 0 C--O 1.202 -1.429 0 CA-C-O 115.75 -2.072 . . . . 0.0 113.328 -170.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.381 3.065 0 N-CA-C 120.035 2.774 . . . . 0.0 120.035 169.757 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 . . . . . 0 CA--C 1.466 -2.26 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.75 139.06 55.32 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.401 HD11 HD12 ' A' ' 130' ' ' LEU . 1.1 tt -116.24 142.6 29.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 121.458 -0.776 . . . . 0.0 109.408 162.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.5 ' HB2' ' CE1' ' A' ' 77' ' ' HIS . 90.3 p -152.76 158.88 42.93 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-O 116.143 -1.885 . . . . 0.0 107.207 -169.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -64.28 -18.16 64.32 Favored 'General case' 0 C--N 1.367 1.365 0 CA-C-N 123.608 2.913 . . . . 0.0 110.598 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.96 -25.9 53.37 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 120.476 -1.39 . . . . 0.0 111.817 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -73.29 -28.66 62.23 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 125.949 1.7 . . . . 0.0 111.275 173.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.427 HD11 HD13 ' A' ' 130' ' ' LEU . 9.7 mt -88.98 3.77 50.45 Favored 'General case' 0 C--O 1.203 -1.35 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 36.8 63.01 0.72 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 120.747 3.61 . . . . 0.0 120.747 -168.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . 0.297 51.0 t80 83.58 149.12 0.08 Allowed 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 129.214 3.006 . . . . 0.0 109.714 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.324 2.1 tp 89.57 81.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 128.989 2.916 . . . . 0.0 109.601 173.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -85.7 124.79 70.64 Favored Pre-proline 0 N--CA 1.479 0.989 0 O-C-N 120.37 -1.456 . . . . 0.0 112.474 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.72 3.2 8.0 Favored 'Trans proline' 0 C--N 1.362 1.253 0 CA-C-N 122.037 1.763 . . . . 0.0 114.637 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.9 mt -120.63 158.27 27.77 Favored 'General case' 0 C--N 1.375 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.95 -165.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.0 p -78.83 -30.08 45.07 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 170.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.5 m -71.91 147.71 10.4 Favored 'Isoleucine or valine' 0 C--N 1.367 1.36 0 C-N-CA 124.506 1.122 . . . . 0.0 111.491 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . 0.256 62.7 t0 -90.15 82.35 6.07 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 118.49 -2.631 . . . . 0.0 111.426 -172.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.5 ' CE1' ' HB2' ' A' ' 63' ' ' SER 0.33 27.5 m170 77.84 178.12 0.15 Allowed 'General case' 0 CA--C 1.474 -1.956 0 O-C-N 120.567 -1.333 . . . . 0.0 114.013 179.016 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.21 -176.57 39.86 Favored Glycine 0 N--CA 1.433 -1.535 0 O-C-N 117.977 -2.952 . . . . 0.0 114.711 -172.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.259 17.0 p -124.24 146.29 48.84 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 118.591 -2.711 . . . . 0.0 105.757 171.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.409 HD11 HD23 ' A' ' 137' ' ' LEU . 2.8 pp -119.84 150.09 22.45 Favored 'Isoleucine or valine' 0 C--N 1.366 1.29 0 CA-C-O 126.644 3.116 . . . . 0.0 112.379 177.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -141.66 137.9 32.1 Favored 'General case' 0 CA--C 1.57 1.745 0 O-C-N 116.536 -3.852 . . . . 0.0 108.524 168.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.9 m -108.29 140.78 41.06 Favored 'General case' 0 C--N 1.368 1.385 0 O-C-N 117.342 -3.349 . . . . 0.0 104.906 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 87' ' ' ASN . 10.7 mt -111.38 146.99 35.73 Favored Pre-proline 0 N--CA 1.432 -1.359 0 C-N-CA 129.501 3.12 . . . . 0.0 102.909 -173.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -40.35 134.58 2.01 Favored 'Trans proline' 0 N--CA 1.507 2.274 1 C-N-CA 126.45 4.767 . . . . 0.0 113.059 -173.483 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.272 1.0 OUTLIER 85.2 31.59 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 122.489 1.137 . . . . 0.0 108.909 170.741 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . 0.281 21.8 m-20 65.84 44.54 2.79 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 116.872 -3.642 . . . . 0.0 115.448 176.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 83' ' ' LEU . 2.3 m-80 -101.74 114.07 27.81 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 174.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.21 120.82 36.09 Favored 'General case' 0 N--CA 1.409 -2.508 0 O-C-N 125.013 1.446 . . . . 0.0 111.284 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.1 t -99.87 145.35 10.84 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 CA-C-O 127.737 3.637 . . . . 0.0 109.883 166.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -111.3 128.56 55.98 Favored 'General case' 0 N--CA 1.44 -0.94 1 O-C-N 115.038 -4.789 . . . . 0.0 106.714 168.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.8 t -110.44 124.57 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.723 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.36 167.15 19.69 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-O 117.222 -1.37 . . . . 0.0 114.367 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -41.13 -34.31 1.54 Allowed 'Trans proline' 0 N--CA 1.52 3.079 0 N-CA-C 120.518 3.238 . . . . 0.0 120.518 165.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.0 p30 -96.99 3.89 51.77 Favored 'General case' 0 CA--C 1.477 -1.846 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.77 -13.25 29.71 Favored Glycine 0 CA--C 1.526 0.725 0 O-C-N 120.262 -1.524 . . . . 0.0 111.91 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.282 47.0 m -66.47 113.02 4.38 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -173.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.68 119.58 10.16 Favored 'General case' 0 C--N 1.375 1.691 0 C-N-CA 128.014 2.526 . . . . 0.0 115.6 171.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -120.04 141.52 49.67 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 166.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.04 149.3 37.37 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 153.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . 0.255 23.1 tp -118.76 -3.26 10.81 Favored 'General case' 0 C--N 1.379 1.883 0 C-N-CA 129.87 3.268 . . . . 0.0 111.848 177.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.2 p30 -158.07 175.1 14.23 Favored 'General case' 0 C--N 1.38 1.897 0 CA-C-N 120.412 1.46 . . . . 0.0 109.916 169.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . 0.315 69.4 m-20 -60.34 -36.91 79.07 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -173.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.4 mtt85 -59.19 -41.34 88.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 127.811 3.194 . . . . 0.0 111.639 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.12 -23.5 28.42 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-O 124.932 2.301 . . . . 0.0 114.659 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -63.7 -47.28 81.78 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.63 -1.623 . . . . 0.0 112.391 163.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -61.32 -38.12 85.71 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-O 125.157 2.408 . . . . 0.0 115.427 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.39 -34.23 68.66 Favored 'General case' 0 CA--C 1.572 1.819 0 O-C-N 119.308 -2.12 . . . . 0.0 113.388 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 127.92 -3.83 6.92 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 120.807 3.083 . . . . 0.0 120.807 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -70.66 143.49 89.88 Favored Pre-proline 0 N--CA 1.487 1.421 0 CA-C-N 121.654 2.727 . . . . 0.0 112.161 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -48.44 146.8 9.84 Favored 'Trans proline' 0 C--N 1.296 -2.229 1 C-N-CA 126.323 4.682 . . . . 0.0 119.431 175.195 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -82.25 151.76 15.85 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 118.266 -1.492 . . . . 0.0 109.503 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.9 tt -86.08 4.19 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.554 1.942 . . . . 0.0 109.784 -171.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.65 -40.28 74.1 Favored Pre-proline 0 CA--C 1.578 2.029 1 N-CA-C 122.04 4.089 . . . . 0.0 122.04 -168.339 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.84 -6.66 14.31 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 113.974 -3.751 . . . . 0.0 114.308 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 31.4 mm -86.19 -16.61 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 C-N-CA 125.904 1.682 . . . . 0.0 106.952 176.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -56.93 145.39 30.2 Favored 'General case' 0 C--O 1.194 -1.834 0 CA-C-O 126.04 2.829 . . . . 0.0 117.49 164.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -93.7 132.59 37.91 Favored 'General case' 0 C--O 1.209 -1.07 0 CA-C-N 112.459 -2.155 . . . . 0.0 111.774 174.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . 0.467 41.3 mtpt -57.65 144.58 37.13 Favored 'General case' 0 C--O 1.178 -2.676 0 O-C-N 119.322 -2.111 . . . . 0.0 112.989 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -110.79 -168.88 19.21 Favored Glycine 0 N--CA 1.494 2.524 0 CA-C-N 119.943 1.247 . . . . 0.0 112.215 -159.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 64.4 m -76.05 119.89 20.61 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 116.145 -1.883 . . . . 0.0 113.487 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.55 49.33 5.83 Favored Glycine 0 C--N 1.365 2.147 0 CA-C-N 121.669 2.031 . . . . 0.0 114.194 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 59.62 -155.85 28.36 Favored Glycine 1 CA--C 1.593 4.918 0 O-C-N 118.245 -2.914 . . . . 0.0 116.375 -158.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 49.81 -152.69 3.58 Favored Glycine 0 C--O 1.213 -1.163 0 CA-C-O 124.395 2.108 . . . . 0.0 114.904 -167.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -134.58 148.44 50.46 Favored 'General case' 0 N--CA 1.418 -2.041 0 C-N-CA 126.594 1.958 . . . . 0.0 111.721 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.9 mt -60.9 140.17 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.363 0 O-C-N 120.324 -1.485 . . . . 0.0 112.391 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.5 t -52.61 137.65 30.13 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 128.844 2.857 . . . . 0.0 112.999 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.4 mt -98.46 4.48 48.37 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.481 -1.387 . . . . 0.0 111.47 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -44.25 -63.88 2.21 Favored Glycine 0 CA--C 1.486 -1.726 0 C-N-CA 127.775 2.607 . . . . 0.0 113.823 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.9 -45.08 93.68 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 173.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.427 HD13 HD11 ' A' ' 67' ' ' LEU . 34.0 tp -63.18 -43.44 98.22 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 124.502 1.126 . . . . 0.0 113.561 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.8 tp -64.72 -45.97 84.27 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 121.736 0.779 . . . . 0.0 112.405 168.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 78.4 p -74.8 -36.46 62.48 Favored 'General case' 0 CA--C 1.497 -1.095 0 O-C-N 117.919 -2.988 . . . . 0.0 113.347 -169.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 52.0 m -59.89 -43.09 94.99 Favored 'General case' 0 C--O 1.266 1.97 0 C-N-CA 128.695 2.798 . . . . 0.0 105.588 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 47.0 m -63.05 -41.65 99.54 Favored 'General case' 0 C--N 1.377 1.787 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.527 -174.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.427 ' HA ' ' SG ' ' A' ' 138' ' ' CYS . 17.8 mt -69.64 -36.95 76.57 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 117.719 2.489 . . . . 0.0 117.719 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -61.39 -37.89 85.09 Favored 'General case' 0 CA--C 1.57 1.715 0 O-C-N 116.801 -3.687 . . . . 0.0 109.839 165.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.409 HD23 HD11 ' A' ' 80' ' ' ILE . 49.0 tp -69.92 -31.25 68.92 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 118.155 -2.841 . . . . 0.0 115.622 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.427 ' SG ' ' HA ' ' A' ' 135' ' ' LEU . 28.6 p -92.21 14.86 14.96 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.088 -1.008 . . . . 0.0 110.957 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.984 0 C-N-CA 125.779 1.656 . . . . 0.0 109.993 -179.902 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -73.76 135.02 43.54 Favored 'General case' 0 N--CA 1.411 -2.402 0 O-C-N 128.338 3.524 . . . . 0.0 111.464 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.424 HD13 ' CD1' ' A' ' 137' ' ' LEU . 9.9 tp -136.54 128.88 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 125.571 2.605 . . . . 0.0 112.945 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.9 p -162.76 171.78 16.24 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 127.271 2.228 . . . . 0.0 107.832 -159.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -45.1 -52.17 9.42 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 128.253 2.621 . . . . 0.0 114.756 173.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.76 93.55 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 174.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -82.45 -19.87 38.08 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 120.293 -1.504 . . . . 0.0 111.522 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.6 tp -75.06 -42.57 56.67 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 117.971 2.582 . . . . 0.0 117.971 166.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 65.56 15.71 10.16 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 130.006 3.322 . . . . 0.0 114.289 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -134.27 166.81 21.94 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 162.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.6 mt -39.31 128.67 1.8 Allowed 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -174.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -66.27 139.62 96.44 Favored Pre-proline 0 CA--C 1.567 1.621 0 CA-C-O 113.296 -3.24 . . . . 0.0 114.806 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -116.97 -3.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 2.015 0 CA-C-O 111.187 -3.755 . . . . 0.0 110.302 -167.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 mt -113.13 152.95 29.01 Favored 'General case' 0 C--N 1.401 2.818 0 O-C-N 127.484 2.99 . . . . 0.0 112.929 -177.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.2 p -79.28 -17.12 55.31 Favored 'General case' 0 N--CA 1.416 -2.132 0 O-C-N 118.281 -2.762 . . . . 0.0 113.64 -171.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.8 m -72.16 147.94 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 129.986 3.314 . . . . 0.0 115.003 166.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -56.59 171.24 0.32 Allowed 'General case' 0 C--O 1.2 -1.527 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 154.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -36.32 127.13 0.79 Allowed 'General case' 0 C--N 1.373 1.62 0 C-N-CA 130.322 3.449 . . . . 0.0 109.778 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.58 -168.24 22.68 Favored Glycine 0 N--CA 1.434 -1.459 0 CA-C-O 123.322 1.512 . . . . 0.0 111.659 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.9 m -120.97 115.57 23.43 Favored 'General case' 0 C--N 1.378 1.825 0 CA-C-N 111.228 -2.486 . . . . 0.0 109.031 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.438 ' H ' HG13 ' A' ' 80' ' ' ILE 0.328 1.9 pp -88.81 138.38 19.31 Favored 'Isoleucine or valine' 0 C--N 1.396 2.605 0 CA-C-N 121.074 1.761 . . . . 0.0 110.534 172.644 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -133.39 132.5 41.28 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.4 m -100.16 130.32 46.28 Favored 'General case' 0 C--N 1.382 1.994 0 CA-C-O 124.053 1.883 . . . . 0.0 110.322 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.3 mt -105.52 157.53 34.31 Favored Pre-proline 0 CA--C 1.569 1.706 0 O-C-N 119.32 -2.113 . . . . 0.0 113.589 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -40.35 145.73 0.32 Allowed 'Trans proline' 0 CA--C 1.475 -2.475 1 C-N-CA 127.084 5.19 . . . . 0.0 113.425 169.1 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.1 m 70.55 41.41 0.95 Allowed 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 118.971 2.952 . . . . 0.0 118.971 173.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 64.98 30.35 11.88 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 129.343 3.057 . . . . 0.0 112.751 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.254 65.5 m-20 -101.06 137.31 39.59 Favored 'General case' 0 C--N 1.373 1.615 0 CA-C-N 120.009 1.277 . . . . 0.0 109.497 -169.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.12 124.2 36.35 Favored 'General case' 0 C--O 1.2 -1.535 0 CA-C-N 122.431 2.378 . . . . 0.0 111.002 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.254 32.7 m -120.11 144.29 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-O 124.361 2.029 . . . . 0.0 113.252 -174.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -121.06 131.37 54.24 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 120.236 -1.54 . . . . 0.0 107.594 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.35 118.32 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.323 0 C-N-CA 126.309 1.843 . . . . 0.0 110.867 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.17 156.51 76.51 Favored Pre-proline 0 CA--C 1.577 1.99 0 O-C-N 126.435 2.334 . . . . 0.0 115.401 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -43.69 -35.1 6.18 Favored 'Trans proline' 0 C--O 1.255 1.372 0 N-CA-C 120.395 3.19 . . . . 0.0 120.395 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -69.98 -33.54 72.19 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 116.779 -1.581 . . . . 0.0 113.719 172.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 127.86 -3.31 6.94 Favored Glycine 0 C--N 1.364 2.086 1 C-N-CA 130.915 4.102 . . . . 0.0 113.745 176.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.8 m -57.07 132.47 53.01 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 125.257 1.423 . . . . 0.0 113.834 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.4 m -106.19 109.0 20.8 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 123.163 2.711 . . . . 0.0 107.072 -174.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -113.26 148.4 35.64 Favored 'General case' 0 C--O 1.255 1.351 0 O-C-N 120.631 -1.293 . . . . 0.0 108.837 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.3 127.65 33.44 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 114.636 -2.602 . . . . 0.0 111.438 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.38 -9.43 30.0 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 120.339 1.427 . . . . 0.0 112.393 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -141.75 171.02 14.63 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.414 1.102 . . . . 0.0 110.484 172.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -65.27 -32.54 74.26 Favored 'General case' 0 N--CA 1.416 -2.172 0 C-N-CA 130.396 3.478 . . . . 0.0 110.909 -171.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -59.09 -42.48 90.55 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 125.482 1.739 . . . . 0.0 113.352 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.419 ' HA ' ' HB3' ' A' ' 107' ' ' ALA . . . -84.6 -17.31 39.12 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -172.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -66.23 -44.14 84.6 Favored 'General case' 0 C--N 1.381 1.952 0 CA-C-O 116.262 -1.828 . . . . 0.0 110.289 158.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -65.31 -42.78 92.66 Favored 'General case' 0 C--N 1.362 1.117 0 O-C-N 126.445 2.341 . . . . 0.0 116.878 173.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 104' ' ' ALA . . . -59.6 -34.74 73.12 Favored 'General case' 0 C--N 1.374 1.67 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 166.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 140.27 -17.88 2.9 Favored Glycine 0 C--N 1.376 2.753 0 N-CA-C 119.408 2.523 . . . . 0.0 119.408 166.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -71.47 140.96 85.01 Favored Pre-proline 0 C--O 1.272 2.243 0 CA-C-N 119.904 1.852 . . . . 0.0 111.4 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.66 136.5 0.66 Allowed 'Trans proline' 0 C--N 1.378 2.113 1 C-N-CA 125.358 4.039 . . . . 0.0 117.412 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -55.61 155.64 20.9 Favored 'Trans proline' 0 CA--C 1.565 2.031 0 C-N-CA 122.862 2.375 . . . . 0.0 112.106 173.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 tp -79.92 -14.7 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 122.455 1.121 . . . . 0.0 113.821 -172.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . 0.303 2.3 m -15.71 -61.61 0.04 OUTLIER Pre-proline 0 C--O 1.248 1.001 1 N-CA-C 122.254 4.168 . . . . 0.0 122.254 169.254 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -48.82 -45.36 28.61 Favored 'Trans proline' 0 C--N 1.29 -2.532 0 C-N-CA 124.207 3.271 . . . . 0.0 115.887 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . 0.255 8.4 pt -106.98 12.82 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 117.531 -3.23 . . . . 0.0 111.415 -162.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -62.96 140.19 58.83 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 166.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.92 137.84 39.67 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 120.62 -1.3 . . . . 0.0 108.082 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 124' ' ' TYR . 43.5 mtpt -58.49 156.23 10.82 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 116.709 2.115 . . . . 0.0 116.709 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -108.53 -165.25 20.95 Favored Glycine 0 CA--C 1.563 3.057 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.8 t -110.19 116.99 32.5 Favored 'General case' 0 C--N 1.388 2.254 0 CA-C-O 116.383 -1.77 . . . . 0.0 108.747 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.16 55.61 2.73 Favored Glycine 0 C--N 1.388 3.439 0 C-N-CA 127.122 2.296 . . . . 0.0 115.988 -162.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.65 -161.84 11.84 Favored Glycine 0 CA--C 1.455 -3.666 0 N-CA-C 119.08 2.392 . . . . 0.0 119.08 -164.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.44 -175.27 25.92 Favored Glycine 0 C--N 1.365 2.157 0 N-CA-C 119.223 2.449 . . . . 0.0 119.223 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 96.3 m-85 -127.59 163.81 23.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.0 mm -61.99 120.5 8.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.92 0 O-C-N 126.559 2.412 . . . . 0.0 108.881 166.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.7 t -62.12 154.83 25.95 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.1 mt -102.43 10.3 39.09 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 124.602 2.144 . . . . 0.0 115.223 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.51 -40.2 86.54 Favored Glycine 0 N--CA 1.486 2.011 0 O-C-N 117.393 -3.317 . . . . 0.0 118.548 -165.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.36 -42.57 96.14 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-O 125.174 2.416 . . . . 0.0 106.614 168.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.45 -38.99 88.59 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 118.437 -2.664 . . . . 0.0 110.267 -174.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.314 8.4 tt -63.26 -53.08 58.54 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.261 1.424 . . . . 0.0 113.96 175.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 89.2 p -69.77 -30.26 67.79 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 122.145 0.974 . . . . 0.0 110.935 -171.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.419 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 9.4 m -67.82 -40.0 83.87 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 171.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 96.0 m -50.01 -48.68 52.43 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.587 1.955 . . . . 0.0 113.32 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 39.2 mt -67.13 -37.11 83.29 Favored 'General case' 0 N--CA 1.389 -3.521 0 O-C-N 127.635 3.085 . . . . 0.0 114.96 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -61.68 -48.44 80.79 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 121.9 2.136 . . . . 0.0 113.875 157.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.424 ' CD1' HD13 ' A' ' 62' ' ' ILE . 90.1 mt -60.13 -42.38 94.69 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 117.24 -1.362 . . . . 0.0 114.198 -176.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . 0.272 15.6 p -92.67 9.11 36.28 Favored 'General case' 0 C--N 1.38 1.927 0 N-CA-C 118.18 2.659 . . . . 0.0 118.18 173.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.529 0 CA-C-O 114.53 -3.372 . . . . 0.0 116.963 -175.908 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.2 p . . . . . 0 C--O 1.239 0.533 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -47.55 157.62 0.83 Allowed 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 123.16 2.573 . . . . 0.0 114.722 169.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.0 136.0 96.47 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.67 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.77 36.13 0.27 Allowed 'Trans proline' 0 N--CA 1.513 2.637 0 C-N-CA 121.555 1.503 . . . . 0.0 113.523 -174.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.2 mt -119.13 152.91 52.79 Favored Pre-proline 0 CA--C 1.566 1.594 0 O-C-N 119.906 -1.746 . . . . 0.0 108.147 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.36 154.76 3.75 Favored 'Trans proline' 0 N--CA 1.513 2.656 0 C-N-CA 124.022 3.148 . . . . 0.0 114.141 153.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 m 39.95 59.68 6.87 Favored Pre-proline 0 C--N 1.359 0.995 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 174.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.54 19.85 0.62 Allowed 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 121.572 1.515 . . . . 0.0 112.223 -156.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.7 m 59.53 32.97 22.0 Favored 'General case' 0 N--CA 1.508 2.473 0 C-N-CA 125.395 1.478 . . . . 0.0 111.277 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.1 m 68.2 25.91 7.15 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 127.302 2.241 . . . . 0.0 113.388 -174.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 82.92 -4.89 1.29 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.589 1.556 . . . . 0.0 111.724 173.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -70.47 142.26 51.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.657 166.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -131.97 110.51 10.81 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 118.391 -0.814 . . . . 0.0 112.725 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.23 136.57 58.0 Favored 'General case' 0 C--O 1.252 1.233 0 O-C-N 125.983 2.052 . . . . 0.0 111.307 164.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.77 142.14 23.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 CA-C-N 113.209 -1.814 . . . . 0.0 112.967 -168.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.8 p -138.98 178.29 7.27 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 -175.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -63.79 -44.91 91.93 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 122.382 1.087 . . . . 0.0 110.413 174.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.15 78.96 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 120.351 -1.468 . . . . 0.0 113.633 172.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -66.94 -43.0 84.31 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-O 117.752 -1.118 . . . . 0.0 112.018 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.7 tp -61.59 -35.98 79.37 Favored 'General case' 0 CA--C 1.582 2.192 0 CA-C-N 120.613 1.551 . . . . 0.0 113.83 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.3 . . 79.02 32.49 0.27 Allowed 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.715 -1.241 . . . . 0.0 112.074 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -156.12 157.96 36.9 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -175.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.9 mt -50.32 127.41 17.22 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 174.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -64.52 124.04 84.78 Favored Pre-proline 0 CA--C 1.567 1.607 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.433 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -99.1 0.76 1.01 Allowed 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.953 2.435 . . . . 0.0 113.5 -159.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 mt -130.91 167.84 18.31 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.2 p -89.6 1.85 55.45 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.7 160.49 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.24 -1.537 . . . . 0.0 111.626 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -77.27 174.36 10.85 Favored 'General case' 0 CA--C 1.561 1.387 0 O-C-N 120.278 -1.514 . . . . 0.0 112.424 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -53.98 140.19 31.95 Favored 'General case' 0 CA--C 1.6 2.887 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.92 -150.29 5.33 Favored Glycine 0 C--N 1.368 2.309 0 C-N-CA 127.877 2.656 . . . . 0.0 115.001 -166.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.3 m -127.58 146.7 50.44 Favored 'General case' 0 C--N 1.364 1.217 0 O-C-N 125.492 1.348 . . . . 0.0 107.821 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.3 pt -115.79 145.69 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 C-N-CA 127.307 2.243 . . . . 0.0 109.699 167.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -147.46 141.21 25.68 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-O 122.473 1.13 . . . . 0.0 111.803 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 62.0 m -88.99 138.23 31.6 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.3 mt -120.32 155.26 56.32 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.257 33.5 Cg_exo -40.67 134.88 2.21 Favored 'Trans proline' 0 N--CA 1.523 3.207 0 N-CA-C 121.804 3.732 . . . . 0.0 121.804 174.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.385 52.9 m 79.59 50.19 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.08 1.352 . . . . 0.0 110.497 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 46.32 44.16 12.29 Favored 'General case' 0 C--N 1.366 1.324 0 CA-C-N 112.456 -2.156 . . . . 0.0 112.365 173.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -96.24 145.38 25.61 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-N 118.964 0.802 . . . . 0.0 110.667 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.659 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -124.71 130.03 51.63 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.0 m -119.47 157.18 21.64 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.798 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -130.39 137.89 50.1 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 102.641 -3.096 . . . . 0.0 102.641 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.0 t -126.57 119.31 53.34 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.76 164.25 2.3 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 171.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.58 -12.21 30.97 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 CA-C-O 114.703 -2.29 . . . . 0.0 114.456 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -90.57 -1.57 57.88 Favored 'General case' 0 C--N 1.367 1.34 0 CA-C-N 120.723 1.601 . . . . 0.0 113.478 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.62 -1.07 42.42 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-O 116.159 -2.467 . . . . 0.0 112.73 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.2 m -79.57 120.18 23.57 Favored 'General case' 0 C--N 1.366 1.314 0 CA-C-N 121.706 2.753 . . . . 0.0 112.899 -171.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.7 m -83.8 130.32 34.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.769 175.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -124.43 162.61 23.53 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.95 1.7 . . . . 0.0 111.743 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.54 129.99 34.98 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 169.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.4 tp -95.46 -45.71 6.98 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 116.89 -1.528 . . . . 0.0 109.43 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -105.95 164.31 12.06 Favored 'General case' 0 C--N 1.368 1.404 0 CA-C-O 122.796 1.284 . . . . 0.0 108.925 174.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -56.62 -36.88 69.95 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 125.637 1.575 . . . . 0.0 112.658 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -60.57 -44.93 95.63 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.572 1.149 . . . . 0.0 111.332 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.95 -37.4 84.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.573 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -71.05 -42.41 69.48 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 118.792 -0.623 . . . . 0.0 110.283 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -55.87 -35.63 66.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 167.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.38 -34.05 77.1 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 116.982 -1.485 . . . . 0.0 114.306 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.48 5.91 6.95 Favored Glycine 0 N--CA 1.504 3.232 0 CA-C-N 120.873 1.67 . . . . 0.0 112.144 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -80.15 130.89 64.42 Favored Pre-proline 0 CA--C 1.565 1.549 0 CA-C-O 118.172 -0.918 . . . . 0.0 108.891 170.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -64.4 148.92 90.85 Favored 'Trans proline' 0 N--CA 1.526 3.419 0 N-CA-C 119.805 2.964 . . . . 0.0 119.805 -168.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -46.49 145.45 6.13 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 N-CA-C 115.031 1.127 . . . . 0.0 115.031 172.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.1 tt -97.06 11.21 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 118.029 -1.468 . . . . 0.0 109.378 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 17.4 p -63.92 -36.45 20.91 Favored Pre-proline 0 N--CA 1.415 -2.206 1 CA-C-O 110.566 -4.54 . . . . 0.0 117.017 -174.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.99 -19.59 22.96 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 125.421 2.972 . . . . 0.0 111.264 -167.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.4 pt -104.97 21.61 3.3 Favored 'Isoleucine or valine' 0 C--N 1.36 1.049 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -175.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.92 139.11 58.09 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 125.555 1.785 . . . . 0.0 113.15 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -96.97 129.73 44.39 Favored 'General case' 0 C--N 1.365 1.262 0 C-N-CA 126.385 1.874 . . . . 0.0 115.145 170.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -81.16 150.91 28.48 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 114.864 -1.062 . . . . 0.0 113.417 166.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.23 176.06 54.33 Favored Glycine 0 CA--C 1.544 1.856 0 O-C-N 125.897 1.998 . . . . 0.0 113.609 163.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.9 m -63.45 146.43 53.62 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 121.037 2.419 . . . . 0.0 116.728 163.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 56.83 24.9 51.04 Favored Glycine 1 C--N 1.4 4.1 0 C-N-CA 126.562 2.029 . . . . 0.0 111.613 -164.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.57 -163.17 51.32 Favored Glycine 0 CA--C 1.551 2.301 0 C-N-CA 127.488 2.47 . . . . 0.0 117.688 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.5 133.08 3.86 Favored Glycine 0 C--N 1.37 2.421 0 CA-C-N 118.967 1.383 . . . . 0.0 111.326 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -79.12 149.95 31.9 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 122.186 0.993 . . . . 0.0 109.89 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 20.5 mm -89.46 147.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 114.649 -1.159 . . . . 0.0 111.576 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.0 t -75.0 147.31 40.88 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.3 mt -96.36 21.0 9.63 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 113.154 -1.839 . . . . 0.0 111.947 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.59 -47.12 5.24 Favored Glycine 0 CA--C 1.499 -0.958 0 CA-C-O 118.291 -1.283 . . . . 0.0 115.804 -168.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.43 93.24 Favored 'General case' 0 N--CA 1.44 -0.926 0 O-C-N 126.954 2.208 . . . . 0.0 109.106 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.4 tp -67.15 -44.36 79.97 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 124.156 0.982 . . . . 0.0 110.985 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.2 tp -61.92 -54.78 37.19 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.846 0.858 . . . . 0.0 110.197 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.0 p -56.52 -44.7 81.03 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.65 0.594 . . . . 0.0 110.588 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.7 m -63.02 -39.74 95.66 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.463 1.105 . . . . 0.0 110.797 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.6 m -62.96 -37.23 86.29 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 115.426 -2.226 . . . . 0.0 114.27 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 88' ' ' ALA . 35.6 mt -88.39 -19.26 26.84 Favored 'General case' 0 C--N 1.383 2.043 0 CA-C-N 121.019 1.736 . . . . 0.0 114.272 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -61.6 -41.12 96.98 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.125 -0.984 . . . . 0.0 110.782 161.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.7 mt -61.04 -43.27 99.14 Favored 'General case' 0 C--N 1.374 1.669 0 O-C-N 124.92 1.387 . . . . 0.0 110.587 -173.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 25.5 p -101.62 27.76 6.12 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.674 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.199 -2.061 0 C-N-CA 126.352 1.929 . . . . 0.0 115.137 175.803 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.2 p . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 114.459 -2.686 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -45.7 143.11 6.68 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 CA-C-O 113.221 -2.908 . . . . 0.0 116.734 167.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.8 t -84.54 120.15 73.82 Favored Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 128.554 3.659 . . . . 0.0 109.086 160.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -81.31 30.78 0.51 Allowed 'Trans proline' 0 C--O 1.262 1.722 0 C-N-CA 124.345 3.363 . . . . 0.0 114.886 -171.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.3 mt -116.12 143.97 31.99 Favored Pre-proline 0 C--N 1.385 2.124 1 C-N-CA 131.83 4.052 . . . . 0.0 109.436 -173.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -37.14 130.8 0.54 Allowed 'Trans proline' 0 C--O 1.2 -1.379 0 C-N-CA 123.151 2.567 . . . . 0.0 116.116 166.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . 0.278 1.2 m 56.84 51.98 5.89 Favored Pre-proline 0 C--O 1.256 1.414 0 C-N-CA 127.039 2.135 . . . . 0.0 112.128 167.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -64.96 -19.22 63.83 Favored 'Trans proline' 0 C--N 1.388 2.608 0 O-C-N 126.047 2.604 . . . . 0.0 115.867 -164.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.296 1.2 m 43.28 49.37 5.85 Favored 'General case' 0 C--N 1.372 1.561 0 N-CA-C 121.103 3.742 . . . . 0.0 121.103 168.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.4 13.2 m 98.64 25.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 128.716 2.806 . . . . 0.0 113.923 174.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.298 23.6 m-20 62.74 49.15 3.87 Favored 'General case' 0 C--N 1.395 2.552 0 O-C-N 118.903 -2.373 . . . . 0.0 112.895 176.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.46 157.74 46.08 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 129.436 3.094 . . . . 0.0 108.852 174.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -137.07 155.03 50.15 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.119 -1.433 . . . . 0.0 109.931 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 76.8 m-20 -90.91 126.62 36.11 Favored 'General case' 0 C--N 1.379 1.879 0 CA-C-O 123.28 1.514 . . . . 0.0 110.023 162.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 tp -115.74 138.02 47.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 127.792 2.437 . . . . 0.0 111.334 -169.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.2 p -131.51 164.55 25.55 Favored 'General case' 0 C--N 1.38 1.894 0 O-C-N 125.725 1.891 . . . . 0.0 111.069 -168.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.78 -43.02 72.45 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 117.102 -3.499 . . . . 0.0 113.104 170.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.08 85.54 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 125.659 1.85 . . . . 0.0 110.869 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -81.38 -18.38 45.73 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.7 tp -74.05 -27.83 61.11 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 119.762 -1.836 . . . . 0.0 107.497 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 66.22 39.37 4.21 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 130.514 3.526 . . . . 0.0 112.433 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -167.67 -161.95 0.42 Allowed 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.5 mt -64.33 126.79 28.91 Favored 'General case' 0 C--O 1.208 -1.112 0 C-N-CA 128.246 2.619 . . . . 0.0 111.452 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -80.94 113.95 44.67 Favored Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.87 9.96 2.79 Favored 'Trans proline' 0 C--N 1.291 -2.482 0 C-N-CA 124.106 3.204 . . . . 0.0 113.894 -171.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.0 mt -131.29 151.45 51.49 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 124.884 1.365 . . . . 0.0 112.636 -171.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.6 p -75.13 -35.85 61.65 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.71 -1.244 . . . . 0.0 110.992 172.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.4 m -75.13 156.13 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.774 0 C-N-CA 118.29 -1.364 . . . . 0.0 114.308 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -87.87 164.71 15.74 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 126.579 3.085 . . . . 0.0 107.837 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -24.3 118.76 0.05 OUTLIER 'General case' 0 N--CA 1.524 3.233 0 C-N-CA 130.25 3.42 . . . . 0.0 115.967 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -135.98 177.52 19.46 Favored Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 104.84 -3.304 . . . . 0.0 104.84 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 5.5 m -71.57 145.06 49.3 Favored 'General case' 0 C--N 1.363 1.155 0 O-C-N 127.025 2.25 . . . . 0.0 115.58 170.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 pt -116.86 135.3 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 118.689 -2.507 . . . . 0.0 105.981 168.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -155.98 146.75 22.04 Favored 'General case' 0 C--O 1.191 -1.999 0 C-N-CA 125.083 1.353 . . . . 0.0 109.924 -168.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 96.4 m -107.25 151.0 26.04 Favored 'General case' 0 C--N 1.381 1.956 0 C-N-CA 125.819 1.648 . . . . 0.0 107.886 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.0 mt -127.02 156.84 73.66 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-N 114.233 -1.348 . . . . 0.0 107.689 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -45.06 144.85 3.56 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 N-CA-C 118.971 2.643 . . . . 0.0 118.971 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t 73.94 41.43 0.41 Allowed 'General case' 0 C--N 1.366 1.3 0 C-N-CA 128.105 2.562 . . . . 0.0 111.37 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 67.64 26.77 7.89 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 119.272 3.064 . . . . 0.0 119.272 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -90.05 135.29 33.74 Favored 'General case' 0 N--CA 1.508 2.464 0 C-N-CA 127.752 2.421 . . . . 0.0 111.466 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.07 140.42 52.29 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 113.174 -1.83 . . . . 0.0 111.825 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.49 153.94 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 -168.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -116.63 118.58 33.0 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 127.234 2.214 . . . . 0.0 106.564 170.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.1 t -101.0 107.74 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.825 0 O-C-N 118.104 -2.873 . . . . 0.0 108.141 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.68 158.55 59.32 Favored Pre-proline 0 N--CA 1.432 -1.354 0 CA-C-N 113.117 -1.856 . . . . 0.0 114.348 -176.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -42.99 -28.22 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 125.21 3.94 . . . . 0.0 115.701 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 59.3 p30 -100.65 8.28 43.46 Favored 'General case' 0 C--O 1.26 1.639 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.46 7.09 82.85 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 116.416 -2.324 . . . . 0.0 117.872 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.2 m -81.07 119.71 23.89 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 123.434 3.617 . . . . 0.0 109.658 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.2 m -92.09 91.86 7.99 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -171.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -70.34 141.51 52.26 Favored 'General case' 0 C--O 1.202 -1.399 0 O-C-N 119.72 -1.863 . . . . 0.0 114.796 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.48 108.52 3.81 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.757 -1.116 . . . . 0.0 110.827 170.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.5 tp -92.84 -8.76 42.58 Favored 'General case' 0 C--O 1.251 1.159 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -135.42 171.31 14.63 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 123.94 1.829 . . . . 0.0 108.75 166.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -67.29 -39.05 85.95 Favored 'General case' 0 CA--C 1.571 1.783 0 O-C-N 118.048 -2.907 . . . . 0.0 109.467 -170.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -58.47 -42.64 87.94 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.057 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . 0.348 . . -51.86 -44.95 63.89 Favored 'General case' 0 C--N 1.37 1.493 0 CA-C-O 125.441 2.543 . . . . 0.0 114.387 170.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -69.42 -42.36 75.11 Favored 'General case' 0 CA--C 1.579 2.091 0 O-C-N 117.281 -3.387 . . . . 0.0 110.974 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -62.08 -35.66 79.33 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 128.165 2.586 . . . . 0.0 113.524 170.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.26 -16.93 58.78 Favored 'General case' 0 CA--C 1.568 1.67 0 O-C-N 121.084 -1.01 . . . . 0.0 110.163 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.0 33.82 4.2 Favored Glycine 0 CA--C 1.487 -1.68 0 N-CA-C 117.939 1.935 . . . . 0.0 117.939 173.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -80.08 154.17 74.92 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-N 118.881 1.34 . . . . 0.0 110.308 165.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -43.58 129.71 6.94 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 124.511 3.474 . . . . 0.0 118.716 164.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.42 142.41 58.48 Favored 'Trans proline' 0 N--CA 1.428 -2.378 0 C-N-CA 123.711 2.94 . . . . 0.0 110.989 169.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.9 tt -90.84 -0.78 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 C-N-CA 125.605 1.562 . . . . 0.0 109.42 -173.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 52.5 m -41.89 -65.72 0.48 Allowed Pre-proline 0 C--N 1.38 1.906 1 CA-C-O 111.203 -4.237 . . . . 0.0 120.153 170.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -70.62 -6.61 19.43 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 125.589 3.032 . . . . 0.0 118.551 -170.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 5.2 pt -107.21 8.05 9.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 122.324 2.329 . . . . 0.0 113.208 165.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -64.73 126.29 27.47 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 123.066 2.666 . . . . 0.0 113.096 169.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.73 144.09 57.48 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.575 1.172 . . . . 0.0 110.179 171.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -80.98 154.68 26.81 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.185 -1.572 . . . . 0.0 113.497 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.485 ' HA2' HD11 ' A' ' 125' ' ' ILE . . . -84.06 -174.39 50.33 Favored Glycine 0 CA--C 1.501 -0.824 0 CA-C-O 124.331 2.073 . . . . 0.0 113.701 172.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.5 t -102.06 139.96 36.98 Favored 'General case' 0 CA--C 1.59 2.494 0 O-C-N 118.126 -2.985 . . . . 0.0 105.604 166.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.43 35.87 21.9 Favored Glycine 0 CA--C 1.502 -0.736 0 O-C-N 118.809 -2.432 . . . . 0.0 111.97 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.27 -170.12 12.61 Favored Glycine 1 CA--C 1.58 4.11 0 CA-C-N 117.885 0.843 . . . . 0.0 114.738 -165.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.61 -179.3 49.24 Favored Glycine 0 C--N 1.361 1.929 0 N-CA-C 120.407 2.923 . . . . 0.0 120.407 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -122.07 154.12 37.75 Favored 'General case' 0 N--CA 1.509 2.491 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.485 HD11 ' HA2' ' A' ' 119' ' ' GLY . 6.4 mm -79.89 117.08 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 C-N-CA 125.081 1.352 . . . . 0.0 110.292 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.8 t -58.23 135.75 57.17 Favored 'General case' 0 CA--C 1.585 2.294 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.6 mt -92.25 10.52 29.24 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 124.763 1.225 . . . . 0.0 113.726 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.14 -53.72 29.57 Favored Glycine 0 N--CA 1.488 2.118 0 CA-C-O 123.832 1.795 . . . . 0.0 114.004 170.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.73 85.7 Favored 'General case' 0 CA--C 1.546 0.816 1 O-C-N 115.255 -4.674 . . . . 0.0 113.959 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.4 tp -64.29 -42.37 96.43 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 173.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.7 tp -59.3 -45.93 89.95 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 118.964 -2.335 . . . . 0.0 111.986 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . 0.323 19.4 p -61.94 -48.49 80.17 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 126.847 2.059 . . . . 0.0 110.426 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 45.4 m -52.98 -44.5 67.22 Favored 'General case' 0 CA--C 1.579 2.069 0 C-N-CA 126.75 2.02 . . . . 0.0 112.448 169.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 37.5 m -60.19 -46.39 89.89 Favored 'General case' 0 C--O 1.194 -1.839 0 O-C-N 117.966 -2.959 . . . . 0.0 109.119 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.0 mt -68.18 -37.22 80.71 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 123.999 1.857 . . . . 0.0 111.42 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -60.61 -42.49 96.91 Favored 'General case' 0 C--O 1.267 2.005 0 O-C-N 118.613 -2.555 . . . . 0.0 116.757 169.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.0 mt -82.77 -21.05 34.76 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . 0.373 2.0 p -98.11 3.79 49.16 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 118.834 2.901 . . . . 0.0 118.834 162.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.074 0 C-N-CA 127.301 2.382 . . . . 0.0 115.541 173.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.107 -1.425 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -49.51 156.81 2.59 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 123.524 2.816 . . . . 0.0 115.539 168.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.4 t -61.42 136.21 94.19 Favored Pre-proline 0 N--CA 1.493 1.71 0 CA-C-O 115.816 -2.04 . . . . 0.0 109.257 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -72.06 33.1 0.27 Allowed 'Trans proline' 0 C--N 1.293 -2.343 0 C-N-CA 122.073 1.849 . . . . 0.0 112.26 -172.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -115.41 154.0 47.62 Favored Pre-proline 0 CA--C 1.584 2.278 0 O-C-N 118.326 -2.734 . . . . 0.0 111.882 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -45.53 151.52 1.09 Allowed 'Trans proline' 0 C--O 1.216 -0.587 1 C-N-CA 125.515 4.143 . . . . 0.0 115.475 152.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . 0.281 4.8 m 42.6 56.06 10.64 Favored Pre-proline 0 C--N 1.364 1.214 0 O-C-N 118.778 -2.451 . . . . 0.0 116.411 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.41 18.05 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 123.865 3.043 . . . . 0.0 110.711 -152.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 m 61.53 32.55 18.71 Favored 'General case' 0 N--CA 1.508 2.436 0 C-N-CA 126.324 1.85 . . . . 0.0 110.478 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.5 m 66.82 24.9 9.71 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 129.347 3.059 . . . . 0.0 112.851 -173.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 87.15 -7.24 0.65 Allowed 'General case' 0 C--O 1.247 0.971 0 C-N-CA 126.789 2.035 . . . . 0.0 109.973 170.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -64.67 140.2 58.84 Favored 'General case' 0 C--N 1.374 1.638 0 CA-C-O 116.632 -1.652 . . . . 0.0 114.601 162.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -132.28 108.64 9.35 Favored 'General case' 0 CA--C 1.466 -2.255 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -57.34 139.12 53.85 Favored 'General case' 0 C--O 1.261 1.675 0 CA-C-O 124.842 2.258 . . . . 0.0 110.419 166.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.8 tp -149.13 142.23 18.14 Favored 'Isoleucine or valine' 0 C--N 1.365 1.269 0 CA-C-O 124.37 2.033 . . . . 0.0 113.747 -167.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.1 p -140.76 177.16 8.22 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -63.39 -45.95 88.7 Favored 'General case' 0 CA--C 1.579 2.09 0 C-N-CA 126.572 1.949 . . . . 0.0 109.068 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.44 75.96 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 119.319 -2.113 . . . . 0.0 116.2 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -67.65 -42.99 81.33 Favored 'General case' 0 C--O 1.178 -2.689 0 CA-C-O 117.056 -1.449 . . . . 0.0 111.875 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.7 tp -62.11 -37.19 84.14 Favored 'General case' 0 CA--C 1.582 2.194 0 CA-C-N 121.678 2.035 . . . . 0.0 114.243 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.351 . . 82.62 30.63 0.1 Allowed 'General case' 0 C--N 1.371 1.532 0 O-C-N 119.719 -1.863 . . . . 0.0 110.589 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -155.02 159.57 40.42 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.81 125.12 14.19 Favored 'General case' 0 N--CA 1.423 -1.806 0 C-N-CA 128.563 2.745 . . . . 0.0 115.225 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -64.41 128.02 92.85 Favored Pre-proline 0 CA--C 1.586 2.331 0 O-C-N 117.029 -3.544 . . . . 0.0 110.818 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -105.76 0.46 0.2 Allowed 'Trans proline' 0 CA--C 1.481 -2.131 0 C-N-CA 123.598 2.865 . . . . 0.0 108.891 -154.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.7 mt -132.82 171.34 14.04 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 p -92.2 -0.27 57.43 Favored 'General case' 0 C--O 1.19 -2.049 0 CA-C-O 124.161 1.934 . . . . 0.0 111.245 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.0 m -93.49 161.26 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 117.045 -3.534 . . . . 0.0 110.474 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -78.9 174.3 11.65 Favored 'General case' 0 C--O 1.205 -1.267 0 O-C-N 120.33 -1.481 . . . . 0.0 113.655 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -53.01 138.84 29.53 Favored 'General case' 0 CA--C 1.61 3.267 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.74 -150.74 5.37 Favored Glycine 0 C--N 1.379 2.956 0 C-N-CA 130.392 3.853 . . . . 0.0 114.386 -166.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.7 m -128.4 145.5 51.07 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 111.762 -2.219 . . . . 0.0 106.177 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.5 pt -113.48 144.45 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.034 0 C-N-CA 129.663 3.185 . . . . 0.0 110.207 165.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -145.84 142.76 29.14 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-O 122.609 1.195 . . . . 0.0 112.093 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 69.7 m -91.45 138.36 31.63 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 170.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.0 mt -120.78 155.91 56.79 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 118.836 -2.415 . . . . 0.0 105.312 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.288 36.9 Cg_exo -39.64 135.3 1.35 Allowed 'Trans proline' 0 N--CA 1.505 2.15 1 C-N-CA 125.696 4.264 . . . . 0.0 122.21 173.046 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.452 68.3 m 78.52 48.12 0.04 OUTLIER 'General case' 0 C--N 1.378 1.842 0 O-C-N 119.553 -1.967 . . . . 0.0 112.348 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 46.5 43.29 12.02 Favored 'General case' 0 C--N 1.391 2.37 0 CA-C-N 112.983 -1.917 . . . . 0.0 113.46 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -95.45 143.8 26.49 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 126.216 1.806 . . . . 0.0 111.465 170.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.689 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -125.36 129.34 49.73 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-O 124.648 2.166 . . . . 0.0 106.142 175.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.2 m -118.22 157.73 19.5 Favored 'Isoleucine or valine' 0 C--N 1.381 1.957 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.993 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -131.26 137.29 48.8 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -125.72 118.76 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 O-C-N 120.623 -1.298 . . . . 0.0 108.033 173.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.57 162.87 1.16 Allowed Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 170.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -68.81 -13.22 36.44 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 CA-C-O 113.786 -2.673 . . . . 0.0 114.589 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -91.75 -1.93 57.18 Favored 'General case' 0 C--N 1.37 1.458 0 CA-C-N 121.084 1.765 . . . . 0.0 112.902 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.61 0.17 36.98 Favored Glycine 0 CA--C 1.49 -1.523 0 CA-C-O 114.397 -3.446 . . . . 0.0 109.843 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.8 m -81.6 119.04 23.29 Favored 'General case' 0 C--N 1.361 1.08 1 CA-C-N 124.212 4.006 . . . . 0.0 112.93 -170.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.7 m -82.06 130.59 35.12 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.015 175.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -125.36 160.81 28.44 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 126.891 2.076 . . . . 0.0 111.675 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.99 127.42 32.94 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 167.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.9 tp -94.77 -47.5 6.45 Favored 'General case' 0 C--O 1.206 -1.227 0 O-C-N 119.671 -1.893 . . . . 0.0 109.844 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -101.77 163.56 12.19 Favored 'General case' 0 C--N 1.391 2.392 0 CA-C-O 123.739 1.733 . . . . 0.0 108.834 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . 0.274 12.9 p-10 -55.29 -36.8 66.53 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 126.432 1.893 . . . . 0.0 113.758 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -61.89 -44.37 96.95 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.808 1.243 . . . . 0.0 112.064 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.95 -40.83 94.79 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.666 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -68.38 -42.02 79.72 Favored 'General case' 0 CA--C 1.557 1.218 0 O-C-N 121.774 -0.579 . . . . 0.0 111.52 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -54.9 -39.63 68.96 Favored 'General case' 0 C--N 1.369 1.422 0 O-C-N 120.224 -1.547 . . . . 0.0 112.542 167.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.01 -36.65 84.27 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 127.0 6.46 5.39 Favored Glycine 0 N--CA 1.507 3.369 0 CA-C-O 124.125 1.959 . . . . 0.0 110.464 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -80.33 133.67 56.45 Favored Pre-proline 0 CA--C 1.588 2.433 0 CA-C-O 116.67 -1.633 . . . . 0.0 110.161 170.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -70.64 150.7 63.29 Favored 'Trans proline' 0 CA--C 1.484 -2.018 0 CA-C-N 126.892 3.497 . . . . 0.0 119.182 -164.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . 0.269 74.7 Cg_exo -44.7 146.92 2.0 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 N-CA-C 117.769 2.18 . . . . 0.0 117.769 171.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.7 tt -98.99 10.15 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 C-N-CA 116.979 -1.888 . . . . 0.0 107.336 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.4 p -62.17 -35.83 23.95 Favored Pre-proline 0 C--N 1.374 1.639 1 CA-C-O 109.169 -5.205 . . . . 0.0 116.972 -174.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.16 -17.59 16.97 Favored 'Trans proline' 0 C--N 1.36 1.137 0 CA-C-N 127.141 3.586 . . . . 0.0 109.018 -165.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.6 pt -106.53 20.65 4.43 Favored 'Isoleucine or valine' 0 C--N 1.368 1.389 0 C-N-CA 125.699 1.6 . . . . 0.0 113.458 -172.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -63.59 138.36 58.47 Favored 'General case' 0 C--N 1.363 1.188 0 C-N-CA 126.645 1.978 . . . . 0.0 111.86 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -95.83 128.13 42.45 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 127.647 2.379 . . . . 0.0 116.999 168.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -78.03 149.47 34.0 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 120.257 -1.527 . . . . 0.0 114.576 166.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.95 174.6 54.34 Favored Glycine 0 C--O 1.202 -1.885 0 C-N-CA 126.438 1.97 . . . . 0.0 113.655 162.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.0 m -60.43 146.97 42.61 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 122.215 3.007 . . . . 0.0 118.584 161.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 52.53 27.87 27.45 Favored Glycine 1 C--N 1.415 4.942 0 C-N-CA 128.471 2.938 . . . . 0.0 111.665 -162.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.23 -161.61 53.84 Favored Glycine 0 CA--C 1.544 1.863 0 C-N-CA 129.892 3.615 . . . . 0.0 119.291 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.26 133.6 4.42 Favored Glycine 0 CA--C 1.549 2.195 0 CA-C-N 120.459 2.129 . . . . 0.0 109.873 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -79.18 151.69 31.12 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 124.842 2.258 . . . . 0.0 107.916 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 22.4 mm -91.17 144.27 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 126.717 2.007 . . . . 0.0 111.529 173.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.4 t -71.71 147.31 47.52 Favored 'General case' 0 C--O 1.195 -1.796 0 N-CA-C 119.868 3.285 . . . . 0.0 119.868 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.5 mt -97.78 20.92 11.21 Favored 'General case' 0 C--O 1.204 -1.338 0 C-N-CA 126.231 1.812 . . . . 0.0 112.317 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -88.71 -41.3 6.05 Favored Glycine 0 CA--C 1.496 -1.121 0 N-CA-C 118.207 2.043 . . . . 0.0 118.207 -169.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.47 98.55 Favored 'General case' 0 N--CA 1.431 -1.375 0 O-C-N 127.045 2.262 . . . . 0.0 110.199 170.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.8 tp -66.69 -44.12 82.58 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-O 122.563 1.173 . . . . 0.0 111.702 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.3 tp -62.68 -53.16 58.73 Favored 'General case' 0 C--N 1.364 1.23 0 O-C-N 120.329 -1.482 . . . . 0.0 110.465 175.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.2 p -57.66 -44.76 85.94 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.66 0.743 . . . . 0.0 111.088 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 83.0 m -62.31 -42.35 99.3 Favored 'General case' 0 C--O 1.264 1.822 0 C-N-CA 125.611 1.564 . . . . 0.0 110.982 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 26.2 m -60.22 -36.88 78.69 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 173.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.689 HD21 ' HB2' ' A' ' 88' ' ' ALA . 23.7 mt -89.59 -16.78 29.82 Favored 'General case' 0 C--N 1.376 1.722 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 176.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -63.41 -38.57 91.65 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 117.12 -1.419 . . . . 0.0 111.375 158.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.4 mt -63.47 -43.0 98.59 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-O 125.227 2.441 . . . . 0.0 110.507 -171.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 21.6 p -100.61 25.66 7.57 Favored 'General case' 0 C--N 1.376 1.74 0 CA-C-N 112.779 -2.009 . . . . 0.0 112.414 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.158 0 C-N-CA 128.368 2.889 . . . . 0.0 114.863 175.626 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 p . . . . . 0 N--CA 1.439 -0.979 0 CA-C-O 117.504 -1.236 . . . . 0.0 108.305 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -47.9 157.4 1.07 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 123.452 2.768 . . . . 0.0 114.425 169.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.06 136.03 96.49 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.731 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -70.94 35.96 0.27 Allowed 'Trans proline' 0 N--CA 1.517 2.879 0 C-N-CA 121.302 1.334 . . . . 0.0 113.34 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.9 mt -118.54 153.21 51.96 Favored Pre-proline 0 CA--C 1.572 1.814 0 O-C-N 119.619 -1.925 . . . . 0.0 107.968 172.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.67 154.68 4.41 Favored 'Trans proline' 0 N--CA 1.519 3.015 0 C-N-CA 123.23 2.62 . . . . 0.0 114.295 153.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . 0.256 7.1 m 40.97 58.87 8.45 Favored Pre-proline 0 C--N 1.362 1.145 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 174.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.62 20.13 0.62 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.446 1.431 . . . . 0.0 112.271 -156.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 m 60.08 32.73 21.11 Favored 'General case' 0 N--CA 1.516 2.856 0 C-N-CA 125.294 1.438 . . . . 0.0 110.717 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 m 68.0 25.68 7.54 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 127.051 2.14 . . . . 0.0 113.386 -174.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 83.41 -5.15 1.2 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.241 1.417 . . . . 0.0 111.605 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -70.62 142.67 51.64 Favored 'General case' 0 C--N 1.36 1.056 0 O-C-N 124.372 1.045 . . . . 0.0 110.747 166.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -132.05 110.15 10.51 Favored 'General case' 0 C--N 1.366 1.323 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.365 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -59.23 137.34 58.01 Favored 'General case' 0 C--O 1.252 1.226 0 O-C-N 126.416 2.323 . . . . 0.0 111.334 164.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.5 tp -145.8 142.33 21.83 Favored 'Isoleucine or valine' 0 C--O 1.264 1.86 0 CA-C-N 112.791 -2.004 . . . . 0.0 113.036 -167.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.9 p -139.36 177.91 7.58 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -63.78 -44.56 93.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 124.704 1.252 . . . . 0.0 110.579 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.92 79.71 Favored 'General case' 0 C--O 1.247 0.946 0 O-C-N 120.228 -1.545 . . . . 0.0 112.972 173.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -67.19 -42.97 83.31 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-O 117.415 -1.278 . . . . 0.0 111.901 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.1 tp -61.94 -36.19 80.64 Favored 'General case' 0 CA--C 1.587 2.392 0 CA-C-N 121.002 1.728 . . . . 0.0 113.293 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.287 . . 79.38 32.66 0.24 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.038 1.335 . . . . 0.0 111.99 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -155.85 158.2 37.66 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.4 mt -50.92 127.39 18.55 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 124.116 1.912 . . . . 0.0 115.461 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -63.82 124.42 84.89 Favored Pre-proline 0 CA--C 1.573 1.86 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.262 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -100.11 1.98 0.82 Allowed 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 122.02 1.813 . . . . 0.0 113.285 -160.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.5 mt -131.15 168.01 18.18 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.2 p -90.01 1.62 56.09 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 122.381 1.086 . . . . 0.0 113.781 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.5 m -92.53 160.54 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 119.976 -1.703 . . . . 0.0 111.654 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -77.39 174.37 10.9 Favored 'General case' 0 CA--C 1.567 1.63 0 O-C-N 119.221 -2.174 . . . . 0.0 111.827 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -53.91 140.35 31.03 Favored 'General case' 0 CA--C 1.601 2.941 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 -177.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.2 -150.09 5.28 Favored Glycine 0 C--N 1.369 2.409 0 C-N-CA 127.53 2.491 . . . . 0.0 114.909 -166.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.1 m -127.88 146.5 50.6 Favored 'General case' 0 C--N 1.371 1.506 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.2 pt -115.49 145.89 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 126.925 2.09 . . . . 0.0 110.081 166.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -147.22 141.63 26.39 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 122.94 1.353 . . . . 0.0 111.426 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 61.8 m -89.27 138.15 31.69 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 169.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.0 mt -120.13 155.41 55.74 Favored Pre-proline 0 N--CA 1.482 1.17 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 172.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.268 31.9 Cg_exo -40.55 134.93 2.11 Favored 'Trans proline' 0 N--CA 1.529 3.583 0 N-CA-C 122.133 3.859 . . . . 0.0 122.133 173.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.383 50.4 m 79.53 50.22 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.075 1.35 . . . . 0.0 110.311 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 45.94 44.64 11.48 Favored 'General case' 0 C--O 1.203 -1.383 0 O-C-N 126.803 2.564 . . . . 0.0 111.954 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.89 145.71 25.63 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 118.644 0.656 . . . . 0.0 110.438 170.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.662 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -124.65 129.9 51.42 Favored 'General case' 0 C--O 1.273 2.312 0 CA-C-O 123.22 1.486 . . . . 0.0 107.481 174.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.19 157.24 21.13 Favored 'Isoleucine or valine' 0 C--N 1.362 1.114 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.157 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -130.36 137.78 50.07 Favored 'General case' 0 C--O 1.254 1.321 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 t -126.35 119.32 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.1 164.53 2.36 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 171.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.79 -11.78 29.99 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 CA-C-O 114.481 -2.383 . . . . 0.0 114.466 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -91.03 -1.43 57.81 Favored 'General case' 0 C--N 1.371 1.529 0 CA-C-N 121.132 1.787 . . . . 0.0 113.544 173.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.81 -0.85 41.83 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-O 116.748 -2.14 . . . . 0.0 113.207 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.5 m -80.01 120.24 23.92 Favored 'General case' 0 C--N 1.38 1.899 0 CA-C-N 120.979 2.39 . . . . 0.0 113.374 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.7 m -83.52 130.54 35.01 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.05 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -124.56 162.18 24.6 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.678 1.591 . . . . 0.0 111.209 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.53 130.2 35.17 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.42 -46.79 6.55 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 116.45 -1.738 . . . . 0.0 108.83 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -105.28 164.33 11.92 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-O 123.398 1.57 . . . . 0.0 108.898 174.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -56.29 -37.41 69.82 Favored 'General case' 0 N--CA 1.511 2.588 0 CA-C-N 113.448 -1.705 . . . . 0.0 112.469 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.6 mtp85 -60.53 -44.59 95.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 124.784 1.303 . . . . 0.0 111.327 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.36 -37.18 84.68 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.78 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -71.2 -42.07 69.46 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 117.767 -1.111 . . . . 0.0 110.084 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -56.57 -35.5 68.24 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 168.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.71 76.23 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 116.223 -1.846 . . . . 0.0 114.124 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.54 6.27 6.76 Favored Glycine 1 N--CA 1.518 4.165 0 CA-C-N 121.162 1.801 . . . . 0.0 111.839 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -80.27 131.45 62.26 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-O 118.054 -0.974 . . . . 0.0 108.642 170.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -65.37 149.28 88.36 Favored 'Trans proline' 1 N--CA 1.546 4.565 0 N-CA-C 119.478 2.838 . . . . 0.0 119.478 -168.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.41 145.74 5.68 Favored 'Trans proline' 0 N--CA 1.519 2.979 0 C-N-CA 117.243 -1.371 . . . . 0.0 114.905 172.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.4 tt -97.46 11.25 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 117.811 -1.555 . . . . 0.0 109.499 175.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 17.2 p -63.96 -35.63 16.64 Favored Pre-proline 0 N--CA 1.399 -2.993 1 CA-C-O 110.185 -4.721 . . . . 0.0 117.667 -174.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.9 -19.68 23.18 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 CA-C-N 124.744 2.73 . . . . 0.0 111.294 -168.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.2 pt -105.56 22.52 3.07 Favored 'Isoleucine or valine' 0 C--N 1.372 1.583 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -61.67 139.3 58.31 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 125.895 1.997 . . . . 0.0 112.978 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . 0.251 . . -97.46 130.13 44.59 Favored 'General case' 0 C--N 1.376 1.731 0 C-N-CA 125.976 1.71 . . . . 0.0 115.138 170.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -82.02 151.37 27.14 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.936 167.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.36 176.08 54.41 Favored Glycine 0 CA--C 1.544 1.887 0 O-C-N 126.99 2.681 . . . . 0.0 113.683 164.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.9 m -63.62 146.66 53.33 Favored 'General case' 0 CA--C 1.597 2.762 0 CA-C-N 120.966 2.383 . . . . 0.0 116.395 164.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 57.2 24.43 51.24 Favored Glycine 1 C--N 1.402 4.212 0 O-C-N 125.735 1.897 . . . . 0.0 111.814 -164.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.81 -163.2 50.97 Favored Glycine 0 CA--C 1.553 2.441 0 C-N-CA 126.951 2.215 . . . . 0.0 117.288 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.52 132.79 3.78 Favored Glycine 0 C--N 1.377 2.86 0 CA-C-N 118.313 1.056 . . . . 0.0 111.358 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -79.42 150.67 31.24 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 122.533 1.159 . . . . 0.0 109.631 -174.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 20.3 mm -90.3 147.52 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.974 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.5 t -74.93 147.74 40.67 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 174.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.0 mt -97.01 21.51 9.66 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 112.807 -1.997 . . . . 0.0 111.741 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.9 -46.66 5.31 Favored Glycine 0 C--O 1.219 -0.784 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 -168.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.48 -43.24 93.32 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 127.514 2.538 . . . . 0.0 109.056 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.2 tp -67.33 -43.92 80.42 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.713 0.805 . . . . 0.0 111.08 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.3 tp -62.03 -54.35 42.81 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.154 0.582 . . . . 0.0 110.589 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.1 p -56.78 -44.28 81.7 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 124.066 0.854 . . . . 0.0 110.823 -175.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.9 m -62.98 -40.26 97.19 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.252 1.021 . . . . 0.0 110.547 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.4 m -62.94 -36.52 83.72 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 115.355 -2.259 . . . . 0.0 114.642 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 88' ' ' ALA . 37.1 mt -89.01 -18.65 26.92 Favored 'General case' 0 C--N 1.387 2.208 0 CA-C-N 121.401 1.91 . . . . 0.0 114.31 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -61.69 -40.79 96.23 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 121.411 -0.806 . . . . 0.0 111.215 160.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.0 mt -61.79 -42.98 99.69 Favored 'General case' 0 C--N 1.381 1.938 0 O-C-N 125.458 1.723 . . . . 0.0 110.074 -173.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.0 p -101.95 27.84 6.22 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.807 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.199 -2.051 0 C-N-CA 125.9 1.715 . . . . 0.0 115.343 175.676 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.564 1.486 0 CA-C-O 114.84 -2.505 . . . . 0.0 114.839 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -40.87 137.58 1.78 Allowed 'Trans proline' 0 N--CA 1.511 2.522 0 C-N-CA 125.167 3.911 . . . . 0.0 116.456 165.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.6 t -118.93 110.26 38.49 Favored Pre-proline 0 CA--C 1.599 2.853 0 O-C-N 125.236 1.585 . . . . 0.0 110.437 -169.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -49.86 134.76 35.41 Favored 'Trans proline' 0 N--CA 1.526 3.405 1 C-N-CA 126.968 5.112 . . . . 0.0 117.197 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.5 mt -51.8 146.11 14.87 Favored Pre-proline 0 C--N 1.363 1.189 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -82.86 66.32 7.97 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 O-C-N 118.879 -1.169 . . . . 0.0 111.425 167.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.6 t -154.66 140.76 12.81 Favored Pre-proline 0 N--CA 1.498 1.93 0 CA-C-O 113.939 -2.934 . . . . 0.0 105.05 170.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -40.25 124.21 1.58 Allowed 'Trans proline' 0 N--CA 1.495 1.569 1 C-N-CA 126.46 4.774 . . . . 0.0 118.71 -170.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 m 50.66 45.23 27.17 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 123.457 1.599 . . . . 0.0 107.981 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.263 46.6 m 61.79 54.08 3.0 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 127.466 3.508 . . . . 0.0 116.522 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.383 39.6 t30 68.25 33.37 4.34 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-N 110.667 -2.97 . . . . 0.0 111.478 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . 0.368 0.0 OUTLIER 69.75 112.62 0.05 OUTLIER 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 116.799 2.148 . . . . 0.0 116.799 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -77.64 155.04 31.65 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.756 0.822 . . . . 0.0 111.0 173.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -87.37 145.47 26.3 Favored 'General case' 0 C--O 1.264 1.831 0 O-C-N 128.698 3.749 . . . . 0.0 111.519 171.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 tp -115.56 144.43 23.17 Favored 'Isoleucine or valine' 0 C--N 1.364 1.219 0 CA-C-N 112.335 -2.211 . . . . 0.0 108.701 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.501 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 38.5 p -132.08 163.05 29.32 Favored 'General case' 0 C--O 1.198 -1.623 0 C-N-CA 126.206 1.803 . . . . 0.0 114.082 -174.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 29.5 mt-10 -62.05 -45.97 91.2 Favored 'General case' 0 C--O 1.202 -1.416 0 C-N-CA 127.536 2.334 . . . . 0.0 108.951 168.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.81 -24.62 61.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 119.346 -2.096 . . . . 0.0 116.161 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -62.55 -46.38 88.63 Favored 'General case' 0 CA--C 1.593 2.623 0 CA-C-O 122.132 0.968 . . . . 0.0 111.418 172.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 mt -71.04 -38.0 72.54 Favored 'General case' 0 C--O 1.211 -0.925 0 C-N-CA 129.275 3.03 . . . . 0.0 114.066 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.36 . . 67.14 -22.29 0.11 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 119.351 3.093 . . . . 0.0 119.351 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . 0.303 84.9 t80 -77.12 167.2 22.19 Favored 'General case' 0 C--O 1.254 1.304 0 CA-C-O 122.615 1.198 . . . . 0.0 112.791 161.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.8 tp -48.09 118.61 2.46 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.097 1.759 . . . . 0.0 115.509 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -61.48 122.04 67.94 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 119.299 -2.125 . . . . 0.0 111.011 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -95.5 26.39 0.29 Allowed 'Trans proline' 0 CA--C 1.552 1.393 0 C-N-CA 122.869 2.379 . . . . 0.0 114.301 -169.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.2 mt -136.9 153.41 50.74 Favored 'General case' 0 C--N 1.39 2.347 0 CA-C-N 120.057 1.299 . . . . 0.0 109.463 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.4 p -73.11 -22.62 60.52 Favored 'General case' 0 C--N 1.364 1.203 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.5 m -83.92 160.55 3.42 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 1 O-C-N 129.435 4.209 . . . . 0.0 108.236 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -91.5 114.62 27.19 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 115.481 -2.199 . . . . 0.0 109.993 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.501 ' CD2' ' HA ' ' A' ' 63' ' ' SER . 61.3 m170 52.85 -167.88 0.05 Allowed 'General case' 0 C--N 1.36 1.025 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.59 -167.45 40.33 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.757 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.1 m -121.45 149.04 43.62 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 103.166 -2.902 . . . . 0.0 103.166 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 pt -121.36 151.65 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.311 0 C-N-CA 124.747 1.219 . . . . 0.0 110.474 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -145.12 139.81 27.57 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 3.8 m -99.25 123.97 43.96 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 83' ' ' LEU . 90.0 mt -96.49 151.35 37.96 Favored Pre-proline 0 N--CA 1.508 2.45 0 CA-C-O 114.265 -2.778 . . . . 0.0 112.58 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -57.59 150.0 63.72 Favored 'Trans proline' 0 N--CA 1.508 2.348 0 CA-C-N 124.654 2.698 . . . . 0.0 117.952 -173.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.9 m 59.46 54.27 4.73 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -168.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 57.11 48.65 15.04 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 170.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -117.03 159.41 22.57 Favored 'General case' 0 C--N 1.369 1.422 0 CA-C-O 117.995 -1.003 . . . . 0.0 111.761 169.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.95 148.04 43.01 Favored 'General case' 0 C--N 1.384 2.089 0 O-C-N 125.53 1.769 . . . . 0.0 112.451 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 99' ' ' ALA . 24.8 m -138.31 170.92 16.12 Favored 'Isoleucine or valine' 0 C--N 1.396 2.61 0 O-C-N 127.068 2.73 . . . . 0.0 113.64 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -140.67 124.5 17.18 Favored 'General case' 0 C--O 1.265 1.87 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -172.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.1 t -102.69 107.76 22.67 Favored 'Isoleucine or valine' 0 C--N 1.359 0.995 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . 0.332 . . -60.18 150.61 70.61 Favored Pre-proline 0 N--CA 1.515 2.818 0 N-CA-C 119.979 3.325 . . . . 0.0 119.979 174.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -46.3 -23.75 2.19 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 N-CA-C 119.952 3.02 . . . . 0.0 119.952 177.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -86.55 -15.26 40.49 Favored 'General case' 0 C--N 1.375 1.716 0 CA-C-O 124.166 1.936 . . . . 0.0 115.589 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 114.15 -3.66 23.88 Favored Glycine 0 N--CA 1.483 1.829 0 C-N-CA 130.304 3.811 . . . . 0.0 116.387 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.323 8.3 m -68.94 114.27 7.09 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 46.6 m -90.16 108.7 19.9 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 124.736 1.272 . . . . 0.0 112.873 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -100.87 142.84 31.77 Favored 'General case' 0 N--CA 1.434 -1.259 0 O-C-N 126.166 2.166 . . . . 0.0 111.259 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.402 ' HA ' HG12 ' A' ' 89' ' ' VAL . . . -67.28 128.34 36.05 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-N 113.46 -1.7 . . . . 0.0 112.861 169.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.1 tp -108.57 1.34 21.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.355 -1.466 . . . . 0.0 108.672 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . 0.34 52.9 p-10 -148.86 159.53 44.08 Favored 'General case' 0 C--N 1.368 1.391 0 O-C-N 120.762 -1.211 . . . . 0.0 111.681 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -58.63 -43.45 89.71 Favored 'General case' 0 C--N 1.363 1.191 0 CA-C-N 112.814 -1.994 . . . . 0.0 113.528 -169.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -66.71 -34.65 78.32 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 121.16 -0.962 . . . . 0.0 111.648 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . 0.371 . . -61.43 -40.52 94.73 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 174.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -62.02 -41.83 98.51 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 115.363 -2.256 . . . . 0.0 108.702 169.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.303 42.5 mmtm -63.24 -42.88 99.27 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.84 2.533 . . . . 0.0 117.84 175.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.95 -34.29 65.54 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 115.497 -2.192 . . . . 0.0 111.396 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 130.57 -1.72 5.64 Favored Glycine 0 C--N 1.366 2.234 0 CA-C-N 121.362 1.892 . . . . 0.0 115.474 173.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -71.25 148.1 93.58 Favored Pre-proline 0 C--N 1.369 1.443 0 CA-C-O 116.818 -1.563 . . . . 0.0 111.706 171.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.09 139.01 23.55 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-O 114.381 -2.425 . . . . 0.0 111.702 -171.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -54.01 142.37 65.28 Favored 'Trans proline' 0 CA--C 1.482 -2.109 0 N-CA-C 119.88 2.992 . . . . 0.0 119.88 168.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.3 tt -89.89 15.56 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.948 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.8 p -64.3 -43.37 72.53 Favored Pre-proline 0 C--N 1.378 1.82 0 CA-C-O 113.127 -3.321 . . . . 0.0 117.077 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -74.35 -1.65 11.28 Favored 'Trans proline' 0 N--CA 1.5 1.863 1 CA-C-N 129.798 4.535 . . . . 0.0 117.408 174.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 27.4 mm -91.2 -0.79 9.65 Favored 'Isoleucine or valine' 0 C--N 1.367 1.349 0 C-N-CA 127.567 2.347 . . . . 0.0 113.595 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -61.92 140.36 58.31 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 119.191 -2.193 . . . . 0.0 116.902 166.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -81.22 128.95 34.34 Favored 'General case' 0 C--O 1.199 -1.599 0 CA-C-O 123.108 1.432 . . . . 0.0 113.62 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -55.92 145.32 25.35 Favored 'General case' 0 N--CA 1.535 3.79 1 N-CA-C 122.609 4.3 . . . . 0.0 122.609 175.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.15 173.8 42.01 Favored Glycine 0 C--N 1.356 1.668 0 CA-C-N 113.287 -1.779 . . . . 0.0 112.381 156.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.6 t -93.73 127.6 39.53 Favored 'General case' 0 C--N 1.386 2.186 0 O-C-N 126.568 1.981 . . . . 0.0 109.916 167.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 67.59 39.37 90.77 Favored Glycine 0 N--CA 1.51 3.612 0 C-N-CA 118.404 -1.855 . . . . 0.0 115.983 -169.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 105.85 -168.9 15.43 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 164.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.33 -170.09 50.76 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-O 123.882 1.823 . . . . 0.0 112.208 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -149.74 149.67 30.91 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.9 mt -66.36 137.16 25.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 O-C-N 119.197 -2.189 . . . . 0.0 109.57 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.3 t -50.56 129.49 22.44 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 58.7 mt -98.93 6.86 46.53 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.501 -1.375 . . . . 0.0 111.594 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.12 -60.15 9.41 Favored Glycine 0 C--N 1.377 2.833 0 C-N-CA 128.563 2.983 . . . . 0.0 114.9 -170.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . 0.354 . . -65.29 -32.21 73.74 Favored 'General case' 0 CA--C 1.6 2.891 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 10.3 tp -55.66 -48.38 75.11 Favored 'General case' 0 C--N 1.383 2.051 0 CA-C-N 120.6 1.545 . . . . 0.0 112.14 163.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 20.2 tp -65.28 -42.53 93.06 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . 0.29 17.7 p -69.07 -40.37 78.52 Favored 'General case' 0 C--N 1.371 1.513 0 CA-C-O 115.79 -2.052 . . . . 0.0 112.758 170.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 90.2 m -64.08 -31.07 72.12 Favored 'General case' 0 C--N 1.36 1.033 0 CA-C-N 122.928 2.604 . . . . 0.0 110.138 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.5 m -64.89 -48.92 72.51 Favored 'General case' 0 C--N 1.389 2.312 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.1 mt -69.29 -43.11 74.49 Favored 'General case' 0 CA--C 1.495 -1.161 0 O-C-N 126.843 2.589 . . . . 0.0 112.883 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.08 -33.94 69.61 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 127.016 2.697 . . . . 0.0 114.885 173.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . 0.291 40.0 tp -69.19 -28.96 66.85 Favored 'General case' 0 N--CA 1.421 -1.892 0 O-C-N 126.338 2.274 . . . . 0.0 110.879 -176.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.6 p -108.01 12.96 26.51 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 174.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.584 0 C-N-CA 128.114 2.769 . . . . 0.0 118.581 -176.312 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.197 -1.709 0 CA-C-O 113.828 -2.987 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -47.31 152.57 2.21 Favored 'Trans proline' 0 N--CA 1.495 1.564 1 C-N-CA 126.889 5.059 . . . . 0.0 114.275 -167.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 t -59.28 116.78 17.4 Favored Pre-proline 0 C--O 1.213 -0.832 0 O-C-N 126.593 2.433 . . . . 0.0 113.005 173.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -98.44 54.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 123.175 2.583 . . . . 0.0 107.734 -168.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.274 24.3 mt -144.79 147.81 36.92 Favored Pre-proline 0 N--CA 1.477 0.907 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 -165.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -59.94 156.54 38.24 Favored 'Trans proline' 0 N--CA 1.508 2.362 0 CA-C-N 122.83 2.046 . . . . 0.0 110.778 169.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.2 m 54.51 67.03 3.63 Favored Pre-proline 0 N--CA 1.517 2.924 0 CA-C-O 114.847 -2.501 . . . . 0.0 116.718 -173.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -85.96 -25.88 1.34 Allowed 'Trans proline' 0 CA--C 1.483 -2.04 0 CA-C-N 127.467 3.703 . . . . 0.0 116.681 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.379 0.7 OUTLIER 63.78 41.5 6.85 Favored 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 125.845 1.658 . . . . 0.0 114.094 169.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.9 m 64.5 33.56 10.88 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 112.322 -2.217 . . . . 0.0 109.956 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.312 92.2 m-20 83.01 46.08 0.02 OUTLIER 'General case' 0 C--N 1.352 0.683 0 C-N-CA 127.669 2.387 . . . . 0.0 112.684 174.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -128.24 120.23 26.77 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 118.305 -2.747 . . . . 0.0 107.216 -174.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -123.38 112.55 17.7 Favored 'General case' 0 C--O 1.193 -1.884 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.436 -159.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -64.86 140.56 58.88 Favored 'General case' 0 C--N 1.368 1.371 0 C-N-CA 128.09 2.556 . . . . 0.0 111.688 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.5 tp -142.13 142.59 27.52 Favored 'Isoleucine or valine' 0 C--O 1.263 1.781 0 O-C-N 117.78 -3.075 . . . . 0.0 110.702 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.3 p -145.78 172.23 13.62 Favored 'General case' 0 C--N 1.39 2.34 0 CA-C-N 112.308 -2.224 . . . . 0.0 112.711 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.68 -46.33 82.9 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 117.516 -1.231 . . . . 0.0 109.006 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.73 -34.96 67.43 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 120.714 1.597 . . . . 0.0 107.67 -174.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -66.12 -40.05 90.38 Favored 'General case' 0 C--N 1.369 1.456 0 O-C-N 120.241 -1.537 . . . . 0.0 113.511 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.2 tp -67.97 -44.91 75.6 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 124.112 0.965 . . . . 0.0 113.556 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 88.61 21.09 0.04 OUTLIER 'General case' 0 C--N 1.356 0.89 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 171.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -151.26 173.6 14.27 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 101.124 -3.658 . . . . 0.0 101.124 -166.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.1 mt -73.69 144.67 45.71 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 118.069 -2.894 . . . . 0.0 114.089 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.448 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 66.0 t-105 -92.18 127.97 47.06 Favored Pre-proline 0 C--O 1.208 -1.109 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.705 -170.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 71' ' ' TRP . 88.0 Cg_endo -93.7 6.36 2.76 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 CA-C-O 115.206 -2.081 . . . . 0.0 110.919 -157.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.5 mt -124.7 158.17 33.87 Favored 'General case' 0 C--N 1.361 1.077 0 CA-C-N 122.638 2.472 . . . . 0.0 108.654 -169.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.2 p -62.38 -48.27 80.48 Favored 'General case' 0 N--CA 1.507 2.401 0 C-N-CA 124.118 0.967 . . . . 0.0 113.156 163.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.1 m -65.6 149.17 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 125.14 2.4 . . . . 0.0 113.022 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.37 176.59 4.51 Favored 'General case' 0 CA--C 1.561 1.369 0 O-C-N 120.275 -1.515 . . . . 0.0 109.084 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -25.16 137.32 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 153.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.33 -118.77 0.95 Allowed Glycine 0 C--N 1.373 2.608 0 CA-C-O 123.962 1.868 . . . . 0.0 112.636 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 m -156.54 154.11 29.77 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 pt -133.35 129.22 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-O 124.447 2.07 . . . . 0.0 107.579 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -130.38 154.43 47.7 Favored 'General case' 0 C--N 1.359 0.984 0 CA-C-N 112.157 -2.292 . . . . 0.0 111.848 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 96.9 m -122.15 134.3 54.74 Favored 'General case' 0 C--O 1.189 -2.116 0 O-C-N 119.959 -1.713 . . . . 0.0 108.275 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.79 153.67 81.68 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-N 122.977 2.626 . . . . 0.0 107.431 -171.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -43.28 150.13 0.44 Allowed 'Trans proline' 0 CA--C 1.509 -0.726 0 C-N-CA 122.09 1.86 . . . . 0.0 114.799 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.338 37.8 m 82.1 33.28 0.09 Allowed 'General case' 0 C--N 1.361 1.106 0 O-C-N 127.529 3.018 . . . . 0.0 116.216 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 49.05 40.95 18.42 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 130.735 3.614 . . . . 0.0 115.037 -167.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -94.75 133.92 37.92 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 123.3 1.524 . . . . 0.0 109.27 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.31 141.25 52.18 Favored 'General case' 0 C--O 1.192 -1.935 0 O-C-N 119.647 -1.908 . . . . 0.0 109.528 171.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.25 153.31 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.382 0 C-N-CA 126.654 1.982 . . . . 0.0 112.232 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -111.74 121.75 45.93 Favored 'General case' 0 CA--C 1.562 1.432 1 C-N-CA 132.282 4.233 . . . . 0.0 106.802 170.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.32 108.49 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 118.697 -2.502 . . . . 0.0 108.321 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.44 154.05 93.75 Favored Pre-proline 0 N--CA 1.434 -1.273 0 C-N-CA 127.245 2.218 . . . . 0.0 115.937 169.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -74.91 12.46 1.19 Allowed 'Trans proline' 0 N--CA 1.515 2.785 0 N-CA-C 116.051 1.52 . . . . 0.0 116.051 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -100.99 1.13 39.34 Favored 'General case' 0 C--N 1.361 1.107 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.528 158.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.33 11.62 60.83 Favored Glycine 0 CA--C 1.465 -3.072 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 m -76.04 117.47 17.79 Favored 'General case' 0 N--CA 1.435 -1.225 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.641 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . 0.263 53.9 m -93.34 80.68 4.41 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 -171.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -70.59 153.64 42.67 Favored 'General case' 0 C--O 1.254 1.318 0 O-C-N 121.1 -1.0 . . . . 0.0 112.882 -173.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.27 114.7 7.77 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 167.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.2 tp -92.33 -25.59 18.48 Favored 'General case' 0 CA--C 1.558 1.267 0 CA-C-O 121.698 0.761 . . . . 0.0 112.997 173.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -120.99 173.84 7.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 119.164 -2.21 . . . . 0.0 110.093 163.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -60.43 -30.99 69.99 Favored 'General case' 0 CA--C 1.576 1.946 0 C-N-CA 130.436 3.494 . . . . 0.0 116.581 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -67.65 -54.08 22.51 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.444 172.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.83 -35.12 74.08 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -61.88 -45.51 93.44 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 122.385 1.088 . . . . 0.0 112.153 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -68.29 -28.12 66.91 Favored 'General case' 0 C--O 1.259 1.554 0 CA-C-O 124.368 2.032 . . . . 0.0 115.859 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.62 -21.13 61.88 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 116.662 2.097 . . . . 0.0 116.662 168.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.69 15.07 11.46 Favored Glycine 0 CA--C 1.463 -3.202 0 CA-C-O 114.915 -3.159 . . . . 0.0 114.396 -174.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -87.31 150.39 49.14 Favored Pre-proline 0 N--CA 1.429 -1.498 0 C-N-CA 114.079 -3.049 . . . . 0.0 110.461 164.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -57.23 142.16 94.6 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 CA-C-O 116.668 -1.472 . . . . 0.0 115.668 -172.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -68.06 139.35 46.49 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 CA-C-O 125.316 2.132 . . . . 0.0 116.532 169.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.4 tt -90.05 10.64 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 O-C-N 118.584 -2.573 . . . . 0.0 107.116 -171.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.27 -52.23 70.8 Favored Pre-proline 0 C--N 1.369 1.45 0 O-C-N 119.791 -1.818 . . . . 0.0 114.093 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.94 -7.34 20.89 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 CA-C-N 121.539 1.585 . . . . 0.0 113.204 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.6 pt -103.79 9.03 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.198 0.908 . . . . 0.0 111.174 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -69.82 137.03 51.46 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.996 0.903 . . . . 0.0 112.794 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -94.31 129.37 41.0 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 122.979 1.371 . . . . 0.0 112.171 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -89.59 140.78 29.21 Favored 'General case' 0 C--O 1.253 1.241 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.49 -168.89 7.75 Favored Glycine 0 C--N 1.383 3.171 0 N-CA-C 118.475 2.15 . . . . 0.0 118.475 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 m -96.97 123.35 40.67 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 124.626 0.839 . . . . 0.0 112.817 164.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 62.68 50.29 65.5 Favored Glycine 0 CA--C 1.496 -1.153 0 C-N-CA 126.362 1.934 . . . . 0.0 113.876 -168.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.89 -175.91 51.91 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 125.865 1.698 . . . . 0.0 113.093 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.7 174.16 44.11 Favored Glycine 0 CA--C 1.539 1.538 0 O-C-N 127.33 2.429 . . . . 0.0 111.977 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -126.75 143.42 51.25 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 -172.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 37.3 mm -74.17 140.55 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 O-C-N 120.077 -1.639 . . . . 0.0 111.657 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 30.9 t -62.01 127.62 32.27 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 -169.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.6 mt -72.62 -17.52 61.67 Favored 'General case' 0 C--N 1.378 1.828 0 O-C-N 118.052 -2.905 . . . . 0.0 111.806 169.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -41.52 -53.85 4.18 Favored Glycine 0 C--N 1.343 0.964 0 C-N-CA 127.548 2.499 . . . . 0.0 117.688 -166.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.37 89.82 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 120.263 -1.728 . . . . 0.0 115.007 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 48.9 tp -64.7 -48.25 75.38 Favored 'General case' 0 C--O 1.206 -1.204 0 O-C-N 118.471 -2.643 . . . . 0.0 112.48 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.0 tp -64.51 -52.15 59.31 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 121.437 -0.789 . . . . 0.0 109.032 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.4 p -60.13 -41.99 93.85 Favored 'General case' 0 N--CA 1.509 2.516 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.7 m -55.75 -42.66 75.73 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 126.419 1.888 . . . . 0.0 110.036 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 78.4 m -60.12 -43.53 95.58 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 127.961 3.288 . . . . 0.0 108.655 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 12.1 mt -66.19 -36.7 83.76 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -57.91 -42.32 84.48 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 119.347 -2.096 . . . . 0.0 112.495 172.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.2 mt -62.96 -42.61 99.87 Favored 'General case' 0 C--O 1.193 -1.914 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.738 -172.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 28.4 p -113.94 27.37 9.57 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 115.332 -2.271 . . . . 0.0 110.625 -165.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.37 2.444 0 CA-C-N 123.714 2.961 . . . . 0.0 115.019 -178.762 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 CA--C 1.604 3.048 0 CA-C-O 115.679 -2.105 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.61 160.73 34.83 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 CA-C-N 125.381 2.957 . . . . 0.0 109.241 162.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 53.7 t -63.44 136.62 96.79 Favored Pre-proline 0 C--N 1.374 1.643 0 CA-C-O 117.148 -1.406 . . . . 0.0 108.277 174.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 88.2 Cg_exo -70.68 -32.87 14.0 Favored 'Trans proline' 0 N--CA 1.507 2.27 0 CA-C-O 124.467 1.778 . . . . 0.0 115.358 -162.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.6 mt -117.95 135.03 23.26 Favored Pre-proline 0 C--O 1.264 1.818 0 O-C-N 118.53 -2.607 . . . . 0.0 107.944 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -86.3 77.64 2.31 Favored 'Trans proline' 0 C--N 1.297 -2.163 0 N-CA-C 105.278 -2.624 . . . . 0.0 105.278 172.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.1 t -56.93 131.35 79.5 Favored Pre-proline 0 CA--C 1.584 2.273 0 C-N-CA 126.464 1.906 . . . . 0.0 112.155 -169.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -42.68 120.95 1.96 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 125.064 3.843 . . . . 0.0 115.799 -170.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.279 13.0 m 82.22 89.9 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 171.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.327 2.1 t 52.7 47.06 25.49 Favored 'General case' 0 C--N 1.391 2.385 0 O-C-N 124.864 1.352 . . . . 0.0 114.21 -174.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.452 64.5 t30 28.15 60.66 0.12 Allowed 'General case' 0 C--N 1.376 1.74 0 N-CA-C 121.158 3.762 . . . . 0.0 121.158 171.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -90.26 106.45 18.5 Favored 'General case' 0 C--N 1.38 1.924 0 CA-C-O 123.052 1.406 . . . . 0.0 111.88 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -72.82 119.85 17.63 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 110.92 -2.855 . . . . 0.0 115.024 -167.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -74.4 155.37 38.16 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 111.58 -2.554 . . . . 0.0 109.784 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 tp -147.54 138.67 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.199 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 -175.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.7 t -145.01 154.3 42.39 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.67 -1.269 . . . . 0.0 109.113 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -54.9 -30.16 57.58 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 126.065 1.746 . . . . 0.0 112.246 168.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.96 -37.44 82.4 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 171.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -70.77 -44.7 66.15 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.297 1.839 . . . . 0.0 113.108 168.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 8.4 mt -58.76 -43.19 90.26 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 82.18 -3.96 1.47 Allowed 'General case' 0 N--CA 1.411 -2.388 0 CA-C-O 122.427 1.108 . . . . 0.0 108.969 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -138.53 151.07 47.02 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 118.678 -2.513 . . . . 0.0 106.147 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 tp -51.09 142.24 12.72 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 126.133 1.773 . . . . 0.0 114.039 -167.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -55.9 134.83 73.19 Favored Pre-proline 0 CA--C 1.583 2.234 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -97.76 2.31 1.47 Allowed 'Trans proline' 0 C--O 1.206 -1.097 0 CA-C-O 113.898 -2.626 . . . . 0.0 112.273 -174.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.3 mt -112.34 165.95 11.73 Favored 'General case' 0 C--N 1.364 1.221 0 CA-C-N 121.558 1.981 . . . . 0.0 110.986 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.2 p -91.99 -25.26 18.93 Favored 'General case' 0 C--N 1.361 1.097 0 O-C-N 120.564 -1.335 . . . . 0.0 111.381 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 m -71.3 135.12 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -79.31 115.11 18.77 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 124.076 0.86 . . . . 0.0 109.207 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.345 38.5 m80 57.74 -164.74 0.17 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 117.115 -1.422 . . . . 0.0 112.042 -178.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.19 -162.48 34.81 Favored Glycine 0 C--N 1.371 2.502 0 N-CA-C 103.37 -3.892 . . . . 0.0 103.37 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.38 151.29 43.38 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 103.49 -2.781 . . . . 0.0 103.49 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.97 161.04 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-O 124.303 2.001 . . . . 0.0 106.821 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -139.36 156.91 46.69 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 118.799 -2.438 . . . . 0.0 106.523 170.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.4 m -134.68 128.48 33.1 Favored 'General case' 0 C--N 1.37 1.461 0 O-C-N 120.041 -1.662 . . . . 0.0 110.808 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.1 mt -113.92 148.0 38.96 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 115.783 -2.056 . . . . 0.0 106.812 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.262 31.3 Cg_exo -50.26 147.75 15.52 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 125.21 3.94 . . . . 0.0 116.485 -166.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.257 12.3 m 72.22 39.97 0.73 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.974 1.71 . . . . 0.0 113.815 -175.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 58.53 46.72 14.46 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 128.688 2.795 . . . . 0.0 112.357 172.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -95.69 113.27 24.9 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 171.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.27 130.76 50.61 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.883 -1.136 . . . . 0.0 110.979 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.9 t -114.12 140.78 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-O 125.484 2.564 . . . . 0.0 106.968 -175.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -111.44 150.24 30.13 Favored 'General case' 0 C--N 1.354 0.799 0 CA-C-N 113.263 -1.79 . . . . 0.0 107.096 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.9 t -132.97 123.27 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 N-CA-C 102.174 -3.269 . . . . 0.0 102.174 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.94 163.05 17.77 Favored Pre-proline 0 CA--C 1.588 2.415 0 CA-C-O 122.625 1.203 . . . . 0.0 112.316 172.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.47 -38.96 28.43 Favored 'Trans proline' 0 N--CA 1.517 2.891 0 C-N-CA 124.861 3.707 . . . . 0.0 114.598 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.2 p-10 -84.24 -10.43 57.69 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 121.253 1.842 . . . . 0.0 113.291 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.9 4.85 36.08 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 125.645 1.593 . . . . 0.0 115.221 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.4 m -58.88 139.4 56.57 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 122.684 1.231 . . . . 0.0 114.015 167.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.1 m -111.74 125.62 54.18 Favored 'General case' 0 C--O 1.206 -1.219 0 O-C-N 121.088 -1.008 . . . . 0.0 110.942 -165.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -133.95 166.23 23.19 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 123.454 1.597 . . . . 0.0 110.641 -165.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -117.38 124.19 48.3 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 119.824 -1.798 . . . . 0.0 112.394 -171.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.1 tp -90.02 -26.76 20.15 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -173.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -135.81 178.17 7.25 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.734 -1.229 . . . . 0.0 108.727 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -53.34 -43.88 68.04 Favored 'General case' 0 C--N 1.399 2.72 0 C-N-CA 125.611 1.564 . . . . 0.0 114.504 -171.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -70.65 -31.71 68.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.64 -37.53 65.31 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 122.578 1.18 . . . . 0.0 109.241 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -62.52 -50.52 71.04 Favored 'General case' 0 C--N 1.364 1.205 0 O-C-N 119.926 -1.734 . . . . 0.0 109.824 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -53.81 -31.77 50.28 Favored 'General case' 0 CA--C 1.586 2.333 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.92 -22.8 66.52 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 115.953 -1.975 . . . . 0.0 112.422 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 128.81 8.47 3.81 Favored Glycine 0 C--N 1.378 2.885 0 CA-C-N 122.696 2.498 . . . . 0.0 116.12 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -118.79 145.65 38.23 Favored Pre-proline 0 C--N 1.376 1.741 0 CA-C-N 121.862 2.831 . . . . 0.0 108.496 -174.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -51.68 148.62 20.95 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.945 3.097 . . . . 0.0 111.042 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -78.98 146.98 20.83 Favored 'Trans proline' 0 CA--C 1.511 -0.641 1 C-N-CA 125.418 4.079 . . . . 0.0 108.048 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.7 tp -89.25 -0.32 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 125.295 2.474 . . . . 0.0 111.229 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.6 p -56.1 -42.21 94.99 Favored Pre-proline 0 C--O 1.213 -0.827 0 CA-C-O 113.663 -3.065 . . . . 0.0 112.9 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -59.94 -31.8 94.19 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 CA-C-N 126.509 3.36 . . . . 0.0 115.693 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.3 tt -98.75 13.55 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -55.19 149.06 13.09 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.011 -1.449 . . . . 0.0 110.3 162.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -92.79 136.09 33.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 112.767 -2.015 . . . . 0.0 110.623 172.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -67.66 145.69 54.56 Favored 'General case' 0 C--O 1.201 -1.489 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.759 164.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.91 175.63 23.3 Favored Glycine 0 N--CA 1.484 1.851 0 CA-C-O 122.947 1.304 . . . . 0.0 110.883 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.3 t -71.72 125.46 27.19 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 112.745 -1.727 . . . . 0.0 110.668 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.1 7.61 57.21 Favored Glycine 0 C--N 1.353 1.525 0 O-C-N 125.385 1.678 . . . . 0.0 116.887 -165.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.98 156.9 22.25 Favored Glycine 0 CA--C 1.54 1.598 0 O-C-N 121.516 -0.991 . . . . 0.0 114.409 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.82 161.0 11.54 Favored Glycine 0 C--N 1.368 2.346 0 C-N-CA 130.347 3.832 . . . . 0.0 114.107 167.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -71.1 138.97 50.15 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 125.941 1.696 . . . . 0.0 108.442 -167.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.1 mt -73.77 140.24 18.04 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-N 110.087 -3.233 . . . . 0.0 112.62 168.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.4 t -65.03 152.15 44.18 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 118.296 2.702 . . . . 0.0 118.296 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 59.5 mt -102.22 11.74 37.76 Favored 'General case' 0 C--O 1.206 -1.214 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -177.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.85 -51.81 56.27 Favored Glycine 0 CA--C 1.555 2.584 0 O-C-N 119.177 -2.202 . . . . 0.0 116.981 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.66 -37.38 82.29 Favored 'General case' 0 N--CA 1.42 -1.928 0 O-C-N 119.164 -2.374 . . . . 0.0 114.184 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.8 tp -60.98 -45.43 94.82 Favored 'General case' 0 C--O 1.252 1.227 0 C-N-CA 124.399 1.079 . . . . 0.0 111.111 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.8 tp -69.95 -42.21 73.52 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 p -63.41 -45.31 91.59 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.16 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 94.4 m -64.23 -42.72 96.44 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 126.118 2.136 . . . . 0.0 109.398 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 92.4 m -46.92 -55.76 7.52 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 115.104 -2.379 . . . . 0.0 116.379 167.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 25.1 mt -71.56 -25.21 62.11 Favored 'General case' 0 CA--C 1.568 1.654 0 O-C-N 128.173 3.42 . . . . 0.0 113.781 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -60.38 -45.88 91.96 Favored 'General case' 0 CA--C 1.58 2.112 0 C-N-CA 126.853 2.061 . . . . 0.0 110.327 164.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.4 mt -65.2 -42.96 93.04 Favored 'General case' 0 C--N 1.416 3.497 0 O-C-N 119.58 -1.95 . . . . 0.0 114.281 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 16.6 p -101.81 15.76 27.97 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 127.256 2.222 . . . . 0.0 110.702 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.942 0 CA-C-O 115.901 -2.611 . . . . 0.0 114.092 174.892 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 137' ' ' LEU . 5.0 t . . . . . 0 N--CA 1.503 2.182 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -93.88 133.74 0.86 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 122.336 1.87 . . . . 0.0 108.239 -167.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.7 p -95.17 131.26 30.37 Favored Pre-proline 0 N--CA 1.431 -1.402 0 C-N-CA 117.446 -1.702 . . . . 0.0 106.778 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -46.46 123.61 7.0 Favored 'Trans proline' 0 N--CA 1.511 2.556 0 N-CA-C 116.853 1.828 . . . . 0.0 116.853 170.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.44 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 64.3 mt -138.47 165.74 30.72 Favored Pre-proline 0 C--N 1.378 1.812 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -173.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 52' ' ' LEU . 4.6 Cg_endo -64.54 134.77 42.69 Favored 'Trans proline' 0 C--O 1.253 1.272 0 CA-C-O 124.836 1.932 . . . . 0.0 112.189 158.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . 0.279 31.7 t 52.62 68.7 2.85 Favored Pre-proline 0 CA--C 1.577 1.982 0 N-CA-C 120.136 3.384 . . . . 0.0 120.136 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.79 -24.9 20.85 Favored 'Trans proline' 0 N--CA 1.506 2.216 0 CA-C-N 125.67 3.061 . . . . 0.0 117.48 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.28 14.1 p 52.37 47.6 24.38 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 120.508 1.504 . . . . 0.0 114.86 172.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t 84.64 35.14 0.04 OUTLIER 'General case' 0 C--O 1.204 -1.327 0 C-N-CA 128.777 2.831 . . . . 0.0 111.228 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 64.02 48.2 3.13 Favored 'General case' 0 N--CA 1.486 1.332 1 C-N-CA 132.499 4.32 . . . . 0.0 115.709 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -79.21 117.36 20.16 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 115.999 -2.28 . . . . 0.0 115.432 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -97.93 126.02 43.12 Favored 'General case' 0 CA--C 1.557 1.222 0 O-C-N 117.704 -3.122 . . . . 0.0 108.106 -177.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -87.18 155.82 19.94 Favored 'General case' 0 CA--C 1.557 1.248 0 O-C-N 117.502 -3.249 . . . . 0.0 111.62 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.7 tp -113.48 117.85 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 123.292 1.52 . . . . 0.0 113.443 165.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.0 p -128.87 179.25 5.83 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 123.645 1.688 . . . . 0.0 109.285 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -61.65 -29.68 70.22 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 119.581 -1.95 . . . . 0.0 114.284 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.99 -42.57 84.8 Favored 'General case' 0 C--O 1.266 1.936 0 C-N-CA 125.448 1.499 . . . . 0.0 112.932 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.44 -46.2 84.18 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 164.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.27 83.3 mt -73.73 -17.38 61.12 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 122.78 2.536 . . . . 0.0 113.872 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.3 . . 65.18 11.76 7.46 Favored 'General case' 0 C--O 1.192 -1.961 0 O-C-N 127.915 3.259 . . . . 0.0 115.953 -177.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -165.12 166.4 19.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 127.307 2.243 . . . . 0.0 107.004 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.7 mt -18.93 133.07 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.443 3.097 . . . . 0.0 119.209 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -73.72 127.01 89.19 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 116.622 -3.799 . . . . 0.0 114.975 164.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -89.15 15.49 2.01 Favored 'Trans proline' 0 CA--C 1.57 2.294 0 CA-C-N 123.292 2.211 . . . . 0.0 112.229 -168.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 mt -136.0 165.1 26.46 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-O 123.753 1.739 . . . . 0.0 110.727 -172.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.8 p -100.97 -1.56 34.1 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.561 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.415 ' H ' HG22 ' A' ' 75' ' ' VAL . 17.2 m -90.27 171.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.381 1.962 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 169.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -81.26 174.7 11.27 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 122.27 1.033 . . . . 0.0 111.816 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -73.37 144.18 46.55 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 128.838 2.855 . . . . 0.0 106.012 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.03 179.54 36.42 Favored Glycine 0 C--N 1.367 2.304 0 CA-C-N 112.058 -2.337 . . . . 0.0 110.501 -164.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.3 m -84.65 120.21 26.12 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-O 123.716 1.722 . . . . 0.0 113.593 -173.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -86.69 143.68 10.91 Favored 'Isoleucine or valine' 0 C--O 1.257 1.489 0 CA-C-O 124.243 1.973 . . . . 0.0 111.574 165.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -145.67 151.68 38.42 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 112.577 -2.101 . . . . 0.0 107.125 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 89.6 m -121.51 115.02 22.07 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-O 125.086 2.374 . . . . 0.0 107.132 172.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mt -92.86 150.81 40.09 Favored Pre-proline 0 CA--C 1.507 -0.701 0 CA-C-O 116.093 -1.908 . . . . 0.0 106.564 -174.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -47.07 138.75 15.93 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 123.848 3.032 . . . . 0.0 116.545 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.6 m 80.14 49.26 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 120.757 1.617 . . . . 0.0 115.229 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 46.98 49.19 14.99 Favored 'General case' 0 C--N 1.392 2.448 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -106.32 116.51 32.06 Favored 'General case' 0 C--N 1.385 2.119 0 C-N-CA 117.868 -1.533 . . . . 0.0 111.942 170.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.77 106.94 15.85 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-O 123.291 1.52 . . . . 0.0 107.575 -173.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.7 m -122.67 144.79 30.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 C-N-CA 127.589 2.356 . . . . 0.0 109.089 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -113.33 128.47 56.47 Favored 'General case' 0 N--CA 1.425 -1.687 0 O-C-N 119.006 -2.309 . . . . 0.0 106.165 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.9 t -106.49 111.64 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -69.98 156.3 92.02 Favored Pre-proline 0 C--O 1.27 2.153 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.598 171.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.478 ' HD2' ' HB1' ' A' ' 92' ' ' ALA . 41.1 Cg_endo -68.61 2.36 2.98 Favored 'Trans proline' 0 CA--C 1.498 -1.31 0 C-N-CA 124.409 3.406 . . . . 0.0 113.241 -166.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -102.66 -25.13 13.67 Favored 'General case' 0 C--O 1.245 0.834 0 O-C-N 127.139 2.774 . . . . 0.0 110.188 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.11 24.85 3.16 Favored Glycine 0 C--N 1.348 1.242 0 C-N-CA 126.282 1.896 . . . . 0.0 110.815 172.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.46 147.32 24.35 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.0 m -129.47 125.68 36.97 Favored 'General case' 0 C--O 1.263 1.814 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -167.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -128.94 126.81 40.45 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 125.852 1.97 . . . . 0.0 108.581 -165.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.04 124.26 19.99 Favored 'General case' 0 C--O 1.211 -0.932 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 69.7 mt -93.77 -30.49 14.83 Favored 'General case' 0 C--N 1.369 1.441 0 O-C-N 119.638 -1.914 . . . . 0.0 112.571 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -122.12 178.11 5.05 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 124.132 1.92 . . . . 0.0 106.51 174.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -79.04 -19.51 51.26 Favored 'General case' 0 CA--C 1.583 2.223 0 O-C-N 118.402 -2.687 . . . . 0.0 117.751 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -59.18 -37.78 78.19 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 126.018 2.074 . . . . 0.0 110.168 172.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.23 -30.75 69.89 Favored 'General case' 0 CA--C 1.472 -2.029 0 CA-C-O 114.998 -2.429 . . . . 0.0 113.271 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -62.7 -41.31 99.06 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 126.788 2.035 . . . . 0.0 114.014 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -66.34 -37.01 84.36 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 168.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.32 -4.68 40.61 Favored 'General case' 0 C--O 1.257 1.475 0 O-C-N 118.801 -2.437 . . . . 0.0 112.348 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.94 28.63 9.83 Favored Glycine 0 C--N 1.353 1.526 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.75 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -86.43 134.92 37.13 Favored Pre-proline 0 CA--C 1.58 2.1 0 CA-C-O 115.468 -2.206 . . . . 0.0 107.862 170.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -56.8 128.26 29.23 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 O-C-N 125.667 2.404 . . . . 0.0 114.313 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -32.27 145.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.362 2.041 . . . . 0.0 115.824 161.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.9 tt -99.96 19.46 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 C-N-CA 126.188 1.795 . . . . 0.0 110.453 173.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.05 -30.47 1.13 Allowed Pre-proline 0 CA--C 1.558 1.251 0 CA-C-O 112.165 -3.778 . . . . 0.0 116.439 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -71.59 -42.33 1.85 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 125.342 2.944 . . . . 0.0 111.716 -169.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 21.5 pt -88.28 6.19 3.75 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 C-N-CA 128.243 2.617 . . . . 0.0 111.774 -165.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -53.11 155.9 2.39 Favored 'General case' 0 C--O 1.221 -0.419 1 O-C-N 116.021 -4.174 . . . . 0.0 118.355 168.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -98.68 147.33 24.96 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 117.31 -1.756 . . . . 0.0 110.04 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . 0.353 13.7 mmmm -64.94 143.99 57.58 Favored 'General case' 0 C--N 1.37 1.476 0 CA-C-O 124.072 1.891 . . . . 0.0 110.568 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -82.06 -146.19 5.6 Favored Glycine 0 CA--C 1.57 3.489 0 CA-C-O 126.374 3.208 . . . . 0.0 117.503 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.4 t -111.42 111.74 22.99 Favored 'General case' 0 CA--C 1.512 -0.507 1 O-C-N 116.113 -4.169 . . . . 0.0 102.86 170.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.48 48.27 5.37 Favored Glycine 1 C--N 1.399 4.053 0 CA-C-N 120.319 1.418 . . . . 0.0 110.096 177.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.82 -164.52 54.78 Favored Glycine 0 C--N 1.381 3.075 0 N-CA-C 117.12 1.608 . . . . 0.0 117.12 -171.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.39 -166.4 1.14 Allowed Glycine 0 C--N 1.338 0.684 1 N-CA-C 123.491 4.157 . . . . 0.0 123.491 -173.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . 0.317 74.3 m-85 -133.54 149.06 51.68 Favored 'General case' 0 C--O 1.253 1.269 0 O-C-N 117.414 -3.403 . . . . 0.0 110.296 -173.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 79.6 mt -63.92 151.67 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.163 0 CA-C-N 124.082 3.128 . . . . 0.0 108.784 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.0 t -62.55 145.24 54.84 Favored 'General case' 0 C--O 1.198 -1.64 0 O-C-N 118.273 -2.767 . . . . 0.0 113.17 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.7 mt -97.52 4.92 50.26 Favored 'General case' 0 CA--C 1.58 2.116 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 -172.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -76.59 -41.72 23.83 Favored Glycine 0 C--N 1.394 3.789 0 C-N-CA 119.683 -1.246 . . . . 0.0 115.38 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.26 -34.52 72.91 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 117.389 -3.418 . . . . 0.0 115.767 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 27.9 tp -54.26 -58.71 6.36 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 126.083 1.753 . . . . 0.0 112.133 165.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 38.3 tp -63.09 -40.3 97.25 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.3 p -71.82 -33.45 68.52 Favored 'General case' 0 C--O 1.251 1.175 0 O-C-N 119.296 -2.128 . . . . 0.0 115.108 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 32.4 m -61.71 -42.69 99.28 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.92 1.288 . . . . 0.0 108.656 169.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.1 m -57.56 -46.85 83.43 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.8 mt -72.12 -30.13 64.75 Favored 'General case' 0 CA--C 1.562 1.406 0 O-C-N 124.865 1.353 . . . . 0.0 112.232 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -58.25 -46.62 85.65 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 116.845 -1.55 . . . . 0.0 113.14 168.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 48' ' ' SER . 71.9 mt -72.63 -45.25 59.96 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 119.236 0.926 . . . . 0.0 111.29 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . 0.342 1.2 p -74.44 -17.76 60.74 Favored 'General case' 0 C--O 1.202 -1.429 0 CA-C-O 115.75 -2.072 . . . . 0.0 113.328 -170.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.381 3.065 0 N-CA-C 120.035 2.774 . . . . 0.0 120.035 169.757 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.481 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 17.9 m . . . . . 0 N--CA 1.508 2.43 0 CA-C-O 115.807 -2.044 . . . . 0.0 116.113 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 40.1 Cg_exo -50.7 152.15 9.82 Favored 'Trans proline' 0 C--O 1.199 -1.453 0 C-N-CA 124.432 3.421 . . . . 0.0 114.583 164.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.3 m -67.13 140.95 96.02 Favored Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-O 117.128 -1.415 . . . . 0.0 112.422 -165.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -41.1 130.81 3.1 Favored 'Trans proline' 0 C--N 1.286 -2.714 0 N-CA-C 120.83 3.358 . . . . 0.0 120.83 167.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.1 tp -129.76 101.12 18.71 Favored Pre-proline 0 CA--C 1.591 2.521 0 O-C-N 125.633 1.833 . . . . 0.0 111.952 -168.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -86.96 89.75 0.62 Allowed 'Trans proline' 0 CA--C 1.474 -2.483 1 C-N-CA 126.822 5.015 . . . . 0.0 108.072 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.8 t -163.77 116.01 1.02 Allowed Pre-proline 0 C--N 1.288 -2.071 0 C-N-CA 119.288 -0.965 . . . . 0.0 112.122 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -33.94 134.7 0.12 Allowed 'Trans proline' 0 CA--C 1.508 -0.802 1 C-N-CA 126.686 4.924 . . . . 0.0 118.572 -175.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 35.78 42.07 0.13 Allowed 'General case' 0 C--O 1.257 1.454 0 C-N-CA 129.771 3.228 . . . . 0.0 114.63 -167.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.364 7.4 m 59.29 54.49 4.74 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 125.999 1.719 . . . . 0.0 114.938 -173.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.0 t30 66.36 38.39 4.42 Favored 'General case' 0 CA--C 1.597 2.76 0 C-N-CA 130.743 3.617 . . . . 0.0 113.759 -175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.79 145.53 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.417 2.687 . . . . 0.0 114.758 -176.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -114.49 104.35 11.94 Favored 'General case' 0 CA--C 1.466 -2.26 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -170.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.75 139.06 55.32 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.401 HD11 HD12 ' A' ' 130' ' ' LEU . 1.1 tt -116.24 142.6 29.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 121.458 -0.776 . . . . 0.0 109.408 162.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.5 ' HB2' ' CE1' ' A' ' 77' ' ' HIS . 90.3 p -152.76 158.88 42.93 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-O 116.143 -1.885 . . . . 0.0 107.207 -169.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -64.28 -18.16 64.32 Favored 'General case' 0 C--N 1.367 1.365 0 CA-C-N 123.608 2.913 . . . . 0.0 110.598 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.96 -25.9 53.37 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 120.476 -1.39 . . . . 0.0 111.817 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -73.29 -28.66 62.23 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 125.949 1.7 . . . . 0.0 111.275 173.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.427 HD11 HD13 ' A' ' 130' ' ' LEU . 9.7 mt -88.98 3.77 50.45 Favored 'General case' 0 C--O 1.203 -1.35 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 36.8 63.01 0.72 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 120.747 3.61 . . . . 0.0 120.747 -168.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . 0.297 51.0 t80 83.58 149.12 0.08 Allowed 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 129.214 3.006 . . . . 0.0 109.714 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.324 2.1 tp 89.57 81.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 128.989 2.916 . . . . 0.0 109.601 173.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -85.7 124.79 70.64 Favored Pre-proline 0 N--CA 1.479 0.989 0 O-C-N 120.37 -1.456 . . . . 0.0 112.474 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.72 3.2 8.0 Favored 'Trans proline' 0 C--N 1.362 1.253 0 CA-C-N 122.037 1.763 . . . . 0.0 114.637 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.9 mt -120.63 158.27 27.77 Favored 'General case' 0 C--N 1.375 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.95 -165.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.0 p -78.83 -30.08 45.07 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 170.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.5 m -71.91 147.71 10.4 Favored 'Isoleucine or valine' 0 C--N 1.367 1.36 0 C-N-CA 124.506 1.122 . . . . 0.0 111.491 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . 0.256 62.7 t0 -90.15 82.35 6.07 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 118.49 -2.631 . . . . 0.0 111.426 -172.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.5 ' CE1' ' HB2' ' A' ' 63' ' ' SER 0.33 27.5 m170 77.84 178.12 0.15 Allowed 'General case' 0 CA--C 1.474 -1.956 0 O-C-N 120.567 -1.333 . . . . 0.0 114.013 179.016 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.21 -176.57 39.86 Favored Glycine 0 N--CA 1.433 -1.535 0 O-C-N 117.977 -2.952 . . . . 0.0 114.711 -172.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.259 17.0 p -124.24 146.29 48.84 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 118.591 -2.711 . . . . 0.0 105.757 171.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.409 HD11 HD23 ' A' ' 137' ' ' LEU . 2.8 pp -119.84 150.09 22.45 Favored 'Isoleucine or valine' 0 C--N 1.366 1.29 0 CA-C-O 126.644 3.116 . . . . 0.0 112.379 177.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -141.66 137.9 32.1 Favored 'General case' 0 CA--C 1.57 1.745 0 O-C-N 116.536 -3.852 . . . . 0.0 108.524 168.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.9 m -108.29 140.78 41.06 Favored 'General case' 0 C--N 1.368 1.385 0 O-C-N 117.342 -3.349 . . . . 0.0 104.906 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 87' ' ' ASN . 10.7 mt -111.38 146.99 35.73 Favored Pre-proline 0 N--CA 1.432 -1.359 0 C-N-CA 129.501 3.12 . . . . 0.0 102.909 -173.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -40.35 134.58 2.01 Favored 'Trans proline' 0 N--CA 1.507 2.274 1 C-N-CA 126.45 4.767 . . . . 0.0 113.059 -173.483 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.272 1.0 OUTLIER 85.2 31.59 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 122.489 1.137 . . . . 0.0 108.909 170.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . 0.281 21.8 m-20 65.84 44.54 2.79 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 116.872 -3.642 . . . . 0.0 115.448 176.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 83' ' ' LEU . 2.3 m-80 -101.74 114.07 27.81 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 174.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.21 120.82 36.09 Favored 'General case' 0 N--CA 1.409 -2.508 0 O-C-N 125.013 1.446 . . . . 0.0 111.284 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.1 t -99.87 145.35 10.84 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 CA-C-O 127.737 3.637 . . . . 0.0 109.883 166.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -111.3 128.56 55.98 Favored 'General case' 0 N--CA 1.44 -0.94 1 O-C-N 115.038 -4.789 . . . . 0.0 106.714 168.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.8 t -110.44 124.57 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.723 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.36 167.15 19.69 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-O 117.222 -1.37 . . . . 0.0 114.367 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -41.13 -34.31 1.54 Allowed 'Trans proline' 0 N--CA 1.52 3.079 0 N-CA-C 120.518 3.238 . . . . 0.0 120.518 165.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.0 p30 -96.99 3.89 51.77 Favored 'General case' 0 CA--C 1.477 -1.846 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.77 -13.25 29.71 Favored Glycine 0 CA--C 1.526 0.725 0 O-C-N 120.262 -1.524 . . . . 0.0 111.91 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.282 47.0 m -66.47 113.02 4.38 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -173.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.68 119.58 10.16 Favored 'General case' 0 C--N 1.375 1.691 0 C-N-CA 128.014 2.526 . . . . 0.0 115.6 171.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -120.04 141.52 49.67 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 166.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.04 149.3 37.37 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 153.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . 0.255 23.1 tp -118.76 -3.26 10.81 Favored 'General case' 0 C--N 1.379 1.883 0 C-N-CA 129.87 3.268 . . . . 0.0 111.848 177.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.2 p30 -158.07 175.1 14.23 Favored 'General case' 0 C--N 1.38 1.897 0 CA-C-N 120.412 1.46 . . . . 0.0 109.916 169.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . 0.315 69.4 m-20 -60.34 -36.91 79.07 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -173.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.4 mtt85 -59.19 -41.34 88.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 127.811 3.194 . . . . 0.0 111.639 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.12 -23.5 28.42 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-O 124.932 2.301 . . . . 0.0 114.659 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -63.7 -47.28 81.78 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.63 -1.623 . . . . 0.0 112.391 163.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -61.32 -38.12 85.71 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-O 125.157 2.408 . . . . 0.0 115.427 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.39 -34.23 68.66 Favored 'General case' 0 CA--C 1.572 1.819 0 O-C-N 119.308 -2.12 . . . . 0.0 113.388 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 127.92 -3.83 6.92 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 120.807 3.083 . . . . 0.0 120.807 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -70.66 143.49 89.88 Favored Pre-proline 0 N--CA 1.487 1.421 0 CA-C-N 121.654 2.727 . . . . 0.0 112.161 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -48.44 146.8 9.84 Favored 'Trans proline' 0 C--N 1.296 -2.229 1 C-N-CA 126.323 4.682 . . . . 0.0 119.431 175.195 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -82.25 151.76 15.85 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 118.266 -1.492 . . . . 0.0 109.503 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.9 tt -86.08 4.19 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.554 1.942 . . . . 0.0 109.784 -171.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.65 -40.28 74.1 Favored Pre-proline 0 CA--C 1.578 2.029 1 N-CA-C 122.04 4.089 . . . . 0.0 122.04 -168.339 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.84 -6.66 14.31 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 113.974 -3.751 . . . . 0.0 114.308 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 31.4 mm -86.19 -16.61 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 C-N-CA 125.904 1.682 . . . . 0.0 106.952 176.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -56.93 145.39 30.2 Favored 'General case' 0 C--O 1.194 -1.834 0 CA-C-O 126.04 2.829 . . . . 0.0 117.49 164.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -93.7 132.59 37.91 Favored 'General case' 0 C--O 1.209 -1.07 0 CA-C-N 112.459 -2.155 . . . . 0.0 111.774 174.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . 0.467 41.3 mtpt -57.65 144.58 37.13 Favored 'General case' 0 C--O 1.178 -2.676 0 O-C-N 119.322 -2.111 . . . . 0.0 112.989 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -110.79 -168.88 19.21 Favored Glycine 0 N--CA 1.494 2.524 0 CA-C-N 119.943 1.247 . . . . 0.0 112.215 -159.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 64.4 m -76.05 119.89 20.61 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 116.145 -1.883 . . . . 0.0 113.487 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.55 49.33 5.83 Favored Glycine 0 C--N 1.365 2.147 0 CA-C-N 121.669 2.031 . . . . 0.0 114.194 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 59.62 -155.85 28.36 Favored Glycine 1 CA--C 1.593 4.918 0 O-C-N 118.245 -2.914 . . . . 0.0 116.375 -158.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 49.81 -152.69 3.58 Favored Glycine 0 C--O 1.213 -1.163 0 CA-C-O 124.395 2.108 . . . . 0.0 114.904 -167.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -134.58 148.44 50.46 Favored 'General case' 0 N--CA 1.418 -2.041 0 C-N-CA 126.594 1.958 . . . . 0.0 111.721 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.9 mt -60.9 140.17 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.363 0 O-C-N 120.324 -1.485 . . . . 0.0 112.391 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.5 t -52.61 137.65 30.13 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 128.844 2.857 . . . . 0.0 112.999 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.4 mt -98.46 4.48 48.37 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.481 -1.387 . . . . 0.0 111.47 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -44.25 -63.88 2.21 Favored Glycine 0 CA--C 1.486 -1.726 0 C-N-CA 127.775 2.607 . . . . 0.0 113.823 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.9 -45.08 93.68 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 173.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.427 HD13 HD11 ' A' ' 67' ' ' LEU . 34.0 tp -63.18 -43.44 98.22 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 124.502 1.126 . . . . 0.0 113.561 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.8 tp -64.72 -45.97 84.27 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 121.736 0.779 . . . . 0.0 112.405 168.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 78.4 p -74.8 -36.46 62.48 Favored 'General case' 0 CA--C 1.497 -1.095 0 O-C-N 117.919 -2.988 . . . . 0.0 113.347 -169.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 52.0 m -59.89 -43.09 94.99 Favored 'General case' 0 C--O 1.266 1.97 0 C-N-CA 128.695 2.798 . . . . 0.0 105.588 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 47.0 m -63.05 -41.65 99.54 Favored 'General case' 0 C--N 1.377 1.787 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.527 -174.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.427 ' HA ' ' SG ' ' A' ' 138' ' ' CYS . 17.8 mt -69.64 -36.95 76.57 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 117.719 2.489 . . . . 0.0 117.719 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -61.39 -37.89 85.09 Favored 'General case' 0 CA--C 1.57 1.715 0 O-C-N 116.801 -3.687 . . . . 0.0 109.839 165.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.409 HD23 HD11 ' A' ' 80' ' ' ILE . 49.0 tp -69.92 -31.25 68.92 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 118.155 -2.841 . . . . 0.0 115.622 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.427 ' SG ' ' HA ' ' A' ' 135' ' ' LEU . 28.6 p -92.21 14.86 14.96 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.088 -1.008 . . . . 0.0 110.957 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.984 0 C-N-CA 125.779 1.656 . . . . 0.0 109.993 -179.902 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -41.67 116.27 0.51 Allowed 'Trans proline' 0 N--CA 1.506 2.262 0 C-N-CA 124.521 3.481 . . . . 0.0 115.577 -168.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 52' ' ' LEU . 84.4 t -80.98 107.4 7.48 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 125.651 1.845 . . . . 0.0 110.674 176.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -77.67 33.34 0.45 Allowed 'Trans proline' 0 N--CA 1.505 2.168 0 N-CA-C 114.876 1.068 . . . . 0.0 114.876 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.417 ' H ' HG12 ' A' ' 50' ' ' VAL . 25.9 mt -115.0 160.17 34.8 Favored Pre-proline 0 C--N 1.378 1.835 0 O-C-N 120.313 -1.492 . . . . 0.0 110.399 -178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -45.79 147.01 3.43 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 N-CA-C 119.088 2.688 . . . . 0.0 119.088 164.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.7 m 35.04 73.13 0.65 Allowed Pre-proline 0 N--CA 1.512 2.629 0 N-CA-C 120.224 3.416 . . . . 0.0 120.224 -167.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.25 -18.28 44.81 Favored 'Trans proline' 0 C--N 1.366 1.485 0 C-N-CA 122.006 1.804 . . . . 0.0 114.103 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.2 m 43.5 58.85 3.28 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 127.552 2.341 . . . . 0.0 113.131 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.275 74.1 m 52.86 34.68 17.1 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 119.969 3.322 . . . . 0.0 119.969 -171.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 60.32 54.91 3.74 Favored 'General case' 0 C--O 1.248 1.026 0 C-N-CA 127.627 2.371 . . . . 0.0 116.438 -167.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.4 mttm -133.05 152.09 51.99 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -145.85 147.06 31.4 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.104 -1.407 . . . . 0.0 113.85 -162.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -73.76 135.02 43.54 Favored 'General case' 0 N--CA 1.411 -2.402 0 O-C-N 128.338 3.524 . . . . 0.0 111.464 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.424 HD13 ' CD1' ' A' ' 137' ' ' LEU . 9.9 tp -136.54 128.88 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 125.571 2.605 . . . . 0.0 112.945 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.9 p -162.76 171.78 16.24 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 127.271 2.228 . . . . 0.0 107.832 -159.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -45.1 -52.17 9.42 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 128.253 2.621 . . . . 0.0 114.756 173.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.76 93.55 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 174.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -82.45 -19.87 38.08 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 120.293 -1.504 . . . . 0.0 111.522 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.6 tp -75.06 -42.57 56.67 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 117.971 2.582 . . . . 0.0 117.971 166.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 65.56 15.71 10.16 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 130.006 3.322 . . . . 0.0 114.289 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -134.27 166.81 21.94 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 162.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.6 mt -39.31 128.67 1.8 Allowed 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -174.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -66.27 139.62 96.44 Favored Pre-proline 0 CA--C 1.567 1.621 0 CA-C-O 113.296 -3.24 . . . . 0.0 114.806 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -116.97 -3.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 2.015 0 CA-C-O 111.187 -3.755 . . . . 0.0 110.302 -167.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 mt -113.13 152.95 29.01 Favored 'General case' 0 C--N 1.401 2.818 0 O-C-N 127.484 2.99 . . . . 0.0 112.929 -177.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.2 p -79.28 -17.12 55.31 Favored 'General case' 0 N--CA 1.416 -2.132 0 O-C-N 118.281 -2.762 . . . . 0.0 113.64 -171.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.8 m -72.16 147.94 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 129.986 3.314 . . . . 0.0 115.003 166.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -56.59 171.24 0.32 Allowed 'General case' 0 C--O 1.2 -1.527 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 154.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -36.32 127.13 0.79 Allowed 'General case' 0 C--N 1.373 1.62 0 C-N-CA 130.322 3.449 . . . . 0.0 109.778 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.58 -168.24 22.68 Favored Glycine 0 N--CA 1.434 -1.459 0 CA-C-O 123.322 1.512 . . . . 0.0 111.659 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.9 m -120.97 115.57 23.43 Favored 'General case' 0 C--N 1.378 1.825 0 CA-C-N 111.228 -2.486 . . . . 0.0 109.031 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.438 ' H ' HG13 ' A' ' 80' ' ' ILE 0.328 1.9 pp -88.81 138.38 19.31 Favored 'Isoleucine or valine' 0 C--N 1.396 2.605 0 CA-C-N 121.074 1.761 . . . . 0.0 110.534 172.644 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -133.39 132.5 41.28 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.4 m -100.16 130.32 46.28 Favored 'General case' 0 C--N 1.382 1.994 0 CA-C-O 124.053 1.883 . . . . 0.0 110.322 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.3 mt -105.52 157.53 34.31 Favored Pre-proline 0 CA--C 1.569 1.706 0 O-C-N 119.32 -2.113 . . . . 0.0 113.589 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -40.35 145.73 0.32 Allowed 'Trans proline' 0 CA--C 1.475 -2.475 1 C-N-CA 127.084 5.19 . . . . 0.0 113.425 169.1 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.1 m 70.55 41.41 0.95 Allowed 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 118.971 2.952 . . . . 0.0 118.971 173.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 64.98 30.35 11.88 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 129.343 3.057 . . . . 0.0 112.751 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.254 65.5 m-20 -101.06 137.31 39.59 Favored 'General case' 0 C--N 1.373 1.615 0 CA-C-N 120.009 1.277 . . . . 0.0 109.497 -169.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.12 124.2 36.35 Favored 'General case' 0 C--O 1.2 -1.535 0 CA-C-N 122.431 2.378 . . . . 0.0 111.002 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.254 32.7 m -120.11 144.29 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-O 124.361 2.029 . . . . 0.0 113.252 -174.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -121.06 131.37 54.24 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 120.236 -1.54 . . . . 0.0 107.594 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.35 118.32 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.323 0 C-N-CA 126.309 1.843 . . . . 0.0 110.867 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.17 156.51 76.51 Favored Pre-proline 0 CA--C 1.577 1.99 0 O-C-N 126.435 2.334 . . . . 0.0 115.401 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -43.69 -35.1 6.18 Favored 'Trans proline' 0 C--O 1.255 1.372 0 N-CA-C 120.395 3.19 . . . . 0.0 120.395 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -69.98 -33.54 72.19 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 116.779 -1.581 . . . . 0.0 113.719 172.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 127.86 -3.31 6.94 Favored Glycine 0 C--N 1.364 2.086 1 C-N-CA 130.915 4.102 . . . . 0.0 113.745 176.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.8 m -57.07 132.47 53.01 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 125.257 1.423 . . . . 0.0 113.834 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.4 m -106.19 109.0 20.8 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 123.163 2.711 . . . . 0.0 107.072 -174.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -113.26 148.4 35.64 Favored 'General case' 0 C--O 1.255 1.351 0 O-C-N 120.631 -1.293 . . . . 0.0 108.837 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.3 127.65 33.44 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 114.636 -2.602 . . . . 0.0 111.438 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.38 -9.43 30.0 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 120.339 1.427 . . . . 0.0 112.393 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -141.75 171.02 14.63 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.414 1.102 . . . . 0.0 110.484 172.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -65.27 -32.54 74.26 Favored 'General case' 0 N--CA 1.416 -2.172 0 C-N-CA 130.396 3.478 . . . . 0.0 110.909 -171.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -59.09 -42.48 90.55 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 125.482 1.739 . . . . 0.0 113.352 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.419 ' HA ' ' HB3' ' A' ' 107' ' ' ALA . . . -84.6 -17.31 39.12 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -172.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -66.23 -44.14 84.6 Favored 'General case' 0 C--N 1.381 1.952 0 CA-C-O 116.262 -1.828 . . . . 0.0 110.289 158.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -65.31 -42.78 92.66 Favored 'General case' 0 C--N 1.362 1.117 0 O-C-N 126.445 2.341 . . . . 0.0 116.878 173.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 104' ' ' ALA . . . -59.6 -34.74 73.12 Favored 'General case' 0 C--N 1.374 1.67 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 166.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 140.27 -17.88 2.9 Favored Glycine 0 C--N 1.376 2.753 0 N-CA-C 119.408 2.523 . . . . 0.0 119.408 166.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -71.47 140.96 85.01 Favored Pre-proline 0 C--O 1.272 2.243 0 CA-C-N 119.904 1.852 . . . . 0.0 111.4 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.66 136.5 0.66 Allowed 'Trans proline' 0 C--N 1.378 2.113 1 C-N-CA 125.358 4.039 . . . . 0.0 117.412 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -55.61 155.64 20.9 Favored 'Trans proline' 0 CA--C 1.565 2.031 0 C-N-CA 122.862 2.375 . . . . 0.0 112.106 173.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 tp -79.92 -14.7 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 122.455 1.121 . . . . 0.0 113.821 -172.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . 0.303 2.3 m -15.71 -61.61 0.04 OUTLIER Pre-proline 0 C--O 1.248 1.001 1 N-CA-C 122.254 4.168 . . . . 0.0 122.254 169.254 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -48.82 -45.36 28.61 Favored 'Trans proline' 0 C--N 1.29 -2.532 0 C-N-CA 124.207 3.271 . . . . 0.0 115.887 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . 0.255 8.4 pt -106.98 12.82 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 117.531 -3.23 . . . . 0.0 111.415 -162.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -62.96 140.19 58.83 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 166.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.92 137.84 39.67 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 120.62 -1.3 . . . . 0.0 108.082 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 124' ' ' TYR . 43.5 mtpt -58.49 156.23 10.82 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 116.709 2.115 . . . . 0.0 116.709 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -108.53 -165.25 20.95 Favored Glycine 0 CA--C 1.563 3.057 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.8 t -110.19 116.99 32.5 Favored 'General case' 0 C--N 1.388 2.254 0 CA-C-O 116.383 -1.77 . . . . 0.0 108.747 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.16 55.61 2.73 Favored Glycine 0 C--N 1.388 3.439 0 C-N-CA 127.122 2.296 . . . . 0.0 115.988 -162.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.65 -161.84 11.84 Favored Glycine 0 CA--C 1.455 -3.666 0 N-CA-C 119.08 2.392 . . . . 0.0 119.08 -164.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.44 -175.27 25.92 Favored Glycine 0 C--N 1.365 2.157 0 N-CA-C 119.223 2.449 . . . . 0.0 119.223 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 96.3 m-85 -127.59 163.81 23.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.0 mm -61.99 120.5 8.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.92 0 O-C-N 126.559 2.412 . . . . 0.0 108.881 166.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.7 t -62.12 154.83 25.95 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.1 mt -102.43 10.3 39.09 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 124.602 2.144 . . . . 0.0 115.223 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.51 -40.2 86.54 Favored Glycine 0 N--CA 1.486 2.011 0 O-C-N 117.393 -3.317 . . . . 0.0 118.548 -165.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.36 -42.57 96.14 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-O 125.174 2.416 . . . . 0.0 106.614 168.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.45 -38.99 88.59 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 118.437 -2.664 . . . . 0.0 110.267 -174.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.314 8.4 tt -63.26 -53.08 58.54 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.261 1.424 . . . . 0.0 113.96 175.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 89.2 p -69.77 -30.26 67.79 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 122.145 0.974 . . . . 0.0 110.935 -171.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.419 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 9.4 m -67.82 -40.0 83.87 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 171.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 96.0 m -50.01 -48.68 52.43 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.587 1.955 . . . . 0.0 113.32 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 39.2 mt -67.13 -37.11 83.29 Favored 'General case' 0 N--CA 1.389 -3.521 0 O-C-N 127.635 3.085 . . . . 0.0 114.96 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -61.68 -48.44 80.79 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 121.9 2.136 . . . . 0.0 113.875 157.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.424 ' CD1' HD13 ' A' ' 62' ' ' ILE . 90.1 mt -60.13 -42.38 94.69 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 117.24 -1.362 . . . . 0.0 114.198 -176.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . 0.272 15.6 p -92.67 9.11 36.28 Favored 'General case' 0 C--N 1.38 1.927 0 N-CA-C 118.18 2.659 . . . . 0.0 118.18 173.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.529 0 CA-C-O 114.53 -3.372 . . . . 0.0 116.963 -175.908 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 . . . . . 0 CA--C 1.495 -1.159 0 CA-C-O 118.391 -0.814 . . . . 0.0 112.725 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.23 136.57 58.0 Favored 'General case' 0 C--O 1.252 1.233 0 O-C-N 125.983 2.052 . . . . 0.0 111.307 164.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.77 142.14 23.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 CA-C-N 113.209 -1.814 . . . . 0.0 112.967 -168.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.8 p -138.98 178.29 7.27 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 -175.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -63.79 -44.91 91.93 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 122.382 1.087 . . . . 0.0 110.413 174.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.15 78.96 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 120.351 -1.468 . . . . 0.0 113.633 172.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -66.94 -43.0 84.31 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-O 117.752 -1.118 . . . . 0.0 112.018 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.7 tp -61.59 -35.98 79.37 Favored 'General case' 0 CA--C 1.582 2.192 0 CA-C-N 120.613 1.551 . . . . 0.0 113.83 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.3 . . 79.02 32.49 0.27 Allowed 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.715 -1.241 . . . . 0.0 112.074 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -156.12 157.96 36.9 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -175.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.9 mt -50.32 127.41 17.22 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 174.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -64.52 124.04 84.78 Favored Pre-proline 0 CA--C 1.567 1.607 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.433 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -99.1 0.76 1.01 Allowed 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.953 2.435 . . . . 0.0 113.5 -159.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 mt -130.91 167.84 18.31 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.2 p -89.6 1.85 55.45 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.7 160.49 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.24 -1.537 . . . . 0.0 111.626 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -77.27 174.36 10.85 Favored 'General case' 0 CA--C 1.561 1.387 0 O-C-N 120.278 -1.514 . . . . 0.0 112.424 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -53.98 140.19 31.95 Favored 'General case' 0 CA--C 1.6 2.887 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.92 -150.29 5.33 Favored Glycine 0 C--N 1.368 2.309 0 C-N-CA 127.877 2.656 . . . . 0.0 115.001 -166.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.3 m -127.58 146.7 50.44 Favored 'General case' 0 C--N 1.364 1.217 0 O-C-N 125.492 1.348 . . . . 0.0 107.821 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.3 pt -115.79 145.69 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 C-N-CA 127.307 2.243 . . . . 0.0 109.699 167.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -147.46 141.21 25.68 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-O 122.473 1.13 . . . . 0.0 111.803 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 62.0 m -88.99 138.23 31.6 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.3 mt -120.32 155.26 56.32 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.257 33.5 Cg_exo -40.67 134.88 2.21 Favored 'Trans proline' 0 N--CA 1.523 3.207 0 N-CA-C 121.804 3.732 . . . . 0.0 121.804 174.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.385 52.9 m 79.59 50.19 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.08 1.352 . . . . 0.0 110.497 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 46.32 44.16 12.29 Favored 'General case' 0 C--N 1.366 1.324 0 CA-C-N 112.456 -2.156 . . . . 0.0 112.365 173.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -96.24 145.38 25.61 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-N 118.964 0.802 . . . . 0.0 110.667 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.659 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -124.71 130.03 51.63 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.0 m -119.47 157.18 21.64 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.798 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -130.39 137.89 50.1 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 102.641 -3.096 . . . . 0.0 102.641 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.0 t -126.57 119.31 53.34 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.76 164.25 2.3 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 171.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.58 -12.21 30.97 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 CA-C-O 114.703 -2.29 . . . . 0.0 114.456 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -90.57 -1.57 57.88 Favored 'General case' 0 C--N 1.367 1.34 0 CA-C-N 120.723 1.601 . . . . 0.0 113.478 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.62 -1.07 42.42 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-O 116.159 -2.467 . . . . 0.0 112.73 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.2 m -79.57 120.18 23.57 Favored 'General case' 0 C--N 1.366 1.314 0 CA-C-N 121.706 2.753 . . . . 0.0 112.899 -171.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.7 m -83.8 130.32 34.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.769 175.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -124.43 162.61 23.53 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.95 1.7 . . . . 0.0 111.743 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.54 129.99 34.98 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 169.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.4 tp -95.46 -45.71 6.98 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 116.89 -1.528 . . . . 0.0 109.43 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -105.95 164.31 12.06 Favored 'General case' 0 C--N 1.368 1.404 0 CA-C-O 122.796 1.284 . . . . 0.0 108.925 174.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -56.62 -36.88 69.95 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 125.637 1.575 . . . . 0.0 112.658 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -60.57 -44.93 95.63 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.572 1.149 . . . . 0.0 111.332 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.95 -37.4 84.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.573 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -71.05 -42.41 69.48 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 118.792 -0.623 . . . . 0.0 110.283 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -55.87 -35.63 66.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 167.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.38 -34.05 77.1 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 116.982 -1.485 . . . . 0.0 114.306 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.48 5.91 6.95 Favored Glycine 0 N--CA 1.504 3.232 0 CA-C-N 120.873 1.67 . . . . 0.0 112.144 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -80.15 130.89 64.42 Favored Pre-proline 0 CA--C 1.565 1.549 0 CA-C-O 118.172 -0.918 . . . . 0.0 108.891 170.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -64.4 148.92 90.85 Favored 'Trans proline' 0 N--CA 1.526 3.419 0 N-CA-C 119.805 2.964 . . . . 0.0 119.805 -168.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -46.49 145.45 6.13 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 N-CA-C 115.031 1.127 . . . . 0.0 115.031 172.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.1 tt -97.06 11.21 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 118.029 -1.468 . . . . 0.0 109.378 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 17.4 p -63.92 -36.45 20.91 Favored Pre-proline 0 N--CA 1.415 -2.206 1 CA-C-O 110.566 -4.54 . . . . 0.0 117.017 -174.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.99 -19.59 22.96 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 125.421 2.972 . . . . 0.0 111.264 -167.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.4 pt -104.97 21.61 3.3 Favored 'Isoleucine or valine' 0 C--N 1.36 1.049 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -175.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.92 139.11 58.09 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 125.555 1.785 . . . . 0.0 113.15 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -96.97 129.73 44.39 Favored 'General case' 0 C--N 1.365 1.262 0 C-N-CA 126.385 1.874 . . . . 0.0 115.145 170.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -81.16 150.91 28.48 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 114.864 -1.062 . . . . 0.0 113.417 166.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.23 176.06 54.33 Favored Glycine 0 CA--C 1.544 1.856 0 O-C-N 125.897 1.998 . . . . 0.0 113.609 163.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.9 m -63.45 146.43 53.62 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 121.037 2.419 . . . . 0.0 116.728 163.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 56.83 24.9 51.04 Favored Glycine 1 C--N 1.4 4.1 0 C-N-CA 126.562 2.029 . . . . 0.0 111.613 -164.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.57 -163.17 51.32 Favored Glycine 0 CA--C 1.551 2.301 0 C-N-CA 127.488 2.47 . . . . 0.0 117.688 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.5 133.08 3.86 Favored Glycine 0 C--N 1.37 2.421 0 CA-C-N 118.967 1.383 . . . . 0.0 111.326 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -79.12 149.95 31.9 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 122.186 0.993 . . . . 0.0 109.89 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 20.5 mm -89.46 147.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 114.649 -1.159 . . . . 0.0 111.576 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.0 t -75.0 147.31 40.88 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.3 mt -96.36 21.0 9.63 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 113.154 -1.839 . . . . 0.0 111.947 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.59 -47.12 5.24 Favored Glycine 0 CA--C 1.499 -0.958 0 CA-C-O 118.291 -1.283 . . . . 0.0 115.804 -168.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.43 93.24 Favored 'General case' 0 N--CA 1.44 -0.926 0 O-C-N 126.954 2.208 . . . . 0.0 109.106 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.4 tp -67.15 -44.36 79.97 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 124.156 0.982 . . . . 0.0 110.985 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.2 tp -61.92 -54.78 37.19 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.846 0.858 . . . . 0.0 110.197 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.0 p -56.52 -44.7 81.03 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.65 0.594 . . . . 0.0 110.588 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.7 m -63.02 -39.74 95.66 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.463 1.105 . . . . 0.0 110.797 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.6 m -62.96 -37.23 86.29 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 115.426 -2.226 . . . . 0.0 114.27 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 88' ' ' ALA . 35.6 mt -88.39 -19.26 26.84 Favored 'General case' 0 C--N 1.383 2.043 0 CA-C-N 121.019 1.736 . . . . 0.0 114.272 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -61.6 -41.12 96.98 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.125 -0.984 . . . . 0.0 110.782 161.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.7 mt -61.04 -43.27 99.14 Favored 'General case' 0 C--N 1.374 1.669 0 O-C-N 124.92 1.387 . . . . 0.0 110.587 -173.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 25.5 p -101.62 27.76 6.12 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.674 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.199 -2.061 0 C-N-CA 126.352 1.929 . . . . 0.0 115.137 175.803 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 76.8 m-20 -90.91 126.62 36.11 Favored 'General case' 0 C--N 1.379 1.879 0 CA-C-O 123.28 1.514 . . . . 0.0 110.023 162.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 tp -115.74 138.02 47.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 127.792 2.437 . . . . 0.0 111.334 -169.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.2 p -131.51 164.55 25.55 Favored 'General case' 0 C--N 1.38 1.894 0 O-C-N 125.725 1.891 . . . . 0.0 111.069 -168.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.78 -43.02 72.45 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 117.102 -3.499 . . . . 0.0 113.104 170.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.08 85.54 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 125.659 1.85 . . . . 0.0 110.869 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -81.38 -18.38 45.73 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.7 tp -74.05 -27.83 61.11 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 119.762 -1.836 . . . . 0.0 107.497 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 66.22 39.37 4.21 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 130.514 3.526 . . . . 0.0 112.433 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -167.67 -161.95 0.42 Allowed 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.5 mt -64.33 126.79 28.91 Favored 'General case' 0 C--O 1.208 -1.112 0 C-N-CA 128.246 2.619 . . . . 0.0 111.452 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -80.94 113.95 44.67 Favored Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.87 9.96 2.79 Favored 'Trans proline' 0 C--N 1.291 -2.482 0 C-N-CA 124.106 3.204 . . . . 0.0 113.894 -171.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.0 mt -131.29 151.45 51.49 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 124.884 1.365 . . . . 0.0 112.636 -171.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.6 p -75.13 -35.85 61.65 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.71 -1.244 . . . . 0.0 110.992 172.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.4 m -75.13 156.13 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.774 0 C-N-CA 118.29 -1.364 . . . . 0.0 114.308 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -87.87 164.71 15.74 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 126.579 3.085 . . . . 0.0 107.837 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -24.3 118.76 0.05 OUTLIER 'General case' 0 N--CA 1.524 3.233 0 C-N-CA 130.25 3.42 . . . . 0.0 115.967 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -135.98 177.52 19.46 Favored Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 104.84 -3.304 . . . . 0.0 104.84 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 5.5 m -71.57 145.06 49.3 Favored 'General case' 0 C--N 1.363 1.155 0 O-C-N 127.025 2.25 . . . . 0.0 115.58 170.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 pt -116.86 135.3 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 118.689 -2.507 . . . . 0.0 105.981 168.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -155.98 146.75 22.04 Favored 'General case' 0 C--O 1.191 -1.999 0 C-N-CA 125.083 1.353 . . . . 0.0 109.924 -168.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 96.4 m -107.25 151.0 26.04 Favored 'General case' 0 C--N 1.381 1.956 0 C-N-CA 125.819 1.648 . . . . 0.0 107.886 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.0 mt -127.02 156.84 73.66 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-N 114.233 -1.348 . . . . 0.0 107.689 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -45.06 144.85 3.56 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 N-CA-C 118.971 2.643 . . . . 0.0 118.971 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t 73.94 41.43 0.41 Allowed 'General case' 0 C--N 1.366 1.3 0 C-N-CA 128.105 2.562 . . . . 0.0 111.37 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 67.64 26.77 7.89 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 119.272 3.064 . . . . 0.0 119.272 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -90.05 135.29 33.74 Favored 'General case' 0 N--CA 1.508 2.464 0 C-N-CA 127.752 2.421 . . . . 0.0 111.466 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.07 140.42 52.29 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 113.174 -1.83 . . . . 0.0 111.825 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.49 153.94 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 -168.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -116.63 118.58 33.0 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 127.234 2.214 . . . . 0.0 106.564 170.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.1 t -101.0 107.74 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.825 0 O-C-N 118.104 -2.873 . . . . 0.0 108.141 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.68 158.55 59.32 Favored Pre-proline 0 N--CA 1.432 -1.354 0 CA-C-N 113.117 -1.856 . . . . 0.0 114.348 -176.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -42.99 -28.22 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 125.21 3.94 . . . . 0.0 115.701 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 59.3 p30 -100.65 8.28 43.46 Favored 'General case' 0 C--O 1.26 1.639 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.46 7.09 82.85 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 116.416 -2.324 . . . . 0.0 117.872 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.2 m -81.07 119.71 23.89 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 123.434 3.617 . . . . 0.0 109.658 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.2 m -92.09 91.86 7.99 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -171.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -70.34 141.51 52.26 Favored 'General case' 0 C--O 1.202 -1.399 0 O-C-N 119.72 -1.863 . . . . 0.0 114.796 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.48 108.52 3.81 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.757 -1.116 . . . . 0.0 110.827 170.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.5 tp -92.84 -8.76 42.58 Favored 'General case' 0 C--O 1.251 1.159 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -135.42 171.31 14.63 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 123.94 1.829 . . . . 0.0 108.75 166.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -67.29 -39.05 85.95 Favored 'General case' 0 CA--C 1.571 1.783 0 O-C-N 118.048 -2.907 . . . . 0.0 109.467 -170.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -58.47 -42.64 87.94 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.057 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . 0.348 . . -51.86 -44.95 63.89 Favored 'General case' 0 C--N 1.37 1.493 0 CA-C-O 125.441 2.543 . . . . 0.0 114.387 170.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -69.42 -42.36 75.11 Favored 'General case' 0 CA--C 1.579 2.091 0 O-C-N 117.281 -3.387 . . . . 0.0 110.974 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -62.08 -35.66 79.33 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 128.165 2.586 . . . . 0.0 113.524 170.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.26 -16.93 58.78 Favored 'General case' 0 CA--C 1.568 1.67 0 O-C-N 121.084 -1.01 . . . . 0.0 110.163 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.0 33.82 4.2 Favored Glycine 0 CA--C 1.487 -1.68 0 N-CA-C 117.939 1.935 . . . . 0.0 117.939 173.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -80.08 154.17 74.92 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-N 118.881 1.34 . . . . 0.0 110.308 165.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -43.58 129.71 6.94 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 124.511 3.474 . . . . 0.0 118.716 164.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.42 142.41 58.48 Favored 'Trans proline' 0 N--CA 1.428 -2.378 0 C-N-CA 123.711 2.94 . . . . 0.0 110.989 169.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.9 tt -90.84 -0.78 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 C-N-CA 125.605 1.562 . . . . 0.0 109.42 -173.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 52.5 m -41.89 -65.72 0.48 Allowed Pre-proline 0 C--N 1.38 1.906 1 CA-C-O 111.203 -4.237 . . . . 0.0 120.153 170.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -70.62 -6.61 19.43 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 125.589 3.032 . . . . 0.0 118.551 -170.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 5.2 pt -107.21 8.05 9.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 122.324 2.329 . . . . 0.0 113.208 165.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -64.73 126.29 27.47 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 123.066 2.666 . . . . 0.0 113.096 169.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.73 144.09 57.48 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.575 1.172 . . . . 0.0 110.179 171.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -80.98 154.68 26.81 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.185 -1.572 . . . . 0.0 113.497 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.485 ' HA2' HD11 ' A' ' 125' ' ' ILE . . . -84.06 -174.39 50.33 Favored Glycine 0 CA--C 1.501 -0.824 0 CA-C-O 124.331 2.073 . . . . 0.0 113.701 172.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.5 t -102.06 139.96 36.98 Favored 'General case' 0 CA--C 1.59 2.494 0 O-C-N 118.126 -2.985 . . . . 0.0 105.604 166.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.43 35.87 21.9 Favored Glycine 0 CA--C 1.502 -0.736 0 O-C-N 118.809 -2.432 . . . . 0.0 111.97 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.27 -170.12 12.61 Favored Glycine 1 CA--C 1.58 4.11 0 CA-C-N 117.885 0.843 . . . . 0.0 114.738 -165.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.61 -179.3 49.24 Favored Glycine 0 C--N 1.361 1.929 0 N-CA-C 120.407 2.923 . . . . 0.0 120.407 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -122.07 154.12 37.75 Favored 'General case' 0 N--CA 1.509 2.491 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.485 HD11 ' HA2' ' A' ' 119' ' ' GLY . 6.4 mm -79.89 117.08 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 C-N-CA 125.081 1.352 . . . . 0.0 110.292 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.8 t -58.23 135.75 57.17 Favored 'General case' 0 CA--C 1.585 2.294 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.6 mt -92.25 10.52 29.24 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 124.763 1.225 . . . . 0.0 113.726 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.14 -53.72 29.57 Favored Glycine 0 N--CA 1.488 2.118 0 CA-C-O 123.832 1.795 . . . . 0.0 114.004 170.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.73 85.7 Favored 'General case' 0 CA--C 1.546 0.816 1 O-C-N 115.255 -4.674 . . . . 0.0 113.959 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.4 tp -64.29 -42.37 96.43 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 173.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.7 tp -59.3 -45.93 89.95 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 118.964 -2.335 . . . . 0.0 111.986 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . 0.323 19.4 p -61.94 -48.49 80.17 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 126.847 2.059 . . . . 0.0 110.426 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 45.4 m -52.98 -44.5 67.22 Favored 'General case' 0 CA--C 1.579 2.069 0 C-N-CA 126.75 2.02 . . . . 0.0 112.448 169.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 37.5 m -60.19 -46.39 89.89 Favored 'General case' 0 C--O 1.194 -1.839 0 O-C-N 117.966 -2.959 . . . . 0.0 109.119 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.0 mt -68.18 -37.22 80.71 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 123.999 1.857 . . . . 0.0 111.42 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -60.61 -42.49 96.91 Favored 'General case' 0 C--O 1.267 2.005 0 O-C-N 118.613 -2.555 . . . . 0.0 116.757 169.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.0 mt -82.77 -21.05 34.76 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . 0.373 2.0 p -98.11 3.79 49.16 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 118.834 2.901 . . . . 0.0 118.834 162.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.074 0 C-N-CA 127.301 2.382 . . . . 0.0 115.541 173.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 . . . . . 0 CA--C 1.466 -2.255 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -57.34 139.12 53.85 Favored 'General case' 0 C--O 1.261 1.675 0 CA-C-O 124.842 2.258 . . . . 0.0 110.419 166.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.8 tp -149.13 142.23 18.14 Favored 'Isoleucine or valine' 0 C--N 1.365 1.269 0 CA-C-O 124.37 2.033 . . . . 0.0 113.747 -167.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.1 p -140.76 177.16 8.22 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -63.39 -45.95 88.7 Favored 'General case' 0 CA--C 1.579 2.09 0 C-N-CA 126.572 1.949 . . . . 0.0 109.068 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.44 75.96 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 119.319 -2.113 . . . . 0.0 116.2 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -67.65 -42.99 81.33 Favored 'General case' 0 C--O 1.178 -2.689 0 CA-C-O 117.056 -1.449 . . . . 0.0 111.875 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.7 tp -62.11 -37.19 84.14 Favored 'General case' 0 CA--C 1.582 2.194 0 CA-C-N 121.678 2.035 . . . . 0.0 114.243 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.351 . . 82.62 30.63 0.1 Allowed 'General case' 0 C--N 1.371 1.532 0 O-C-N 119.719 -1.863 . . . . 0.0 110.589 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -155.02 159.57 40.42 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.81 125.12 14.19 Favored 'General case' 0 N--CA 1.423 -1.806 0 C-N-CA 128.563 2.745 . . . . 0.0 115.225 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -64.41 128.02 92.85 Favored Pre-proline 0 CA--C 1.586 2.331 0 O-C-N 117.029 -3.544 . . . . 0.0 110.818 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -105.76 0.46 0.2 Allowed 'Trans proline' 0 CA--C 1.481 -2.131 0 C-N-CA 123.598 2.865 . . . . 0.0 108.891 -154.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.7 mt -132.82 171.34 14.04 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 p -92.2 -0.27 57.43 Favored 'General case' 0 C--O 1.19 -2.049 0 CA-C-O 124.161 1.934 . . . . 0.0 111.245 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.0 m -93.49 161.26 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 117.045 -3.534 . . . . 0.0 110.474 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -78.9 174.3 11.65 Favored 'General case' 0 C--O 1.205 -1.267 0 O-C-N 120.33 -1.481 . . . . 0.0 113.655 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -53.01 138.84 29.53 Favored 'General case' 0 CA--C 1.61 3.267 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.74 -150.74 5.37 Favored Glycine 0 C--N 1.379 2.956 0 C-N-CA 130.392 3.853 . . . . 0.0 114.386 -166.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.7 m -128.4 145.5 51.07 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 111.762 -2.219 . . . . 0.0 106.177 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.5 pt -113.48 144.45 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.034 0 C-N-CA 129.663 3.185 . . . . 0.0 110.207 165.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -145.84 142.76 29.14 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-O 122.609 1.195 . . . . 0.0 112.093 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 69.7 m -91.45 138.36 31.63 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 170.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.0 mt -120.78 155.91 56.79 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 118.836 -2.415 . . . . 0.0 105.312 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.288 36.9 Cg_exo -39.64 135.3 1.35 Allowed 'Trans proline' 0 N--CA 1.505 2.15 1 C-N-CA 125.696 4.264 . . . . 0.0 122.21 173.046 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.452 68.3 m 78.52 48.12 0.04 OUTLIER 'General case' 0 C--N 1.378 1.842 0 O-C-N 119.553 -1.967 . . . . 0.0 112.348 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 46.5 43.29 12.02 Favored 'General case' 0 C--N 1.391 2.37 0 CA-C-N 112.983 -1.917 . . . . 0.0 113.46 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -95.45 143.8 26.49 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 126.216 1.806 . . . . 0.0 111.465 170.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.689 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -125.36 129.34 49.73 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-O 124.648 2.166 . . . . 0.0 106.142 175.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.2 m -118.22 157.73 19.5 Favored 'Isoleucine or valine' 0 C--N 1.381 1.957 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.993 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -131.26 137.29 48.8 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -125.72 118.76 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 O-C-N 120.623 -1.298 . . . . 0.0 108.033 173.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.57 162.87 1.16 Allowed Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 170.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -68.81 -13.22 36.44 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 CA-C-O 113.786 -2.673 . . . . 0.0 114.589 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -91.75 -1.93 57.18 Favored 'General case' 0 C--N 1.37 1.458 0 CA-C-N 121.084 1.765 . . . . 0.0 112.902 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.61 0.17 36.98 Favored Glycine 0 CA--C 1.49 -1.523 0 CA-C-O 114.397 -3.446 . . . . 0.0 109.843 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.8 m -81.6 119.04 23.29 Favored 'General case' 0 C--N 1.361 1.08 1 CA-C-N 124.212 4.006 . . . . 0.0 112.93 -170.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.7 m -82.06 130.59 35.12 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.015 175.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -125.36 160.81 28.44 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 126.891 2.076 . . . . 0.0 111.675 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.99 127.42 32.94 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 167.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.9 tp -94.77 -47.5 6.45 Favored 'General case' 0 C--O 1.206 -1.227 0 O-C-N 119.671 -1.893 . . . . 0.0 109.844 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -101.77 163.56 12.19 Favored 'General case' 0 C--N 1.391 2.392 0 CA-C-O 123.739 1.733 . . . . 0.0 108.834 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . 0.274 12.9 p-10 -55.29 -36.8 66.53 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 126.432 1.893 . . . . 0.0 113.758 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -61.89 -44.37 96.95 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.808 1.243 . . . . 0.0 112.064 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.95 -40.83 94.79 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.666 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -68.38 -42.02 79.72 Favored 'General case' 0 CA--C 1.557 1.218 0 O-C-N 121.774 -0.579 . . . . 0.0 111.52 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -54.9 -39.63 68.96 Favored 'General case' 0 C--N 1.369 1.422 0 O-C-N 120.224 -1.547 . . . . 0.0 112.542 167.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.01 -36.65 84.27 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 127.0 6.46 5.39 Favored Glycine 0 N--CA 1.507 3.369 0 CA-C-O 124.125 1.959 . . . . 0.0 110.464 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -80.33 133.67 56.45 Favored Pre-proline 0 CA--C 1.588 2.433 0 CA-C-O 116.67 -1.633 . . . . 0.0 110.161 170.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -70.64 150.7 63.29 Favored 'Trans proline' 0 CA--C 1.484 -2.018 0 CA-C-N 126.892 3.497 . . . . 0.0 119.182 -164.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . 0.269 74.7 Cg_exo -44.7 146.92 2.0 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 N-CA-C 117.769 2.18 . . . . 0.0 117.769 171.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.7 tt -98.99 10.15 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 C-N-CA 116.979 -1.888 . . . . 0.0 107.336 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.4 p -62.17 -35.83 23.95 Favored Pre-proline 0 C--N 1.374 1.639 1 CA-C-O 109.169 -5.205 . . . . 0.0 116.972 -174.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.16 -17.59 16.97 Favored 'Trans proline' 0 C--N 1.36 1.137 0 CA-C-N 127.141 3.586 . . . . 0.0 109.018 -165.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.6 pt -106.53 20.65 4.43 Favored 'Isoleucine or valine' 0 C--N 1.368 1.389 0 C-N-CA 125.699 1.6 . . . . 0.0 113.458 -172.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -63.59 138.36 58.47 Favored 'General case' 0 C--N 1.363 1.188 0 C-N-CA 126.645 1.978 . . . . 0.0 111.86 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -95.83 128.13 42.45 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 127.647 2.379 . . . . 0.0 116.999 168.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -78.03 149.47 34.0 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 120.257 -1.527 . . . . 0.0 114.576 166.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.95 174.6 54.34 Favored Glycine 0 C--O 1.202 -1.885 0 C-N-CA 126.438 1.97 . . . . 0.0 113.655 162.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.0 m -60.43 146.97 42.61 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 122.215 3.007 . . . . 0.0 118.584 161.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 52.53 27.87 27.45 Favored Glycine 1 C--N 1.415 4.942 0 C-N-CA 128.471 2.938 . . . . 0.0 111.665 -162.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.23 -161.61 53.84 Favored Glycine 0 CA--C 1.544 1.863 0 C-N-CA 129.892 3.615 . . . . 0.0 119.291 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.26 133.6 4.42 Favored Glycine 0 CA--C 1.549 2.195 0 CA-C-N 120.459 2.129 . . . . 0.0 109.873 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -79.18 151.69 31.12 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 124.842 2.258 . . . . 0.0 107.916 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 22.4 mm -91.17 144.27 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 126.717 2.007 . . . . 0.0 111.529 173.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.4 t -71.71 147.31 47.52 Favored 'General case' 0 C--O 1.195 -1.796 0 N-CA-C 119.868 3.285 . . . . 0.0 119.868 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.5 mt -97.78 20.92 11.21 Favored 'General case' 0 C--O 1.204 -1.338 0 C-N-CA 126.231 1.812 . . . . 0.0 112.317 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -88.71 -41.3 6.05 Favored Glycine 0 CA--C 1.496 -1.121 0 N-CA-C 118.207 2.043 . . . . 0.0 118.207 -169.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.47 98.55 Favored 'General case' 0 N--CA 1.431 -1.375 0 O-C-N 127.045 2.262 . . . . 0.0 110.199 170.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.8 tp -66.69 -44.12 82.58 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-O 122.563 1.173 . . . . 0.0 111.702 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.3 tp -62.68 -53.16 58.73 Favored 'General case' 0 C--N 1.364 1.23 0 O-C-N 120.329 -1.482 . . . . 0.0 110.465 175.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.2 p -57.66 -44.76 85.94 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.66 0.743 . . . . 0.0 111.088 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 83.0 m -62.31 -42.35 99.3 Favored 'General case' 0 C--O 1.264 1.822 0 C-N-CA 125.611 1.564 . . . . 0.0 110.982 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 26.2 m -60.22 -36.88 78.69 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 173.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.689 HD21 ' HB2' ' A' ' 88' ' ' ALA . 23.7 mt -89.59 -16.78 29.82 Favored 'General case' 0 C--N 1.376 1.722 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 176.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -63.41 -38.57 91.65 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 117.12 -1.419 . . . . 0.0 111.375 158.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.4 mt -63.47 -43.0 98.59 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-O 125.227 2.441 . . . . 0.0 110.507 -171.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 21.6 p -100.61 25.66 7.57 Favored 'General case' 0 C--N 1.376 1.74 0 CA-C-N 112.779 -2.009 . . . . 0.0 112.414 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.158 0 C-N-CA 128.368 2.889 . . . . 0.0 114.863 175.626 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 CA--C 1.497 -1.069 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -59.23 137.34 58.01 Favored 'General case' 0 C--O 1.252 1.226 0 O-C-N 126.416 2.323 . . . . 0.0 111.334 164.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.5 tp -145.8 142.33 21.83 Favored 'Isoleucine or valine' 0 C--O 1.264 1.86 0 CA-C-N 112.791 -2.004 . . . . 0.0 113.036 -167.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.9 p -139.36 177.91 7.58 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -63.78 -44.56 93.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 124.704 1.252 . . . . 0.0 110.579 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.92 79.71 Favored 'General case' 0 C--O 1.247 0.946 0 O-C-N 120.228 -1.545 . . . . 0.0 112.972 173.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -67.19 -42.97 83.31 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-O 117.415 -1.278 . . . . 0.0 111.901 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.1 tp -61.94 -36.19 80.64 Favored 'General case' 0 CA--C 1.587 2.392 0 CA-C-N 121.002 1.728 . . . . 0.0 113.293 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.287 . . 79.38 32.66 0.24 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.038 1.335 . . . . 0.0 111.99 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -155.85 158.2 37.66 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.4 mt -50.92 127.39 18.55 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 124.116 1.912 . . . . 0.0 115.461 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -63.82 124.42 84.89 Favored Pre-proline 0 CA--C 1.573 1.86 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.262 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -100.11 1.98 0.82 Allowed 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 122.02 1.813 . . . . 0.0 113.285 -160.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.5 mt -131.15 168.01 18.18 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.2 p -90.01 1.62 56.09 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 122.381 1.086 . . . . 0.0 113.781 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.5 m -92.53 160.54 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 119.976 -1.703 . . . . 0.0 111.654 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -77.39 174.37 10.9 Favored 'General case' 0 CA--C 1.567 1.63 0 O-C-N 119.221 -2.174 . . . . 0.0 111.827 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -53.91 140.35 31.03 Favored 'General case' 0 CA--C 1.601 2.941 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 -177.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.2 -150.09 5.28 Favored Glycine 0 C--N 1.369 2.409 0 C-N-CA 127.53 2.491 . . . . 0.0 114.909 -166.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.1 m -127.88 146.5 50.6 Favored 'General case' 0 C--N 1.371 1.506 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.2 pt -115.49 145.89 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 126.925 2.09 . . . . 0.0 110.081 166.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -147.22 141.63 26.39 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 122.94 1.353 . . . . 0.0 111.426 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 61.8 m -89.27 138.15 31.69 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 169.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.0 mt -120.13 155.41 55.74 Favored Pre-proline 0 N--CA 1.482 1.17 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 172.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.268 31.9 Cg_exo -40.55 134.93 2.11 Favored 'Trans proline' 0 N--CA 1.529 3.583 0 N-CA-C 122.133 3.859 . . . . 0.0 122.133 173.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.383 50.4 m 79.53 50.22 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.075 1.35 . . . . 0.0 110.311 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 45.94 44.64 11.48 Favored 'General case' 0 C--O 1.203 -1.383 0 O-C-N 126.803 2.564 . . . . 0.0 111.954 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.89 145.71 25.63 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 118.644 0.656 . . . . 0.0 110.438 170.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.662 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -124.65 129.9 51.42 Favored 'General case' 0 C--O 1.273 2.312 0 CA-C-O 123.22 1.486 . . . . 0.0 107.481 174.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.19 157.24 21.13 Favored 'Isoleucine or valine' 0 C--N 1.362 1.114 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.157 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -130.36 137.78 50.07 Favored 'General case' 0 C--O 1.254 1.321 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 t -126.35 119.32 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.1 164.53 2.36 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 171.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.79 -11.78 29.99 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 CA-C-O 114.481 -2.383 . . . . 0.0 114.466 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -91.03 -1.43 57.81 Favored 'General case' 0 C--N 1.371 1.529 0 CA-C-N 121.132 1.787 . . . . 0.0 113.544 173.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.81 -0.85 41.83 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-O 116.748 -2.14 . . . . 0.0 113.207 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.5 m -80.01 120.24 23.92 Favored 'General case' 0 C--N 1.38 1.899 0 CA-C-N 120.979 2.39 . . . . 0.0 113.374 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.7 m -83.52 130.54 35.01 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.05 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -124.56 162.18 24.6 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.678 1.591 . . . . 0.0 111.209 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.53 130.2 35.17 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.42 -46.79 6.55 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 116.45 -1.738 . . . . 0.0 108.83 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -105.28 164.33 11.92 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-O 123.398 1.57 . . . . 0.0 108.898 174.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -56.29 -37.41 69.82 Favored 'General case' 0 N--CA 1.511 2.588 0 CA-C-N 113.448 -1.705 . . . . 0.0 112.469 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.6 mtp85 -60.53 -44.59 95.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 124.784 1.303 . . . . 0.0 111.327 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.36 -37.18 84.68 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.78 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -71.2 -42.07 69.46 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 117.767 -1.111 . . . . 0.0 110.084 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -56.57 -35.5 68.24 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 168.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.71 76.23 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 116.223 -1.846 . . . . 0.0 114.124 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.54 6.27 6.76 Favored Glycine 1 N--CA 1.518 4.165 0 CA-C-N 121.162 1.801 . . . . 0.0 111.839 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -80.27 131.45 62.26 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-O 118.054 -0.974 . . . . 0.0 108.642 170.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -65.37 149.28 88.36 Favored 'Trans proline' 1 N--CA 1.546 4.565 0 N-CA-C 119.478 2.838 . . . . 0.0 119.478 -168.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.41 145.74 5.68 Favored 'Trans proline' 0 N--CA 1.519 2.979 0 C-N-CA 117.243 -1.371 . . . . 0.0 114.905 172.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.4 tt -97.46 11.25 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 117.811 -1.555 . . . . 0.0 109.499 175.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 17.2 p -63.96 -35.63 16.64 Favored Pre-proline 0 N--CA 1.399 -2.993 1 CA-C-O 110.185 -4.721 . . . . 0.0 117.667 -174.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.9 -19.68 23.18 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 CA-C-N 124.744 2.73 . . . . 0.0 111.294 -168.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.2 pt -105.56 22.52 3.07 Favored 'Isoleucine or valine' 0 C--N 1.372 1.583 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -61.67 139.3 58.31 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 125.895 1.997 . . . . 0.0 112.978 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . 0.251 . . -97.46 130.13 44.59 Favored 'General case' 0 C--N 1.376 1.731 0 C-N-CA 125.976 1.71 . . . . 0.0 115.138 170.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -82.02 151.37 27.14 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.936 167.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.36 176.08 54.41 Favored Glycine 0 CA--C 1.544 1.887 0 O-C-N 126.99 2.681 . . . . 0.0 113.683 164.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.9 m -63.62 146.66 53.33 Favored 'General case' 0 CA--C 1.597 2.762 0 CA-C-N 120.966 2.383 . . . . 0.0 116.395 164.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 57.2 24.43 51.24 Favored Glycine 1 C--N 1.402 4.212 0 O-C-N 125.735 1.897 . . . . 0.0 111.814 -164.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.81 -163.2 50.97 Favored Glycine 0 CA--C 1.553 2.441 0 C-N-CA 126.951 2.215 . . . . 0.0 117.288 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.52 132.79 3.78 Favored Glycine 0 C--N 1.377 2.86 0 CA-C-N 118.313 1.056 . . . . 0.0 111.358 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -79.42 150.67 31.24 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 122.533 1.159 . . . . 0.0 109.631 -174.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 20.3 mm -90.3 147.52 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.974 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.5 t -74.93 147.74 40.67 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 174.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.0 mt -97.01 21.51 9.66 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 112.807 -1.997 . . . . 0.0 111.741 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.9 -46.66 5.31 Favored Glycine 0 C--O 1.219 -0.784 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 -168.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.48 -43.24 93.32 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 127.514 2.538 . . . . 0.0 109.056 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.2 tp -67.33 -43.92 80.42 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.713 0.805 . . . . 0.0 111.08 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.3 tp -62.03 -54.35 42.81 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.154 0.582 . . . . 0.0 110.589 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.1 p -56.78 -44.28 81.7 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 124.066 0.854 . . . . 0.0 110.823 -175.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.9 m -62.98 -40.26 97.19 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.252 1.021 . . . . 0.0 110.547 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.4 m -62.94 -36.52 83.72 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 115.355 -2.259 . . . . 0.0 114.642 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 88' ' ' ALA . 37.1 mt -89.01 -18.65 26.92 Favored 'General case' 0 C--N 1.387 2.208 0 CA-C-N 121.401 1.91 . . . . 0.0 114.31 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -61.69 -40.79 96.23 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 121.411 -0.806 . . . . 0.0 111.215 160.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.0 mt -61.79 -42.98 99.69 Favored 'General case' 0 C--N 1.381 1.938 0 O-C-N 125.458 1.723 . . . . 0.0 110.074 -173.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.0 p -101.95 27.84 6.22 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.807 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.199 -2.051 0 C-N-CA 125.9 1.715 . . . . 0.0 115.343 175.676 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 . . . . . 0 CA--C 1.552 1.046 0 CA-C-O 121.512 0.673 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -87.37 145.47 26.3 Favored 'General case' 0 C--O 1.264 1.831 0 O-C-N 128.698 3.749 . . . . 0.0 111.519 171.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 tp -115.56 144.43 23.17 Favored 'Isoleucine or valine' 0 C--N 1.364 1.219 0 CA-C-N 112.335 -2.211 . . . . 0.0 108.701 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.501 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 38.5 p -132.08 163.05 29.32 Favored 'General case' 0 C--O 1.198 -1.623 0 C-N-CA 126.206 1.803 . . . . 0.0 114.082 -174.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 29.5 mt-10 -62.05 -45.97 91.2 Favored 'General case' 0 C--O 1.202 -1.416 0 C-N-CA 127.536 2.334 . . . . 0.0 108.951 168.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.81 -24.62 61.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 119.346 -2.096 . . . . 0.0 116.161 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -62.55 -46.38 88.63 Favored 'General case' 0 CA--C 1.593 2.623 0 CA-C-O 122.132 0.968 . . . . 0.0 111.418 172.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 mt -71.04 -38.0 72.54 Favored 'General case' 0 C--O 1.211 -0.925 0 C-N-CA 129.275 3.03 . . . . 0.0 114.066 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.36 . . 67.14 -22.29 0.11 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 119.351 3.093 . . . . 0.0 119.351 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . 0.303 84.9 t80 -77.12 167.2 22.19 Favored 'General case' 0 C--O 1.254 1.304 0 CA-C-O 122.615 1.198 . . . . 0.0 112.791 161.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.8 tp -48.09 118.61 2.46 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.097 1.759 . . . . 0.0 115.509 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -61.48 122.04 67.94 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 119.299 -2.125 . . . . 0.0 111.011 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -95.5 26.39 0.29 Allowed 'Trans proline' 0 CA--C 1.552 1.393 0 C-N-CA 122.869 2.379 . . . . 0.0 114.301 -169.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.2 mt -136.9 153.41 50.74 Favored 'General case' 0 C--N 1.39 2.347 0 CA-C-N 120.057 1.299 . . . . 0.0 109.463 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.4 p -73.11 -22.62 60.52 Favored 'General case' 0 C--N 1.364 1.203 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.5 m -83.92 160.55 3.42 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 1 O-C-N 129.435 4.209 . . . . 0.0 108.236 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -91.5 114.62 27.19 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 115.481 -2.199 . . . . 0.0 109.993 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.501 ' CD2' ' HA ' ' A' ' 63' ' ' SER . 61.3 m170 52.85 -167.88 0.05 Allowed 'General case' 0 C--N 1.36 1.025 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.59 -167.45 40.33 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.757 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.1 m -121.45 149.04 43.62 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 103.166 -2.902 . . . . 0.0 103.166 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 pt -121.36 151.65 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.311 0 C-N-CA 124.747 1.219 . . . . 0.0 110.474 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -145.12 139.81 27.57 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 3.8 m -99.25 123.97 43.96 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 83' ' ' LEU . 90.0 mt -96.49 151.35 37.96 Favored Pre-proline 0 N--CA 1.508 2.45 0 CA-C-O 114.265 -2.778 . . . . 0.0 112.58 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -57.59 150.0 63.72 Favored 'Trans proline' 0 N--CA 1.508 2.348 0 CA-C-N 124.654 2.698 . . . . 0.0 117.952 -173.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.9 m 59.46 54.27 4.73 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -168.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 57.11 48.65 15.04 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 170.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -117.03 159.41 22.57 Favored 'General case' 0 C--N 1.369 1.422 0 CA-C-O 117.995 -1.003 . . . . 0.0 111.761 169.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.95 148.04 43.01 Favored 'General case' 0 C--N 1.384 2.089 0 O-C-N 125.53 1.769 . . . . 0.0 112.451 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 99' ' ' ALA . 24.8 m -138.31 170.92 16.12 Favored 'Isoleucine or valine' 0 C--N 1.396 2.61 0 O-C-N 127.068 2.73 . . . . 0.0 113.64 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -140.67 124.5 17.18 Favored 'General case' 0 C--O 1.265 1.87 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -172.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.1 t -102.69 107.76 22.67 Favored 'Isoleucine or valine' 0 C--N 1.359 0.995 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . 0.332 . . -60.18 150.61 70.61 Favored Pre-proline 0 N--CA 1.515 2.818 0 N-CA-C 119.979 3.325 . . . . 0.0 119.979 174.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -46.3 -23.75 2.19 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 N-CA-C 119.952 3.02 . . . . 0.0 119.952 177.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -86.55 -15.26 40.49 Favored 'General case' 0 C--N 1.375 1.716 0 CA-C-O 124.166 1.936 . . . . 0.0 115.589 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 114.15 -3.66 23.88 Favored Glycine 0 N--CA 1.483 1.829 0 C-N-CA 130.304 3.811 . . . . 0.0 116.387 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.323 8.3 m -68.94 114.27 7.09 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 46.6 m -90.16 108.7 19.9 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 124.736 1.272 . . . . 0.0 112.873 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -100.87 142.84 31.77 Favored 'General case' 0 N--CA 1.434 -1.259 0 O-C-N 126.166 2.166 . . . . 0.0 111.259 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.402 ' HA ' HG12 ' A' ' 89' ' ' VAL . . . -67.28 128.34 36.05 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-N 113.46 -1.7 . . . . 0.0 112.861 169.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.1 tp -108.57 1.34 21.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.355 -1.466 . . . . 0.0 108.672 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . 0.34 52.9 p-10 -148.86 159.53 44.08 Favored 'General case' 0 C--N 1.368 1.391 0 O-C-N 120.762 -1.211 . . . . 0.0 111.681 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -58.63 -43.45 89.71 Favored 'General case' 0 C--N 1.363 1.191 0 CA-C-N 112.814 -1.994 . . . . 0.0 113.528 -169.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -66.71 -34.65 78.32 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 121.16 -0.962 . . . . 0.0 111.648 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . 0.371 . . -61.43 -40.52 94.73 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 174.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -62.02 -41.83 98.51 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 115.363 -2.256 . . . . 0.0 108.702 169.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.303 42.5 mmtm -63.24 -42.88 99.27 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.84 2.533 . . . . 0.0 117.84 175.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.95 -34.29 65.54 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 115.497 -2.192 . . . . 0.0 111.396 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 130.57 -1.72 5.64 Favored Glycine 0 C--N 1.366 2.234 0 CA-C-N 121.362 1.892 . . . . 0.0 115.474 173.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -71.25 148.1 93.58 Favored Pre-proline 0 C--N 1.369 1.443 0 CA-C-O 116.818 -1.563 . . . . 0.0 111.706 171.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.09 139.01 23.55 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-O 114.381 -2.425 . . . . 0.0 111.702 -171.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -54.01 142.37 65.28 Favored 'Trans proline' 0 CA--C 1.482 -2.109 0 N-CA-C 119.88 2.992 . . . . 0.0 119.88 168.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.3 tt -89.89 15.56 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.948 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.8 p -64.3 -43.37 72.53 Favored Pre-proline 0 C--N 1.378 1.82 0 CA-C-O 113.127 -3.321 . . . . 0.0 117.077 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -74.35 -1.65 11.28 Favored 'Trans proline' 0 N--CA 1.5 1.863 1 CA-C-N 129.798 4.535 . . . . 0.0 117.408 174.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 27.4 mm -91.2 -0.79 9.65 Favored 'Isoleucine or valine' 0 C--N 1.367 1.349 0 C-N-CA 127.567 2.347 . . . . 0.0 113.595 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -61.92 140.36 58.31 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 119.191 -2.193 . . . . 0.0 116.902 166.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -81.22 128.95 34.34 Favored 'General case' 0 C--O 1.199 -1.599 0 CA-C-O 123.108 1.432 . . . . 0.0 113.62 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -55.92 145.32 25.35 Favored 'General case' 0 N--CA 1.535 3.79 1 N-CA-C 122.609 4.3 . . . . 0.0 122.609 175.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.15 173.8 42.01 Favored Glycine 0 C--N 1.356 1.668 0 CA-C-N 113.287 -1.779 . . . . 0.0 112.381 156.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.6 t -93.73 127.6 39.53 Favored 'General case' 0 C--N 1.386 2.186 0 O-C-N 126.568 1.981 . . . . 0.0 109.916 167.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 67.59 39.37 90.77 Favored Glycine 0 N--CA 1.51 3.612 0 C-N-CA 118.404 -1.855 . . . . 0.0 115.983 -169.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 105.85 -168.9 15.43 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 164.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.33 -170.09 50.76 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-O 123.882 1.823 . . . . 0.0 112.208 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -149.74 149.67 30.91 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.9 mt -66.36 137.16 25.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 O-C-N 119.197 -2.189 . . . . 0.0 109.57 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.3 t -50.56 129.49 22.44 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 58.7 mt -98.93 6.86 46.53 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.501 -1.375 . . . . 0.0 111.594 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.12 -60.15 9.41 Favored Glycine 0 C--N 1.377 2.833 0 C-N-CA 128.563 2.983 . . . . 0.0 114.9 -170.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . 0.354 . . -65.29 -32.21 73.74 Favored 'General case' 0 CA--C 1.6 2.891 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 10.3 tp -55.66 -48.38 75.11 Favored 'General case' 0 C--N 1.383 2.051 0 CA-C-N 120.6 1.545 . . . . 0.0 112.14 163.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 20.2 tp -65.28 -42.53 93.06 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . 0.29 17.7 p -69.07 -40.37 78.52 Favored 'General case' 0 C--N 1.371 1.513 0 CA-C-O 115.79 -2.052 . . . . 0.0 112.758 170.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 90.2 m -64.08 -31.07 72.12 Favored 'General case' 0 C--N 1.36 1.033 0 CA-C-N 122.928 2.604 . . . . 0.0 110.138 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.5 m -64.89 -48.92 72.51 Favored 'General case' 0 C--N 1.389 2.312 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.1 mt -69.29 -43.11 74.49 Favored 'General case' 0 CA--C 1.495 -1.161 0 O-C-N 126.843 2.589 . . . . 0.0 112.883 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.08 -33.94 69.61 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 127.016 2.697 . . . . 0.0 114.885 173.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . 0.291 40.0 tp -69.19 -28.96 66.85 Favored 'General case' 0 N--CA 1.421 -1.892 0 O-C-N 126.338 2.274 . . . . 0.0 110.879 -176.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.6 p -108.01 12.96 26.51 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 174.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.584 0 C-N-CA 128.114 2.769 . . . . 0.0 118.581 -176.312 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 . . . . . 0 C--O 1.193 -1.884 0 CA-C-O 122.018 0.913 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -64.86 140.56 58.88 Favored 'General case' 0 C--N 1.368 1.371 0 C-N-CA 128.09 2.556 . . . . 0.0 111.688 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.5 tp -142.13 142.59 27.52 Favored 'Isoleucine or valine' 0 C--O 1.263 1.781 0 O-C-N 117.78 -3.075 . . . . 0.0 110.702 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.3 p -145.78 172.23 13.62 Favored 'General case' 0 C--N 1.39 2.34 0 CA-C-N 112.308 -2.224 . . . . 0.0 112.711 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.68 -46.33 82.9 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 117.516 -1.231 . . . . 0.0 109.006 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.73 -34.96 67.43 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 120.714 1.597 . . . . 0.0 107.67 -174.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -66.12 -40.05 90.38 Favored 'General case' 0 C--N 1.369 1.456 0 O-C-N 120.241 -1.537 . . . . 0.0 113.511 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.2 tp -67.97 -44.91 75.6 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 124.112 0.965 . . . . 0.0 113.556 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 88.61 21.09 0.04 OUTLIER 'General case' 0 C--N 1.356 0.89 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 171.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -151.26 173.6 14.27 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 101.124 -3.658 . . . . 0.0 101.124 -166.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.1 mt -73.69 144.67 45.71 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 118.069 -2.894 . . . . 0.0 114.089 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.448 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 66.0 t-105 -92.18 127.97 47.06 Favored Pre-proline 0 C--O 1.208 -1.109 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.705 -170.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 71' ' ' TRP . 88.0 Cg_endo -93.7 6.36 2.76 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 CA-C-O 115.206 -2.081 . . . . 0.0 110.919 -157.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.5 mt -124.7 158.17 33.87 Favored 'General case' 0 C--N 1.361 1.077 0 CA-C-N 122.638 2.472 . . . . 0.0 108.654 -169.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.2 p -62.38 -48.27 80.48 Favored 'General case' 0 N--CA 1.507 2.401 0 C-N-CA 124.118 0.967 . . . . 0.0 113.156 163.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.1 m -65.6 149.17 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 125.14 2.4 . . . . 0.0 113.022 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.37 176.59 4.51 Favored 'General case' 0 CA--C 1.561 1.369 0 O-C-N 120.275 -1.515 . . . . 0.0 109.084 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -25.16 137.32 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 153.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.33 -118.77 0.95 Allowed Glycine 0 C--N 1.373 2.608 0 CA-C-O 123.962 1.868 . . . . 0.0 112.636 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 m -156.54 154.11 29.77 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 pt -133.35 129.22 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-O 124.447 2.07 . . . . 0.0 107.579 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -130.38 154.43 47.7 Favored 'General case' 0 C--N 1.359 0.984 0 CA-C-N 112.157 -2.292 . . . . 0.0 111.848 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 96.9 m -122.15 134.3 54.74 Favored 'General case' 0 C--O 1.189 -2.116 0 O-C-N 119.959 -1.713 . . . . 0.0 108.275 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.79 153.67 81.68 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-N 122.977 2.626 . . . . 0.0 107.431 -171.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -43.28 150.13 0.44 Allowed 'Trans proline' 0 CA--C 1.509 -0.726 0 C-N-CA 122.09 1.86 . . . . 0.0 114.799 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.338 37.8 m 82.1 33.28 0.09 Allowed 'General case' 0 C--N 1.361 1.106 0 O-C-N 127.529 3.018 . . . . 0.0 116.216 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 49.05 40.95 18.42 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 130.735 3.614 . . . . 0.0 115.037 -167.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -94.75 133.92 37.92 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 123.3 1.524 . . . . 0.0 109.27 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.31 141.25 52.18 Favored 'General case' 0 C--O 1.192 -1.935 0 O-C-N 119.647 -1.908 . . . . 0.0 109.528 171.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.25 153.31 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.382 0 C-N-CA 126.654 1.982 . . . . 0.0 112.232 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -111.74 121.75 45.93 Favored 'General case' 0 CA--C 1.562 1.432 1 C-N-CA 132.282 4.233 . . . . 0.0 106.802 170.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.32 108.49 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 118.697 -2.502 . . . . 0.0 108.321 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.44 154.05 93.75 Favored Pre-proline 0 N--CA 1.434 -1.273 0 C-N-CA 127.245 2.218 . . . . 0.0 115.937 169.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -74.91 12.46 1.19 Allowed 'Trans proline' 0 N--CA 1.515 2.785 0 N-CA-C 116.051 1.52 . . . . 0.0 116.051 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -100.99 1.13 39.34 Favored 'General case' 0 C--N 1.361 1.107 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.528 158.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.33 11.62 60.83 Favored Glycine 0 CA--C 1.465 -3.072 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 m -76.04 117.47 17.79 Favored 'General case' 0 N--CA 1.435 -1.225 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.641 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . 0.263 53.9 m -93.34 80.68 4.41 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 -171.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -70.59 153.64 42.67 Favored 'General case' 0 C--O 1.254 1.318 0 O-C-N 121.1 -1.0 . . . . 0.0 112.882 -173.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.27 114.7 7.77 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 167.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.2 tp -92.33 -25.59 18.48 Favored 'General case' 0 CA--C 1.558 1.267 0 CA-C-O 121.698 0.761 . . . . 0.0 112.997 173.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -120.99 173.84 7.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 119.164 -2.21 . . . . 0.0 110.093 163.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -60.43 -30.99 69.99 Favored 'General case' 0 CA--C 1.576 1.946 0 C-N-CA 130.436 3.494 . . . . 0.0 116.581 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -67.65 -54.08 22.51 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.444 172.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.83 -35.12 74.08 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -61.88 -45.51 93.44 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 122.385 1.088 . . . . 0.0 112.153 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -68.29 -28.12 66.91 Favored 'General case' 0 C--O 1.259 1.554 0 CA-C-O 124.368 2.032 . . . . 0.0 115.859 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.62 -21.13 61.88 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 116.662 2.097 . . . . 0.0 116.662 168.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.69 15.07 11.46 Favored Glycine 0 CA--C 1.463 -3.202 0 CA-C-O 114.915 -3.159 . . . . 0.0 114.396 -174.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -87.31 150.39 49.14 Favored Pre-proline 0 N--CA 1.429 -1.498 0 C-N-CA 114.079 -3.049 . . . . 0.0 110.461 164.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -57.23 142.16 94.6 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 CA-C-O 116.668 -1.472 . . . . 0.0 115.668 -172.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -68.06 139.35 46.49 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 CA-C-O 125.316 2.132 . . . . 0.0 116.532 169.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.4 tt -90.05 10.64 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 O-C-N 118.584 -2.573 . . . . 0.0 107.116 -171.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.27 -52.23 70.8 Favored Pre-proline 0 C--N 1.369 1.45 0 O-C-N 119.791 -1.818 . . . . 0.0 114.093 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.94 -7.34 20.89 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 CA-C-N 121.539 1.585 . . . . 0.0 113.204 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.6 pt -103.79 9.03 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.198 0.908 . . . . 0.0 111.174 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -69.82 137.03 51.46 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.996 0.903 . . . . 0.0 112.794 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -94.31 129.37 41.0 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 122.979 1.371 . . . . 0.0 112.171 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -89.59 140.78 29.21 Favored 'General case' 0 C--O 1.253 1.241 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.49 -168.89 7.75 Favored Glycine 0 C--N 1.383 3.171 0 N-CA-C 118.475 2.15 . . . . 0.0 118.475 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 m -96.97 123.35 40.67 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 124.626 0.839 . . . . 0.0 112.817 164.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 62.68 50.29 65.5 Favored Glycine 0 CA--C 1.496 -1.153 0 C-N-CA 126.362 1.934 . . . . 0.0 113.876 -168.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.89 -175.91 51.91 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 125.865 1.698 . . . . 0.0 113.093 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.7 174.16 44.11 Favored Glycine 0 CA--C 1.539 1.538 0 O-C-N 127.33 2.429 . . . . 0.0 111.977 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -126.75 143.42 51.25 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 -172.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 37.3 mm -74.17 140.55 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 O-C-N 120.077 -1.639 . . . . 0.0 111.657 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 30.9 t -62.01 127.62 32.27 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 -169.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.6 mt -72.62 -17.52 61.67 Favored 'General case' 0 C--N 1.378 1.828 0 O-C-N 118.052 -2.905 . . . . 0.0 111.806 169.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -41.52 -53.85 4.18 Favored Glycine 0 C--N 1.343 0.964 0 C-N-CA 127.548 2.499 . . . . 0.0 117.688 -166.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.37 89.82 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 120.263 -1.728 . . . . 0.0 115.007 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 48.9 tp -64.7 -48.25 75.38 Favored 'General case' 0 C--O 1.206 -1.204 0 O-C-N 118.471 -2.643 . . . . 0.0 112.48 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.0 tp -64.51 -52.15 59.31 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 121.437 -0.789 . . . . 0.0 109.032 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.4 p -60.13 -41.99 93.85 Favored 'General case' 0 N--CA 1.509 2.516 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.7 m -55.75 -42.66 75.73 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 126.419 1.888 . . . . 0.0 110.036 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 78.4 m -60.12 -43.53 95.58 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 127.961 3.288 . . . . 0.0 108.655 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 12.1 mt -66.19 -36.7 83.76 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -57.91 -42.32 84.48 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 119.347 -2.096 . . . . 0.0 112.495 172.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.2 mt -62.96 -42.61 99.87 Favored 'General case' 0 C--O 1.193 -1.914 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.738 -172.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 28.4 p -113.94 27.37 9.57 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 115.332 -2.271 . . . . 0.0 110.625 -165.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.37 2.444 0 CA-C-N 123.714 2.961 . . . . 0.0 115.019 -178.762 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 . . . . . 0 C--O 1.214 -0.803 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -74.4 155.37 38.16 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 111.58 -2.554 . . . . 0.0 109.784 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 tp -147.54 138.67 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.199 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 -175.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.7 t -145.01 154.3 42.39 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.67 -1.269 . . . . 0.0 109.113 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -54.9 -30.16 57.58 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 126.065 1.746 . . . . 0.0 112.246 168.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.96 -37.44 82.4 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 171.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -70.77 -44.7 66.15 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.297 1.839 . . . . 0.0 113.108 168.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 8.4 mt -58.76 -43.19 90.26 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 82.18 -3.96 1.47 Allowed 'General case' 0 N--CA 1.411 -2.388 0 CA-C-O 122.427 1.108 . . . . 0.0 108.969 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -138.53 151.07 47.02 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 118.678 -2.513 . . . . 0.0 106.147 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 tp -51.09 142.24 12.72 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 126.133 1.773 . . . . 0.0 114.039 -167.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -55.9 134.83 73.19 Favored Pre-proline 0 CA--C 1.583 2.234 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -97.76 2.31 1.47 Allowed 'Trans proline' 0 C--O 1.206 -1.097 0 CA-C-O 113.898 -2.626 . . . . 0.0 112.273 -174.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.3 mt -112.34 165.95 11.73 Favored 'General case' 0 C--N 1.364 1.221 0 CA-C-N 121.558 1.981 . . . . 0.0 110.986 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.2 p -91.99 -25.26 18.93 Favored 'General case' 0 C--N 1.361 1.097 0 O-C-N 120.564 -1.335 . . . . 0.0 111.381 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 m -71.3 135.12 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -79.31 115.11 18.77 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 124.076 0.86 . . . . 0.0 109.207 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.345 38.5 m80 57.74 -164.74 0.17 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 117.115 -1.422 . . . . 0.0 112.042 -178.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.19 -162.48 34.81 Favored Glycine 0 C--N 1.371 2.502 0 N-CA-C 103.37 -3.892 . . . . 0.0 103.37 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.38 151.29 43.38 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 103.49 -2.781 . . . . 0.0 103.49 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.97 161.04 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-O 124.303 2.001 . . . . 0.0 106.821 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -139.36 156.91 46.69 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 118.799 -2.438 . . . . 0.0 106.523 170.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.4 m -134.68 128.48 33.1 Favored 'General case' 0 C--N 1.37 1.461 0 O-C-N 120.041 -1.662 . . . . 0.0 110.808 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.1 mt -113.92 148.0 38.96 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 115.783 -2.056 . . . . 0.0 106.812 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.262 31.3 Cg_exo -50.26 147.75 15.52 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 125.21 3.94 . . . . 0.0 116.485 -166.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.257 12.3 m 72.22 39.97 0.73 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.974 1.71 . . . . 0.0 113.815 -175.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 58.53 46.72 14.46 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 128.688 2.795 . . . . 0.0 112.357 172.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.69 113.27 24.9 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 171.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.27 130.76 50.61 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.883 -1.136 . . . . 0.0 110.979 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.9 t -114.12 140.78 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-O 125.484 2.564 . . . . 0.0 106.968 -175.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -111.44 150.24 30.13 Favored 'General case' 0 C--N 1.354 0.799 0 CA-C-N 113.263 -1.79 . . . . 0.0 107.096 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.9 t -132.97 123.27 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 N-CA-C 102.174 -3.269 . . . . 0.0 102.174 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.94 163.05 17.77 Favored Pre-proline 0 CA--C 1.588 2.415 0 CA-C-O 122.625 1.203 . . . . 0.0 112.316 172.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.47 -38.96 28.43 Favored 'Trans proline' 0 N--CA 1.517 2.891 0 C-N-CA 124.861 3.707 . . . . 0.0 114.598 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.2 p-10 -84.24 -10.43 57.69 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 121.253 1.842 . . . . 0.0 113.291 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.9 4.85 36.08 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 125.645 1.593 . . . . 0.0 115.221 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.4 m -58.88 139.4 56.57 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 122.684 1.231 . . . . 0.0 114.015 167.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.1 m -111.74 125.62 54.18 Favored 'General case' 0 C--O 1.206 -1.219 0 O-C-N 121.088 -1.008 . . . . 0.0 110.942 -165.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -133.95 166.23 23.19 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 123.454 1.597 . . . . 0.0 110.641 -165.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -117.38 124.19 48.3 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 119.824 -1.798 . . . . 0.0 112.394 -171.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.1 tp -90.02 -26.76 20.15 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -173.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -135.81 178.17 7.25 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.734 -1.229 . . . . 0.0 108.727 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -53.34 -43.88 68.04 Favored 'General case' 0 C--N 1.399 2.72 0 C-N-CA 125.611 1.564 . . . . 0.0 114.504 -171.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -70.65 -31.71 68.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.64 -37.53 65.31 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 122.578 1.18 . . . . 0.0 109.241 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -62.52 -50.52 71.04 Favored 'General case' 0 C--N 1.364 1.205 0 O-C-N 119.926 -1.734 . . . . 0.0 109.824 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -53.81 -31.77 50.28 Favored 'General case' 0 CA--C 1.586 2.333 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.92 -22.8 66.52 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 115.953 -1.975 . . . . 0.0 112.422 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 128.81 8.47 3.81 Favored Glycine 0 C--N 1.378 2.885 0 CA-C-N 122.696 2.498 . . . . 0.0 116.12 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -118.79 145.65 38.23 Favored Pre-proline 0 C--N 1.376 1.741 0 CA-C-N 121.862 2.831 . . . . 0.0 108.496 -174.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -51.68 148.62 20.95 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.945 3.097 . . . . 0.0 111.042 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -78.98 146.98 20.83 Favored 'Trans proline' 0 CA--C 1.511 -0.641 1 C-N-CA 125.418 4.079 . . . . 0.0 108.048 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.7 tp -89.25 -0.32 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 125.295 2.474 . . . . 0.0 111.229 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.6 p -56.1 -42.21 94.99 Favored Pre-proline 0 C--O 1.213 -0.827 0 CA-C-O 113.663 -3.065 . . . . 0.0 112.9 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -59.94 -31.8 94.19 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 CA-C-N 126.509 3.36 . . . . 0.0 115.693 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.3 tt -98.75 13.55 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -55.19 149.06 13.09 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.011 -1.449 . . . . 0.0 110.3 162.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -92.79 136.09 33.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 112.767 -2.015 . . . . 0.0 110.623 172.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -67.66 145.69 54.56 Favored 'General case' 0 C--O 1.201 -1.489 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.759 164.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.91 175.63 23.3 Favored Glycine 0 N--CA 1.484 1.851 0 CA-C-O 122.947 1.304 . . . . 0.0 110.883 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.3 t -71.72 125.46 27.19 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 112.745 -1.727 . . . . 0.0 110.668 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.1 7.61 57.21 Favored Glycine 0 C--N 1.353 1.525 0 O-C-N 125.385 1.678 . . . . 0.0 116.887 -165.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.98 156.9 22.25 Favored Glycine 0 CA--C 1.54 1.598 0 O-C-N 121.516 -0.991 . . . . 0.0 114.409 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.82 161.0 11.54 Favored Glycine 0 C--N 1.368 2.346 0 C-N-CA 130.347 3.832 . . . . 0.0 114.107 167.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -71.1 138.97 50.15 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 125.941 1.696 . . . . 0.0 108.442 -167.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.1 mt -73.77 140.24 18.04 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-N 110.087 -3.233 . . . . 0.0 112.62 168.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.4 t -65.03 152.15 44.18 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 118.296 2.702 . . . . 0.0 118.296 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 59.5 mt -102.22 11.74 37.76 Favored 'General case' 0 C--O 1.206 -1.214 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -177.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.85 -51.81 56.27 Favored Glycine 0 CA--C 1.555 2.584 0 O-C-N 119.177 -2.202 . . . . 0.0 116.981 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.66 -37.38 82.29 Favored 'General case' 0 N--CA 1.42 -1.928 0 O-C-N 119.164 -2.374 . . . . 0.0 114.184 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.8 tp -60.98 -45.43 94.82 Favored 'General case' 0 C--O 1.252 1.227 0 C-N-CA 124.399 1.079 . . . . 0.0 111.111 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.8 tp -69.95 -42.21 73.52 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 p -63.41 -45.31 91.59 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.16 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 94.4 m -64.23 -42.72 96.44 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 126.118 2.136 . . . . 0.0 109.398 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 92.4 m -46.92 -55.76 7.52 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 115.104 -2.379 . . . . 0.0 116.379 167.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 25.1 mt -71.56 -25.21 62.11 Favored 'General case' 0 CA--C 1.568 1.654 0 O-C-N 128.173 3.42 . . . . 0.0 113.781 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -60.38 -45.88 91.96 Favored 'General case' 0 CA--C 1.58 2.112 0 C-N-CA 126.853 2.061 . . . . 0.0 110.327 164.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.4 mt -65.2 -42.96 93.04 Favored 'General case' 0 C--N 1.416 3.497 0 O-C-N 119.58 -1.95 . . . . 0.0 114.281 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 16.6 p -101.81 15.76 27.97 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 127.256 2.222 . . . . 0.0 110.702 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.942 0 CA-C-O 115.901 -2.611 . . . . 0.0 114.092 174.892 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 . . . . . 0 CA--C 1.557 1.222 0 CA-C-O 123.29 1.519 . . . . 0.0 108.106 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -87.18 155.82 19.94 Favored 'General case' 0 CA--C 1.557 1.248 0 O-C-N 117.502 -3.249 . . . . 0.0 111.62 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.7 tp -113.48 117.85 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 123.292 1.52 . . . . 0.0 113.443 165.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.0 p -128.87 179.25 5.83 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 123.645 1.688 . . . . 0.0 109.285 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -61.65 -29.68 70.22 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 119.581 -1.95 . . . . 0.0 114.284 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.99 -42.57 84.8 Favored 'General case' 0 C--O 1.266 1.936 0 C-N-CA 125.448 1.499 . . . . 0.0 112.932 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.44 -46.2 84.18 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 164.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.27 83.3 mt -73.73 -17.38 61.12 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 122.78 2.536 . . . . 0.0 113.872 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.3 . . 65.18 11.76 7.46 Favored 'General case' 0 C--O 1.192 -1.961 0 O-C-N 127.915 3.259 . . . . 0.0 115.953 -177.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -165.12 166.4 19.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 127.307 2.243 . . . . 0.0 107.004 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.7 mt -18.93 133.07 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.443 3.097 . . . . 0.0 119.209 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -73.72 127.01 89.19 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 116.622 -3.799 . . . . 0.0 114.975 164.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -89.15 15.49 2.01 Favored 'Trans proline' 0 CA--C 1.57 2.294 0 CA-C-N 123.292 2.211 . . . . 0.0 112.229 -168.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 mt -136.0 165.1 26.46 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-O 123.753 1.739 . . . . 0.0 110.727 -172.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.8 p -100.97 -1.56 34.1 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.561 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.415 ' H ' HG22 ' A' ' 75' ' ' VAL . 17.2 m -90.27 171.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.381 1.962 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 169.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -81.26 174.7 11.27 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 122.27 1.033 . . . . 0.0 111.816 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -73.37 144.18 46.55 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 128.838 2.855 . . . . 0.0 106.012 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.03 179.54 36.42 Favored Glycine 0 C--N 1.367 2.304 0 CA-C-N 112.058 -2.337 . . . . 0.0 110.501 -164.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.3 m -84.65 120.21 26.12 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-O 123.716 1.722 . . . . 0.0 113.593 -173.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -86.69 143.68 10.91 Favored 'Isoleucine or valine' 0 C--O 1.257 1.489 0 CA-C-O 124.243 1.973 . . . . 0.0 111.574 165.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -145.67 151.68 38.42 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 112.577 -2.101 . . . . 0.0 107.125 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 89.6 m -121.51 115.02 22.07 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-O 125.086 2.374 . . . . 0.0 107.132 172.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mt -92.86 150.81 40.09 Favored Pre-proline 0 CA--C 1.507 -0.701 0 CA-C-O 116.093 -1.908 . . . . 0.0 106.564 -174.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -47.07 138.75 15.93 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 123.848 3.032 . . . . 0.0 116.545 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.6 m 80.14 49.26 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 120.757 1.617 . . . . 0.0 115.229 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 46.98 49.19 14.99 Favored 'General case' 0 C--N 1.392 2.448 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -106.32 116.51 32.06 Favored 'General case' 0 C--N 1.385 2.119 0 C-N-CA 117.868 -1.533 . . . . 0.0 111.942 170.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.77 106.94 15.85 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-O 123.291 1.52 . . . . 0.0 107.575 -173.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.7 m -122.67 144.79 30.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 C-N-CA 127.589 2.356 . . . . 0.0 109.089 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -113.33 128.47 56.47 Favored 'General case' 0 N--CA 1.425 -1.687 0 O-C-N 119.006 -2.309 . . . . 0.0 106.165 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.9 t -106.49 111.64 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -69.98 156.3 92.02 Favored Pre-proline 0 C--O 1.27 2.153 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.598 171.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.478 ' HD2' ' HB1' ' A' ' 92' ' ' ALA . 41.1 Cg_endo -68.61 2.36 2.98 Favored 'Trans proline' 0 CA--C 1.498 -1.31 0 C-N-CA 124.409 3.406 . . . . 0.0 113.241 -166.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -102.66 -25.13 13.67 Favored 'General case' 0 C--O 1.245 0.834 0 O-C-N 127.139 2.774 . . . . 0.0 110.188 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.11 24.85 3.16 Favored Glycine 0 C--N 1.348 1.242 0 C-N-CA 126.282 1.896 . . . . 0.0 110.815 172.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.46 147.32 24.35 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.0 m -129.47 125.68 36.97 Favored 'General case' 0 C--O 1.263 1.814 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -167.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -128.94 126.81 40.45 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 125.852 1.97 . . . . 0.0 108.581 -165.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.04 124.26 19.99 Favored 'General case' 0 C--O 1.211 -0.932 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 69.7 mt -93.77 -30.49 14.83 Favored 'General case' 0 C--N 1.369 1.441 0 O-C-N 119.638 -1.914 . . . . 0.0 112.571 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -122.12 178.11 5.05 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 124.132 1.92 . . . . 0.0 106.51 174.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -79.04 -19.51 51.26 Favored 'General case' 0 CA--C 1.583 2.223 0 O-C-N 118.402 -2.687 . . . . 0.0 117.751 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -59.18 -37.78 78.19 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 126.018 2.074 . . . . 0.0 110.168 172.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.23 -30.75 69.89 Favored 'General case' 0 CA--C 1.472 -2.029 0 CA-C-O 114.998 -2.429 . . . . 0.0 113.271 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -62.7 -41.31 99.06 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 126.788 2.035 . . . . 0.0 114.014 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -66.34 -37.01 84.36 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 168.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.32 -4.68 40.61 Favored 'General case' 0 C--O 1.257 1.475 0 O-C-N 118.801 -2.437 . . . . 0.0 112.348 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.94 28.63 9.83 Favored Glycine 0 C--N 1.353 1.526 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.75 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -86.43 134.92 37.13 Favored Pre-proline 0 CA--C 1.58 2.1 0 CA-C-O 115.468 -2.206 . . . . 0.0 107.862 170.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -56.8 128.26 29.23 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 O-C-N 125.667 2.404 . . . . 0.0 114.313 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -32.27 145.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.362 2.041 . . . . 0.0 115.824 161.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.9 tt -99.96 19.46 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 C-N-CA 126.188 1.795 . . . . 0.0 110.453 173.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.05 -30.47 1.13 Allowed Pre-proline 0 CA--C 1.558 1.251 0 CA-C-O 112.165 -3.778 . . . . 0.0 116.439 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -71.59 -42.33 1.85 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 125.342 2.944 . . . . 0.0 111.716 -169.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 21.5 pt -88.28 6.19 3.75 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 C-N-CA 128.243 2.617 . . . . 0.0 111.774 -165.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -53.11 155.9 2.39 Favored 'General case' 0 C--O 1.221 -0.419 1 O-C-N 116.021 -4.174 . . . . 0.0 118.355 168.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -98.68 147.33 24.96 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 117.31 -1.756 . . . . 0.0 110.04 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . 0.353 13.7 mmmm -64.94 143.99 57.58 Favored 'General case' 0 C--N 1.37 1.476 0 CA-C-O 124.072 1.891 . . . . 0.0 110.568 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -82.06 -146.19 5.6 Favored Glycine 0 CA--C 1.57 3.489 0 CA-C-O 126.374 3.208 . . . . 0.0 117.503 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.4 t -111.42 111.74 22.99 Favored 'General case' 0 CA--C 1.512 -0.507 1 O-C-N 116.113 -4.169 . . . . 0.0 102.86 170.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.48 48.27 5.37 Favored Glycine 1 C--N 1.399 4.053 0 CA-C-N 120.319 1.418 . . . . 0.0 110.096 177.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.82 -164.52 54.78 Favored Glycine 0 C--N 1.381 3.075 0 N-CA-C 117.12 1.608 . . . . 0.0 117.12 -171.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.39 -166.4 1.14 Allowed Glycine 0 C--N 1.338 0.684 1 N-CA-C 123.491 4.157 . . . . 0.0 123.491 -173.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . 0.317 74.3 m-85 -133.54 149.06 51.68 Favored 'General case' 0 C--O 1.253 1.269 0 O-C-N 117.414 -3.403 . . . . 0.0 110.296 -173.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 79.6 mt -63.92 151.67 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.163 0 CA-C-N 124.082 3.128 . . . . 0.0 108.784 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.0 t -62.55 145.24 54.84 Favored 'General case' 0 C--O 1.198 -1.64 0 O-C-N 118.273 -2.767 . . . . 0.0 113.17 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.7 mt -97.52 4.92 50.26 Favored 'General case' 0 CA--C 1.58 2.116 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 -172.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -76.59 -41.72 23.83 Favored Glycine 0 C--N 1.394 3.789 0 C-N-CA 119.683 -1.246 . . . . 0.0 115.38 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.26 -34.52 72.91 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 117.389 -3.418 . . . . 0.0 115.767 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 27.9 tp -54.26 -58.71 6.36 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 126.083 1.753 . . . . 0.0 112.133 165.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 38.3 tp -63.09 -40.3 97.25 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.3 p -71.82 -33.45 68.52 Favored 'General case' 0 C--O 1.251 1.175 0 O-C-N 119.296 -2.128 . . . . 0.0 115.108 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 32.4 m -61.71 -42.69 99.28 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.92 1.288 . . . . 0.0 108.656 169.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.1 m -57.56 -46.85 83.43 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.8 mt -72.12 -30.13 64.75 Favored 'General case' 0 CA--C 1.562 1.406 0 O-C-N 124.865 1.353 . . . . 0.0 112.232 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -58.25 -46.62 85.65 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 116.845 -1.55 . . . . 0.0 113.14 168.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 71.9 mt -72.63 -45.25 59.96 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 119.236 0.926 . . . . 0.0 111.29 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . 0.342 1.2 p -74.44 -17.76 60.74 Favored 'General case' 0 C--O 1.202 -1.429 0 CA-C-O 115.75 -2.072 . . . . 0.0 113.328 -170.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.381 3.065 0 N-CA-C 120.035 2.774 . . . . 0.0 120.035 169.757 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 . . . . . 0 CA--C 1.466 -2.26 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.75 139.06 55.32 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.401 HD11 HD12 ' A' ' 130' ' ' LEU . 1.1 tt -116.24 142.6 29.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 121.458 -0.776 . . . . 0.0 109.408 162.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.5 ' HB2' ' CE1' ' A' ' 77' ' ' HIS . 90.3 p -152.76 158.88 42.93 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-O 116.143 -1.885 . . . . 0.0 107.207 -169.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -64.28 -18.16 64.32 Favored 'General case' 0 C--N 1.367 1.365 0 CA-C-N 123.608 2.913 . . . . 0.0 110.598 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.96 -25.9 53.37 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 120.476 -1.39 . . . . 0.0 111.817 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -73.29 -28.66 62.23 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 125.949 1.7 . . . . 0.0 111.275 173.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.427 HD11 HD13 ' A' ' 130' ' ' LEU . 9.7 mt -88.98 3.77 50.45 Favored 'General case' 0 C--O 1.203 -1.35 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 36.8 63.01 0.72 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 120.747 3.61 . . . . 0.0 120.747 -168.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . 0.297 51.0 t80 83.58 149.12 0.08 Allowed 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 129.214 3.006 . . . . 0.0 109.714 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.324 2.1 tp 89.57 81.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 128.989 2.916 . . . . 0.0 109.601 173.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -85.7 124.79 70.64 Favored Pre-proline 0 N--CA 1.479 0.989 0 O-C-N 120.37 -1.456 . . . . 0.0 112.474 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.72 3.2 8.0 Favored 'Trans proline' 0 C--N 1.362 1.253 0 CA-C-N 122.037 1.763 . . . . 0.0 114.637 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.9 mt -120.63 158.27 27.77 Favored 'General case' 0 C--N 1.375 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.95 -165.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.0 p -78.83 -30.08 45.07 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 170.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.5 m -71.91 147.71 10.4 Favored 'Isoleucine or valine' 0 C--N 1.367 1.36 0 C-N-CA 124.506 1.122 . . . . 0.0 111.491 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . 0.256 62.7 t0 -90.15 82.35 6.07 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 118.49 -2.631 . . . . 0.0 111.426 -172.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.5 ' CE1' ' HB2' ' A' ' 63' ' ' SER 0.33 27.5 m170 77.84 178.12 0.15 Allowed 'General case' 0 CA--C 1.474 -1.956 0 O-C-N 120.567 -1.333 . . . . 0.0 114.013 179.016 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.21 -176.57 39.86 Favored Glycine 0 N--CA 1.433 -1.535 0 O-C-N 117.977 -2.952 . . . . 0.0 114.711 -172.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.259 17.0 p -124.24 146.29 48.84 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 118.591 -2.711 . . . . 0.0 105.757 171.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.409 HD11 HD23 ' A' ' 137' ' ' LEU . 2.8 pp -119.84 150.09 22.45 Favored 'Isoleucine or valine' 0 C--N 1.366 1.29 0 CA-C-O 126.644 3.116 . . . . 0.0 112.379 177.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -141.66 137.9 32.1 Favored 'General case' 0 CA--C 1.57 1.745 0 O-C-N 116.536 -3.852 . . . . 0.0 108.524 168.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.9 m -108.29 140.78 41.06 Favored 'General case' 0 C--N 1.368 1.385 0 O-C-N 117.342 -3.349 . . . . 0.0 104.906 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 87' ' ' ASN . 10.7 mt -111.38 146.99 35.73 Favored Pre-proline 0 N--CA 1.432 -1.359 0 C-N-CA 129.501 3.12 . . . . 0.0 102.909 -173.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -40.35 134.58 2.01 Favored 'Trans proline' 0 N--CA 1.507 2.274 1 C-N-CA 126.45 4.767 . . . . 0.0 113.059 -173.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.272 1.0 OUTLIER 85.2 31.59 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 122.489 1.137 . . . . 0.0 108.909 170.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . 0.281 21.8 m-20 65.84 44.54 2.79 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 116.872 -3.642 . . . . 0.0 115.448 176.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 83' ' ' LEU . 2.3 m-80 -101.74 114.07 27.81 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 174.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.21 120.82 36.09 Favored 'General case' 0 N--CA 1.409 -2.508 0 O-C-N 125.013 1.446 . . . . 0.0 111.284 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.1 t -99.87 145.35 10.84 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 CA-C-O 127.737 3.637 . . . . 0.0 109.883 166.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -111.3 128.56 55.98 Favored 'General case' 0 N--CA 1.44 -0.94 1 O-C-N 115.038 -4.789 . . . . 0.0 106.714 168.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.8 t -110.44 124.57 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.723 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.36 167.15 19.69 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-O 117.222 -1.37 . . . . 0.0 114.367 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -41.13 -34.31 1.54 Allowed 'Trans proline' 0 N--CA 1.52 3.079 0 N-CA-C 120.518 3.238 . . . . 0.0 120.518 165.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.0 p30 -96.99 3.89 51.77 Favored 'General case' 0 CA--C 1.477 -1.846 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.77 -13.25 29.71 Favored Glycine 0 CA--C 1.526 0.725 0 O-C-N 120.262 -1.524 . . . . 0.0 111.91 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.282 47.0 m -66.47 113.02 4.38 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -173.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.68 119.58 10.16 Favored 'General case' 0 C--N 1.375 1.691 0 C-N-CA 128.014 2.526 . . . . 0.0 115.6 171.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -120.04 141.52 49.67 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 166.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.04 149.3 37.37 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 153.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . 0.255 23.1 tp -118.76 -3.26 10.81 Favored 'General case' 0 C--N 1.379 1.883 0 C-N-CA 129.87 3.268 . . . . 0.0 111.848 177.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.2 p30 -158.07 175.1 14.23 Favored 'General case' 0 C--N 1.38 1.897 0 CA-C-N 120.412 1.46 . . . . 0.0 109.916 169.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . 0.315 69.4 m-20 -60.34 -36.91 79.07 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -173.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.4 mtt85 -59.19 -41.34 88.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 127.811 3.194 . . . . 0.0 111.639 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.12 -23.5 28.42 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-O 124.932 2.301 . . . . 0.0 114.659 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -63.7 -47.28 81.78 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.63 -1.623 . . . . 0.0 112.391 163.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -61.32 -38.12 85.71 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-O 125.157 2.408 . . . . 0.0 115.427 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.39 -34.23 68.66 Favored 'General case' 0 CA--C 1.572 1.819 0 O-C-N 119.308 -2.12 . . . . 0.0 113.388 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 127.92 -3.83 6.92 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 120.807 3.083 . . . . 0.0 120.807 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -70.66 143.49 89.88 Favored Pre-proline 0 N--CA 1.487 1.421 0 CA-C-N 121.654 2.727 . . . . 0.0 112.161 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -48.44 146.8 9.84 Favored 'Trans proline' 0 C--N 1.296 -2.229 1 C-N-CA 126.323 4.682 . . . . 0.0 119.431 175.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -82.25 151.76 15.85 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 118.266 -1.492 . . . . 0.0 109.503 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.9 tt -86.08 4.19 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.554 1.942 . . . . 0.0 109.784 -171.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.65 -40.28 74.1 Favored Pre-proline 0 CA--C 1.578 2.029 1 N-CA-C 122.04 4.089 . . . . 0.0 122.04 -168.339 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.84 -6.66 14.31 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 113.974 -3.751 . . . . 0.0 114.308 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 31.4 mm -86.19 -16.61 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 C-N-CA 125.904 1.682 . . . . 0.0 106.952 176.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -56.93 145.39 30.2 Favored 'General case' 0 C--O 1.194 -1.834 0 CA-C-O 126.04 2.829 . . . . 0.0 117.49 164.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -93.7 132.59 37.91 Favored 'General case' 0 C--O 1.209 -1.07 0 CA-C-N 112.459 -2.155 . . . . 0.0 111.774 174.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . 0.467 41.3 mtpt -57.65 144.58 37.13 Favored 'General case' 0 C--O 1.178 -2.676 0 O-C-N 119.322 -2.111 . . . . 0.0 112.989 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -110.79 -168.88 19.21 Favored Glycine 0 N--CA 1.494 2.524 0 CA-C-N 119.943 1.247 . . . . 0.0 112.215 -159.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 64.4 m -76.05 119.89 20.61 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 116.145 -1.883 . . . . 0.0 113.487 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.55 49.33 5.83 Favored Glycine 0 C--N 1.365 2.147 0 CA-C-N 121.669 2.031 . . . . 0.0 114.194 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 59.62 -155.85 28.36 Favored Glycine 1 CA--C 1.593 4.918 0 O-C-N 118.245 -2.914 . . . . 0.0 116.375 -158.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 49.81 -152.69 3.58 Favored Glycine 0 C--O 1.213 -1.163 0 CA-C-O 124.395 2.108 . . . . 0.0 114.904 -167.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -134.58 148.44 50.46 Favored 'General case' 0 N--CA 1.418 -2.041 0 C-N-CA 126.594 1.958 . . . . 0.0 111.721 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.9 mt -60.9 140.17 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.363 0 O-C-N 120.324 -1.485 . . . . 0.0 112.391 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.5 t -52.61 137.65 30.13 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 128.844 2.857 . . . . 0.0 112.999 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.4 mt -98.46 4.48 48.37 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.481 -1.387 . . . . 0.0 111.47 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -44.25 -63.88 2.21 Favored Glycine 0 CA--C 1.486 -1.726 0 C-N-CA 127.775 2.607 . . . . 0.0 113.823 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.9 -45.08 93.68 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 173.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.427 HD13 HD11 ' A' ' 67' ' ' LEU . 34.0 tp -63.18 -43.44 98.22 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 124.502 1.126 . . . . 0.0 113.561 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.8 tp -64.72 -45.97 84.27 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 121.736 0.779 . . . . 0.0 112.405 168.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 78.4 p -74.8 -36.46 62.48 Favored 'General case' 0 CA--C 1.497 -1.095 0 O-C-N 117.919 -2.988 . . . . 0.0 113.347 -169.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 52.0 m -59.89 -43.09 94.99 Favored 'General case' 0 C--O 1.266 1.97 0 C-N-CA 128.695 2.798 . . . . 0.0 105.588 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 47.0 m -63.05 -41.65 99.54 Favored 'General case' 0 C--N 1.377 1.787 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.527 -174.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.427 ' HA ' ' SG ' ' A' ' 138' ' ' CYS . 17.8 mt -69.64 -36.95 76.57 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 117.719 2.489 . . . . 0.0 117.719 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -61.39 -37.89 85.09 Favored 'General case' 0 CA--C 1.57 1.715 0 O-C-N 116.801 -3.687 . . . . 0.0 109.839 165.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.409 HD23 HD11 ' A' ' 80' ' ' ILE . 49.0 tp -69.92 -31.25 68.92 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 118.155 -2.841 . . . . 0.0 115.622 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.427 ' SG ' ' HA ' ' A' ' 135' ' ' LEU . 28.6 p -92.21 14.86 14.96 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.088 -1.008 . . . . 0.0 110.957 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.984 0 C-N-CA 125.779 1.656 . . . . 0.0 109.993 -179.902 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -73.76 135.02 43.54 Favored 'General case' 0 N--CA 1.411 -2.402 0 O-C-N 128.338 3.524 . . . . 0.0 111.464 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.424 HD13 ' CD1' ' A' ' 137' ' ' LEU . 9.9 tp -136.54 128.88 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 125.571 2.605 . . . . 0.0 112.945 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.9 p -162.76 171.78 16.24 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 127.271 2.228 . . . . 0.0 107.832 -159.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -45.1 -52.17 9.42 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 128.253 2.621 . . . . 0.0 114.756 173.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.76 93.55 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 174.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -82.45 -19.87 38.08 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 120.293 -1.504 . . . . 0.0 111.522 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.6 tp -75.06 -42.57 56.67 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 117.971 2.582 . . . . 0.0 117.971 166.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 65.56 15.71 10.16 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 130.006 3.322 . . . . 0.0 114.289 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -134.27 166.81 21.94 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 162.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.6 mt -39.31 128.67 1.8 Allowed 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -174.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -66.27 139.62 96.44 Favored Pre-proline 0 CA--C 1.567 1.621 0 CA-C-O 113.296 -3.24 . . . . 0.0 114.806 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -116.97 -3.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 2.015 0 CA-C-O 111.187 -3.755 . . . . 0.0 110.302 -167.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 mt -113.13 152.95 29.01 Favored 'General case' 0 C--N 1.401 2.818 0 O-C-N 127.484 2.99 . . . . 0.0 112.929 -177.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.2 p -79.28 -17.12 55.31 Favored 'General case' 0 N--CA 1.416 -2.132 0 O-C-N 118.281 -2.762 . . . . 0.0 113.64 -171.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.8 m -72.16 147.94 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 129.986 3.314 . . . . 0.0 115.003 166.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -56.59 171.24 0.32 Allowed 'General case' 0 C--O 1.2 -1.527 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 154.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -36.32 127.13 0.79 Allowed 'General case' 0 C--N 1.373 1.62 0 C-N-CA 130.322 3.449 . . . . 0.0 109.778 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.58 -168.24 22.68 Favored Glycine 0 N--CA 1.434 -1.459 0 CA-C-O 123.322 1.512 . . . . 0.0 111.659 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.9 m -120.97 115.57 23.43 Favored 'General case' 0 C--N 1.378 1.825 0 CA-C-N 111.228 -2.486 . . . . 0.0 109.031 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.438 ' H ' HG13 ' A' ' 80' ' ' ILE 0.328 1.9 pp -88.81 138.38 19.31 Favored 'Isoleucine or valine' 0 C--N 1.396 2.605 0 CA-C-N 121.074 1.761 . . . . 0.0 110.534 172.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -133.39 132.5 41.28 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.4 m -100.16 130.32 46.28 Favored 'General case' 0 C--N 1.382 1.994 0 CA-C-O 124.053 1.883 . . . . 0.0 110.322 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.3 mt -105.52 157.53 34.31 Favored Pre-proline 0 CA--C 1.569 1.706 0 O-C-N 119.32 -2.113 . . . . 0.0 113.589 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -40.35 145.73 0.32 Allowed 'Trans proline' 0 CA--C 1.475 -2.475 1 C-N-CA 127.084 5.19 . . . . 0.0 113.425 169.1 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.1 m 70.55 41.41 0.95 Allowed 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 118.971 2.952 . . . . 0.0 118.971 173.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 64.98 30.35 11.88 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 129.343 3.057 . . . . 0.0 112.751 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.254 65.5 m-20 -101.06 137.31 39.59 Favored 'General case' 0 C--N 1.373 1.615 0 CA-C-N 120.009 1.277 . . . . 0.0 109.497 -169.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.12 124.2 36.35 Favored 'General case' 0 C--O 1.2 -1.535 0 CA-C-N 122.431 2.378 . . . . 0.0 111.002 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.254 32.7 m -120.11 144.29 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-O 124.361 2.029 . . . . 0.0 113.252 -174.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -121.06 131.37 54.24 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 120.236 -1.54 . . . . 0.0 107.594 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.35 118.32 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.323 0 C-N-CA 126.309 1.843 . . . . 0.0 110.867 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.17 156.51 76.51 Favored Pre-proline 0 CA--C 1.577 1.99 0 O-C-N 126.435 2.334 . . . . 0.0 115.401 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -43.69 -35.1 6.18 Favored 'Trans proline' 0 C--O 1.255 1.372 0 N-CA-C 120.395 3.19 . . . . 0.0 120.395 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -69.98 -33.54 72.19 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 116.779 -1.581 . . . . 0.0 113.719 172.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 127.86 -3.31 6.94 Favored Glycine 0 C--N 1.364 2.086 1 C-N-CA 130.915 4.102 . . . . 0.0 113.745 176.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.8 m -57.07 132.47 53.01 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 125.257 1.423 . . . . 0.0 113.834 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.4 m -106.19 109.0 20.8 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 123.163 2.711 . . . . 0.0 107.072 -174.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -113.26 148.4 35.64 Favored 'General case' 0 C--O 1.255 1.351 0 O-C-N 120.631 -1.293 . . . . 0.0 108.837 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.3 127.65 33.44 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 114.636 -2.602 . . . . 0.0 111.438 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.38 -9.43 30.0 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 120.339 1.427 . . . . 0.0 112.393 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -141.75 171.02 14.63 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.414 1.102 . . . . 0.0 110.484 172.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -65.27 -32.54 74.26 Favored 'General case' 0 N--CA 1.416 -2.172 0 C-N-CA 130.396 3.478 . . . . 0.0 110.909 -171.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -59.09 -42.48 90.55 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 125.482 1.739 . . . . 0.0 113.352 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.419 ' HA ' ' HB3' ' A' ' 107' ' ' ALA . . . -84.6 -17.31 39.12 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -172.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -66.23 -44.14 84.6 Favored 'General case' 0 C--N 1.381 1.952 0 CA-C-O 116.262 -1.828 . . . . 0.0 110.289 158.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -65.31 -42.78 92.66 Favored 'General case' 0 C--N 1.362 1.117 0 O-C-N 126.445 2.341 . . . . 0.0 116.878 173.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 104' ' ' ALA . . . -59.6 -34.74 73.12 Favored 'General case' 0 C--N 1.374 1.67 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 166.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 140.27 -17.88 2.9 Favored Glycine 0 C--N 1.376 2.753 0 N-CA-C 119.408 2.523 . . . . 0.0 119.408 166.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -71.47 140.96 85.01 Favored Pre-proline 0 C--O 1.272 2.243 0 CA-C-N 119.904 1.852 . . . . 0.0 111.4 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.66 136.5 0.66 Allowed 'Trans proline' 0 C--N 1.378 2.113 1 C-N-CA 125.358 4.039 . . . . 0.0 117.412 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -55.61 155.64 20.9 Favored 'Trans proline' 0 CA--C 1.565 2.031 0 C-N-CA 122.862 2.375 . . . . 0.0 112.106 173.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 tp -79.92 -14.7 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 122.455 1.121 . . . . 0.0 113.821 -172.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . 0.303 2.3 m -15.71 -61.61 0.04 OUTLIER Pre-proline 0 C--O 1.248 1.001 1 N-CA-C 122.254 4.168 . . . . 0.0 122.254 169.254 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -48.82 -45.36 28.61 Favored 'Trans proline' 0 C--N 1.29 -2.532 0 C-N-CA 124.207 3.271 . . . . 0.0 115.887 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . 0.255 8.4 pt -106.98 12.82 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 117.531 -3.23 . . . . 0.0 111.415 -162.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -62.96 140.19 58.83 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 166.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.92 137.84 39.67 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 120.62 -1.3 . . . . 0.0 108.082 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 124' ' ' TYR . 43.5 mtpt -58.49 156.23 10.82 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 116.709 2.115 . . . . 0.0 116.709 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -108.53 -165.25 20.95 Favored Glycine 0 CA--C 1.563 3.057 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.8 t -110.19 116.99 32.5 Favored 'General case' 0 C--N 1.388 2.254 0 CA-C-O 116.383 -1.77 . . . . 0.0 108.747 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.16 55.61 2.73 Favored Glycine 0 C--N 1.388 3.439 0 C-N-CA 127.122 2.296 . . . . 0.0 115.988 -162.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.65 -161.84 11.84 Favored Glycine 0 CA--C 1.455 -3.666 0 N-CA-C 119.08 2.392 . . . . 0.0 119.08 -164.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.44 -175.27 25.92 Favored Glycine 0 C--N 1.365 2.157 0 N-CA-C 119.223 2.449 . . . . 0.0 119.223 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 96.3 m-85 -127.59 163.81 23.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.0 mm -61.99 120.5 8.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.92 0 O-C-N 126.559 2.412 . . . . 0.0 108.881 166.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.7 t -62.12 154.83 25.95 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.1 mt -102.43 10.3 39.09 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 124.602 2.144 . . . . 0.0 115.223 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.51 -40.2 86.54 Favored Glycine 0 N--CA 1.486 2.011 0 O-C-N 117.393 -3.317 . . . . 0.0 118.548 -165.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.36 -42.57 96.14 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-O 125.174 2.416 . . . . 0.0 106.614 168.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.45 -38.99 88.59 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 118.437 -2.664 . . . . 0.0 110.267 -174.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.314 8.4 tt -63.26 -53.08 58.54 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.261 1.424 . . . . 0.0 113.96 175.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 89.2 p -69.77 -30.26 67.79 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 122.145 0.974 . . . . 0.0 110.935 -171.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.419 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 9.4 m -67.82 -40.0 83.87 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 171.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 96.0 m -50.01 -48.68 52.43 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.587 1.955 . . . . 0.0 113.32 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 39.2 mt -67.13 -37.11 83.29 Favored 'General case' 0 N--CA 1.389 -3.521 0 O-C-N 127.635 3.085 . . . . 0.0 114.96 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -61.68 -48.44 80.79 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 121.9 2.136 . . . . 0.0 113.875 157.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.424 ' CD1' HD13 ' A' ' 62' ' ' ILE . 90.1 mt -60.13 -42.38 94.69 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 117.24 -1.362 . . . . 0.0 114.198 -176.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . 0.272 15.6 p -92.67 9.11 36.28 Favored 'General case' 0 C--N 1.38 1.927 0 N-CA-C 118.18 2.659 . . . . 0.0 118.18 173.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.529 0 CA-C-O 114.53 -3.372 . . . . 0.0 116.963 -175.908 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.2 p . . . . . 0 C--O 1.239 0.533 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -47.55 157.62 0.83 Allowed 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 123.16 2.573 . . . . 0.0 114.722 169.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.0 136.0 96.47 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.67 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.77 36.13 0.27 Allowed 'Trans proline' 0 N--CA 1.513 2.637 0 C-N-CA 121.555 1.503 . . . . 0.0 113.523 -174.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.2 mt -119.13 152.91 52.79 Favored Pre-proline 0 CA--C 1.566 1.594 0 O-C-N 119.906 -1.746 . . . . 0.0 108.147 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.36 154.76 3.75 Favored 'Trans proline' 0 N--CA 1.513 2.656 0 C-N-CA 124.022 3.148 . . . . 0.0 114.141 153.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 m 39.95 59.68 6.87 Favored Pre-proline 0 C--N 1.359 0.995 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 174.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.54 19.85 0.62 Allowed 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 121.572 1.515 . . . . 0.0 112.223 -156.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.7 m 59.53 32.97 22.0 Favored 'General case' 0 N--CA 1.508 2.473 0 C-N-CA 125.395 1.478 . . . . 0.0 111.277 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.1 m 68.2 25.91 7.15 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 127.302 2.241 . . . . 0.0 113.388 -174.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 82.92 -4.89 1.29 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.589 1.556 . . . . 0.0 111.724 173.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -70.47 142.26 51.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.657 166.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -131.97 110.51 10.81 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 118.391 -0.814 . . . . 0.0 112.725 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.23 136.57 58.0 Favored 'General case' 0 C--O 1.252 1.233 0 O-C-N 125.983 2.052 . . . . 0.0 111.307 164.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.77 142.14 23.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.254 0 CA-C-N 113.209 -1.814 . . . . 0.0 112.967 -168.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.8 p -138.98 178.29 7.27 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 -175.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -63.79 -44.91 91.93 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 122.382 1.087 . . . . 0.0 110.413 174.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.15 78.96 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 120.351 -1.468 . . . . 0.0 113.633 172.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -66.94 -43.0 84.31 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-O 117.752 -1.118 . . . . 0.0 112.018 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.7 tp -61.59 -35.98 79.37 Favored 'General case' 0 CA--C 1.582 2.192 0 CA-C-N 120.613 1.551 . . . . 0.0 113.83 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.3 . . 79.02 32.49 0.27 Allowed 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.715 -1.241 . . . . 0.0 112.074 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -156.12 157.96 36.9 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -175.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.9 mt -50.32 127.41 17.22 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 174.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -64.52 124.04 84.78 Favored Pre-proline 0 CA--C 1.567 1.607 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.433 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -99.1 0.76 1.01 Allowed 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.953 2.435 . . . . 0.0 113.5 -159.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 mt -130.91 167.84 18.31 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.2 p -89.6 1.85 55.45 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.7 160.49 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.24 -1.537 . . . . 0.0 111.626 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -77.27 174.36 10.85 Favored 'General case' 0 CA--C 1.561 1.387 0 O-C-N 120.278 -1.514 . . . . 0.0 112.424 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -53.98 140.19 31.95 Favored 'General case' 0 CA--C 1.6 2.887 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.92 -150.29 5.33 Favored Glycine 0 C--N 1.368 2.309 0 C-N-CA 127.877 2.656 . . . . 0.0 115.001 -166.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.3 m -127.58 146.7 50.44 Favored 'General case' 0 C--N 1.364 1.217 0 O-C-N 125.492 1.348 . . . . 0.0 107.821 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.3 pt -115.79 145.69 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 C-N-CA 127.307 2.243 . . . . 0.0 109.699 167.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -147.46 141.21 25.68 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-O 122.473 1.13 . . . . 0.0 111.803 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 62.0 m -88.99 138.23 31.6 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.3 mt -120.32 155.26 56.32 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.257 33.5 Cg_exo -40.67 134.88 2.21 Favored 'Trans proline' 0 N--CA 1.523 3.207 0 N-CA-C 121.804 3.732 . . . . 0.0 121.804 174.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.385 52.9 m 79.59 50.19 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.08 1.352 . . . . 0.0 110.497 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 46.32 44.16 12.29 Favored 'General case' 0 C--N 1.366 1.324 0 CA-C-N 112.456 -2.156 . . . . 0.0 112.365 173.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -96.24 145.38 25.61 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-N 118.964 0.802 . . . . 0.0 110.667 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.659 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -124.71 130.03 51.63 Favored 'General case' 0 C--O 1.264 1.861 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.0 m -119.47 157.18 21.64 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.798 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -130.39 137.89 50.1 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 102.641 -3.096 . . . . 0.0 102.641 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.0 t -126.57 119.31 53.34 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.76 164.25 2.3 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 171.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.58 -12.21 30.97 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 CA-C-O 114.703 -2.29 . . . . 0.0 114.456 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -90.57 -1.57 57.88 Favored 'General case' 0 C--N 1.367 1.34 0 CA-C-N 120.723 1.601 . . . . 0.0 113.478 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.62 -1.07 42.42 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-O 116.159 -2.467 . . . . 0.0 112.73 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.2 m -79.57 120.18 23.57 Favored 'General case' 0 C--N 1.366 1.314 0 CA-C-N 121.706 2.753 . . . . 0.0 112.899 -171.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.7 m -83.8 130.32 34.94 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.769 175.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -124.43 162.61 23.53 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.95 1.7 . . . . 0.0 111.743 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.54 129.99 34.98 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 169.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.4 tp -95.46 -45.71 6.98 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 116.89 -1.528 . . . . 0.0 109.43 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -105.95 164.31 12.06 Favored 'General case' 0 C--N 1.368 1.404 0 CA-C-O 122.796 1.284 . . . . 0.0 108.925 174.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -56.62 -36.88 69.95 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 125.637 1.575 . . . . 0.0 112.658 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -60.57 -44.93 95.63 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.572 1.149 . . . . 0.0 111.332 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.95 -37.4 84.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.573 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -71.05 -42.41 69.48 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 118.792 -0.623 . . . . 0.0 110.283 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -55.87 -35.63 66.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 167.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.38 -34.05 77.1 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 116.982 -1.485 . . . . 0.0 114.306 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.48 5.91 6.95 Favored Glycine 0 N--CA 1.504 3.232 0 CA-C-N 120.873 1.67 . . . . 0.0 112.144 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -80.15 130.89 64.42 Favored Pre-proline 0 CA--C 1.565 1.549 0 CA-C-O 118.172 -0.918 . . . . 0.0 108.891 170.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -64.4 148.92 90.85 Favored 'Trans proline' 0 N--CA 1.526 3.419 0 N-CA-C 119.805 2.964 . . . . 0.0 119.805 -168.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -46.49 145.45 6.13 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 N-CA-C 115.031 1.127 . . . . 0.0 115.031 172.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.1 tt -97.06 11.21 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 118.029 -1.468 . . . . 0.0 109.378 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 17.4 p -63.92 -36.45 20.91 Favored Pre-proline 0 N--CA 1.415 -2.206 1 CA-C-O 110.566 -4.54 . . . . 0.0 117.017 -174.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.99 -19.59 22.96 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 125.421 2.972 . . . . 0.0 111.264 -167.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.4 pt -104.97 21.61 3.3 Favored 'Isoleucine or valine' 0 C--N 1.36 1.049 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -175.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.92 139.11 58.09 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 125.555 1.785 . . . . 0.0 113.15 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -96.97 129.73 44.39 Favored 'General case' 0 C--N 1.365 1.262 0 C-N-CA 126.385 1.874 . . . . 0.0 115.145 170.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -81.16 150.91 28.48 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 114.864 -1.062 . . . . 0.0 113.417 166.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.23 176.06 54.33 Favored Glycine 0 CA--C 1.544 1.856 0 O-C-N 125.897 1.998 . . . . 0.0 113.609 163.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.9 m -63.45 146.43 53.62 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 121.037 2.419 . . . . 0.0 116.728 163.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 56.83 24.9 51.04 Favored Glycine 1 C--N 1.4 4.1 0 C-N-CA 126.562 2.029 . . . . 0.0 111.613 -164.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.57 -163.17 51.32 Favored Glycine 0 CA--C 1.551 2.301 0 C-N-CA 127.488 2.47 . . . . 0.0 117.688 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.5 133.08 3.86 Favored Glycine 0 C--N 1.37 2.421 0 CA-C-N 118.967 1.383 . . . . 0.0 111.326 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -79.12 149.95 31.9 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 122.186 0.993 . . . . 0.0 109.89 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 20.5 mm -89.46 147.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 114.649 -1.159 . . . . 0.0 111.576 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.0 t -75.0 147.31 40.88 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.3 mt -96.36 21.0 9.63 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 113.154 -1.839 . . . . 0.0 111.947 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.59 -47.12 5.24 Favored Glycine 0 CA--C 1.499 -0.958 0 CA-C-O 118.291 -1.283 . . . . 0.0 115.804 -168.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.43 93.24 Favored 'General case' 0 N--CA 1.44 -0.926 0 O-C-N 126.954 2.208 . . . . 0.0 109.106 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.4 tp -67.15 -44.36 79.97 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 124.156 0.982 . . . . 0.0 110.985 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.2 tp -61.92 -54.78 37.19 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.846 0.858 . . . . 0.0 110.197 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.0 p -56.52 -44.7 81.03 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.65 0.594 . . . . 0.0 110.588 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.7 m -63.02 -39.74 95.66 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.463 1.105 . . . . 0.0 110.797 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.6 m -62.96 -37.23 86.29 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 115.426 -2.226 . . . . 0.0 114.27 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 88' ' ' ALA . 35.6 mt -88.39 -19.26 26.84 Favored 'General case' 0 C--N 1.383 2.043 0 CA-C-N 121.019 1.736 . . . . 0.0 114.272 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -61.6 -41.12 96.98 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.125 -0.984 . . . . 0.0 110.782 161.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.7 mt -61.04 -43.27 99.14 Favored 'General case' 0 C--N 1.374 1.669 0 O-C-N 124.92 1.387 . . . . 0.0 110.587 -173.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 25.5 p -101.62 27.76 6.12 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.081 -1.418 . . . . 0.0 111.674 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.199 -2.061 0 C-N-CA 126.352 1.929 . . . . 0.0 115.137 175.803 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.2 p . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 114.459 -2.686 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -45.7 143.11 6.68 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 CA-C-O 113.221 -2.908 . . . . 0.0 116.734 167.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.8 t -84.54 120.15 73.82 Favored Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 128.554 3.659 . . . . 0.0 109.086 160.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -81.31 30.78 0.51 Allowed 'Trans proline' 0 C--O 1.262 1.722 0 C-N-CA 124.345 3.363 . . . . 0.0 114.886 -171.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.3 mt -116.12 143.97 31.99 Favored Pre-proline 0 C--N 1.385 2.124 1 C-N-CA 131.83 4.052 . . . . 0.0 109.436 -173.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -37.14 130.8 0.54 Allowed 'Trans proline' 0 C--O 1.2 -1.379 0 C-N-CA 123.151 2.567 . . . . 0.0 116.116 166.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . 0.278 1.2 m 56.84 51.98 5.89 Favored Pre-proline 0 C--O 1.256 1.414 0 C-N-CA 127.039 2.135 . . . . 0.0 112.128 167.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -64.96 -19.22 63.83 Favored 'Trans proline' 0 C--N 1.388 2.608 0 O-C-N 126.047 2.604 . . . . 0.0 115.867 -164.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.296 1.2 m 43.28 49.37 5.85 Favored 'General case' 0 C--N 1.372 1.561 0 N-CA-C 121.103 3.742 . . . . 0.0 121.103 168.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.4 13.2 m 98.64 25.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 128.716 2.806 . . . . 0.0 113.923 174.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.298 23.6 m-20 62.74 49.15 3.87 Favored 'General case' 0 C--N 1.395 2.552 0 O-C-N 118.903 -2.373 . . . . 0.0 112.895 176.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.46 157.74 46.08 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 129.436 3.094 . . . . 0.0 108.852 174.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -137.07 155.03 50.15 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.119 -1.433 . . . . 0.0 109.931 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 76.8 m-20 -90.91 126.62 36.11 Favored 'General case' 0 C--N 1.379 1.879 0 CA-C-O 123.28 1.514 . . . . 0.0 110.023 162.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 tp -115.74 138.02 47.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 127.792 2.437 . . . . 0.0 111.334 -169.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.2 p -131.51 164.55 25.55 Favored 'General case' 0 C--N 1.38 1.894 0 O-C-N 125.725 1.891 . . . . 0.0 111.069 -168.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.78 -43.02 72.45 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 117.102 -3.499 . . . . 0.0 113.104 170.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.08 85.54 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 125.659 1.85 . . . . 0.0 110.869 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -81.38 -18.38 45.73 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.7 tp -74.05 -27.83 61.11 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 119.762 -1.836 . . . . 0.0 107.497 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 66.22 39.37 4.21 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 130.514 3.526 . . . . 0.0 112.433 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -167.67 -161.95 0.42 Allowed 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.5 mt -64.33 126.79 28.91 Favored 'General case' 0 C--O 1.208 -1.112 0 C-N-CA 128.246 2.619 . . . . 0.0 111.452 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -80.94 113.95 44.67 Favored Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.87 9.96 2.79 Favored 'Trans proline' 0 C--N 1.291 -2.482 0 C-N-CA 124.106 3.204 . . . . 0.0 113.894 -171.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.0 mt -131.29 151.45 51.49 Favored 'General case' 0 CA--C 1.564 1.505 0 O-C-N 124.884 1.365 . . . . 0.0 112.636 -171.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.6 p -75.13 -35.85 61.65 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.71 -1.244 . . . . 0.0 110.992 172.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.4 m -75.13 156.13 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.774 0 C-N-CA 118.29 -1.364 . . . . 0.0 114.308 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -87.87 164.71 15.74 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 126.579 3.085 . . . . 0.0 107.837 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -24.3 118.76 0.05 OUTLIER 'General case' 0 N--CA 1.524 3.233 0 C-N-CA 130.25 3.42 . . . . 0.0 115.967 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -135.98 177.52 19.46 Favored Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 104.84 -3.304 . . . . 0.0 104.84 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 5.5 m -71.57 145.06 49.3 Favored 'General case' 0 C--N 1.363 1.155 0 O-C-N 127.025 2.25 . . . . 0.0 115.58 170.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.5 pt -116.86 135.3 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 118.689 -2.507 . . . . 0.0 105.981 168.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -155.98 146.75 22.04 Favored 'General case' 0 C--O 1.191 -1.999 0 C-N-CA 125.083 1.353 . . . . 0.0 109.924 -168.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 96.4 m -107.25 151.0 26.04 Favored 'General case' 0 C--N 1.381 1.956 0 C-N-CA 125.819 1.648 . . . . 0.0 107.886 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.0 mt -127.02 156.84 73.66 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-N 114.233 -1.348 . . . . 0.0 107.689 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -45.06 144.85 3.56 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 N-CA-C 118.971 2.643 . . . . 0.0 118.971 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t 73.94 41.43 0.41 Allowed 'General case' 0 C--N 1.366 1.3 0 C-N-CA 128.105 2.562 . . . . 0.0 111.37 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 67.64 26.77 7.89 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 119.272 3.064 . . . . 0.0 119.272 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -90.05 135.29 33.74 Favored 'General case' 0 N--CA 1.508 2.464 0 C-N-CA 127.752 2.421 . . . . 0.0 111.466 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.07 140.42 52.29 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 113.174 -1.83 . . . . 0.0 111.825 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.49 153.94 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 -168.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -116.63 118.58 33.0 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 127.234 2.214 . . . . 0.0 106.564 170.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.1 t -101.0 107.74 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.825 0 O-C-N 118.104 -2.873 . . . . 0.0 108.141 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.68 158.55 59.32 Favored Pre-proline 0 N--CA 1.432 -1.354 0 CA-C-N 113.117 -1.856 . . . . 0.0 114.348 -176.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -42.99 -28.22 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 125.21 3.94 . . . . 0.0 115.701 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 59.3 p30 -100.65 8.28 43.46 Favored 'General case' 0 C--O 1.26 1.639 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.46 7.09 82.85 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 116.416 -2.324 . . . . 0.0 117.872 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.2 m -81.07 119.71 23.89 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 123.434 3.617 . . . . 0.0 109.658 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.2 m -92.09 91.86 7.99 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -171.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -70.34 141.51 52.26 Favored 'General case' 0 C--O 1.202 -1.399 0 O-C-N 119.72 -1.863 . . . . 0.0 114.796 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.48 108.52 3.81 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.757 -1.116 . . . . 0.0 110.827 170.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.5 tp -92.84 -8.76 42.58 Favored 'General case' 0 C--O 1.251 1.159 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -135.42 171.31 14.63 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 123.94 1.829 . . . . 0.0 108.75 166.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -67.29 -39.05 85.95 Favored 'General case' 0 CA--C 1.571 1.783 0 O-C-N 118.048 -2.907 . . . . 0.0 109.467 -170.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -58.47 -42.64 87.94 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.057 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . 0.348 . . -51.86 -44.95 63.89 Favored 'General case' 0 C--N 1.37 1.493 0 CA-C-O 125.441 2.543 . . . . 0.0 114.387 170.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -69.42 -42.36 75.11 Favored 'General case' 0 CA--C 1.579 2.091 0 O-C-N 117.281 -3.387 . . . . 0.0 110.974 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -62.08 -35.66 79.33 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 128.165 2.586 . . . . 0.0 113.524 170.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.26 -16.93 58.78 Favored 'General case' 0 CA--C 1.568 1.67 0 O-C-N 121.084 -1.01 . . . . 0.0 110.163 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.0 33.82 4.2 Favored Glycine 0 CA--C 1.487 -1.68 0 N-CA-C 117.939 1.935 . . . . 0.0 117.939 173.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -80.08 154.17 74.92 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-N 118.881 1.34 . . . . 0.0 110.308 165.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -43.58 129.71 6.94 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 124.511 3.474 . . . . 0.0 118.716 164.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.42 142.41 58.48 Favored 'Trans proline' 0 N--CA 1.428 -2.378 0 C-N-CA 123.711 2.94 . . . . 0.0 110.989 169.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.9 tt -90.84 -0.78 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.27 0 C-N-CA 125.605 1.562 . . . . 0.0 109.42 -173.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 52.5 m -41.89 -65.72 0.48 Allowed Pre-proline 0 C--N 1.38 1.906 1 CA-C-O 111.203 -4.237 . . . . 0.0 120.153 170.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -70.62 -6.61 19.43 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 125.589 3.032 . . . . 0.0 118.551 -170.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 5.2 pt -107.21 8.05 9.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 122.324 2.329 . . . . 0.0 113.208 165.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -64.73 126.29 27.47 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 123.066 2.666 . . . . 0.0 113.096 169.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.73 144.09 57.48 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.575 1.172 . . . . 0.0 110.179 171.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -80.98 154.68 26.81 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.185 -1.572 . . . . 0.0 113.497 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.485 ' HA2' HD11 ' A' ' 125' ' ' ILE . . . -84.06 -174.39 50.33 Favored Glycine 0 CA--C 1.501 -0.824 0 CA-C-O 124.331 2.073 . . . . 0.0 113.701 172.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.5 t -102.06 139.96 36.98 Favored 'General case' 0 CA--C 1.59 2.494 0 O-C-N 118.126 -2.985 . . . . 0.0 105.604 166.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.43 35.87 21.9 Favored Glycine 0 CA--C 1.502 -0.736 0 O-C-N 118.809 -2.432 . . . . 0.0 111.97 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 62.27 -170.12 12.61 Favored Glycine 1 CA--C 1.58 4.11 0 CA-C-N 117.885 0.843 . . . . 0.0 114.738 -165.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.61 -179.3 49.24 Favored Glycine 0 C--N 1.361 1.929 0 N-CA-C 120.407 2.923 . . . . 0.0 120.407 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -122.07 154.12 37.75 Favored 'General case' 0 N--CA 1.509 2.491 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.485 HD11 ' HA2' ' A' ' 119' ' ' GLY . 6.4 mm -79.89 117.08 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 C-N-CA 125.081 1.352 . . . . 0.0 110.292 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.8 t -58.23 135.75 57.17 Favored 'General case' 0 CA--C 1.585 2.294 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.6 mt -92.25 10.52 29.24 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 124.763 1.225 . . . . 0.0 113.726 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.14 -53.72 29.57 Favored Glycine 0 N--CA 1.488 2.118 0 CA-C-O 123.832 1.795 . . . . 0.0 114.004 170.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.73 85.7 Favored 'General case' 0 CA--C 1.546 0.816 1 O-C-N 115.255 -4.674 . . . . 0.0 113.959 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.4 tp -64.29 -42.37 96.43 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 173.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.7 tp -59.3 -45.93 89.95 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 118.964 -2.335 . . . . 0.0 111.986 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . 0.323 19.4 p -61.94 -48.49 80.17 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 126.847 2.059 . . . . 0.0 110.426 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 45.4 m -52.98 -44.5 67.22 Favored 'General case' 0 CA--C 1.579 2.069 0 C-N-CA 126.75 2.02 . . . . 0.0 112.448 169.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 37.5 m -60.19 -46.39 89.89 Favored 'General case' 0 C--O 1.194 -1.839 0 O-C-N 117.966 -2.959 . . . . 0.0 109.119 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.0 mt -68.18 -37.22 80.71 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 123.999 1.857 . . . . 0.0 111.42 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -60.61 -42.49 96.91 Favored 'General case' 0 C--O 1.267 2.005 0 O-C-N 118.613 -2.555 . . . . 0.0 116.757 169.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.0 mt -82.77 -21.05 34.76 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . 0.373 2.0 p -98.11 3.79 49.16 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 118.834 2.901 . . . . 0.0 118.834 162.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.074 0 C-N-CA 127.301 2.382 . . . . 0.0 115.541 173.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.107 -1.425 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -49.51 156.81 2.59 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 123.524 2.816 . . . . 0.0 115.539 168.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.4 t -61.42 136.21 94.19 Favored Pre-proline 0 N--CA 1.493 1.71 0 CA-C-O 115.816 -2.04 . . . . 0.0 109.257 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -72.06 33.1 0.27 Allowed 'Trans proline' 0 C--N 1.293 -2.343 0 C-N-CA 122.073 1.849 . . . . 0.0 112.26 -172.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -115.41 154.0 47.62 Favored Pre-proline 0 CA--C 1.584 2.278 0 O-C-N 118.326 -2.734 . . . . 0.0 111.882 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -45.53 151.52 1.09 Allowed 'Trans proline' 0 C--O 1.216 -0.587 1 C-N-CA 125.515 4.143 . . . . 0.0 115.475 152.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . 0.281 4.8 m 42.6 56.06 10.64 Favored Pre-proline 0 C--N 1.364 1.214 0 O-C-N 118.778 -2.451 . . . . 0.0 116.411 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.41 18.05 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 123.865 3.043 . . . . 0.0 110.711 -152.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 m 61.53 32.55 18.71 Favored 'General case' 0 N--CA 1.508 2.436 0 C-N-CA 126.324 1.85 . . . . 0.0 110.478 178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.5 m 66.82 24.9 9.71 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 129.347 3.059 . . . . 0.0 112.851 -173.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 87.15 -7.24 0.65 Allowed 'General case' 0 C--O 1.247 0.971 0 C-N-CA 126.789 2.035 . . . . 0.0 109.973 170.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -64.67 140.2 58.84 Favored 'General case' 0 C--N 1.374 1.638 0 CA-C-O 116.632 -1.652 . . . . 0.0 114.601 162.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -132.28 108.64 9.35 Favored 'General case' 0 CA--C 1.466 -2.255 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -57.34 139.12 53.85 Favored 'General case' 0 C--O 1.261 1.675 0 CA-C-O 124.842 2.258 . . . . 0.0 110.419 166.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.8 tp -149.13 142.23 18.14 Favored 'Isoleucine or valine' 0 C--N 1.365 1.269 0 CA-C-O 124.37 2.033 . . . . 0.0 113.747 -167.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.1 p -140.76 177.16 8.22 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -63.39 -45.95 88.7 Favored 'General case' 0 CA--C 1.579 2.09 0 C-N-CA 126.572 1.949 . . . . 0.0 109.068 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.44 75.96 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 119.319 -2.113 . . . . 0.0 116.2 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -67.65 -42.99 81.33 Favored 'General case' 0 C--O 1.178 -2.689 0 CA-C-O 117.056 -1.449 . . . . 0.0 111.875 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.7 tp -62.11 -37.19 84.14 Favored 'General case' 0 CA--C 1.582 2.194 0 CA-C-N 121.678 2.035 . . . . 0.0 114.243 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.351 . . 82.62 30.63 0.1 Allowed 'General case' 0 C--N 1.371 1.532 0 O-C-N 119.719 -1.863 . . . . 0.0 110.589 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -155.02 159.57 40.42 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.81 125.12 14.19 Favored 'General case' 0 N--CA 1.423 -1.806 0 C-N-CA 128.563 2.745 . . . . 0.0 115.225 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -64.41 128.02 92.85 Favored Pre-proline 0 CA--C 1.586 2.331 0 O-C-N 117.029 -3.544 . . . . 0.0 110.818 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -105.76 0.46 0.2 Allowed 'Trans proline' 0 CA--C 1.481 -2.131 0 C-N-CA 123.598 2.865 . . . . 0.0 108.891 -154.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.7 mt -132.82 171.34 14.04 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 p -92.2 -0.27 57.43 Favored 'General case' 0 C--O 1.19 -2.049 0 CA-C-O 124.161 1.934 . . . . 0.0 111.245 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.0 m -93.49 161.26 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 117.045 -3.534 . . . . 0.0 110.474 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -78.9 174.3 11.65 Favored 'General case' 0 C--O 1.205 -1.267 0 O-C-N 120.33 -1.481 . . . . 0.0 113.655 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -53.01 138.84 29.53 Favored 'General case' 0 CA--C 1.61 3.267 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.74 -150.74 5.37 Favored Glycine 0 C--N 1.379 2.956 0 C-N-CA 130.392 3.853 . . . . 0.0 114.386 -166.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.7 m -128.4 145.5 51.07 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 111.762 -2.219 . . . . 0.0 106.177 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.5 pt -113.48 144.45 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.034 0 C-N-CA 129.663 3.185 . . . . 0.0 110.207 165.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -145.84 142.76 29.14 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-O 122.609 1.195 . . . . 0.0 112.093 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 69.7 m -91.45 138.36 31.63 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 170.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.0 mt -120.78 155.91 56.79 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 118.836 -2.415 . . . . 0.0 105.312 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.288 36.9 Cg_exo -39.64 135.3 1.35 Allowed 'Trans proline' 0 N--CA 1.505 2.15 1 C-N-CA 125.696 4.264 . . . . 0.0 122.21 173.046 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.452 68.3 m 78.52 48.12 0.04 OUTLIER 'General case' 0 C--N 1.378 1.842 0 O-C-N 119.553 -1.967 . . . . 0.0 112.348 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 46.5 43.29 12.02 Favored 'General case' 0 C--N 1.391 2.37 0 CA-C-N 112.983 -1.917 . . . . 0.0 113.46 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -95.45 143.8 26.49 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 126.216 1.806 . . . . 0.0 111.465 170.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.689 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -125.36 129.34 49.73 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-O 124.648 2.166 . . . . 0.0 106.142 175.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.2 m -118.22 157.73 19.5 Favored 'Isoleucine or valine' 0 C--N 1.381 1.957 0 CA-C-N 113.591 -1.64 . . . . 0.0 110.993 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -131.26 137.29 48.8 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -125.72 118.76 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 O-C-N 120.623 -1.298 . . . . 0.0 108.033 173.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.57 162.87 1.16 Allowed Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 170.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -68.81 -13.22 36.44 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 CA-C-O 113.786 -2.673 . . . . 0.0 114.589 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -91.75 -1.93 57.18 Favored 'General case' 0 C--N 1.37 1.458 0 CA-C-N 121.084 1.765 . . . . 0.0 112.902 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.61 0.17 36.98 Favored Glycine 0 CA--C 1.49 -1.523 0 CA-C-O 114.397 -3.446 . . . . 0.0 109.843 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.8 m -81.6 119.04 23.29 Favored 'General case' 0 C--N 1.361 1.08 1 CA-C-N 124.212 4.006 . . . . 0.0 112.93 -170.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.7 m -82.06 130.59 35.12 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.015 175.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -125.36 160.81 28.44 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 126.891 2.076 . . . . 0.0 111.675 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.99 127.42 32.94 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 167.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.9 tp -94.77 -47.5 6.45 Favored 'General case' 0 C--O 1.206 -1.227 0 O-C-N 119.671 -1.893 . . . . 0.0 109.844 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -101.77 163.56 12.19 Favored 'General case' 0 C--N 1.391 2.392 0 CA-C-O 123.739 1.733 . . . . 0.0 108.834 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . 0.274 12.9 p-10 -55.29 -36.8 66.53 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 126.432 1.893 . . . . 0.0 113.758 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -61.89 -44.37 96.95 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.808 1.243 . . . . 0.0 112.064 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.95 -40.83 94.79 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.666 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -68.38 -42.02 79.72 Favored 'General case' 0 CA--C 1.557 1.218 0 O-C-N 121.774 -0.579 . . . . 0.0 111.52 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -54.9 -39.63 68.96 Favored 'General case' 0 C--N 1.369 1.422 0 O-C-N 120.224 -1.547 . . . . 0.0 112.542 167.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.01 -36.65 84.27 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 127.0 6.46 5.39 Favored Glycine 0 N--CA 1.507 3.369 0 CA-C-O 124.125 1.959 . . . . 0.0 110.464 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -80.33 133.67 56.45 Favored Pre-proline 0 CA--C 1.588 2.433 0 CA-C-O 116.67 -1.633 . . . . 0.0 110.161 170.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -70.64 150.7 63.29 Favored 'Trans proline' 0 CA--C 1.484 -2.018 0 CA-C-N 126.892 3.497 . . . . 0.0 119.182 -164.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . 0.269 74.7 Cg_exo -44.7 146.92 2.0 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 N-CA-C 117.769 2.18 . . . . 0.0 117.769 171.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.7 tt -98.99 10.15 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 C-N-CA 116.979 -1.888 . . . . 0.0 107.336 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.4 p -62.17 -35.83 23.95 Favored Pre-proline 0 C--N 1.374 1.639 1 CA-C-O 109.169 -5.205 . . . . 0.0 116.972 -174.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.16 -17.59 16.97 Favored 'Trans proline' 0 C--N 1.36 1.137 0 CA-C-N 127.141 3.586 . . . . 0.0 109.018 -165.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.6 pt -106.53 20.65 4.43 Favored 'Isoleucine or valine' 0 C--N 1.368 1.389 0 C-N-CA 125.699 1.6 . . . . 0.0 113.458 -172.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -63.59 138.36 58.47 Favored 'General case' 0 C--N 1.363 1.188 0 C-N-CA 126.645 1.978 . . . . 0.0 111.86 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -95.83 128.13 42.45 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 127.647 2.379 . . . . 0.0 116.999 168.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -78.03 149.47 34.0 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 120.257 -1.527 . . . . 0.0 114.576 166.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.95 174.6 54.34 Favored Glycine 0 C--O 1.202 -1.885 0 C-N-CA 126.438 1.97 . . . . 0.0 113.655 162.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.0 m -60.43 146.97 42.61 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 122.215 3.007 . . . . 0.0 118.584 161.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 52.53 27.87 27.45 Favored Glycine 1 C--N 1.415 4.942 0 C-N-CA 128.471 2.938 . . . . 0.0 111.665 -162.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.23 -161.61 53.84 Favored Glycine 0 CA--C 1.544 1.863 0 C-N-CA 129.892 3.615 . . . . 0.0 119.291 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.26 133.6 4.42 Favored Glycine 0 CA--C 1.549 2.195 0 CA-C-N 120.459 2.129 . . . . 0.0 109.873 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -79.18 151.69 31.12 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 124.842 2.258 . . . . 0.0 107.916 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 22.4 mm -91.17 144.27 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 126.717 2.007 . . . . 0.0 111.529 173.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.4 t -71.71 147.31 47.52 Favored 'General case' 0 C--O 1.195 -1.796 0 N-CA-C 119.868 3.285 . . . . 0.0 119.868 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.5 mt -97.78 20.92 11.21 Favored 'General case' 0 C--O 1.204 -1.338 0 C-N-CA 126.231 1.812 . . . . 0.0 112.317 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -88.71 -41.3 6.05 Favored Glycine 0 CA--C 1.496 -1.121 0 N-CA-C 118.207 2.043 . . . . 0.0 118.207 -169.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.47 98.55 Favored 'General case' 0 N--CA 1.431 -1.375 0 O-C-N 127.045 2.262 . . . . 0.0 110.199 170.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.8 tp -66.69 -44.12 82.58 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-O 122.563 1.173 . . . . 0.0 111.702 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 29.3 tp -62.68 -53.16 58.73 Favored 'General case' 0 C--N 1.364 1.23 0 O-C-N 120.329 -1.482 . . . . 0.0 110.465 175.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.2 p -57.66 -44.76 85.94 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.66 0.743 . . . . 0.0 111.088 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 83.0 m -62.31 -42.35 99.3 Favored 'General case' 0 C--O 1.264 1.822 0 C-N-CA 125.611 1.564 . . . . 0.0 110.982 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 26.2 m -60.22 -36.88 78.69 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 173.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.689 HD21 ' HB2' ' A' ' 88' ' ' ALA . 23.7 mt -89.59 -16.78 29.82 Favored 'General case' 0 C--N 1.376 1.722 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 176.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -63.41 -38.57 91.65 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 117.12 -1.419 . . . . 0.0 111.375 158.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.4 mt -63.47 -43.0 98.59 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-O 125.227 2.441 . . . . 0.0 110.507 -171.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 21.6 p -100.61 25.66 7.57 Favored 'General case' 0 C--N 1.376 1.74 0 CA-C-N 112.779 -2.009 . . . . 0.0 112.414 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.158 0 C-N-CA 128.368 2.889 . . . . 0.0 114.863 175.626 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 p . . . . . 0 N--CA 1.439 -0.979 0 CA-C-O 117.504 -1.236 . . . . 0.0 108.305 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -47.9 157.4 1.07 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 123.452 2.768 . . . . 0.0 114.425 169.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.06 136.03 96.49 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.731 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -70.94 35.96 0.27 Allowed 'Trans proline' 0 N--CA 1.517 2.879 0 C-N-CA 121.302 1.334 . . . . 0.0 113.34 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.9 mt -118.54 153.21 51.96 Favored Pre-proline 0 CA--C 1.572 1.814 0 O-C-N 119.619 -1.925 . . . . 0.0 107.968 172.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.67 154.68 4.41 Favored 'Trans proline' 0 N--CA 1.519 3.015 0 C-N-CA 123.23 2.62 . . . . 0.0 114.295 153.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . 0.256 7.1 m 40.97 58.87 8.45 Favored Pre-proline 0 C--N 1.362 1.145 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 174.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.62 20.13 0.62 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.446 1.431 . . . . 0.0 112.271 -156.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 m 60.08 32.73 21.11 Favored 'General case' 0 N--CA 1.516 2.856 0 C-N-CA 125.294 1.438 . . . . 0.0 110.717 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 m 68.0 25.68 7.54 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 127.051 2.14 . . . . 0.0 113.386 -174.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 83.41 -5.15 1.2 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.241 1.417 . . . . 0.0 111.605 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -70.62 142.67 51.64 Favored 'General case' 0 C--N 1.36 1.056 0 O-C-N 124.372 1.045 . . . . 0.0 110.747 166.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -132.05 110.15 10.51 Favored 'General case' 0 C--N 1.366 1.323 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.365 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -59.23 137.34 58.01 Favored 'General case' 0 C--O 1.252 1.226 0 O-C-N 126.416 2.323 . . . . 0.0 111.334 164.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.5 tp -145.8 142.33 21.83 Favored 'Isoleucine or valine' 0 C--O 1.264 1.86 0 CA-C-N 112.791 -2.004 . . . . 0.0 113.036 -167.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.9 p -139.36 177.91 7.58 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -63.78 -44.56 93.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 124.704 1.252 . . . . 0.0 110.579 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.92 79.71 Favored 'General case' 0 C--O 1.247 0.946 0 O-C-N 120.228 -1.545 . . . . 0.0 112.972 173.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -67.19 -42.97 83.31 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-O 117.415 -1.278 . . . . 0.0 111.901 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.1 tp -61.94 -36.19 80.64 Favored 'General case' 0 CA--C 1.587 2.392 0 CA-C-N 121.002 1.728 . . . . 0.0 113.293 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.287 . . 79.38 32.66 0.24 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.038 1.335 . . . . 0.0 111.99 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -155.85 158.2 37.66 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.4 mt -50.92 127.39 18.55 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 124.116 1.912 . . . . 0.0 115.461 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -63.82 124.42 84.89 Favored Pre-proline 0 CA--C 1.573 1.86 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.262 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -100.11 1.98 0.82 Allowed 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 122.02 1.813 . . . . 0.0 113.285 -160.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.5 mt -131.15 168.01 18.18 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 17.2 p -90.01 1.62 56.09 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-O 122.381 1.086 . . . . 0.0 113.781 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.5 m -92.53 160.54 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 119.976 -1.703 . . . . 0.0 111.654 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -77.39 174.37 10.9 Favored 'General case' 0 CA--C 1.567 1.63 0 O-C-N 119.221 -2.174 . . . . 0.0 111.827 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -53.91 140.35 31.03 Favored 'General case' 0 CA--C 1.601 2.941 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 -177.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.2 -150.09 5.28 Favored Glycine 0 C--N 1.369 2.409 0 C-N-CA 127.53 2.491 . . . . 0.0 114.909 -166.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.1 m -127.88 146.5 50.6 Favored 'General case' 0 C--N 1.371 1.506 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.2 pt -115.49 145.89 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 126.925 2.09 . . . . 0.0 110.081 166.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -147.22 141.63 26.39 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 122.94 1.353 . . . . 0.0 111.426 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 61.8 m -89.27 138.15 31.69 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 169.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.0 mt -120.13 155.41 55.74 Favored Pre-proline 0 N--CA 1.482 1.17 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 172.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.268 31.9 Cg_exo -40.55 134.93 2.11 Favored 'Trans proline' 0 N--CA 1.529 3.583 0 N-CA-C 122.133 3.859 . . . . 0.0 122.133 173.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.383 50.4 m 79.53 50.22 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.075 1.35 . . . . 0.0 110.311 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 45.94 44.64 11.48 Favored 'General case' 0 C--O 1.203 -1.383 0 O-C-N 126.803 2.564 . . . . 0.0 111.954 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -96.89 145.71 25.63 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 118.644 0.656 . . . . 0.0 110.438 170.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.662 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -124.65 129.9 51.42 Favored 'General case' 0 C--O 1.273 2.312 0 CA-C-O 123.22 1.486 . . . . 0.0 107.481 174.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.19 157.24 21.13 Favored 'Isoleucine or valine' 0 C--N 1.362 1.114 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.157 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -130.36 137.78 50.07 Favored 'General case' 0 C--O 1.254 1.321 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 t -126.35 119.32 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.1 164.53 2.36 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 171.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.79 -11.78 29.99 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 CA-C-O 114.481 -2.383 . . . . 0.0 114.466 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -91.03 -1.43 57.81 Favored 'General case' 0 C--N 1.371 1.529 0 CA-C-N 121.132 1.787 . . . . 0.0 113.544 173.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.81 -0.85 41.83 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-O 116.748 -2.14 . . . . 0.0 113.207 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.5 m -80.01 120.24 23.92 Favored 'General case' 0 C--N 1.38 1.899 0 CA-C-N 120.979 2.39 . . . . 0.0 113.374 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.7 m -83.52 130.54 35.01 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.05 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -124.56 162.18 24.6 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.678 1.591 . . . . 0.0 111.209 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.53 130.2 35.17 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 168.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.42 -46.79 6.55 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 116.45 -1.738 . . . . 0.0 108.83 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -105.28 164.33 11.92 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-O 123.398 1.57 . . . . 0.0 108.898 174.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -56.29 -37.41 69.82 Favored 'General case' 0 N--CA 1.511 2.588 0 CA-C-N 113.448 -1.705 . . . . 0.0 112.469 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.6 mtp85 -60.53 -44.59 95.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 124.784 1.303 . . . . 0.0 111.327 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.36 -37.18 84.68 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.78 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -71.2 -42.07 69.46 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 117.767 -1.111 . . . . 0.0 110.084 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -56.57 -35.5 68.24 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 168.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.71 76.23 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 116.223 -1.846 . . . . 0.0 114.124 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.54 6.27 6.76 Favored Glycine 1 N--CA 1.518 4.165 0 CA-C-N 121.162 1.801 . . . . 0.0 111.839 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -80.27 131.45 62.26 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-O 118.054 -0.974 . . . . 0.0 108.642 170.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -65.37 149.28 88.36 Favored 'Trans proline' 1 N--CA 1.546 4.565 0 N-CA-C 119.478 2.838 . . . . 0.0 119.478 -168.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.41 145.74 5.68 Favored 'Trans proline' 0 N--CA 1.519 2.979 0 C-N-CA 117.243 -1.371 . . . . 0.0 114.905 172.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.4 tt -97.46 11.25 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 117.811 -1.555 . . . . 0.0 109.499 175.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 17.2 p -63.96 -35.63 16.64 Favored Pre-proline 0 N--CA 1.399 -2.993 1 CA-C-O 110.185 -4.721 . . . . 0.0 117.667 -174.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.9 -19.68 23.18 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 CA-C-N 124.744 2.73 . . . . 0.0 111.294 -168.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.2 pt -105.56 22.52 3.07 Favored 'Isoleucine or valine' 0 C--N 1.372 1.583 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -61.67 139.3 58.31 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 125.895 1.997 . . . . 0.0 112.978 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . 0.251 . . -97.46 130.13 44.59 Favored 'General case' 0 C--N 1.376 1.731 0 C-N-CA 125.976 1.71 . . . . 0.0 115.138 170.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -82.02 151.37 27.14 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.936 167.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.36 176.08 54.41 Favored Glycine 0 CA--C 1.544 1.887 0 O-C-N 126.99 2.681 . . . . 0.0 113.683 164.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.9 m -63.62 146.66 53.33 Favored 'General case' 0 CA--C 1.597 2.762 0 CA-C-N 120.966 2.383 . . . . 0.0 116.395 164.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 57.2 24.43 51.24 Favored Glycine 1 C--N 1.402 4.212 0 O-C-N 125.735 1.897 . . . . 0.0 111.814 -164.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.81 -163.2 50.97 Favored Glycine 0 CA--C 1.553 2.441 0 C-N-CA 126.951 2.215 . . . . 0.0 117.288 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.52 132.79 3.78 Favored Glycine 0 C--N 1.377 2.86 0 CA-C-N 118.313 1.056 . . . . 0.0 111.358 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -79.42 150.67 31.24 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 122.533 1.159 . . . . 0.0 109.631 -174.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 20.3 mm -90.3 147.52 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 113.858 -1.519 . . . . 0.0 110.974 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.5 t -74.93 147.74 40.67 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 174.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.0 mt -97.01 21.51 9.66 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 112.807 -1.997 . . . . 0.0 111.741 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.9 -46.66 5.31 Favored Glycine 0 C--O 1.219 -0.784 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 -168.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.48 -43.24 93.32 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 127.514 2.538 . . . . 0.0 109.056 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.2 tp -67.33 -43.92 80.42 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.713 0.805 . . . . 0.0 111.08 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 30.3 tp -62.03 -54.35 42.81 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.154 0.582 . . . . 0.0 110.589 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.1 p -56.78 -44.28 81.7 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 124.066 0.854 . . . . 0.0 110.823 -175.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.9 m -62.98 -40.26 97.19 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.252 1.021 . . . . 0.0 110.547 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 30.4 m -62.94 -36.52 83.72 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 115.355 -2.259 . . . . 0.0 114.642 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 88' ' ' ALA . 37.1 mt -89.01 -18.65 26.92 Favored 'General case' 0 C--N 1.387 2.208 0 CA-C-N 121.401 1.91 . . . . 0.0 114.31 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -61.69 -40.79 96.23 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 121.411 -0.806 . . . . 0.0 111.215 160.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.0 mt -61.79 -42.98 99.69 Favored 'General case' 0 C--N 1.381 1.938 0 O-C-N 125.458 1.723 . . . . 0.0 110.074 -173.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.0 p -101.95 27.84 6.22 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.807 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.199 -2.051 0 C-N-CA 125.9 1.715 . . . . 0.0 115.343 175.676 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.564 1.486 0 CA-C-O 114.84 -2.505 . . . . 0.0 114.839 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -40.87 137.58 1.78 Allowed 'Trans proline' 0 N--CA 1.511 2.522 0 C-N-CA 125.167 3.911 . . . . 0.0 116.456 165.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.6 t -118.93 110.26 38.49 Favored Pre-proline 0 CA--C 1.599 2.853 0 O-C-N 125.236 1.585 . . . . 0.0 110.437 -169.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -49.86 134.76 35.41 Favored 'Trans proline' 0 N--CA 1.526 3.405 1 C-N-CA 126.968 5.112 . . . . 0.0 117.197 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.5 mt -51.8 146.11 14.87 Favored Pre-proline 0 C--N 1.363 1.189 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -82.86 66.32 7.97 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 O-C-N 118.879 -1.169 . . . . 0.0 111.425 167.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.6 t -154.66 140.76 12.81 Favored Pre-proline 0 N--CA 1.498 1.93 0 CA-C-O 113.939 -2.934 . . . . 0.0 105.05 170.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -40.25 124.21 1.58 Allowed 'Trans proline' 0 N--CA 1.495 1.569 1 C-N-CA 126.46 4.774 . . . . 0.0 118.71 -170.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 m 50.66 45.23 27.17 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 123.457 1.599 . . . . 0.0 107.981 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.263 46.6 m 61.79 54.08 3.0 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 127.466 3.508 . . . . 0.0 116.522 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.383 39.6 t30 68.25 33.37 4.34 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-N 110.667 -2.97 . . . . 0.0 111.478 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . 0.368 0.0 OUTLIER 69.75 112.62 0.05 OUTLIER 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 116.799 2.148 . . . . 0.0 116.799 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -77.64 155.04 31.65 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.756 0.822 . . . . 0.0 111.0 173.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -87.37 145.47 26.3 Favored 'General case' 0 C--O 1.264 1.831 0 O-C-N 128.698 3.749 . . . . 0.0 111.519 171.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 tp -115.56 144.43 23.17 Favored 'Isoleucine or valine' 0 C--N 1.364 1.219 0 CA-C-N 112.335 -2.211 . . . . 0.0 108.701 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.501 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 38.5 p -132.08 163.05 29.32 Favored 'General case' 0 C--O 1.198 -1.623 0 C-N-CA 126.206 1.803 . . . . 0.0 114.082 -174.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 29.5 mt-10 -62.05 -45.97 91.2 Favored 'General case' 0 C--O 1.202 -1.416 0 C-N-CA 127.536 2.334 . . . . 0.0 108.951 168.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.81 -24.62 61.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 119.346 -2.096 . . . . 0.0 116.161 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -62.55 -46.38 88.63 Favored 'General case' 0 CA--C 1.593 2.623 0 CA-C-O 122.132 0.968 . . . . 0.0 111.418 172.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 mt -71.04 -38.0 72.54 Favored 'General case' 0 C--O 1.211 -0.925 0 C-N-CA 129.275 3.03 . . . . 0.0 114.066 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.36 . . 67.14 -22.29 0.11 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 119.351 3.093 . . . . 0.0 119.351 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . 0.303 84.9 t80 -77.12 167.2 22.19 Favored 'General case' 0 C--O 1.254 1.304 0 CA-C-O 122.615 1.198 . . . . 0.0 112.791 161.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 62.8 tp -48.09 118.61 2.46 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.097 1.759 . . . . 0.0 115.509 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -61.48 122.04 67.94 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 119.299 -2.125 . . . . 0.0 111.011 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -95.5 26.39 0.29 Allowed 'Trans proline' 0 CA--C 1.552 1.393 0 C-N-CA 122.869 2.379 . . . . 0.0 114.301 -169.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.2 mt -136.9 153.41 50.74 Favored 'General case' 0 C--N 1.39 2.347 0 CA-C-N 120.057 1.299 . . . . 0.0 109.463 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.4 p -73.11 -22.62 60.52 Favored 'General case' 0 C--N 1.364 1.203 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.5 m -83.92 160.55 3.42 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 1 O-C-N 129.435 4.209 . . . . 0.0 108.236 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -91.5 114.62 27.19 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 115.481 -2.199 . . . . 0.0 109.993 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.501 ' CD2' ' HA ' ' A' ' 63' ' ' SER . 61.3 m170 52.85 -167.88 0.05 Allowed 'General case' 0 C--N 1.36 1.025 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.59 -167.45 40.33 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 118.381 -1.233 . . . . 0.0 112.757 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.1 m -121.45 149.04 43.62 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 103.166 -2.902 . . . . 0.0 103.166 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 pt -121.36 151.65 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.311 0 C-N-CA 124.747 1.219 . . . . 0.0 110.474 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -145.12 139.81 27.57 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 3.8 m -99.25 123.97 43.96 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 83' ' ' LEU . 90.0 mt -96.49 151.35 37.96 Favored Pre-proline 0 N--CA 1.508 2.45 0 CA-C-O 114.265 -2.778 . . . . 0.0 112.58 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -57.59 150.0 63.72 Favored 'Trans proline' 0 N--CA 1.508 2.348 0 CA-C-N 124.654 2.698 . . . . 0.0 117.952 -173.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.9 m 59.46 54.27 4.73 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -168.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 57.11 48.65 15.04 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 170.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -117.03 159.41 22.57 Favored 'General case' 0 C--N 1.369 1.422 0 CA-C-O 117.995 -1.003 . . . . 0.0 111.761 169.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.95 148.04 43.01 Favored 'General case' 0 C--N 1.384 2.089 0 O-C-N 125.53 1.769 . . . . 0.0 112.451 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 99' ' ' ALA . 24.8 m -138.31 170.92 16.12 Favored 'Isoleucine or valine' 0 C--N 1.396 2.61 0 O-C-N 127.068 2.73 . . . . 0.0 113.64 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -140.67 124.5 17.18 Favored 'General case' 0 C--O 1.265 1.87 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -172.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.1 t -102.69 107.76 22.67 Favored 'Isoleucine or valine' 0 C--N 1.359 0.995 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . 0.332 . . -60.18 150.61 70.61 Favored Pre-proline 0 N--CA 1.515 2.818 0 N-CA-C 119.979 3.325 . . . . 0.0 119.979 174.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -46.3 -23.75 2.19 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 N-CA-C 119.952 3.02 . . . . 0.0 119.952 177.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -86.55 -15.26 40.49 Favored 'General case' 0 C--N 1.375 1.716 0 CA-C-O 124.166 1.936 . . . . 0.0 115.589 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 114.15 -3.66 23.88 Favored Glycine 0 N--CA 1.483 1.829 0 C-N-CA 130.304 3.811 . . . . 0.0 116.387 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.323 8.3 m -68.94 114.27 7.09 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 46.6 m -90.16 108.7 19.9 Favored 'General case' 0 CA--C 1.504 -0.79 0 O-C-N 124.736 1.272 . . . . 0.0 112.873 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -100.87 142.84 31.77 Favored 'General case' 0 N--CA 1.434 -1.259 0 O-C-N 126.166 2.166 . . . . 0.0 111.259 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.402 ' HA ' HG12 ' A' ' 89' ' ' VAL . . . -67.28 128.34 36.05 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-N 113.46 -1.7 . . . . 0.0 112.861 169.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.1 tp -108.57 1.34 21.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.355 -1.466 . . . . 0.0 108.672 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . 0.34 52.9 p-10 -148.86 159.53 44.08 Favored 'General case' 0 C--N 1.368 1.391 0 O-C-N 120.762 -1.211 . . . . 0.0 111.681 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -58.63 -43.45 89.71 Favored 'General case' 0 C--N 1.363 1.191 0 CA-C-N 112.814 -1.994 . . . . 0.0 113.528 -169.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -66.71 -34.65 78.32 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 121.16 -0.962 . . . . 0.0 111.648 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . 0.371 . . -61.43 -40.52 94.73 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 174.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -62.02 -41.83 98.51 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 115.363 -2.256 . . . . 0.0 108.702 169.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.303 42.5 mmtm -63.24 -42.88 99.27 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.84 2.533 . . . . 0.0 117.84 175.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.95 -34.29 65.54 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-O 115.497 -2.192 . . . . 0.0 111.396 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 130.57 -1.72 5.64 Favored Glycine 0 C--N 1.366 2.234 0 CA-C-N 121.362 1.892 . . . . 0.0 115.474 173.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -71.25 148.1 93.58 Favored Pre-proline 0 C--N 1.369 1.443 0 CA-C-O 116.818 -1.563 . . . . 0.0 111.706 171.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.09 139.01 23.55 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-O 114.381 -2.425 . . . . 0.0 111.702 -171.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -54.01 142.37 65.28 Favored 'Trans proline' 0 CA--C 1.482 -2.109 0 N-CA-C 119.88 2.992 . . . . 0.0 119.88 168.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.3 tt -89.89 15.56 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.948 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.8 p -64.3 -43.37 72.53 Favored Pre-proline 0 C--N 1.378 1.82 0 CA-C-O 113.127 -3.321 . . . . 0.0 117.077 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -74.35 -1.65 11.28 Favored 'Trans proline' 0 N--CA 1.5 1.863 1 CA-C-N 129.798 4.535 . . . . 0.0 117.408 174.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 27.4 mm -91.2 -0.79 9.65 Favored 'Isoleucine or valine' 0 C--N 1.367 1.349 0 C-N-CA 127.567 2.347 . . . . 0.0 113.595 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -61.92 140.36 58.31 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 119.191 -2.193 . . . . 0.0 116.902 166.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -81.22 128.95 34.34 Favored 'General case' 0 C--O 1.199 -1.599 0 CA-C-O 123.108 1.432 . . . . 0.0 113.62 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -55.92 145.32 25.35 Favored 'General case' 0 N--CA 1.535 3.79 1 N-CA-C 122.609 4.3 . . . . 0.0 122.609 175.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.15 173.8 42.01 Favored Glycine 0 C--N 1.356 1.668 0 CA-C-N 113.287 -1.779 . . . . 0.0 112.381 156.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.6 t -93.73 127.6 39.53 Favored 'General case' 0 C--N 1.386 2.186 0 O-C-N 126.568 1.981 . . . . 0.0 109.916 167.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 67.59 39.37 90.77 Favored Glycine 0 N--CA 1.51 3.612 0 C-N-CA 118.404 -1.855 . . . . 0.0 115.983 -169.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 105.85 -168.9 15.43 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 164.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.33 -170.09 50.76 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-O 123.882 1.823 . . . . 0.0 112.208 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -149.74 149.67 30.91 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.9 mt -66.36 137.16 25.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 O-C-N 119.197 -2.189 . . . . 0.0 109.57 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.3 t -50.56 129.49 22.44 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 58.7 mt -98.93 6.86 46.53 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.501 -1.375 . . . . 0.0 111.594 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -59.12 -60.15 9.41 Favored Glycine 0 C--N 1.377 2.833 0 C-N-CA 128.563 2.983 . . . . 0.0 114.9 -170.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . 0.354 . . -65.29 -32.21 73.74 Favored 'General case' 0 CA--C 1.6 2.891 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 10.3 tp -55.66 -48.38 75.11 Favored 'General case' 0 C--N 1.383 2.051 0 CA-C-N 120.6 1.545 . . . . 0.0 112.14 163.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 20.2 tp -65.28 -42.53 93.06 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . 0.29 17.7 p -69.07 -40.37 78.52 Favored 'General case' 0 C--N 1.371 1.513 0 CA-C-O 115.79 -2.052 . . . . 0.0 112.758 170.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 90.2 m -64.08 -31.07 72.12 Favored 'General case' 0 C--N 1.36 1.033 0 CA-C-N 122.928 2.604 . . . . 0.0 110.138 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.5 m -64.89 -48.92 72.51 Favored 'General case' 0 C--N 1.389 2.312 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.1 mt -69.29 -43.11 74.49 Favored 'General case' 0 CA--C 1.495 -1.161 0 O-C-N 126.843 2.589 . . . . 0.0 112.883 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -58.08 -33.94 69.61 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 127.016 2.697 . . . . 0.0 114.885 173.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . 0.291 40.0 tp -69.19 -28.96 66.85 Favored 'General case' 0 N--CA 1.421 -1.892 0 O-C-N 126.338 2.274 . . . . 0.0 110.879 -176.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.6 p -108.01 12.96 26.51 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 174.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.584 0 C-N-CA 128.114 2.769 . . . . 0.0 118.581 -176.312 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.197 -1.709 0 CA-C-O 113.828 -2.987 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -47.31 152.57 2.21 Favored 'Trans proline' 0 N--CA 1.495 1.564 1 C-N-CA 126.889 5.059 . . . . 0.0 114.275 -167.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 t -59.28 116.78 17.4 Favored Pre-proline 0 C--O 1.213 -0.832 0 O-C-N 126.593 2.433 . . . . 0.0 113.005 173.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -98.44 54.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 123.175 2.583 . . . . 0.0 107.734 -168.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . 0.274 24.3 mt -144.79 147.81 36.92 Favored Pre-proline 0 N--CA 1.477 0.907 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 -165.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -59.94 156.54 38.24 Favored 'Trans proline' 0 N--CA 1.508 2.362 0 CA-C-N 122.83 2.046 . . . . 0.0 110.778 169.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.2 m 54.51 67.03 3.63 Favored Pre-proline 0 N--CA 1.517 2.924 0 CA-C-O 114.847 -2.501 . . . . 0.0 116.718 -173.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -85.96 -25.88 1.34 Allowed 'Trans proline' 0 CA--C 1.483 -2.04 0 CA-C-N 127.467 3.703 . . . . 0.0 116.681 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.379 0.7 OUTLIER 63.78 41.5 6.85 Favored 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 125.845 1.658 . . . . 0.0 114.094 169.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.9 m 64.5 33.56 10.88 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 112.322 -2.217 . . . . 0.0 109.956 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.312 92.2 m-20 83.01 46.08 0.02 OUTLIER 'General case' 0 C--N 1.352 0.683 0 C-N-CA 127.669 2.387 . . . . 0.0 112.684 174.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -128.24 120.23 26.77 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 118.305 -2.747 . . . . 0.0 107.216 -174.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -123.38 112.55 17.7 Favored 'General case' 0 C--O 1.193 -1.884 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.436 -159.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -64.86 140.56 58.88 Favored 'General case' 0 C--N 1.368 1.371 0 C-N-CA 128.09 2.556 . . . . 0.0 111.688 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.5 tp -142.13 142.59 27.52 Favored 'Isoleucine or valine' 0 C--O 1.263 1.781 0 O-C-N 117.78 -3.075 . . . . 0.0 110.702 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.3 p -145.78 172.23 13.62 Favored 'General case' 0 C--N 1.39 2.34 0 CA-C-N 112.308 -2.224 . . . . 0.0 112.711 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.68 -46.33 82.9 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 117.516 -1.231 . . . . 0.0 109.006 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.73 -34.96 67.43 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 120.714 1.597 . . . . 0.0 107.67 -174.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -66.12 -40.05 90.38 Favored 'General case' 0 C--N 1.369 1.456 0 O-C-N 120.241 -1.537 . . . . 0.0 113.511 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.2 tp -67.97 -44.91 75.6 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 124.112 0.965 . . . . 0.0 113.556 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 88.61 21.09 0.04 OUTLIER 'General case' 0 C--N 1.356 0.89 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 171.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -151.26 173.6 14.27 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 101.124 -3.658 . . . . 0.0 101.124 -166.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.1 mt -73.69 144.67 45.71 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 118.069 -2.894 . . . . 0.0 114.089 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.448 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 66.0 t-105 -92.18 127.97 47.06 Favored Pre-proline 0 C--O 1.208 -1.109 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.705 -170.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 71' ' ' TRP . 88.0 Cg_endo -93.7 6.36 2.76 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 CA-C-O 115.206 -2.081 . . . . 0.0 110.919 -157.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.5 mt -124.7 158.17 33.87 Favored 'General case' 0 C--N 1.361 1.077 0 CA-C-N 122.638 2.472 . . . . 0.0 108.654 -169.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.2 p -62.38 -48.27 80.48 Favored 'General case' 0 N--CA 1.507 2.401 0 C-N-CA 124.118 0.967 . . . . 0.0 113.156 163.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.1 m -65.6 149.17 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 125.14 2.4 . . . . 0.0 113.022 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.37 176.59 4.51 Favored 'General case' 0 CA--C 1.561 1.369 0 O-C-N 120.275 -1.515 . . . . 0.0 109.084 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -25.16 137.32 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 153.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.33 -118.77 0.95 Allowed Glycine 0 C--N 1.373 2.608 0 CA-C-O 123.962 1.868 . . . . 0.0 112.636 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 m -156.54 154.11 29.77 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 6.2 pt -133.35 129.22 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-O 124.447 2.07 . . . . 0.0 107.579 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -130.38 154.43 47.7 Favored 'General case' 0 C--N 1.359 0.984 0 CA-C-N 112.157 -2.292 . . . . 0.0 111.848 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 96.9 m -122.15 134.3 54.74 Favored 'General case' 0 C--O 1.189 -2.116 0 O-C-N 119.959 -1.713 . . . . 0.0 108.275 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.79 153.67 81.68 Favored Pre-proline 0 N--CA 1.497 1.878 0 CA-C-N 122.977 2.626 . . . . 0.0 107.431 -171.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -43.28 150.13 0.44 Allowed 'Trans proline' 0 CA--C 1.509 -0.726 0 C-N-CA 122.09 1.86 . . . . 0.0 114.799 173.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.338 37.8 m 82.1 33.28 0.09 Allowed 'General case' 0 C--N 1.361 1.106 0 O-C-N 127.529 3.018 . . . . 0.0 116.216 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 49.05 40.95 18.42 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 130.735 3.614 . . . . 0.0 115.037 -167.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -94.75 133.92 37.92 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 123.3 1.524 . . . . 0.0 109.27 -175.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.31 141.25 52.18 Favored 'General case' 0 C--O 1.192 -1.935 0 O-C-N 119.647 -1.908 . . . . 0.0 109.528 171.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.25 153.31 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.382 0 C-N-CA 126.654 1.982 . . . . 0.0 112.232 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -111.74 121.75 45.93 Favored 'General case' 0 CA--C 1.562 1.432 1 C-N-CA 132.282 4.233 . . . . 0.0 106.802 170.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.32 108.49 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 118.697 -2.502 . . . . 0.0 108.321 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.44 154.05 93.75 Favored Pre-proline 0 N--CA 1.434 -1.273 0 C-N-CA 127.245 2.218 . . . . 0.0 115.937 169.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -74.91 12.46 1.19 Allowed 'Trans proline' 0 N--CA 1.515 2.785 0 N-CA-C 116.051 1.52 . . . . 0.0 116.051 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -100.99 1.13 39.34 Favored 'General case' 0 C--N 1.361 1.107 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.528 158.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.33 11.62 60.83 Favored Glycine 0 CA--C 1.465 -3.072 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 m -76.04 117.47 17.79 Favored 'General case' 0 N--CA 1.435 -1.225 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.641 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . 0.263 53.9 m -93.34 80.68 4.41 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 -171.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -70.59 153.64 42.67 Favored 'General case' 0 C--O 1.254 1.318 0 O-C-N 121.1 -1.0 . . . . 0.0 112.882 -173.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.27 114.7 7.77 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 167.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.2 tp -92.33 -25.59 18.48 Favored 'General case' 0 CA--C 1.558 1.267 0 CA-C-O 121.698 0.761 . . . . 0.0 112.997 173.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -120.99 173.84 7.0 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 119.164 -2.21 . . . . 0.0 110.093 163.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -60.43 -30.99 69.99 Favored 'General case' 0 CA--C 1.576 1.946 0 C-N-CA 130.436 3.494 . . . . 0.0 116.581 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -67.65 -54.08 22.51 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.444 172.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.83 -35.12 74.08 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -61.88 -45.51 93.44 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 122.385 1.088 . . . . 0.0 112.153 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -68.29 -28.12 66.91 Favored 'General case' 0 C--O 1.259 1.554 0 CA-C-O 124.368 2.032 . . . . 0.0 115.859 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.62 -21.13 61.88 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 116.662 2.097 . . . . 0.0 116.662 168.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.69 15.07 11.46 Favored Glycine 0 CA--C 1.463 -3.202 0 CA-C-O 114.915 -3.159 . . . . 0.0 114.396 -174.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -87.31 150.39 49.14 Favored Pre-proline 0 N--CA 1.429 -1.498 0 C-N-CA 114.079 -3.049 . . . . 0.0 110.461 164.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -57.23 142.16 94.6 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 CA-C-O 116.668 -1.472 . . . . 0.0 115.668 -172.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -68.06 139.35 46.49 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 CA-C-O 125.316 2.132 . . . . 0.0 116.532 169.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 10.4 tt -90.05 10.64 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 O-C-N 118.584 -2.573 . . . . 0.0 107.116 -171.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.27 -52.23 70.8 Favored Pre-proline 0 C--N 1.369 1.45 0 O-C-N 119.791 -1.818 . . . . 0.0 114.093 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.94 -7.34 20.89 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 CA-C-N 121.539 1.585 . . . . 0.0 113.204 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 13.6 pt -103.79 9.03 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.198 0.908 . . . . 0.0 111.174 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -69.82 137.03 51.46 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.996 0.903 . . . . 0.0 112.794 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -94.31 129.37 41.0 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 122.979 1.371 . . . . 0.0 112.171 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -89.59 140.78 29.21 Favored 'General case' 0 C--O 1.253 1.241 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.49 -168.89 7.75 Favored Glycine 0 C--N 1.383 3.171 0 N-CA-C 118.475 2.15 . . . . 0.0 118.475 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 m -96.97 123.35 40.67 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 124.626 0.839 . . . . 0.0 112.817 164.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 62.68 50.29 65.5 Favored Glycine 0 CA--C 1.496 -1.153 0 C-N-CA 126.362 1.934 . . . . 0.0 113.876 -168.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 83.89 -175.91 51.91 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 125.865 1.698 . . . . 0.0 113.093 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.7 174.16 44.11 Favored Glycine 0 CA--C 1.539 1.538 0 O-C-N 127.33 2.429 . . . . 0.0 111.977 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -126.75 143.42 51.25 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 -172.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 37.3 mm -74.17 140.55 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 O-C-N 120.077 -1.639 . . . . 0.0 111.657 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 30.9 t -62.01 127.62 32.27 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 -169.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.6 mt -72.62 -17.52 61.67 Favored 'General case' 0 C--N 1.378 1.828 0 O-C-N 118.052 -2.905 . . . . 0.0 111.806 169.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -41.52 -53.85 4.18 Favored Glycine 0 C--N 1.343 0.964 0 C-N-CA 127.548 2.499 . . . . 0.0 117.688 -166.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.37 89.82 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 120.263 -1.728 . . . . 0.0 115.007 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 48.9 tp -64.7 -48.25 75.38 Favored 'General case' 0 C--O 1.206 -1.204 0 O-C-N 118.471 -2.643 . . . . 0.0 112.48 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.0 tp -64.51 -52.15 59.31 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 121.437 -0.789 . . . . 0.0 109.032 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.4 p -60.13 -41.99 93.85 Favored 'General case' 0 N--CA 1.509 2.516 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.7 m -55.75 -42.66 75.73 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 126.419 1.888 . . . . 0.0 110.036 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 78.4 m -60.12 -43.53 95.58 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 127.961 3.288 . . . . 0.0 108.655 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 12.1 mt -66.19 -36.7 83.76 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -57.91 -42.32 84.48 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 119.347 -2.096 . . . . 0.0 112.495 172.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.2 mt -62.96 -42.61 99.87 Favored 'General case' 0 C--O 1.193 -1.914 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.738 -172.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 28.4 p -113.94 27.37 9.57 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 115.332 -2.271 . . . . 0.0 110.625 -165.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.37 2.444 0 CA-C-N 123.714 2.961 . . . . 0.0 115.019 -178.762 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 CA--C 1.604 3.048 0 CA-C-O 115.679 -2.105 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.61 160.73 34.83 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 CA-C-N 125.381 2.957 . . . . 0.0 109.241 162.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 53.7 t -63.44 136.62 96.79 Favored Pre-proline 0 C--N 1.374 1.643 0 CA-C-O 117.148 -1.406 . . . . 0.0 108.277 174.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 50' ' ' VAL . 88.2 Cg_exo -70.68 -32.87 14.0 Favored 'Trans proline' 0 N--CA 1.507 2.27 0 CA-C-O 124.467 1.778 . . . . 0.0 115.358 -162.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.6 mt -117.95 135.03 23.26 Favored Pre-proline 0 C--O 1.264 1.818 0 O-C-N 118.53 -2.607 . . . . 0.0 107.944 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -86.3 77.64 2.31 Favored 'Trans proline' 0 C--N 1.297 -2.163 0 N-CA-C 105.278 -2.624 . . . . 0.0 105.278 172.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.1 t -56.93 131.35 79.5 Favored Pre-proline 0 CA--C 1.584 2.273 0 C-N-CA 126.464 1.906 . . . . 0.0 112.155 -169.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -42.68 120.95 1.96 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 125.064 3.843 . . . . 0.0 115.799 -170.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.279 13.0 m 82.22 89.9 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 171.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.327 2.1 t 52.7 47.06 25.49 Favored 'General case' 0 C--N 1.391 2.385 0 O-C-N 124.864 1.352 . . . . 0.0 114.21 -174.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.452 64.5 t30 28.15 60.66 0.12 Allowed 'General case' 0 C--N 1.376 1.74 0 N-CA-C 121.158 3.762 . . . . 0.0 121.158 171.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -90.26 106.45 18.5 Favored 'General case' 0 C--N 1.38 1.924 0 CA-C-O 123.052 1.406 . . . . 0.0 111.88 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -72.82 119.85 17.63 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 110.92 -2.855 . . . . 0.0 115.024 -167.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -74.4 155.37 38.16 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 111.58 -2.554 . . . . 0.0 109.784 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 tp -147.54 138.67 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.199 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 -175.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.7 t -145.01 154.3 42.39 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.67 -1.269 . . . . 0.0 109.113 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -54.9 -30.16 57.58 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 126.065 1.746 . . . . 0.0 112.246 168.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.96 -37.44 82.4 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 171.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -70.77 -44.7 66.15 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.297 1.839 . . . . 0.0 113.108 168.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 8.4 mt -58.76 -43.19 90.26 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 67' ' ' LEU . . . 82.18 -3.96 1.47 Allowed 'General case' 0 N--CA 1.411 -2.388 0 CA-C-O 122.427 1.108 . . . . 0.0 108.969 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -138.53 151.07 47.02 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 118.678 -2.513 . . . . 0.0 106.147 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 tp -51.09 142.24 12.72 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 126.133 1.773 . . . . 0.0 114.039 -167.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -55.9 134.83 73.19 Favored Pre-proline 0 CA--C 1.583 2.234 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -97.76 2.31 1.47 Allowed 'Trans proline' 0 C--O 1.206 -1.097 0 CA-C-O 113.898 -2.626 . . . . 0.0 112.273 -174.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.3 mt -112.34 165.95 11.73 Favored 'General case' 0 C--N 1.364 1.221 0 CA-C-N 121.558 1.981 . . . . 0.0 110.986 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.2 p -91.99 -25.26 18.93 Favored 'General case' 0 C--N 1.361 1.097 0 O-C-N 120.564 -1.335 . . . . 0.0 111.381 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 m -71.3 135.12 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -79.31 115.11 18.77 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 124.076 0.86 . . . . 0.0 109.207 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.345 38.5 m80 57.74 -164.74 0.17 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 117.115 -1.422 . . . . 0.0 112.042 -178.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.19 -162.48 34.81 Favored Glycine 0 C--N 1.371 2.502 0 N-CA-C 103.37 -3.892 . . . . 0.0 103.37 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.38 151.29 43.38 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 103.49 -2.781 . . . . 0.0 103.49 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.97 161.04 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-O 124.303 2.001 . . . . 0.0 106.821 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -139.36 156.91 46.69 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 118.799 -2.438 . . . . 0.0 106.523 170.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.4 m -134.68 128.48 33.1 Favored 'General case' 0 C--N 1.37 1.461 0 O-C-N 120.041 -1.662 . . . . 0.0 110.808 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.1 mt -113.92 148.0 38.96 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 115.783 -2.056 . . . . 0.0 106.812 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . 0.262 31.3 Cg_exo -50.26 147.75 15.52 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 125.21 3.94 . . . . 0.0 116.485 -166.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.257 12.3 m 72.22 39.97 0.73 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.974 1.71 . . . . 0.0 113.815 -175.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 58.53 46.72 14.46 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 128.688 2.795 . . . . 0.0 112.357 172.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.69 113.27 24.9 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 171.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.27 130.76 50.61 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.883 -1.136 . . . . 0.0 110.979 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.9 t -114.12 140.78 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-O 125.484 2.564 . . . . 0.0 106.968 -175.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -111.44 150.24 30.13 Favored 'General case' 0 C--N 1.354 0.799 0 CA-C-N 113.263 -1.79 . . . . 0.0 107.096 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.9 t -132.97 123.27 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 N-CA-C 102.174 -3.269 . . . . 0.0 102.174 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.94 163.05 17.77 Favored Pre-proline 0 CA--C 1.588 2.415 0 CA-C-O 122.625 1.203 . . . . 0.0 112.316 172.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.47 -38.96 28.43 Favored 'Trans proline' 0 N--CA 1.517 2.891 0 C-N-CA 124.861 3.707 . . . . 0.0 114.598 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.2 p-10 -84.24 -10.43 57.69 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 121.253 1.842 . . . . 0.0 113.291 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.9 4.85 36.08 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 125.645 1.593 . . . . 0.0 115.221 176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.4 m -58.88 139.4 56.57 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 122.684 1.231 . . . . 0.0 114.015 167.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.1 m -111.74 125.62 54.18 Favored 'General case' 0 C--O 1.206 -1.219 0 O-C-N 121.088 -1.008 . . . . 0.0 110.942 -165.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -133.95 166.23 23.19 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 123.454 1.597 . . . . 0.0 110.641 -165.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -117.38 124.19 48.3 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 119.824 -1.798 . . . . 0.0 112.394 -171.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.1 tp -90.02 -26.76 20.15 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -173.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -135.81 178.17 7.25 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.734 -1.229 . . . . 0.0 108.727 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -53.34 -43.88 68.04 Favored 'General case' 0 C--N 1.399 2.72 0 C-N-CA 125.611 1.564 . . . . 0.0 114.504 -171.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -70.65 -31.71 68.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.64 -37.53 65.31 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 122.578 1.18 . . . . 0.0 109.241 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -62.52 -50.52 71.04 Favored 'General case' 0 C--N 1.364 1.205 0 O-C-N 119.926 -1.734 . . . . 0.0 109.824 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -53.81 -31.77 50.28 Favored 'General case' 0 CA--C 1.586 2.333 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 173.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.92 -22.8 66.52 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 115.953 -1.975 . . . . 0.0 112.422 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 128.81 8.47 3.81 Favored Glycine 0 C--N 1.378 2.885 0 CA-C-N 122.696 2.498 . . . . 0.0 116.12 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -118.79 145.65 38.23 Favored Pre-proline 0 C--N 1.376 1.741 0 CA-C-N 121.862 2.831 . . . . 0.0 108.496 -174.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -51.68 148.62 20.95 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.945 3.097 . . . . 0.0 111.042 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -78.98 146.98 20.83 Favored 'Trans proline' 0 CA--C 1.511 -0.641 1 C-N-CA 125.418 4.079 . . . . 0.0 108.048 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.7 tp -89.25 -0.32 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 125.295 2.474 . . . . 0.0 111.229 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.6 p -56.1 -42.21 94.99 Favored Pre-proline 0 C--O 1.213 -0.827 0 CA-C-O 113.663 -3.065 . . . . 0.0 112.9 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -59.94 -31.8 94.19 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 CA-C-N 126.509 3.36 . . . . 0.0 115.693 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.3 tt -98.75 13.55 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -55.19 149.06 13.09 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 114.011 -1.449 . . . . 0.0 110.3 162.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -92.79 136.09 33.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 112.767 -2.015 . . . . 0.0 110.623 172.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -67.66 145.69 54.56 Favored 'General case' 0 C--O 1.201 -1.489 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.759 164.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.91 175.63 23.3 Favored Glycine 0 N--CA 1.484 1.851 0 CA-C-O 122.947 1.304 . . . . 0.0 110.883 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.3 t -71.72 125.46 27.19 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 112.745 -1.727 . . . . 0.0 110.668 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.1 7.61 57.21 Favored Glycine 0 C--N 1.353 1.525 0 O-C-N 125.385 1.678 . . . . 0.0 116.887 -165.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.98 156.9 22.25 Favored Glycine 0 CA--C 1.54 1.598 0 O-C-N 121.516 -0.991 . . . . 0.0 114.409 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.82 161.0 11.54 Favored Glycine 0 C--N 1.368 2.346 0 C-N-CA 130.347 3.832 . . . . 0.0 114.107 167.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -71.1 138.97 50.15 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 125.941 1.696 . . . . 0.0 108.442 -167.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.1 mt -73.77 140.24 18.04 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-N 110.087 -3.233 . . . . 0.0 112.62 168.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.4 t -65.03 152.15 44.18 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 118.296 2.702 . . . . 0.0 118.296 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 59.5 mt -102.22 11.74 37.76 Favored 'General case' 0 C--O 1.206 -1.214 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -177.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.85 -51.81 56.27 Favored Glycine 0 CA--C 1.555 2.584 0 O-C-N 119.177 -2.202 . . . . 0.0 116.981 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.66 -37.38 82.29 Favored 'General case' 0 N--CA 1.42 -1.928 0 O-C-N 119.164 -2.374 . . . . 0.0 114.184 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.8 tp -60.98 -45.43 94.82 Favored 'General case' 0 C--O 1.252 1.227 0 C-N-CA 124.399 1.079 . . . . 0.0 111.111 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.8 tp -69.95 -42.21 73.52 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 p -63.41 -45.31 91.59 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.16 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 94.4 m -64.23 -42.72 96.44 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 126.118 2.136 . . . . 0.0 109.398 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 92.4 m -46.92 -55.76 7.52 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 115.104 -2.379 . . . . 0.0 116.379 167.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 25.1 mt -71.56 -25.21 62.11 Favored 'General case' 0 CA--C 1.568 1.654 0 O-C-N 128.173 3.42 . . . . 0.0 113.781 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -60.38 -45.88 91.96 Favored 'General case' 0 CA--C 1.58 2.112 0 C-N-CA 126.853 2.061 . . . . 0.0 110.327 164.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 13.4 mt -65.2 -42.96 93.04 Favored 'General case' 0 C--N 1.416 3.497 0 O-C-N 119.58 -1.95 . . . . 0.0 114.281 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 16.6 p -101.81 15.76 27.97 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 127.256 2.222 . . . . 0.0 110.702 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.942 0 CA-C-O 115.901 -2.611 . . . . 0.0 114.092 174.892 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 137' ' ' LEU . 5.0 t . . . . . 0 N--CA 1.503 2.182 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -93.88 133.74 0.86 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 122.336 1.87 . . . . 0.0 108.239 -167.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.7 p -95.17 131.26 30.37 Favored Pre-proline 0 N--CA 1.431 -1.402 0 C-N-CA 117.446 -1.702 . . . . 0.0 106.778 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -46.46 123.61 7.0 Favored 'Trans proline' 0 N--CA 1.511 2.556 0 N-CA-C 116.853 1.828 . . . . 0.0 116.853 170.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.44 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 64.3 mt -138.47 165.74 30.72 Favored Pre-proline 0 C--N 1.378 1.812 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -173.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 52' ' ' LEU . 4.6 Cg_endo -64.54 134.77 42.69 Favored 'Trans proline' 0 C--O 1.253 1.272 0 CA-C-O 124.836 1.932 . . . . 0.0 112.189 158.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . 0.279 31.7 t 52.62 68.7 2.85 Favored Pre-proline 0 CA--C 1.577 1.982 0 N-CA-C 120.136 3.384 . . . . 0.0 120.136 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.79 -24.9 20.85 Favored 'Trans proline' 0 N--CA 1.506 2.216 0 CA-C-N 125.67 3.061 . . . . 0.0 117.48 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.28 14.1 p 52.37 47.6 24.38 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 120.508 1.504 . . . . 0.0 114.86 172.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t 84.64 35.14 0.04 OUTLIER 'General case' 0 C--O 1.204 -1.327 0 C-N-CA 128.777 2.831 . . . . 0.0 111.228 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 64.02 48.2 3.13 Favored 'General case' 0 N--CA 1.486 1.332 1 C-N-CA 132.499 4.32 . . . . 0.0 115.709 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -79.21 117.36 20.16 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 115.999 -2.28 . . . . 0.0 115.432 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -97.93 126.02 43.12 Favored 'General case' 0 CA--C 1.557 1.222 0 O-C-N 117.704 -3.122 . . . . 0.0 108.106 -177.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -87.18 155.82 19.94 Favored 'General case' 0 CA--C 1.557 1.248 0 O-C-N 117.502 -3.249 . . . . 0.0 111.62 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.7 tp -113.48 117.85 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 123.292 1.52 . . . . 0.0 113.443 165.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.0 p -128.87 179.25 5.83 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 123.645 1.688 . . . . 0.0 109.285 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -61.65 -29.68 70.22 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 119.581 -1.95 . . . . 0.0 114.284 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.99 -42.57 84.8 Favored 'General case' 0 C--O 1.266 1.936 0 C-N-CA 125.448 1.499 . . . . 0.0 112.932 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.44 -46.2 84.18 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 164.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.27 83.3 mt -73.73 -17.38 61.12 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 122.78 2.536 . . . . 0.0 113.872 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.3 . . 65.18 11.76 7.46 Favored 'General case' 0 C--O 1.192 -1.961 0 O-C-N 127.915 3.259 . . . . 0.0 115.953 -177.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -165.12 166.4 19.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 127.307 2.243 . . . . 0.0 107.004 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.7 mt -18.93 133.07 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.443 3.097 . . . . 0.0 119.209 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -73.72 127.01 89.19 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 116.622 -3.799 . . . . 0.0 114.975 164.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -89.15 15.49 2.01 Favored 'Trans proline' 0 CA--C 1.57 2.294 0 CA-C-N 123.292 2.211 . . . . 0.0 112.229 -168.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 mt -136.0 165.1 26.46 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-O 123.753 1.739 . . . . 0.0 110.727 -172.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.8 p -100.97 -1.56 34.1 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.561 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.415 ' H ' HG22 ' A' ' 75' ' ' VAL . 17.2 m -90.27 171.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.381 1.962 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 169.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -81.26 174.7 11.27 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 122.27 1.033 . . . . 0.0 111.816 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -73.37 144.18 46.55 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 128.838 2.855 . . . . 0.0 106.012 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.03 179.54 36.42 Favored Glycine 0 C--N 1.367 2.304 0 CA-C-N 112.058 -2.337 . . . . 0.0 110.501 -164.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.3 m -84.65 120.21 26.12 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-O 123.716 1.722 . . . . 0.0 113.593 -173.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 pp -86.69 143.68 10.91 Favored 'Isoleucine or valine' 0 C--O 1.257 1.489 0 CA-C-O 124.243 1.973 . . . . 0.0 111.574 165.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -145.67 151.68 38.42 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 112.577 -2.101 . . . . 0.0 107.125 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 89.6 m -121.51 115.02 22.07 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-O 125.086 2.374 . . . . 0.0 107.132 172.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mt -92.86 150.81 40.09 Favored Pre-proline 0 CA--C 1.507 -0.701 0 CA-C-O 116.093 -1.908 . . . . 0.0 106.564 -174.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -47.07 138.75 15.93 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 123.848 3.032 . . . . 0.0 116.545 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.6 m 80.14 49.26 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 120.757 1.617 . . . . 0.0 115.229 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 46.98 49.19 14.99 Favored 'General case' 0 C--N 1.392 2.448 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -106.32 116.51 32.06 Favored 'General case' 0 C--N 1.385 2.119 0 C-N-CA 117.868 -1.533 . . . . 0.0 111.942 170.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.77 106.94 15.85 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-O 123.291 1.52 . . . . 0.0 107.575 -173.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.7 m -122.67 144.79 30.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 C-N-CA 127.589 2.356 . . . . 0.0 109.089 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -113.33 128.47 56.47 Favored 'General case' 0 N--CA 1.425 -1.687 0 O-C-N 119.006 -2.309 . . . . 0.0 106.165 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.9 t -106.49 111.64 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' A' ' 93' ' ' PRO . . . -69.98 156.3 92.02 Favored Pre-proline 0 C--O 1.27 2.153 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.598 171.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.478 ' HD2' ' HB1' ' A' ' 92' ' ' ALA . 41.1 Cg_endo -68.61 2.36 2.98 Favored 'Trans proline' 0 CA--C 1.498 -1.31 0 C-N-CA 124.409 3.406 . . . . 0.0 113.241 -166.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -102.66 -25.13 13.67 Favored 'General case' 0 C--O 1.245 0.834 0 O-C-N 127.139 2.774 . . . . 0.0 110.188 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.11 24.85 3.16 Favored Glycine 0 C--N 1.348 1.242 0 C-N-CA 126.282 1.896 . . . . 0.0 110.815 172.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.46 147.32 24.35 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.0 m -129.47 125.68 36.97 Favored 'General case' 0 C--O 1.263 1.814 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -167.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -128.94 126.81 40.45 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 125.852 1.97 . . . . 0.0 108.581 -165.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.04 124.26 19.99 Favored 'General case' 0 C--O 1.211 -0.932 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 69.7 mt -93.77 -30.49 14.83 Favored 'General case' 0 C--N 1.369 1.441 0 O-C-N 119.638 -1.914 . . . . 0.0 112.571 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -122.12 178.11 5.05 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 124.132 1.92 . . . . 0.0 106.51 174.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -79.04 -19.51 51.26 Favored 'General case' 0 CA--C 1.583 2.223 0 O-C-N 118.402 -2.687 . . . . 0.0 117.751 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -59.18 -37.78 78.19 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 126.018 2.074 . . . . 0.0 110.168 172.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.23 -30.75 69.89 Favored 'General case' 0 CA--C 1.472 -2.029 0 CA-C-O 114.998 -2.429 . . . . 0.0 113.271 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -62.7 -41.31 99.06 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 126.788 2.035 . . . . 0.0 114.014 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -66.34 -37.01 84.36 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 168.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.32 -4.68 40.61 Favored 'General case' 0 C--O 1.257 1.475 0 O-C-N 118.801 -2.437 . . . . 0.0 112.348 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.94 28.63 9.83 Favored Glycine 0 C--N 1.353 1.526 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.75 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -86.43 134.92 37.13 Favored Pre-proline 0 CA--C 1.58 2.1 0 CA-C-O 115.468 -2.206 . . . . 0.0 107.862 170.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -56.8 128.26 29.23 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 O-C-N 125.667 2.404 . . . . 0.0 114.313 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -32.27 145.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.362 2.041 . . . . 0.0 115.824 161.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.9 tt -99.96 19.46 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 C-N-CA 126.188 1.795 . . . . 0.0 110.453 173.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.05 -30.47 1.13 Allowed Pre-proline 0 CA--C 1.558 1.251 0 CA-C-O 112.165 -3.778 . . . . 0.0 116.439 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -71.59 -42.33 1.85 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 125.342 2.944 . . . . 0.0 111.716 -169.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 21.5 pt -88.28 6.19 3.75 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 C-N-CA 128.243 2.617 . . . . 0.0 111.774 -165.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -53.11 155.9 2.39 Favored 'General case' 0 C--O 1.221 -0.419 1 O-C-N 116.021 -4.174 . . . . 0.0 118.355 168.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -98.68 147.33 24.96 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 117.31 -1.756 . . . . 0.0 110.04 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . 0.353 13.7 mmmm -64.94 143.99 57.58 Favored 'General case' 0 C--N 1.37 1.476 0 CA-C-O 124.072 1.891 . . . . 0.0 110.568 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -82.06 -146.19 5.6 Favored Glycine 0 CA--C 1.57 3.489 0 CA-C-O 126.374 3.208 . . . . 0.0 117.503 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.4 t -111.42 111.74 22.99 Favored 'General case' 0 CA--C 1.512 -0.507 1 O-C-N 116.113 -4.169 . . . . 0.0 102.86 170.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.48 48.27 5.37 Favored Glycine 1 C--N 1.399 4.053 0 CA-C-N 120.319 1.418 . . . . 0.0 110.096 177.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.82 -164.52 54.78 Favored Glycine 0 C--N 1.381 3.075 0 N-CA-C 117.12 1.608 . . . . 0.0 117.12 -171.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.39 -166.4 1.14 Allowed Glycine 0 C--N 1.338 0.684 1 N-CA-C 123.491 4.157 . . . . 0.0 123.491 -173.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . 0.317 74.3 m-85 -133.54 149.06 51.68 Favored 'General case' 0 C--O 1.253 1.269 0 O-C-N 117.414 -3.403 . . . . 0.0 110.296 -173.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 79.6 mt -63.92 151.67 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.163 0 CA-C-N 124.082 3.128 . . . . 0.0 108.784 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.0 t -62.55 145.24 54.84 Favored 'General case' 0 C--O 1.198 -1.64 0 O-C-N 118.273 -2.767 . . . . 0.0 113.17 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.7 mt -97.52 4.92 50.26 Favored 'General case' 0 CA--C 1.58 2.116 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 -172.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -76.59 -41.72 23.83 Favored Glycine 0 C--N 1.394 3.789 0 C-N-CA 119.683 -1.246 . . . . 0.0 115.38 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.26 -34.52 72.91 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 117.389 -3.418 . . . . 0.0 115.767 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 27.9 tp -54.26 -58.71 6.36 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 126.083 1.753 . . . . 0.0 112.133 165.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 38.3 tp -63.09 -40.3 97.25 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.3 p -71.82 -33.45 68.52 Favored 'General case' 0 C--O 1.251 1.175 0 O-C-N 119.296 -2.128 . . . . 0.0 115.108 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 32.4 m -61.71 -42.69 99.28 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.92 1.288 . . . . 0.0 108.656 169.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.1 m -57.56 -46.85 83.43 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.8 mt -72.12 -30.13 64.75 Favored 'General case' 0 CA--C 1.562 1.406 0 O-C-N 124.865 1.353 . . . . 0.0 112.232 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -58.25 -46.62 85.65 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 116.845 -1.55 . . . . 0.0 113.14 168.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 48' ' ' SER . 71.9 mt -72.63 -45.25 59.96 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 119.236 0.926 . . . . 0.0 111.29 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . 0.342 1.2 p -74.44 -17.76 60.74 Favored 'General case' 0 C--O 1.202 -1.429 0 CA-C-O 115.75 -2.072 . . . . 0.0 113.328 -170.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.381 3.065 0 N-CA-C 120.035 2.774 . . . . 0.0 120.035 169.757 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.481 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 17.9 m . . . . . 0 N--CA 1.508 2.43 0 CA-C-O 115.807 -2.044 . . . . 0.0 116.113 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 40.1 Cg_exo -50.7 152.15 9.82 Favored 'Trans proline' 0 C--O 1.199 -1.453 0 C-N-CA 124.432 3.421 . . . . 0.0 114.583 164.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.3 m -67.13 140.95 96.02 Favored Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-O 117.128 -1.415 . . . . 0.0 112.422 -165.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -41.1 130.81 3.1 Favored 'Trans proline' 0 C--N 1.286 -2.714 0 N-CA-C 120.83 3.358 . . . . 0.0 120.83 167.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.1 tp -129.76 101.12 18.71 Favored Pre-proline 0 CA--C 1.591 2.521 0 O-C-N 125.633 1.833 . . . . 0.0 111.952 -168.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -86.96 89.75 0.62 Allowed 'Trans proline' 0 CA--C 1.474 -2.483 1 C-N-CA 126.822 5.015 . . . . 0.0 108.072 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.8 t -163.77 116.01 1.02 Allowed Pre-proline 0 C--N 1.288 -2.071 0 C-N-CA 119.288 -0.965 . . . . 0.0 112.122 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -33.94 134.7 0.12 Allowed 'Trans proline' 0 CA--C 1.508 -0.802 1 C-N-CA 126.686 4.924 . . . . 0.0 118.572 -175.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 35.78 42.07 0.13 Allowed 'General case' 0 C--O 1.257 1.454 0 C-N-CA 129.771 3.228 . . . . 0.0 114.63 -167.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.364 7.4 m 59.29 54.49 4.74 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 125.999 1.719 . . . . 0.0 114.938 -173.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.0 t30 66.36 38.39 4.42 Favored 'General case' 0 CA--C 1.597 2.76 0 C-N-CA 130.743 3.617 . . . . 0.0 113.759 -175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.79 145.53 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.417 2.687 . . . . 0.0 114.758 -176.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 68.2 mm-40 -114.49 104.35 11.94 Favored 'General case' 0 CA--C 1.466 -2.26 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -170.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.75 139.06 55.32 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.401 HD11 HD12 ' A' ' 130' ' ' LEU . 1.1 tt -116.24 142.6 29.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 121.458 -0.776 . . . . 0.0 109.408 162.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.5 ' HB2' ' CE1' ' A' ' 77' ' ' HIS . 90.3 p -152.76 158.88 42.93 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-O 116.143 -1.885 . . . . 0.0 107.207 -169.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -64.28 -18.16 64.32 Favored 'General case' 0 C--N 1.367 1.365 0 CA-C-N 123.608 2.913 . . . . 0.0 110.598 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.96 -25.9 53.37 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 120.476 -1.39 . . . . 0.0 111.817 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -73.29 -28.66 62.23 Favored 'General case' 0 CA--C 1.499 -1.003 0 C-N-CA 125.949 1.7 . . . . 0.0 111.275 173.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.427 HD11 HD13 ' A' ' 130' ' ' LEU . 9.7 mt -88.98 3.77 50.45 Favored 'General case' 0 C--O 1.203 -1.35 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 36.8 63.01 0.72 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 120.747 3.61 . . . . 0.0 120.747 -168.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . 0.297 51.0 t80 83.58 149.12 0.08 Allowed 'General case' 0 N--CA 1.413 -2.312 0 C-N-CA 129.214 3.006 . . . . 0.0 109.714 -177.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.324 2.1 tp 89.57 81.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 128.989 2.916 . . . . 0.0 109.601 173.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -85.7 124.79 70.64 Favored Pre-proline 0 N--CA 1.479 0.989 0 O-C-N 120.37 -1.456 . . . . 0.0 112.474 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.72 3.2 8.0 Favored 'Trans proline' 0 C--N 1.362 1.253 0 CA-C-N 122.037 1.763 . . . . 0.0 114.637 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.9 mt -120.63 158.27 27.77 Favored 'General case' 0 C--N 1.375 1.683 0 O-C-N 121.251 -0.906 . . . . 0.0 110.95 -165.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.0 p -78.83 -30.08 45.07 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 170.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.5 m -71.91 147.71 10.4 Favored 'Isoleucine or valine' 0 C--N 1.367 1.36 0 C-N-CA 124.506 1.122 . . . . 0.0 111.491 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . 0.256 62.7 t0 -90.15 82.35 6.07 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 118.49 -2.631 . . . . 0.0 111.426 -172.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.5 ' CE1' ' HB2' ' A' ' 63' ' ' SER 0.33 27.5 m170 77.84 178.12 0.15 Allowed 'General case' 0 CA--C 1.474 -1.956 0 O-C-N 120.567 -1.333 . . . . 0.0 114.013 179.016 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.21 -176.57 39.86 Favored Glycine 0 N--CA 1.433 -1.535 0 O-C-N 117.977 -2.952 . . . . 0.0 114.711 -172.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.259 17.0 p -124.24 146.29 48.84 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 118.591 -2.711 . . . . 0.0 105.757 171.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.409 HD11 HD23 ' A' ' 137' ' ' LEU . 2.8 pp -119.84 150.09 22.45 Favored 'Isoleucine or valine' 0 C--N 1.366 1.29 0 CA-C-O 126.644 3.116 . . . . 0.0 112.379 177.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -141.66 137.9 32.1 Favored 'General case' 0 CA--C 1.57 1.745 0 O-C-N 116.536 -3.852 . . . . 0.0 108.524 168.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.9 m -108.29 140.78 41.06 Favored 'General case' 0 C--N 1.368 1.385 0 O-C-N 117.342 -3.349 . . . . 0.0 104.906 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 87' ' ' ASN . 10.7 mt -111.38 146.99 35.73 Favored Pre-proline 0 N--CA 1.432 -1.359 0 C-N-CA 129.501 3.12 . . . . 0.0 102.909 -173.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -40.35 134.58 2.01 Favored 'Trans proline' 0 N--CA 1.507 2.274 1 C-N-CA 126.45 4.767 . . . . 0.0 113.059 -173.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . 0.272 1.0 OUTLIER 85.2 31.59 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 122.489 1.137 . . . . 0.0 108.909 170.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . 0.281 21.8 m-20 65.84 44.54 2.79 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 116.872 -3.642 . . . . 0.0 115.448 176.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 83' ' ' LEU . 2.3 m-80 -101.74 114.07 27.81 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 174.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.21 120.82 36.09 Favored 'General case' 0 N--CA 1.409 -2.508 0 O-C-N 125.013 1.446 . . . . 0.0 111.284 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.1 t -99.87 145.35 10.84 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 CA-C-O 127.737 3.637 . . . . 0.0 109.883 166.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -111.3 128.56 55.98 Favored 'General case' 0 N--CA 1.44 -0.94 1 O-C-N 115.038 -4.789 . . . . 0.0 106.714 168.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.8 t -110.44 124.57 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.723 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.36 167.15 19.69 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-O 117.222 -1.37 . . . . 0.0 114.367 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -41.13 -34.31 1.54 Allowed 'Trans proline' 0 N--CA 1.52 3.079 0 N-CA-C 120.518 3.238 . . . . 0.0 120.518 165.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.0 p30 -96.99 3.89 51.77 Favored 'General case' 0 CA--C 1.477 -1.846 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.77 -13.25 29.71 Favored Glycine 0 CA--C 1.526 0.725 0 O-C-N 120.262 -1.524 . . . . 0.0 111.91 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.282 47.0 m -66.47 113.02 4.38 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -173.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.68 119.58 10.16 Favored 'General case' 0 C--N 1.375 1.691 0 C-N-CA 128.014 2.526 . . . . 0.0 115.6 171.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -120.04 141.52 49.67 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 166.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.04 149.3 37.37 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 153.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . 0.255 23.1 tp -118.76 -3.26 10.81 Favored 'General case' 0 C--N 1.379 1.883 0 C-N-CA 129.87 3.268 . . . . 0.0 111.848 177.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 45.2 p30 -158.07 175.1 14.23 Favored 'General case' 0 C--N 1.38 1.897 0 CA-C-N 120.412 1.46 . . . . 0.0 109.916 169.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . 0.315 69.4 m-20 -60.34 -36.91 79.07 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -173.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.4 mtt85 -59.19 -41.34 88.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 127.811 3.194 . . . . 0.0 111.639 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.12 -23.5 28.42 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-O 124.932 2.301 . . . . 0.0 114.659 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -63.7 -47.28 81.78 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.63 -1.623 . . . . 0.0 112.391 163.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -61.32 -38.12 85.71 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-O 125.157 2.408 . . . . 0.0 115.427 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.39 -34.23 68.66 Favored 'General case' 0 CA--C 1.572 1.819 0 O-C-N 119.308 -2.12 . . . . 0.0 113.388 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 127.92 -3.83 6.92 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 120.807 3.083 . . . . 0.0 120.807 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -70.66 143.49 89.88 Favored Pre-proline 0 N--CA 1.487 1.421 0 CA-C-N 121.654 2.727 . . . . 0.0 112.161 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -48.44 146.8 9.84 Favored 'Trans proline' 0 C--N 1.296 -2.229 1 C-N-CA 126.323 4.682 . . . . 0.0 119.431 175.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -82.25 151.76 15.85 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 118.266 -1.492 . . . . 0.0 109.503 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.9 tt -86.08 4.19 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.554 1.942 . . . . 0.0 109.784 -171.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.65 -40.28 74.1 Favored Pre-proline 0 CA--C 1.578 2.029 1 N-CA-C 122.04 4.089 . . . . 0.0 122.04 -168.339 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.84 -6.66 14.31 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 113.974 -3.751 . . . . 0.0 114.308 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 31.4 mm -86.19 -16.61 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 C-N-CA 125.904 1.682 . . . . 0.0 106.952 176.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -56.93 145.39 30.2 Favored 'General case' 0 C--O 1.194 -1.834 0 CA-C-O 126.04 2.829 . . . . 0.0 117.49 164.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -93.7 132.59 37.91 Favored 'General case' 0 C--O 1.209 -1.07 0 CA-C-N 112.459 -2.155 . . . . 0.0 111.774 174.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . 0.467 41.3 mtpt -57.65 144.58 37.13 Favored 'General case' 0 C--O 1.178 -2.676 0 O-C-N 119.322 -2.111 . . . . 0.0 112.989 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -110.79 -168.88 19.21 Favored Glycine 0 N--CA 1.494 2.524 0 CA-C-N 119.943 1.247 . . . . 0.0 112.215 -159.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 64.4 m -76.05 119.89 20.61 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 116.145 -1.883 . . . . 0.0 113.487 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.55 49.33 5.83 Favored Glycine 0 C--N 1.365 2.147 0 CA-C-N 121.669 2.031 . . . . 0.0 114.194 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 59.62 -155.85 28.36 Favored Glycine 1 CA--C 1.593 4.918 0 O-C-N 118.245 -2.914 . . . . 0.0 116.375 -158.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 49.81 -152.69 3.58 Favored Glycine 0 C--O 1.213 -1.163 0 CA-C-O 124.395 2.108 . . . . 0.0 114.904 -167.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -134.58 148.44 50.46 Favored 'General case' 0 N--CA 1.418 -2.041 0 C-N-CA 126.594 1.958 . . . . 0.0 111.721 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.9 mt -60.9 140.17 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.363 0 O-C-N 120.324 -1.485 . . . . 0.0 112.391 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.5 t -52.61 137.65 30.13 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 128.844 2.857 . . . . 0.0 112.999 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.4 mt -98.46 4.48 48.37 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.481 -1.387 . . . . 0.0 111.47 175.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -44.25 -63.88 2.21 Favored Glycine 0 CA--C 1.486 -1.726 0 C-N-CA 127.775 2.607 . . . . 0.0 113.823 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.9 -45.08 93.68 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 173.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.427 HD13 HD11 ' A' ' 67' ' ' LEU . 34.0 tp -63.18 -43.44 98.22 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 124.502 1.126 . . . . 0.0 113.561 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.8 tp -64.72 -45.97 84.27 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 121.736 0.779 . . . . 0.0 112.405 168.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 78.4 p -74.8 -36.46 62.48 Favored 'General case' 0 CA--C 1.497 -1.095 0 O-C-N 117.919 -2.988 . . . . 0.0 113.347 -169.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 52.0 m -59.89 -43.09 94.99 Favored 'General case' 0 C--O 1.266 1.97 0 C-N-CA 128.695 2.798 . . . . 0.0 105.588 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 47.0 m -63.05 -41.65 99.54 Favored 'General case' 0 C--N 1.377 1.787 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.527 -174.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.427 ' HA ' ' SG ' ' A' ' 138' ' ' CYS . 17.8 mt -69.64 -36.95 76.57 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 117.719 2.489 . . . . 0.0 117.719 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -61.39 -37.89 85.09 Favored 'General case' 0 CA--C 1.57 1.715 0 O-C-N 116.801 -3.687 . . . . 0.0 109.839 165.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.409 HD23 HD11 ' A' ' 80' ' ' ILE . 49.0 tp -69.92 -31.25 68.92 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 118.155 -2.841 . . . . 0.0 115.622 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.427 ' SG ' ' HA ' ' A' ' 135' ' ' LEU . 28.6 p -92.21 14.86 14.96 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.088 -1.008 . . . . 0.0 110.957 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.984 0 C-N-CA 125.779 1.656 . . . . 0.0 109.993 -179.902 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -41.67 116.27 0.51 Allowed 'Trans proline' 0 N--CA 1.506 2.262 0 C-N-CA 124.521 3.481 . . . . 0.0 115.577 -168.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 52' ' ' LEU . 84.4 t -80.98 107.4 7.48 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 125.651 1.845 . . . . 0.0 110.674 176.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -77.67 33.34 0.45 Allowed 'Trans proline' 0 N--CA 1.505 2.168 0 N-CA-C 114.876 1.068 . . . . 0.0 114.876 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.417 ' H ' HG12 ' A' ' 50' ' ' VAL . 25.9 mt -115.0 160.17 34.8 Favored Pre-proline 0 C--N 1.378 1.835 0 O-C-N 120.313 -1.492 . . . . 0.0 110.399 -178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -45.79 147.01 3.43 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 N-CA-C 119.088 2.688 . . . . 0.0 119.088 164.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.7 m 35.04 73.13 0.65 Allowed Pre-proline 0 N--CA 1.512 2.629 0 N-CA-C 120.224 3.416 . . . . 0.0 120.224 -167.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.25 -18.28 44.81 Favored 'Trans proline' 0 C--N 1.366 1.485 0 C-N-CA 122.006 1.804 . . . . 0.0 114.103 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.2 m 43.5 58.85 3.28 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 127.552 2.341 . . . . 0.0 113.131 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.275 74.1 m 52.86 34.68 17.1 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 119.969 3.322 . . . . 0.0 119.969 -171.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 60.32 54.91 3.74 Favored 'General case' 0 C--O 1.248 1.026 0 C-N-CA 127.627 2.371 . . . . 0.0 116.438 -167.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.4 mttm -133.05 152.09 51.99 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -145.85 147.06 31.4 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.104 -1.407 . . . . 0.0 113.85 -162.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -73.76 135.02 43.54 Favored 'General case' 0 N--CA 1.411 -2.402 0 O-C-N 128.338 3.524 . . . . 0.0 111.464 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.424 HD13 ' CD1' ' A' ' 137' ' ' LEU . 9.9 tp -136.54 128.88 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 125.571 2.605 . . . . 0.0 112.945 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.9 p -162.76 171.78 16.24 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 127.271 2.228 . . . . 0.0 107.832 -159.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -45.1 -52.17 9.42 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 128.253 2.621 . . . . 0.0 114.756 173.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.76 93.55 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 174.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -82.45 -19.87 38.08 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 120.293 -1.504 . . . . 0.0 111.522 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.6 tp -75.06 -42.57 56.67 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 117.971 2.582 . . . . 0.0 117.971 166.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 65.56 15.71 10.16 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 130.006 3.322 . . . . 0.0 114.289 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -134.27 166.81 21.94 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 162.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.6 mt -39.31 128.67 1.8 Allowed 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -174.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -66.27 139.62 96.44 Favored Pre-proline 0 CA--C 1.567 1.621 0 CA-C-O 113.296 -3.24 . . . . 0.0 114.806 176.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -116.97 -3.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 2.015 0 CA-C-O 111.187 -3.755 . . . . 0.0 110.302 -167.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 mt -113.13 152.95 29.01 Favored 'General case' 0 C--N 1.401 2.818 0 O-C-N 127.484 2.99 . . . . 0.0 112.929 -177.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 63.2 p -79.28 -17.12 55.31 Favored 'General case' 0 N--CA 1.416 -2.132 0 O-C-N 118.281 -2.762 . . . . 0.0 113.64 -171.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.8 m -72.16 147.94 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 129.986 3.314 . . . . 0.0 115.003 166.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -56.59 171.24 0.32 Allowed 'General case' 0 C--O 1.2 -1.527 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 154.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -36.32 127.13 0.79 Allowed 'General case' 0 C--N 1.373 1.62 0 C-N-CA 130.322 3.449 . . . . 0.0 109.778 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -106.58 -168.24 22.68 Favored Glycine 0 N--CA 1.434 -1.459 0 CA-C-O 123.322 1.512 . . . . 0.0 111.659 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.9 m -120.97 115.57 23.43 Favored 'General case' 0 C--N 1.378 1.825 0 CA-C-N 111.228 -2.486 . . . . 0.0 109.031 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.438 ' H ' HG13 ' A' ' 80' ' ' ILE 0.328 1.9 pp -88.81 138.38 19.31 Favored 'Isoleucine or valine' 0 C--N 1.396 2.605 0 CA-C-N 121.074 1.761 . . . . 0.0 110.534 172.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -133.39 132.5 41.28 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.4 m -100.16 130.32 46.28 Favored 'General case' 0 C--N 1.382 1.994 0 CA-C-O 124.053 1.883 . . . . 0.0 110.322 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.3 mt -105.52 157.53 34.31 Favored Pre-proline 0 CA--C 1.569 1.706 0 O-C-N 119.32 -2.113 . . . . 0.0 113.589 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -40.35 145.73 0.32 Allowed 'Trans proline' 0 CA--C 1.475 -2.475 1 C-N-CA 127.084 5.19 . . . . 0.0 113.425 169.1 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.1 m 70.55 41.41 0.95 Allowed 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 118.971 2.952 . . . . 0.0 118.971 173.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 64.98 30.35 11.88 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 129.343 3.057 . . . . 0.0 112.751 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . 0.254 65.5 m-20 -101.06 137.31 39.59 Favored 'General case' 0 C--N 1.373 1.615 0 CA-C-N 120.009 1.277 . . . . 0.0 109.497 -169.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.12 124.2 36.35 Favored 'General case' 0 C--O 1.2 -1.535 0 CA-C-N 122.431 2.378 . . . . 0.0 111.002 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.254 32.7 m -120.11 144.29 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-O 124.361 2.029 . . . . 0.0 113.252 -174.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -121.06 131.37 54.24 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 120.236 -1.54 . . . . 0.0 107.594 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.35 118.32 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.323 0 C-N-CA 126.309 1.843 . . . . 0.0 110.867 169.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.17 156.51 76.51 Favored Pre-proline 0 CA--C 1.577 1.99 0 O-C-N 126.435 2.334 . . . . 0.0 115.401 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -43.69 -35.1 6.18 Favored 'Trans proline' 0 C--O 1.255 1.372 0 N-CA-C 120.395 3.19 . . . . 0.0 120.395 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -69.98 -33.54 72.19 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 116.779 -1.581 . . . . 0.0 113.719 172.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 127.86 -3.31 6.94 Favored Glycine 0 C--N 1.364 2.086 1 C-N-CA 130.915 4.102 . . . . 0.0 113.745 176.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.8 m -57.07 132.47 53.01 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 125.257 1.423 . . . . 0.0 113.834 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.4 m -106.19 109.0 20.8 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 123.163 2.711 . . . . 0.0 107.072 -174.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -113.26 148.4 35.64 Favored 'General case' 0 C--O 1.255 1.351 0 O-C-N 120.631 -1.293 . . . . 0.0 108.837 -171.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.3 127.65 33.44 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 114.636 -2.602 . . . . 0.0 111.438 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.38 -9.43 30.0 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 120.339 1.427 . . . . 0.0 112.393 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -141.75 171.02 14.63 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.414 1.102 . . . . 0.0 110.484 172.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -65.27 -32.54 74.26 Favored 'General case' 0 N--CA 1.416 -2.172 0 C-N-CA 130.396 3.478 . . . . 0.0 110.909 -171.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -59.09 -42.48 90.55 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 125.482 1.739 . . . . 0.0 113.352 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.419 ' HA ' ' HB3' ' A' ' 107' ' ' ALA . . . -84.6 -17.31 39.12 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -172.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -66.23 -44.14 84.6 Favored 'General case' 0 C--N 1.381 1.952 0 CA-C-O 116.262 -1.828 . . . . 0.0 110.289 158.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -65.31 -42.78 92.66 Favored 'General case' 0 C--N 1.362 1.117 0 O-C-N 126.445 2.341 . . . . 0.0 116.878 173.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 104' ' ' ALA . . . -59.6 -34.74 73.12 Favored 'General case' 0 C--N 1.374 1.67 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 166.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 140.27 -17.88 2.9 Favored Glycine 0 C--N 1.376 2.753 0 N-CA-C 119.408 2.523 . . . . 0.0 119.408 166.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -71.47 140.96 85.01 Favored Pre-proline 0 C--O 1.272 2.243 0 CA-C-N 119.904 1.852 . . . . 0.0 111.4 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.66 136.5 0.66 Allowed 'Trans proline' 0 C--N 1.378 2.113 1 C-N-CA 125.358 4.039 . . . . 0.0 117.412 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -55.61 155.64 20.9 Favored 'Trans proline' 0 CA--C 1.565 2.031 0 C-N-CA 122.862 2.375 . . . . 0.0 112.106 173.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 tp -79.92 -14.7 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 122.455 1.121 . . . . 0.0 113.821 -172.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . 0.303 2.3 m -15.71 -61.61 0.04 OUTLIER Pre-proline 0 C--O 1.248 1.001 1 N-CA-C 122.254 4.168 . . . . 0.0 122.254 169.254 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -48.82 -45.36 28.61 Favored 'Trans proline' 0 C--N 1.29 -2.532 0 C-N-CA 124.207 3.271 . . . . 0.0 115.887 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . 0.255 8.4 pt -106.98 12.82 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 117.531 -3.23 . . . . 0.0 111.415 -162.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -62.96 140.19 58.83 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 166.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.92 137.84 39.67 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 120.62 -1.3 . . . . 0.0 108.082 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 124' ' ' TYR . 43.5 mtpt -58.49 156.23 10.82 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 116.709 2.115 . . . . 0.0 116.709 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -108.53 -165.25 20.95 Favored Glycine 0 CA--C 1.563 3.057 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.8 t -110.19 116.99 32.5 Favored 'General case' 0 C--N 1.388 2.254 0 CA-C-O 116.383 -1.77 . . . . 0.0 108.747 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.16 55.61 2.73 Favored Glycine 0 C--N 1.388 3.439 0 C-N-CA 127.122 2.296 . . . . 0.0 115.988 -162.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.65 -161.84 11.84 Favored Glycine 0 CA--C 1.455 -3.666 0 N-CA-C 119.08 2.392 . . . . 0.0 119.08 -164.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 67.44 -175.27 25.92 Favored Glycine 0 C--N 1.365 2.157 0 N-CA-C 119.223 2.449 . . . . 0.0 119.223 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 118' ' ' LYS . 96.3 m-85 -127.59 163.81 23.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.0 mm -61.99 120.5 8.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.92 0 O-C-N 126.559 2.412 . . . . 0.0 108.881 166.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.7 t -62.12 154.83 25.95 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.1 mt -102.43 10.3 39.09 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 124.602 2.144 . . . . 0.0 115.223 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.51 -40.2 86.54 Favored Glycine 0 N--CA 1.486 2.011 0 O-C-N 117.393 -3.317 . . . . 0.0 118.548 -165.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.36 -42.57 96.14 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-O 125.174 2.416 . . . . 0.0 106.614 168.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.45 -38.99 88.59 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 118.437 -2.664 . . . . 0.0 110.267 -174.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . 0.314 8.4 tt -63.26 -53.08 58.54 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.261 1.424 . . . . 0.0 113.96 175.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 89.2 p -69.77 -30.26 67.79 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 122.145 0.974 . . . . 0.0 110.935 -171.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.419 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 9.4 m -67.82 -40.0 83.87 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 171.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 96.0 m -50.01 -48.68 52.43 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.587 1.955 . . . . 0.0 113.32 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 39.2 mt -67.13 -37.11 83.29 Favored 'General case' 0 N--CA 1.389 -3.521 0 O-C-N 127.635 3.085 . . . . 0.0 114.96 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -61.68 -48.44 80.79 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 121.9 2.136 . . . . 0.0 113.875 157.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.424 ' CD1' HD13 ' A' ' 62' ' ' ILE . 90.1 mt -60.13 -42.38 94.69 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 117.24 -1.362 . . . . 0.0 114.198 -176.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . 0.272 15.6 p -92.67 9.11 36.28 Favored 'General case' 0 C--N 1.38 1.927 0 N-CA-C 118.18 2.659 . . . . 0.0 118.18 173.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.529 0 CA-C-O 114.53 -3.372 . . . . 0.0 116.963 -175.908 . . . . . . . . 0 0 . 1 stop_ save_